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Abstract  
This work is focused on the recognition of natural lipopolysaccharide (LPS) by the 
innate immune protein human lung surfactant protein D (hSP-D) in the form of a 
biologically active recombinant fragment (rfhSP-D), containing the α-helical coiled-coil and 
three carbohydrate recognition domains (CRD). Intact LPS from two bacterial strains, S. 
minnesota (R5 mutant) and H. influenzae type b Eagan (CA7 mutant), were delipidated by 
means of mild acid hydrolysis, leaving the purified polysaccharide (PS) to be used in X-ray 
diffraction studies by means of co-crystallisation with rfhSP-D. S. minnesota R7 full LPS 
was also investigated following development of a suitable solubilisation method which also 
utilised the LPS from E. coli O111:B4. 
The structural studies of rfhSP-D bound to H. influenzae Eagan CA7 PS (solved 
and refined at 2.98 Å) and to S. minnesota rough mutant LPS/PS (solved and refined at 
3.3 Å) reveal that rfhSP-D binds to LPS preferentially through the non-terminal inner core 
heptose HepI via the O6’ and O7’ hydroxyls. rfhSP-D recognition of S. minnesota HepI 
shows a similar bound heptose orientation to that previously reported for heptose binding 
by rfhSP-D in the literature with an indication of normal Kdo in the inner core Kdo-Hep-
Hep trisaccharide.  
rfhSP-D recognition of the HepI of H. influenzae Eagan CA7 reveals a novel bound 
heptose orientation, with the heptose rotated by 180° about C5-C6, resulting in the O6’ 
and O7’ hydroxyls being interchanged with respect to coordination to Ca1 and protein. 
The novel orientation of HepI is accompanied by a salt bridge being formed between the 
flanking residue Arg343 and Glu347, both of which adopt a previously unseen 
conformation. The novel binding mechanism of rfhSP-D for Eagan CA7 suggests flexibility 
in recognition and offers evidence to explain why this mutant binds more weakly than the 
Eagan 4A mutant to both rfhSP-D and hSP-D.
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Chapter 1 - Introduction 
1.1 The human lung and the immune system  
The immune system in vertebrates is composed of two distinct mechanisms that 
work together, with the aim of eliminating pathogens and particles. The innate immune 
system is the first line of defence, with non-specific properties common to most species, 
leading to the response to pathogens and particles in a non-specific manner. The 
adaptive immune system is based on an immunological memory after an initial response 
to a specific pathogen, leading to an enhanced response to subsequent encounters with 
that specific pathogen. 
The manner in which the host’s immune system destroys and clears both 
commensal and pathogenic microbes in the lung is mediated by various different 
components of the innate and adaptive immune system. The clearance of foreign 
pathogens and particles occurs through an adequate immune response, with the aim of 
minimising inflammation and maintaining normal lung homeostasis.  
 Innate Immunity in the lung 
The innate immune system acts as the first line of defence and includes a variety 
of secreted molecules and physical barriers, with the aim of protecting the host while 
maintaining normal lung physiology. Anatomically the lung can be divided into two sub-
structures; the conducting airway, which includes the trachea, bronchi and bronchioles, 
and the peripheral airway, consisting of the alveoli. Both of these sub-structures operate 
distinct roles in the innate immune defence of the lung, with various different cells 
presented in the epithelium layer. 
The conducting airway epithelium has been reported to be mostly decorated with 
ciliated cells and secretory cells such as serous, club cells (also known as clara or 
nonciliated bronchoalveolar cells) and globet cells. Underneath the variety of cells lining 
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the epithelium, submucosal glands line the inner layer of the epithelium. The various cells 
present in the conducting airway and the submucosal glands work together in secreting 
host-defence proteins onto the airway surface, in response to environmental stimuli. A 
variety of defence molecules can be secreted including β-defensins, lysozyme, lactoferrin, 
cathelicidin LL37 and surfactant protein A and D (SP-A and SP-D, respectively), leading to 
aggregation, trapping and destruction of microbes and particles (Whitsett & Alenghat, 
2015).  
In the peripheral airway, only two types of cell line the epithelium; squamous type I 
alveolar cells, covering 90% of the surface of the alveolar surface, and cuboidal type II 
epithelial cells, important in the production of surfactant lipids and proteins and crucial in 
preventing atelectasis (lung collapse) (Whitsett & Alenghat, 2015).  
The innate immune system not only has the ability to recognise microbial 
infections and elicit immediate defence, but also has the ability to generate long lasting 
adaptive immunity. The innate immune system relies on recognising common structural 
and functional features, which are associated with different classes of microorganisms, 
and determining the type of infection encountered, impacting and instructing the 
lymphocytes into inducing an appropriate class of immune response (Iwasaki & 
Medzhitov, 2015). 
 Primary antimicrobial defences in the alveolar lining layer  
The mucus and alveolar lining layer is composed of a variety of different immune 
molecules, including alveolar macrophages, lysozymes, defensins and cathelicidin. 
Defensins belong to a large family of antimicrobial peptides, divided into β and α 
defensins, with α-defensins expressed in neutrophils, while β-defensins are widely 
expressed in epithelia cells. Both of these contain a broad spectrum of activity, with the 
ability to recognise bacteria, fungi and viruses, and to recruit inflammatory cells, promoting 
innate and adaptive immune responses. Cathelicidin LL37 is an antimicrobial peptide 
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produced by neutrophils and respiratory epithelial cells, with a similar role to the defensins 
(Tecle et al., 2010). Mucins are glycoproteins with repeating amino acids rich in serine 
and threonine, which can form large oligomeric structures with antimicrobial and anti-
inflammatory properties (Voynow et al., 2009).  Surfactant proteins A and D are pattern 
recognition receptors (PRRs) present in the alveolar lining layer with antimicrobial 
properties, these will be discussed in more detail in 1.3 and 1.4. Surfactant proteins also 
impact on the normal physiology of the lung, and this is discussed in more detail below. If 
pathogens successfully evade the physical epithelial and mucus barriers, PRRs are 
activated by epithelial cells and secreted to the site of “invasion”.   
 PRRs in the lung 
A variety of PRRs have been reported in the human lung and these can be divided 
into two separate subgroups; (1) Signalling PRRs, which include membrane bound and 
cytoplasmic PRRs; (2) Endocytic PRRs, which promote the attachment, engulfment and 
destruction of invading microorganisms, by phagocytosis, with the ability to recognise 
carbohydrates. PRRs are primitive components of the immune system, with a broad 
variety of secreted, cytoplasmic and membrane bound PRRs reported to date. Secreted 
PRRs include collectins, ficolins, pentraxins and complement receptors; membrane bound 
PRRs include Toll-Like-Receptors (TLRs), C-type lectins Group I (Mannose Receptor) and 
Group II (asiaglycoprotein), while cytoplasmic PRRs include NOD-like receptors (NLR) 
and RIG-I-like protein (RLIR).  (Lambrecht & Hammad, 2012; Basset et al., 2003; 
Iwasaki & Medzhitov, 2015). 
The primary role of PRRs is the recognition of pathogen associated molecular 
patterns (PAMPs) and danger associated molecular patterns (DAMPs), present on the 
surface of microbial pathogens and viral nucleic acid (Iwasaki & Medzhitov, 2015; 
Newton & Dixit, 2012), and the activation of phagocytic cells, secretory cells and natural 
killer cells with the effect of the safe elimination of the unwanted cells and pathogens. 
PRRs have the ability to distinguish DAMPs and PAMPs from self-cells (host cells), due to 
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the molecular patterns associated with foreign microorganisms and particles differing from 
the molecular patterns presented by self-cells, in other words by means of cell-surface 
recognition (Jiang & Chess, 2009). 
PAMPs include a variety of microbial structures such as lipopolysaccharides (LPS) 
from gram-negative bacteria, lipoproteins, lipoteichoic acid (LTA) from gram-positive 
bacteria, glucans from fungal cell walls and peptidoglycan found in the bacteria cell wall. 
DAMPs are endogenous molecules, normally found inside cells but which are released 
during necrosis. DAMPs include ATP, cytoplasmic proteins, uric acid, nuclear proteins and 
DNA (Basset et al., 2003; Newton & Dixit, 2012; Iwasaki & Medzhitov, 2015). 
When the PRRs recognise the PAMPs or DAMPs, intracellular or extracellular 
signals inform the host of the presence of infection, triggering pro-inflammatory and 
antimicrobial responses towards the pathogen or particle. This results in either 
agglutination, opsonisation and/or activation of complement and subsequent activation of 
non-specific innate immune cells (Mogensen, 2009; Newton & Dixit, 2012; Iwasaki & 
Medzhitov, 2015). 
 Pulmonary surfactant- important in the lung normal physiology 
Surfactant proteins are important in ensuring a normal lung physiology, acting in 
combination with pulmonary surfactants. Pulmonary surfactants are a mixture of lipids 
(90%) and proteins (10%), where 80% of the lipids are phospholipids, produced by 
alveolar type II cells in the peripheral airway, that work together in lowering the surface 
tension at the air-liquid interface (Ogasawara et al., 1992; Glasser & Mallampalli, 2012). 
The elastic structure of the alveoli and the necessity to dynamically diminish the surface 
tension at the gas-liquid interface at the alveolar surface, presents a biophysical and host 
defence challenge. A failure in one of these dynamic processes, can lead to infection, 
tissue damage, alveolar capillary leakage and potential atelectasis (lung collapse), 
impairing ventilation and the pathogenesis of respiratory distress syndromes in infants and 
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adults. Surfactant deficiency can result in Respiratory Distress Syndrome (RDS), which 
occurs when infants are born prematurely, before their surfactant biosynthetic machinery 
has matured. Treatment with exogenous surfactants replacements has been reported to 
reduce morbidity and mortality (Clark et al., 2010).  
1.1.4.1 Lamellar bodies and tubular myelin  
Following biosynthesis of surfactant proteins and lipids in the alveolar type II cells, 
these are packaged within the lamellar bodies prior to secretion into the alveolar surface 
(Goerke, 1998; O’Reilly et al., 1988). Upon secretion, these lamellar bodies are 
transformed into tubular myelin, which is a mesh like structure, suggested to be a 
precursor of the surfactant monolayer that is present at the air-liquid interface. The tubular 
layer is then absorbed by alveolar surface and compressed, facilitating the reduction in 
surface tension (Barreira et al., 2011). The compression of the tubular layer has been 
suggested to cause the release of surfactant proteins (Goerke, 1998). Surfactant proteins 
and lipids are constantly being recycled, with a vast number of surfactants exchanged 
between in and out of alveolar surface, maintaining a constant surfactant pool size 
(Barreira et al., 2011). 
1.1.4.2 Surfactant Lipids 
Surfactant lipids are composed of approximately 85-90% phospholipids and 10-
15% neutral lipids. Phosphatidylcholine (PC) is the most predominant phospholipid 
accounting for 70-80% of all phospholipids (Haagsman et al., 2008). The most common 
species of PC is termed dipalmitoylphosphatidylcholine (DPPC), which is a saturated 
phospholipid comprising approximately 50% of all phospholipids and with a key role in 
lowering the surface tension. Phosphatidyglycerol (PG) and phosphatidylinositol (PI) 
account for 8-15% of the phospholipid portion, and the remainder is comprised of minor 
phospholipids (Blanco & Perez-Gil, 2007; Picardi et al., 2011). Neutral lipids are 
composed of a variety of different lipids, including cholesterol (30-40%), free fatty acids 
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(25-30%), cholesterol ester (12%), monoglycerides (10-15%), diglycerides (14%) and 
triglycerides (8%) (Markart et al., 2007). 
1.1.4.3 Surfactant Proteins  
To date four surfactant proteins have been reported, SP-A, SP-B, SP-C and SP-D. 
SP-B and SP-C are small hydrophobic proteins, crucial in phospholipid packing, 
organisation of surfactant levels and important in lowering the surface tension in the air-
liquid interface in the lung following expiration. SP-A and SP-D are surfactant proteins that 
belong to the collectin protein family and are important “players” in the host innate 
immunity response, with the ability to recognise a wide variety of pathogens in a calcium 
dependent binding mechanism (Wright, 2005). Pathogen recognition leads to 
agglutination, opsonisation and phagocytosis and complement activation through the 
lectin pathway, towards the clearance of the targets. Transgenic studies into surfactant 
homeostasis have showed that SP-D and SP-A are also important in regulating the levels 
of surfactant lipids and tubular myelin, the normal shape of type II cells and regulation of 
inflammation, highlighting a second role in ensuring and achieving a disease-free lung 
(Korfhagen et al., 1998; Botas et al., 1998). Therefore, it has been suggested that the 
collectins SP-A and SP-D possess the dual role of maintaining a disease-free lung, by 
stimulating the clearance of pathogens, which include a variety of microbes, allergens and 
dying cells, while maintaining an inflammation free mucosal environment (Weis et al., 
1998; Haczku, 2008). 
The experimental work performed in this thesis used a recombinant fragment of 
human SP-D (rfhSP-D) in combination with various ligands, investigated in structural 
studies by means of X-ray crystallography. Structural studies are of considerable 
importance in elucidating the binding mechanisms of SP-D and rfhSP-D towards natural 
ligands such as bacterial lipopolysaccharides (LPS). 
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1.2 Lipopolysaccharides (LPS) 
Bacterial surface lipopolysaccharides (LPS) are an important constituent of the 
outer membrane of gram-negative bacteria and a target ligand for immune system 
defence molecules. LPS has the ability to cause pyrogenic effects on living organisms and 
was initially reported to be an endotoxin by Richard Pfeiter in 1892. Richard Pfeiter 
showed that Vibrio cholerae, which today is known to cause cholera, produced a heat 
stable toxic substance with insoluble properties. Richard Pfeiter postulated that the toxic 
particle was located inside the cell membrane and named it endo (inside- Classical 
Greek)-toxin (Caroff et al., 2002; Alexander & Rietschel, 2001). 
The LPS of different species and phenotypes were used in the experimental work 
presented in this thesis. In this sub-chapter a general overview of lipopolysaccharides 
from Haemophilus influenzae, Escherichia coli and Salmonella enterica (minnesota) 
species, and the LPS type (smooth - long; rough - short), will be given.   
 Bacteria- gram-negative Vs gram-positive  
Bacteria can be divided into gram-negative or gram-positive, which reflect 
structural differences in the cell envelope (Fig. 1.1).  All bacteria species possess a 
cytoplasmic/plasma membrane composed of a phospholipid bilayer, surrounding the 
cytosol and providing a physical barrier for the movement of molecules in and out of the 
cell.  The cell wall of bacteria is composed of peptidoglycan, which is a rigid layer that 
confers shape and osmotic strength to the bacterial cell, enclosing the cytoplasmic 
membrane. The major differences between the two types of cell wall are the difference in 
size and thickness of the peptidoglycan layer, with gram-positive bacteria containing 
around 95% of peptidoglycan in the cell wall, while gram negative contain approximately 
10%; and the number of membranes present, with gram-positive bacteria containing one 
membrane (plasma membrane) and gram-negative containing two membranes (plasma 
membrane and outer membrane). Peptidoglycan in gram-positive bacteria constitutes the 
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outer layer and external portion of the cell wall, acting as an anchor for lipoteichoid acid 
(LTA) (an antigen similar to LPS), while gram-negative bacteria possess an outer 
membrane (OM) that surrounds the thin layer of peptidoglycans and acts as an anchor for 
LPS.    
 Lipopolysaccharide (LPS) - Biological Role 
Lipopolysaccharides (LPS) are major components of the outer membrane of gram-
negative bacteria and contribute to the integrity and stability of the OM. The OM has the 
ability to act as permeability barrier to various different molecules such as detergents, 
antibiotics and toxic dyes and metals, and due to their external location can also 
participate in host-bacterium interactions such as adhesion, colonisation, virulence and 
symbiosis, making it indispensable for the viability of bacterial species. LPS is a strong 
endotoxin with the ability to elicit innate immune responses, playing a crucial role in the 
pathogenesis of gram-negative bacterial infections. LPS has the ability to cause septic 
shock if untreated, with very small quantities (one-nano-gram) of LPS necessary to induce 
Fig. 1.1 A representation of both types of cell wall present in bacteria. The gram-
positive bacteria cell wall is composed of a thick layer of peptidoglycan which the LTAs 
are anchored to. In the gram-negative bacteria cell wall this peptidoglycan layer is 
much thinner, with an outer membrane (OM) surrounding the thin peptidoglycan layer 
and acting as the site of anchoring for the LPS. Image taken from Sigma-Aldrich 
(“Peptidoglycans”). 
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and cause septic shock (Takeuchi & Akira, 2010; De Castro et al., 2010; Kucerka et al., 
2008). LPS is most often anchored into the OM of bacteria, where the Lipid A is 
embedded in the cell membrane, but when the bacteria multiply or die, LPS is released 
into the blood stream and interacts with a variety of immune receptors; lipid A is the main 
inducer of immunological reactions by the host caused by gram-negative bacteria (Raetz 
et al., 1991; Kabanov & Prokhorenko, 2011). Even though LPS has the ability to cause 
damage to the host, it is presented as a pathogen associated molecular pattern (PAMP) 
that can be recognised by the immune system, leading to the opportunity for elimination of 
the pathogen. Since PAMPs (make the bacteria more easily recognisable by host immune 
PRRs), bacteria have evolved different mechanisms that lead to LPS structure 
modification, which can lead to them becoming invisible and unrecognisable by the 
immune system and resistant to other defence components such as complement and 
antibiotics (Wu et al., 2013).  
 LPS common structure  
The LPS common structure consists of a Lipid A composed of β1-6 di-glucosamine 
with an asymmetrical distribution of fatty acids, embedded in the cell membrane and 
acting as a hydrophobic membrane anchor. This is glycosidically linked to the core region 
by 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) (Fig. 1.2). The core is divided into two 
parts, the inner core region and the outer core region. The inner core region links the lipid 
A to the remainder of the LPS, through Kdo.  The Kdo has been shown to be an essential 
sugar for the majority of LPS. The inner core also contains heptose (Hep) residues, which 
are normally substituted by phosphate (P) or phosphoethanolamine (PEA) or 
pyrophosphate ethanolamine (PPEA).  The outer core usually consists of hexoses such 
as D-glucose, D-galactose, D-glucosamine, D-galactosamine or N-acteyl derivatives. 
Finally, O-specific antigen/polysaccharide structures, when present, confer serotype 
specificity to the strain and consist of up to 70 repeating oligosaccharide units formed by 
2-8 monosaccharide moieties, with extremely high structural variability within the bacterial 
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Fig. 1.2 The classification of rough LPS mutants according to their core length into 
chemotypes Ra-Re. Re contains only Kdo, while the Rd1, Rd2 and Rc mutants are 
progressively longer. Rb3 divides the core region into inner core and outer core. The Ra 
mutant contains the longest core region but lacking the O-antigen and rendering it a rough 
LPS; smooth LPS contains the O-antigen. In the figure a typical structure of LPS is given (Ra 
core Salmonella enterica) displaying the linkage between the oligosaccharides in the core 
region and lipid A region. Glc- Glucose; Hep- L-D-Heptose, KDO- 3-deoxy-D-manno-2-
octulosonic acid; Gal- Galactose; GlcNAc - N-acetyl-glucosamine; GalNAc - N-acetyl-
galactosamine; P- Phosphate or Phosphoethanolamine (PEA). Image adapted from Kato, 
1993 and Mansfield & Forsythe, 2001.  
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species. LPS can be divided into two different phenotype categories; smooth, containing 
the O-antigen and rough, which lacks the O-antigen (Brade et al., 1985; Alexander & 
Rietschel, 2001). There is heterogeneity between strains of the same species and 
between different bacteria. Lipid A seems to be highly conserved throughout bacteria 
species. The number of Kdos present can also vary between species, with some different 
LPS containing either 1, 2, or 3 Kdos. The inner core is also very varied across the 
bacterial species, with different strains containing a varied number of heptoses followed 
by a variation in the substitution of those heptoses; some LPS have been reported to 
contain just Kdo (Caroff et al., 2002; Gronow et al., 2009; Cox et al., 2002). 
Rough LPS or rough mutant LPS with varying inner core and outer core chain 
lengths can be classified according to their length into chemotypes Ra-Re, with the Ra 
showing a complete inner and outer core, while Re mutants consist only of Kdo groups. 
See Fig. 1.2 for an illustration of the possible rough LPS variants using a Salmonella 
enterica Ra core LPS.  
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Variations in LPS between species occur in the number of and links between the 
different carbohydrates, with mutations in the biosynthesis often suggested as one of the 
reasons for the diversity seen. In the structures presented in this thesis, three separate 
species of LPS from three different species of bacteria were investigated. Both smooth 
and rough LPS were investigated as potential natural ligands for the structural studies. An 
overview is given below of the three-separate species of bacteria used, highlighting each 
typical LPS structure and its heterogeneous nature.   
 Escherichia coli, Salmonella enterica (serotype minnesota) and 
Haemophilus influenzae  
The LPS from three different bacteria have been investigated as natural ligands for 
rfhSP-D.  Due to E. coli and S. enterica (serotype minnesota) belonging to the same 
family of gram-negative bacteria, denominated Enterobacteriaceae, these will be 
discussed together as some structural features are conserved in this family. H. influenzae 
belongs to the family of Pasteurellaceae bacteria.  
1.2.4.1 Enterobacteriaceae – Escherichia coli and Salmonella enterica 
(serotype minnesota) 
The family Enterobacteriacea is exclusively composed of gram negatives species 
such as Salmonella enterica, Escherichia coli, Shigella dysenteriae, Yersinia pestis, 
Klebsiella pneumoniae and Serratia marcescens. All of the Enterobacteriaceae contain 
LPS, as this gives the bacteria enhanced survival, by providing membrane stability and 
acting as a protection mechanism against antibiotics and bactericidal components of the 
hosts (Holst, 2007).    
The LPS of the Enterobactereacease family share a common LPS architecture 
with limited structural diversity for the core region, but a high structural variation for the O-
antigen (Brade et al., 1985). In the work described in this thesis, both rough and smooth 
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LPS from Escherichia coli and a rough mutant LPS of Salmonella enterica (minnesota) 
were used. 
Escherichia coli is a facultatively anaerobic, rod shaped, gram-negative bacterium. 
E. coli contains the typical gram-negative bacteria LPS present in the outer membrane 
and can cause sepsis/meningitis, urinary tract infections and diarrhoea (food poisoning), 
depending on the pathogenic strain. E. coli is the predominant facultative anaerobe of the 
human colonic flora with mutual benefits for host and coloniser. Some strains have 
acquired specific virulence factors, increasing their ability to adapt to new niches and 
causing a broad range of diseases (Stenutz et al., 2006; Wu et al., 2013). 
Salmonella enterica is a facultatively anaerobic, rod shape, flagellated gram-
negative bacteria, which can be further divided into six subspecies and over 2500 
serovars (Chessa et al., 2014). Salmonella enterica can be divided into thyphoidal and 
non-thyphoidal Salmonella (NTS). The subtype enterica serovar used for the experimental 
work presented here was the NTS serovar minnesota. This type of serovar has been 
reported to be a major cause of gastrointestinal illness, which includes intestinal infection, 
diarrhoea, fever and abdominal cramps, after the consumption of infected food or water 
(Steinebrunner et al., 2013; Eckerle et al., 2010). S. enterica minnesota has been 
reported to have the ability to act as a severe pathogen in immunocompromised hosts, by 
causing septic urinary tract infections (Steinebrunner et al., 2013). 
1.2.4.2 E. coli and S. enterica (minnesota) LPS 
The LPS from E. coli and S. enterica (minnesota) contain a common structure of 
an acylated 1, 4 diphosphorylated β (1→6) linked glucosamine disaccharide (lipid A). The 
lipid A is attached to a fairly conserved Kdo structure, which in turn is attached to a L-
glycero-α-D-manno-heptopyranose (Hep) (Fig. 1.2). S. enterica (minnesota) LPS contains 
three Kdos, while in E. coli two or three Kdos can be present, depending on the core type. 
Phosphate residues are also present, highlighting its role in the outer membrane stability. 
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In E. coli LPS the oligosaccharide core can be subdivided into the inner and outer core, 
with five different core types being reported (R1 - 69.4% of all E. coli species tested, R2- 
11.1%, R3- 11.1%, R4-2.8% and K-12 -5.6%) (Amor et al., 2000; Muller-Loennies et al., 
2003; Muller-Loennies et al., 2002; Vinogradov et al., 1999), that differ in the outer core 
structure. For S. enterica (minnesota) two cores have been reported, the Ra-core type 
and non-Ra core type (Tsang et al., 1991; Olsthoorn et al., 1998). Both species of LPS 
can be divided into smooth, which contains the O-polysaccharides attached to a sugar in 
the outer core, or rough that contains no O-polysaccharide. The rough mutants are 
normally the result of a mutation in the biosynthesis. As shown in Fig. 1.2, rough LPS can 
be divided into Ra, Rb, Rc, Rd and Re, with the Ra containing a complete core, while the 
Re contains a short core, in this case just Kdo groups (Klein et al., 2013; Mansfield & 
Forsythe, 2001; Nnalue, 1999). 
1.2.4.2.1 O-antigen/O-polysaccharide  
The O-antigen is typical of smooth LPS in isolates from Enterobacteriaceae and 
other gram-negative bacteria. These possess a high structural diversity of O-antigens and 
these have been reviewed extensively in the literature. In E. coli over 180 O-
antigens/serotypes forms have been reported, while in S. enterica (minnesota) over 46 
antigens/serotypes have been discovered (Stenutz et al., 2006; Heinrichs et al., 1998; 
Liu et al., 2013). 
Upon the completion of the outer core (Ra mutant), pre-assembled O-antigen can 
ligate the pre-assembled O-antigen to the Lipid A – Core region, through the action of 
various different enzymes that ensure transport and ligation into one complex (Han et al., 
2014).  The O-antigen reveals a large number of possible glycoconjugates making up the 
O-antigen in the Enterobacteriaceae family. The O-antigen is made up of a repeating unit 
composed of 2 to 8 sugar residues, with an n number of possible repeats and specific to 
each sub-species and serotype. S. enterica (minnesota) was shown to have on average 
70 repeat units and E. coli to have on average 27-28 repeat units in the O-antigen 
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(Peterson & McGroarty, 1985), with the ability to present itself as linear, branched or 
double structure, with each sugar residue in either an α or β configuration, Fig.1.2 
displays a typical O-antigen repeat unit of S. enterica. The O-antigens can be divided into 
two major groups: N-acteylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) or 
Gal as the first sugar in the O unit (Liu et al., 2013; Stenutz et al., 2006). Common 
sugars found in the E. coli O-antigen are D-Glc, D-GlcNAc, D-Gal, D-GalNAc, D-Man and 
L-Rha, in both anomeric configurations, while L-FucNAc has only been found in one 
anomeric configuration (Stenutz et al., 2006). For Salmonella, the common sugars found 
in the O-polysaccharide are D-GlcNac, D-GalNac, D-Glc and D-Gal (Fig. 1.2) (Liu et al., 
2013). 
1.2.4.2.2 Biosynthesis of E. coli and S. enterica LPS structure 
E. coli and S. enterica share common mutations in the biosynthesis of their LPS 
structures. The main difference between both species is that in E. coli there is a higher 
variability of possible cores, which in turn means that more genes are expressing for more 
enzymes. This variability can be seen in the variation of the outer core and O-antigen 
region; the inner core region remains fairly conserved within and between both species. 
The fact that Salmonella and E. coli contain similar variations can be attributed to both 
organisms sharing a common ancestor, but also the fact that the core region of the LPS is 
known to be important in the stability of the outer membrane in bacteria cells, so it is not 
expected to contain a high degree of difference across gram-negative bacteria. LPS 
biosynthesis in E. coli and S. enterica have been reviewed and reported in a variety of 
studies (Raetz & Whitefield, 2002; Gronow & Brade, 2001; Brade et al., 1984; Luderitz 
et al., 1967; Klein et al., 2013; Liu et al., 2013; Stenutz et al., 2006).  
1.2.4.2.3 Rough, rough mutant and smooth LPS 
Rough mutant LPS occur when mutations affect the biosynthesis of the LPS, 
inhibiting enzyme activation or addition of glycosyl/heptosyl sugar precursors, leading to 
an incomplete core region without the addition of O-antigen (see Fig. 1.2). Attention is 
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needed when referring to rough mutant LPS and rough LPS. Rough mutant LPS strains 
lack the O-antigen due to a genetic defect, while rough LPS indicates the absence of an 
O-antigen independent of whether this due to a genetic error or not (Gronow & Brade, 
2001; De Castro et al., 2010). This is the case for some non-enteric bacteria such as 
Neisseria, Haemophilus and Chlamydia, which produce only rough type LPS, naturally 
lacking the O-antigen (Cox et al., 2002; Gronow et al., 2009; Schweda et al., 2007). In 
the case of E. coli and Salmonella, rough mutant phenotypes are the result of defects in 
biosynthesis. Both species of bacteria contain genetic similarities in regards to the 
production of LPS mutant cores and have been reported to contain defects in the same 
genes (Parker et al., 1992; Parker et al., 1992a). 
The ability of rough mutants to multiply in vivo suggests that the O-chain is 
dispensable for bacterial survival. However, there are indications that pathogenic 
enterobacteria can only persist and survive if the O-antigen is present, as it protects the 
bacteria against uptake for phagocytosis and the attack of serum complement 
(Vukajlovich, 1986) and provides enhanced bacterial virulence and survival opportunities. 
The O-antigen also offers a vast diversity of glycoconjungates, contributing to a selective 
advantage to adjust to a particular environment by the bacteria (Liu et al., 2013). 
Due to the high heterogeneity, smooth and rough LPS interact with molecules of 
the immune system differently. Rough LPS has been shown to activate a broader 
spectrum of cells with higher potency than smooth LPS. Toll-like receptor 4 (TLR4) 
present in mast cells was reported to be readily activated by rough LPS, while the smooth 
LPS interactions required the activation of the co-receptors lipopolysaccharide binding 
protein (LBP) and cluster of differentiation 14 (CD-14). Tumour necrosis factor alpha 
(TNF-α) has also been shown to have increased expression when rough LPS is detected 
rather than smooth (Huber et al., 2006), with rough mutant LPS being more susceptible 
than smooth to growth inhibition by collectins (Wu et al., 2003). 
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LPS has been suggested to exist in a heterogeneous form where smooth and 
rough are mixed together, with the aim of ensuring rapid adaptation to specific 
environments (Freudenberg et al., 2008). This ability to change between smooth (S) and 
rough (R) has been reported to occur in Enterobacteriaceae species (McCallum et al., 
1989; Walsh & Moran, 1997). The variation of the O-antigen has been suggested to offer 
bacteria selective advantage to specific environments. One interesting fact to consider is 
that some species of bacteria have been reported to lose the O-antigen when cultured in 
laboratories, by “self-inflicting” or controlling mutations in the biosynthesis or transfers. 
This suggests that the bacteria have the ability to adapt to different environments, by 
modulation of LPS composition and that the O-antigen is only required to be present in a 
natural environment (Reeves, 1995). This mechanism remains mostly unexplored. 
1.2.4.3 Pasteurellaceae – Haemophilus influenzae 
Haemophilus influenzae is a coccobacillus and facultatively anaerobic gram-
negative bacteria, belonging to the Pasteurellaceae family.  H. influenzae is divided into 
typeable and nontypeable strains, depending on the presence of a polysaccharide 
capsule. The typeable strains containing capsules are classified into six serotypes (a to f). 
Nonencapsulated forms are referred as nontypeable H. influenzae (NTHi) (King, 2012). 
NTHi strains are known to be the main pathogens in otitis media and acute and 
chronic lower respiratory tract infections (Schweda et al., 2007). In terms of typeable 
strains, H. influenzae type b is the most prominent typeable form. Type b capsular strains 
are associated with invasive bacteraemia diseases, such as meningitis, epiglottitis, 
cellulitis and pneumonia (King, 2012). 
The capsule of the typeable form of H. influenzae has been the focus of extensive 
research in order to produce vaccines against it. Glycoconjugates based on the capsular 
polysaccharide structure of H. influenzae type b have been developed and are available 
commercially (Hib vaccine), and these have proved to be successful against H. influenzae 
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type b by acting as prophylactic treatment and reducing morbidity in children 
("Haemophilus Influenzae Type B (Hib) - NHS Choices"). The Hib vaccine uses a 
capsular polysaccharide antigen, which incorporates a synthetic bactericidal carbohydrate 
antigen mimicking the effect of the type b H. influenzae (Verez-Bencomo et al., 2004). 
These vaccines are only effective against the type b capsular H. influenzae due to their 
specificity, having no effect on the other typeable serotypes or NTHi strains (Schweda et 
al., 2007). 
1.2.4.3.1 LPS from Haemophilus influenzae 
Haemophilus influenzae LPS contains a natural rough phenotype, independent of 
any mutations of the biosynthesis, consisting of a short LPS lacking the O-antigen. 
Studies of H. influenzae LPS have identified a conserved glucose-substituted triheptosyl 
inner core moiety; L-α-D-Hep-(1->2)-[PEA ->6]-L- α-D-Hep-(1->3)-[β-D-Glc-(1->4)]-L- α-D-
Hep linked to a lipid A via a Kdo 4-phosphate, where variations can occur from R1, R2, 
R3, R4 and Y as shown in Fig. 1.3 (Schweda et al., 2007), which shows a representation 
of the typical LPS from H. influenzae and its variations. H. influenzae LPS contains only 
one KDO, phosphorylated at position 4, whereas a second Kdo is present for E. coli and 
S. enterica (minnesota). 
LPS from H. influenzae has the characteristic feature of having extensive intra- 
and inter-strain heterogeneity in the glycoform populations, in other words the LPS 
produced by H. influenzae is extremely heterogeneous (Mannerstedt et al., 2008). Many 
oligosaccharide structures have been identified as extensions from the three conserved 
heptoses. One important fact about these varied oligosaccharide structures is the 
resemblance to some human glycolipids (Li et al., 2001). H. influenzae has the ability to 
express epitopes containing the Gal-Gal glycoconjugate, which is elongated from Hep II 
and is believed to be behind the masking of the LPS in the host. This Gal-Gal 
glycocojungate is found in human cells, such as in human glycolipids from the blood group 
Pk antigen, where it acts as a receptor for bacterial ligands (Massoud et al., 2003; 
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Massoud et al.,1997).  H. influenzae LPS seems to have the ability to mimic human 
glycolipids and the ability to reversibly switch off its terminal epitopes in the 
oligosaccharide portion (Li et al., 2001). It is not just the position of the carbohydrates that 
is variable, the location and pattern of non-carbohydrate components, such as phosphate 
substituents, O-acetyl groups and ester linked glycine moieties is also highly variable 
(Schweda et al., 2007). 
 Phosphorylation  
Substitution of phosphate (P), phosphocholine (PCho) or phosphoethanolamine 
(PEA) to either of HepII, HepIII, GlcI and KdoI inner core residues add to the 
heterogeneity of the LPS (Fig. 1.3). The addition of PCho increases the ability of the LPS 
to colonise and persist within the human respiratory tract. PCho mediates bacterial 
adherence to and invasion of hosts epithelia (Weiser & Pan, 1998). However, expression 
of the PCho also makes it easily targeted by human C-reactive protein (CRP). When CRP 
binds PCho it mediates killing via the activation of the complement system (Schweda et 
al., 2007). The biosynthesis of PCho, requires that a choline be acquired from the hosts 
lipids turnover during bacterial colonisation (Clark et al., 2012). The addition of the PCho 
Fig. 1.3 A representation of a typical rough LPS from H. influenzae. The R1 position 
can be further substituted by hydrogen, phosphocholine, D,D-Hep or L,D-Hep; the R2 
position can be further substituted by Glc, Gal or acetyl group; the R3 position can be 
further substituted by Glc; the R4 position can be further substituted by Glc, Gal or 
acetyl group and the Y position can be further substituted by an acetyl group, glycine, 
phosphate (P) or phosphoethanolamine (PEA). Kdo I is substituted at position 4 by 
pyrophosphate ethanolamine (PPEA). Image adapted from Schweda et al., 2007. 
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during colonisation has been shown to reduce binding of antibodies and increase survival 
in the presence of antibody-dependent complement mediated killing. This reduction in 
antibody binding is only present in LPS containing Hep III and phosphorylation of the Kdo 
conserved structures (Clark et al., 2013). In the conserved structure, the Kdo has been 
shown to be substituted at O-4 by pyrophosphate ethanolamine (PPEA), while Hep II is 
substituted at the O-6 position by phosphoethanolamine (PEA). PCho substitution has 
also been shown at O-6 of GlcI in Rd LPS strains, while PCho substitution at O-6 of a 
terminal Gal residue at Hep III has been noted in RM7004 and Eagan strains (Schweda 
et al., 2007). 
 Sialic Acids 
Sialic acids are a common structural feature of H. influenzae LPS, that create 
further heterogeneity in the LPS species. A survey of H. influenzae LPS strains reported 
that one third of the typeable strains and over two thirds of the non-typeable strains 
contained sialic acid in their LPS. In the Neisseria gram-negative bacteria, sialylation has 
been linked with resistance to killing by complement, but reduced ability to enter mucosal 
cells. In H. influenzae LPS the sialylation is believed to help the bacteria resist the killing 
by normal human serum anti-bacterial components, but has no effect on attachment or 
invasion of cultured human cells or neutrophils (Hood et al., 1999). In terms of NTHi 
strains the presence of sialic acid in H. influenzae LPS has been linked with infection in a 
study of experimental otitis media, while in strains deficient in sialic acid the infections 
were reduced or absent (Bouchet et al., 2003). Sialylation of the LPS seems to present 
the bacteria with an advantage through masking with host-like epitopes that could 
potentially interfere with the activation of the classical or alternative pathways of the 
complement mediated response to pathogens (Schweda et al., 2007). The O-acetylation 
of LPS in H. influenzae has been shown to be linked with resistance to killing of the 
bacteria by normal human serum cells. Inactivation of the oaf A gene, which is responsible 
for the addition of the O-acetyl groups in the inner core of the LPS, caused an increased 
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killing of the bacteria when comparing with the wild type containing an active oaf A gene 
(Fox et al., 2005). 
1.3 C-type lectins  
The C-type lectin super family are Ca2+ dependent carbohydrate binding proteins 
that share primary and secondary homology in their carbohydrate recognition domains 
(CRDs). This super family of proteins contains a conserved C-type lectin fold, which is a 
structural reference for all members of the family, independent of their ability to bind 
carbohydrates. C-type lectin members have varied in vivo roles and include collectins, 
selectins and endocytic receptors among others (Cummings & McEver, 1999). In 1993 
Drickamer, introduced a classification of C-type lectins with 7 subgroups (I to VII) 
proposed by using differences in the overall domain architecture (Drickamer et al., 1993). 
Recently, ten extra subgroups have been added (VIII to XVII), and again these were 
based on differences in the structure of the proteins, without any consideration of function 
as in many cases it remains unclear (Zelensky & Gready, 2005). The 17 subgroups are; 
I- Lecticans, II- Asialoglycoprotein and DC receptors, III- collectins, IV- selectins, V- NK- 
cell receptors, VI- Multi-CTLD endocytic receptors, VII- Reg group, VIII- Chondrolectin, 
Layilin, IX- Tetranectin, X- Polycystin, XI- Attractin, XII- Eosinophil major basic protein 
(EMBP), XIII- DGCR2, XIV- Thrombomodulin, XV- Bimlec, XVI- SEEC and XVII 
CBCP/Frem1/QBRICK.   
 C-type lectin domain (CTLD) and the C-type lectin-like domain 
(CTLD*) 
The term C-type lectin was first introduced to distinguish a group of Ca2+ 
dependent lectin animal proteins from the other Ca2+ independent types of animal lectins. 
The binding activity of proteins containing a C-type lectin domain (CTLD) towards 
carbohydrates was initially reported to occur by means of a compact module, the CTLD or 
carbohydrate recognition domain (CRD). When new protein sequences were compared 
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with the CTLD, if they showed a conserved motif characteristic of the CTLD, these 
proteins were grouped into the CTLD subgroups. However, as the number of known 
sequences grew, it became clear that not all proteins containing the CTLD were able to 
bind carbohydrates or even Ca2+, and these CTLD domains were termed C-type lectin-like 
domain (CTLD*).  The conserved CTLD fold seen across many proteins is independent of 
functionality and has been reported to have occurred due to convergent evolution, where 
the 17 subgroups of C-type lectins share structural homology (CTLD fold) but not 
functional homology (Zelensky & Gready, 2005). 
 CTLD / CRD FOLD 
The CTLD fold (universally referred to in collectins as the CRD) is well conserved 
and is present in all C-type lectins super family members, consisting of approximately 
110-140 residues. The first CRD structure solved was that of rat Mannose Binding Protein 
(rMBP), using MAD phasing (Weis et al., 1991). The reported structure of the rMBP CRD 
showed antiparallel β-sheets (β1- β7), two α-helices and four loops, stabilised by four 
cysteine residues (C1-C4), where C1 and C4 linked β7 to α1, while C2 and C3 linked β5 
to β6, forming two disulphide bridges, shown in Fig.1.4. Structurally the CRD can be 
divided into two lobes and a loop region; the lower lobe containing the β1, β2, β3, β7, α1 
and α2, the upper lobe β4, β5, β6 and the long loop region (LLR). The C1-C4 disulphide 
bond helps the stabilisation of the main domain loop, while the C2-C3 disulphide bond 
stabilises the LLR region. Structurally the CRD follows the following pattern; N-terminal - 
β1-β2-α1-β3-α2-β4-L1-L2-L3-L4-β5-β6-β7-C-terminal. The LLR is of special interest for 
this experimental work, as it is involved in the Ca2+ dependent lectin activity of the 
collectins and SP-D (Veldhuizen et al., 2011; Zelensky & Gready, 2003; Hakansson & 
Reid, 2000). 
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1.4 Collectins 
Collectins are a family of Ca2+ dependent binding C-type lectins, and to date nine 
members have been reported, shown in Table 1.1. The family includes mannose binding 
protein (MBP), pulmonary surfactant protein A and D (SP- A and SP-D respectively), 
collectin kidney 1 (CL-K1), collectin liver 1 (CL-L1), collectin placenta 1 (CL-P1) and three 
bovine serum collectins, CL-43, CL-46 and conglutinin (Kishore et al., 2006; van de 
Wetering et al., 2004; Ohtani et al., 2012).   
A B 
Upper lobe 
Lower lobe 
Fig. 1.4 - A- three-dimensional representation of the typical CTLD fold. In this case a 
recombinant fragment of hSP-D, showing the β-strands and α-helices, numbered β1-β7 in 
red and α1-α2, in yellow, with the four reported Ca2+ in SP-D in green. The long loop 
region (LLR) is shown in blue, numbered L1-L4 and finally the disulphide bridges in 
orange C1-C4 and C2-C3. Image generated using PYMOL from PBD code: 1PW9. B- 
Two-dimensional representation of typical CTLD fold, where it shows the typical pattern of 
N-terminus - β1-β2-α1-β3-α2-β4-LLR-β5-β6-β7-C-terminus, present in all C-type lectins, 
with the upper lobe and lower lobe displayed.  Image adapted from Hakansson & Reid, 
2000. 
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Collectin Site of Expression Polypeptide Length Literature reported in: 
Human 
SP-D 
 
Lungs, Mucosal 
surfaces 
375aa (signalling 
peptide 20aa). 
Mature protein 355aa 
Hartshorn et al., 2002 
Kishore et al., 2006 
Human 
SP-A1 and 
SP-A2 
Lungs, Mucosal 
Surfaces 
248aa (signalling 
peptide 20aa). 
Mature protein 
228aa. 
Hartshorn et al., 2002 
Silveyra & Floros, 
2012 
Human 
MBP 
Liver 248aa (signalling 
peptide 20aa). 
Mature protein  
225aa 
Weis & Drickamer, 
1994 
Rat MBP-A Liver, Kidney, Small 
Intestine 
238aa (signalling 
17aa). Mature protein  
221aa 
Weis et al., 1991 
Van de wetering et 
al., 2004 
Rat MBP-
C 
Liver, Kidney, Small 
Intestine 
244aa (Signalling 
peptide 18aa). 
Mature protein 226aa 
Van de wetering et 
al., 2004 
Ng et al., 1996 
Ng et al., 1998 
 Human 
CL-K1 or 
COLEC 11 
Adrenal Glands, 
Kidneys, Liver, Small 
intestines, thymus, 
spinal cord, placenta 
and pancreas 
271aa (signalling 
peptide 25aa) – 
Mature protein 246aa 
Hansen et al., 2010 
Keshi et al., 2006 
Motomura et al., 2008 
Ohtani et al., 2012 
Human 
CL-L1 or 
COLEC 10 
Liver 277aa (signalling 
peptide 27aa). 
Mature protein 250aa 
Ohtani et al., 1999 
Axelgaard et al., 2013 
Human 
CL-P1 
Expressed in most 
tissues, especially 
vascular endothelial 
cells in all murine and 
human heart 
742aa (signalling 
unknown at present, 
so assumed 20aa)- 
Mature protein 722aa 
Ohtani et al., 2001 
Bovine CL-
46 
Thymus and Liver 371aa (signalling 
peptide 20aa). 
Mature protein 351aa 
Dec & Wernicki, 2006 
Hansen et al., 2002 
Bovine CL-
43 
Liver 321aa (signalling 
peptide 20aa). 
Mature protein 301aa 
Hartshorn et al., 2002 
Holmskov et al., 1995 
Dec & Wernicki, 2006 
Hansen et al., 2003 
 
 
Bovine 
Conglutinin 
Liver 371aa (signalling 
peptide 20aa). 
Mature protein 351aa 
Holmskov et al., 1995 
Dec & Wernicki, 2006 
Lim & Holmskov, 
1996 
 
Table 1.1 In total 11 collectins are shown in the above table. The site of 
expression and polypeptide length of each monomer (including signalling 
peptide) is given. Different species often produce more than one single isoform 
of each collectin, such as in Human SP-A and Rat MBP. Human SP-A has been 
reported to exist in two isoforms, SP-A1 and SP-A2, while Rat MBP has also 
been reported to exist as two isoforms, with MBP-A and MBP-C reported.  
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The name collectin derives from the words collagen and lectin (collagen-containing 
C-type lectins), two structural features present in all collectins with all collectins reported 
to date displaying both features. Collectins are known to act as PRRs against PAMPs and 
DAMPs and are a crucial part of the innate immune system. Collectins have the ability to 
recognise different pathogens through the PAMPs present on the surface of bacteria, 
fungi, viruses and allergens. Upon recognition the collectins have the ability to aggregate 
and agglutinate, neutralise, opsonise, activate macrophages and complement receptors, 
effect inflammatory responses and activate the adaptive immune system (Alcorn et al., 
2004; Veldhuizen et al., 2011). 
 Collectins: Function  
1.4.1.1 Mannose-Binding Protein (MBP) 
MBP is a liver derived serum protein, consisting of two forms in rats, rMBP-A 
(serum) and rMBP-C (liver), while in Humans only one type of MBP has been found, often 
referred to as MBL (mannose binding lectin). MBP has been reported to have the ability to 
interact with a variety of pathogens, including gram-positive and gram-negative bacteria, 
yeast, parasites, mycobacteria and viruses. MBP binding preferences have been 
extensively reviewed in Dommett et al., 2006.  
MBP has a variety of immunological roles, such as the activation of the lectin 
pathway, through the activation of MBL-associated serine proteases (MASPs) (Thiel et 
al., 1997). MBP has also been shown to hold a conflicting relationship in ischemic heart 
disease conditions. Studies in Humans have shown that MBP deficiency in ischemic 
diseases could hold beneficial effects such as reduced mortality for patients who suffered 
an acute myocardial infarction and long lasting protection in cerebral ischemia. Patients 
with unstable angina were shown to contain higher levels of MBP, with MBP transfusion to 
patients who suffered a myocardial infarction shown to be fatal (Pagowska-Klimek & 
Cedzynski, 2014). The above information has been disputed by evidence highlighting 
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that high levels of MBP in serum seemed to reduce the risk for myocardial infarction 
(Saevarsdottir et al., 2005). The complete role of MBP in cardiovascular diseases 
remains undefined. MBP protein deficiency has also been reported to increase the risk for 
infections from a neonatal age to adulthood. In neonatal age, MBP has been regarded as 
key for specific protection, until the development of the adaptive immune system 
(Dommett et al., 2006; Strunk et al., 2011). Septic events have also been linked with low 
serum of MBP levels (Auriti et al., 2010), with the suggestion that low serum MBP is a 
susceptible factor for gram-negative neonatal sepsis (Schlapbach et al., 2010).  
1.4.1.2 Surfactant Protein A (SP-A) 
SP-A is a surfactant protein, similar to SP-D (see 1.4.1.5), which has the dual roles 
of aiding in the reduction of surface tension in the lung and acting as a component of the 
innate immune system. SP-A has been reported to interact with a variety of pathogens, 
including gram-positive/negative bacteria, viruses, yeast and fungi and this has been 
reviewed in Kishore et al., 2006. SP-A is often reported to be of clinical importance in the 
pathogenesis of interstitial lung diseases (IDL). IDL are a group of diseases characterised 
by interstitial changes, such as pulmonary alveolar proteinosis (PAP), idiopathic 
pulmonary fibrosis (IPF), asthma and allergy, cystic fibrosis and chronic obstructive 
pulmonary disease (COPD). The IDLs are characterised by raised or lowered SP-A levels, 
suggesting that varied SP-A levels could be cause or consequence of the specific disease 
states (Doyle et al., 1998; Vazquez de lara et al., 2000; McCormack et al., 1991; 
Greene et al., 2002; Wang et al., 2011). 
The way in which SP-A assembles into the biological unit (a trimer) has been the 
focus of extensive discussion, as SP-A has two isoforms SP-A1 and SP-A2 with the ratio 
of the two reported to vary in the trimer. An initial report into to the ratio suggested two 
SP-A1 and one SP-A2 molecules, in a 2:1 ratio (Voss et al., 1991), while recent studies 
into mRNA levels do not support the idea of a 2:1 ratio (Wang et al., 2007). 
Understanding the ratio of SP-A1 and SP-A2 in the trimer is of biological importance, with 
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reports suggesting a link between SP-A1 levels and age and disease state (Tagaram et 
al., 2007); and the fact that SP-A2 has been reported to be more efficient in enhancing 
phagocytosis and in stimulating TNF-α than SP-A1 (Mikerov et al., 2004; Mikerov et al., 
2007; Wang et al., 2000). It is interesting to note that SP-A1 and SP-A2 have been shown 
to hold different affinities for a variety of sugars (Table 1.6) (Oberley & Sneyder, 2003). 
1.4.1.3 Bovine/Cattle Collectins- CL-43, CL-46 and Conglutinin  
Bovine collectins share structural and sequence homology and were initially 
reported to be exclusively present in cattle, with later studies suggesting that this may not 
be the case (Wernicki & Urban-Chmiel, 2011). The bovine collectins CL-43, CL-46 and 
conglutinin share high homology with bovine SP-D, with conglutinin and CL-43 reported to 
have arisen from a duplication of an ancestral SP-D-like gene (Thiel & Takahashi, 2013; 
Lim et al., 1994).  Conglutinin was the first reported collectin, initially reported in 1902 by 
Elrich and Sachs (Sliwa-Dominiak et al., 2010); in 1993 CL-43 was reported in cattle 
(Holmskov et al., 1993) and in 2002 CL-46 was reported (Hansen et al., 2002). The 
bovine collectins differ in their site of expression and their ability to form higher order 
multimers, with the main site of expression for CL-43, CL-46 and conglutinin being the 
liver, but for CL-46 also the thymus, mammary glands and digestive system (Hansen et 
al., 2002; Holmskov et al., 1995).  
The complete biological role of the bovine collectins remains undefined at present, 
as changes in serum concentrations of the collectins can occur due to season, diet and 
infections, making it hard to investigate the specific collectins. Bovine collectins have been 
suggested to be key components of the innate immune system. Conglutinin has been 
reported to interact with a variety of cells and pathogens, including erythrocytes, the 
complement component Cb3, bacterial microbes, such as Listeria monocytogenes, 
Streptococcus pyogenes and Salmonella typhimirium, and IAV (Sliwa-Dominiak et al., 
2010). CL-43 has been reported to interact with IAV, gram-negative bacteria, rotavirus 
Nebraska calf diarrhoea virus and yeast Cryptococcus neoformans (Hartshorn et al., 
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2002; Reading et al., 1998; Schelenz et al., 1995). At present, no studies showcasing 
the CL-46 biological role and the ability to bind to pathogens have been reported, however 
it has been suggested that CL-46 will hold similar properties to the reported CL-43 and 
conglutinin.   
1.4.1.4 Novel Collectins - CL-K1, CL-L1 and CL-P1 
Novel collectins were identified by screening short single read transcript 
sequences with C-terminal sequence homology, with three new collectins identified. CL-
L1 was first reported in 1999 (Ohtani et al., 1999), while CL-P1 was reported in 2001 as a 
new scavenger receptor membrane bound type collectin (type II transmembrane protein) 
present in vascular rich tissues, such as heart and umbilical veins/arterial endothelial cells 
(Ohtani et al., 2001; Ohtani et al., 2012). CL-K1 is the latest reported collectin, present in 
a variety of organs tested (Keshi et al., 2006; Motomura et al., 2008). 
The novel collectins have been suggested to share a biological role with classical 
collectins, by possessing the ability to interact and recognise glycoconjugates. CL-P1 has 
been reported to bind and enhance phagocytosis of gram-positive/negative bacteria and 
yeast. CL-P1 holds similar structural characteristics to the scavenger receptor AI (SR-AI), 
which is known to be expressed in macrophages and to bind to low density lipoproteins 
(LDL), with CL-P1suggested to play a role in innate immunity and the ability to control 
bacteria numbers, yeast and the amount of modified LDLs in vascular spaces (Ohtani et 
al., 2001). It is interesting to note that recent research has suggested that CL-P1 has the 
ability to bind antigens present in human carcinoma cells, preventing tumour metastasis 
(Yoshida et al., 2003); and to be important in Alzheimer disease (AD), with increased 
expression of CL-P1 in AD patients, suggesting that the CL-P1 might be involved in the 
clearance of amyloid molecules (Nakamura et al., 2006). CL-K1 has been reported to 
have similar anti-microbial properties to CL-P1, by binding to both gram-positive/negative 
bacteria and yeast, including LPS from Klebsiella pneumonia, lipoteichoic acid (LTA) of 
Staphylococcus aureus and Streptococcus pyogenes/sanguis and mannan from 
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Saccharomyces cerevisiae (Keshi et al., 2006). The biological role and binding ability of 
CL-L1 remains to be investigated, however it is expected to hold similar properties to the 
novel collectins and the whole collectin family, with the ability to recognise a variety of 
microbial ligands and act as a component of the innate immune system (Axelgaard et al., 
2013; Ohtani et al., 1999).  
It is worth mentioning that a CL-L1:CL-K1 heterotrimer complex has been 
reported, containing one chain of CL-L1 and two polypeptide chains of CL-K1 chains. This 
complex has been shown to interact with mannan-binding lectin (MBL)-associated serine 
proteases (MASPs) 1 and 2, with the ability to activate the complement system through 
C4b (Henriksen et al., 2013). The significance of this complex and if other mixed 
complexes can occur, remains to be investigated. 
1.4.1.5 Surfactant protein D 
Surfactant protein D (SP-D) is a member of the collectin subfamily of C-type lectins 
and is involved in immunologic functions as part of the innate immune system. SP-D is a 
pattern recognition receptor (PRR) and has the ability to interact with carbohydrates 
structures present on the surface of a wide variety of microorganisms targets, such as 
viruses, bacteria, yeasts and fungi (Singh et al., 2003). 
SP-D has been reported to have the ability to interact and increase the clearance 
of pathogens, by mediating different immunological events and interacting with different 
components of host immune system (McCormack & Whitsett, 2002). The way that SP-D 
interacts and recognises pathogens is dependent on the repetitive PAMPs and DAMPs 
displayed on the surface of the microbes or particles, with SP-D holding varying affinities 
for different carbohydrates. The binding of SP-D onto repetitive arrays of carbohydrates 
found on the surfaces of bacteria, viruses, fungi, allergens and nucleic acids, can lead to 
agglutination, enhanced phagocytosis and an oxidative response, with the aim of 
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enhanced killing and clearance by macrophages, neutrophils or the adaptive immune 
system.  
SP-D was initially reported in 1988 in freshly prepared rat alveolar type II cells. 
These type II cells were shown to synthesise various collagenous proteins and one of 
these proteins was initially termed CP4 (SP-D), the second reported soluble surfactant 
protein, after SP-A (Persson et al., 1988).  A second site of production in the lung was 
reported for SP-D in 1992 in non-ciliated bronchial epithelial cells (or clara cells) (Crouch 
et al., 1992). SP-D mRNA and protein have also been detected in other non-pulmonary 
surfaces such as pancreatic ducts, intrahepatic biliary ducts and gall bladder in the 
gastrointestinal tract, the sweat glands and epithelial cells of the skin, parotid and 
lachrymal glands (McCormack & Whitsett, 2002). 
1.4.1.5.1 Agglutination 
The binding of microorganisms by SP-D can lead to direct agglutination or 
neutralisation of the microorganisms, with various reported cases where SP-D 
agglutinates foreign pathogens; SP-D has been reported to have the ability to agglutinate 
Group B streptococcus (GBS) a gram-positive bacterium and H. influenzae gram-negative 
bacterium. This agglutination was calcium dependent (LeVine et al., 2000). Influenza A 
virus (IAV) has also been shown to be agglutinated by SP-D (LeVine et al., 2001). 
The ability of SP-D in instigating agglutination of the intact microbes or particles is 
due to its multimeric structure and the ability to recognise a wide variety of carbohydrates 
present on the surface of the various microbes. The aggregation of the intact microbes 
has been suggested to aid in the mucociliary removal in the respiratory tract, while 
preventing adhesion of pathogens to cell surfaces, microbial colonisation and increased 
phagocytosis (Van de Wetering et al., 2004).  It is interesting to note that agglutination 
can also lead to reduced phagocytosis. Candida albicans is a diploid fungus that was 
shown to be recognised and agglutinated by SP-D, causing a reduction of fungal growth. 
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This study also reported that SP-D inhibited the phagocytosis of Candida albicans by 
alveolar macrophages, suggesting that agglutination and limitation of growth is sufficient 
to impair the Candida albicans fungus (van Rozendaal et al., 2000). A second study also 
reported that aggregation of Pneumocystic carini by SP-D impaired phagocytosis by 
alveolar macrophages, with the authors suggesting that SP-D mediated aggregation could 
aid the organisms in avoiding elimination (Yong et al., 2003). 
1.4.1.5.2 Opsonisation  
SP-D has also been reported to have the ability to act as an opsonin, where it 
decorates the surface of pathogens and necrotic cells and presents them directly to 
alveolar macrophages. SP-D has been reported to bind nucleic acids from disrupted cells, 
both liberated and cell-surface DNA. SP-D was able to bind free DNA and DNA present 
on the surface of apoptotic cells, by forming large complexes with DNA and with the CRD 
being suggested as the main region where the interaction takes place. SP-D (-/-) mice 
showed a high concentration of alveolar macrophages containing degraded DNA. The 
intranasal delivery of a recombinant fragment of SP-D including the CRD resulted in the 
clearance of apoptotic macrophages from the lungs, suggesting that the CRD could be the 
domain necessary to recognise and bind to nucleic acids. SP-D acts as an opsonin when 
bound to the DNA of apoptotic cells, leading to aggregation and phagocytosis (Palaniyar 
et al., 2003; Palaniyar et al., 2004).  
1.4.1.5.3 Phagocytosis 
Even though phagocytosis was showed to be reduced upon agglutination of 
Candida albicans by SP-D (van Rozendaal et al., 2000), various other studies have 
shown the ability of SP-D to promote phagocytosis of apoptotic cells and foreign 
pathogens. SP-D has been described to increase the calcium-dependent neutrophil 
uptake of Escherichia coli, Streptococcus pneumoniae and Staphylococcus aureus. The 
increased uptake was a consequence of mechanisms involving bacterial aggregation and 
the direct action of SP-D on neutrophils (Hartshorn et al., 1998). SP-D has also been 
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reported to enhance the uptake of influenza A virus by neutrophils, which was dependent 
on the viral aggregation and multerisation of the SP-D (Hartshorn et al., 1997). The 
ability to enhance phagocytosis seems to be dependent on the aggregation of the bacteria 
and viruses (Hartshorn et al., 1998), suggesting that SP-D has the ability to alter the 
uptake of foreign pathogens by phagocytes and act as a bridge between neutrophils and 
pathogens, with the aim of promoting clearance.   
It is interesting to note that a previously reported study demonstrated that SP-D 
was an insufficient agonist and did not alter the uptake of gram-negative bacteria by rat 
alveolar macrophages (Pikaar et al., 1995). The contradictory results seen in different 
studies have been suggested to be the consequence of different interactions between SP-
D with macrophages or neutrophils, and the differences in the SP-D multimerisation used 
in the different studies (Hartshorn et al., 1998).   
1.4.1.5.4 Direct Microbial Activity  
SP-D (and SP-A) has been reported to inhibit the proliferation of gram-negative 
bacteria. SP-D was shown to inhibit the growth of E. coli, Klebseilla pneumoniae and 
Enterobacter aerogenes, independent of host defence macrophage action, opsonisation 
and agglutination. This inhibition has been reported to impact on the bacteria cell 
membrane, with an increase of microbial membrane permeability reported. The authors 
suggested that this novel mechanism plays a role in macrophage-independent control of 
gram-negative bacteria in the airspace (Wu et al., 2003). This direct microbial activity has 
also been reported in Candida albicans, where SP-D inhibited phagocytosis of the fungi, 
but inhibited the fungal growth (van Rozendaal et al., 2000). 
1.4.1.5.5 Bacteria and mycobacteria  
SP-D has been reported to be able to interact with both gram-positive and gram-
negative bacteria, and mycobacteria, via its CRD in a calcium dependent manner 
(Haagsman et al., 2008), see Table 1.2. The interaction of SP-D with gram-
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positive/negative bacterial cell walls occurs by means of interaction with the specific 
antigens presented. For gram-positive bacteria, SP-D binds peptidoglycan and lipoteichoic 
acid in a calcium dependent manner via the CRD (van de Wetering et al., 2001). In the 
case of gram-negative bacteria, SP-D binds to the core oligosaccharides or the 
polysaccharides in the O-antigen, both characteristic regions of LPS, with no reported 
interactions with lipid A; it is interesting to note that SP-A has been reported to bind to lipid 
A (Lim et al., 1994; Alcorn et al., 2004). 
Gram Type Species Literature reported in: 
Gram Negative Escherichia coli Lim et al., 1994 
Hartshorn et al., 1998 
Wu et al., 2003 
Haemophilus influenzae Restrepo et al., 1999 
Klebsiella pneumoniae Lim et al., 1994 
Sahly et al., 2002 
Pseudomonas aeruginosa Lim et al., 1994 
Kishore et al., 1996 
Helicobacter pylori Moran et al., 2005 
Chlamydia trachomatis Oberley et al., 2004 
Oberley et al., 2004a 
Chlamydia pneumoniae Oberley et al., 2004a 
Gram Positive Staphylococcus aureus Hartshorn et al., 1998 
Streptococcus pneumoniae Hartshorn et al., 1998 
Bacillus subtilis van de Wetering et al., 2001 
Mycobacteria Mycobacterium tuberculosis Ferguson et al., 1999 
Mycobacterium avium Kudo et al., 2004 
Table 1.2 The reported gram-negative, gram-positive and mycobacteria species 
that SP-D has been reported to interact with. 
 
The ability of SP-D to interact with smooth and rough LPS has been reported to be 
different. SP-D preferentially binds to rough LPS, by recognising the core oligosaccharide 
domain, which is rich in glucose and heptose residues, with an enhanced cellular 
response towards rough LPS reported (Wang et al., 2008; Yamazoe et al., 2008; Kuan 
et al., 1992). In terms of smooth LPS, there is contradictory information in the literature 
regarding the ability of SP-D to directly bind to smooth LPS. The ability to bind smooth 
Chapter 1 Collectins 
33 | P a g e  
 
LPS has been suggested to be dependent on the extent and variation of the O-antigen. 
Following a challenge by smooth or rough LPS, SP-D has the potential to promote a pro-
inflammatory cell response, with the aim of clearing the invading bacterium (Bufler et al., 
2003; Yamazoe et al., 2008; Sahly et al., 2002). One study demonstrated the ability of 
SP-D to interact with rough LPS mutants; SP-D has been shown to have the ability to bind 
rough LPS mutants such as Rc and Rd mutants, but not the Re (shortest rough mutant) or 
Ra (longest rough mutant). This implies that LPS core sugars such as glucose and 
heptose are recognised by SP-D. Affinity binding studies reported that SP-D has a 
preference for heptosyl and glucosyl saccharides, with the affinity towards glucosyl 
disrupted by the addition of heptoses, suggesting a higher affinity for heptosyl saccharides 
(Kuan et al., 1992). Smooth LPS and rough Ra mutant LPS were reported to interact 
weakly with SP-D, with limited agglutination by SP-D towards the LPS. The poor 
interaction between SP-D and smooth and Ra LPS was suggested to be due to the longer 
chains in both types of LPS, where the additional outer core oligosaccharides (for Ra 
mutant + smooth LPS) and the additional polysaccharides (for smooth LPS), mask the 
binding of the inner sites associated with the key oligosaccharides (Kuan et al., 1992).  
1.4.1.5.6 Viruses 
Viruses differ in their infectivity from other pathogens, as they have the 
requirement of needing entry into cells for subsequent replication and survival, leading to 
devastating effects in host cells. SP-D has also been reported to be important in the 
recognition of viruses (Table 1.3). Respiratory syncytial virus (RSV) is a common 
pathology in children with severe morbidity. SP-D has the ability to bind to the 
glycosylated G protein of the RSV, through the CRD, with the loss of viral infectivity 
(Hickling et al., 1999). A case control study reported significant differences between 
infants with RSV and controls, in terms of the allele for the SP-D residue located at 
position 11. In this position two alternative residues were noted, methionine (Met) and 
threonine (Thr), with the Met residue being hydrophobic and the Thr polar. Position 11 in 
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SP-D is situated near the Cys15 and Cys20, crucial in inter-chain disulphide binding and 
the formation of higher order multimers, with enhanced antiviral properties. The authors 
suggested that the prevalence of Met at position 11 in children infected with RSV could 
impact on the formation of disulphide bonds thus halting the formation of higher order 
multimers (Lahti et al., 2002). IAV is normally highly glycosylated for both the 
neuraminidase (NA) and hemagglutinin (HA) protein components of the virus, which SP-D 
can recognise and bind to (Tate et al., 2014). 
 
1.4.1.5.7 Fungi and Parasites 
SP-D has been reported to interact and recognise a variety of yeast and fungus 
(Table 1.4). Pneumocystis carinii, an opportunistic pathogen with the potential of creating 
pathogenesis in immunosuppressed patients, has been reported to be a ligand for SP-D, 
leading to enhanced binding of Pneumocystis carinii to macrophages (O’Riordan et al., 
1995). Candida albicans fungus, a commensal and normal constituent of gut flora, which 
can impact on the health of immunosuppressed patients, has been reported to be 
recognised by SP-D leading to increased agglutination of the microorganisms and 
inhibition of their growth (van Rozendaal et al., 2000). Schistosoma mansoni is a 
multicellular parasite with significant infection in humans. SP-D was reported to bind to the 
Schistosoma mansoni by recognising fucose repeats on the surface of the organism (van 
de Wetering et al., 2004a). 
 
 
Virus Notes Literature reported in: 
Influenza A Virus (IAV) N/A Hartshorn et al., 1994 
LeVine et al., 2001 
Respiratory syncytial virus 
(RSV) 
Binds to RSV G Protein. Hickling et al., 1999 
 
Human immunodeficiency 
virus (HIV) 
Binds to envelope protein gp120, 
inhibiting HIV replication 
Meschi et al., 2005 
Table 1.3 Virus species that SP-D has been reported to interact with. 
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Fungi and Parasite Notes: Reference: 
Pneumocystis carinii N/A O’Riordan et al., 1995 
Yong et al., 2003 
Candida albicans N/A van Rozendaal et al., 
2000 
Aspergillus 
fumigatus 
Can cause an allergic reaction Madan et al., 1997 
Schistosoma 
mansoni 
First study showing that SP-D 
can interact with multicellular 
lung pathogens. 
van de Wetering et al., 
2004a 
Table 1.4 The fungi and parasite species reported to interact with SP-D. 
1.4.1.5.8 Allergens 
Allergens have the ability to induce an allergic reaction and airway inflammation, 
causing the activation of various different components of the immune system such as 
dendritic cells, T helper lymphocytes, IgE – producing B lymphocytes (plasma cells), mast 
cells and eosinophils.  
In the lung, allergens that can induce inflammation are initially dissolved in the 
airway lining fluid before any contact with immune cells. This airway lining is packed with 
surfactant components, including SP-D and SP-A. SP-D has been shown to bind to whole 
mite extracts (Dermatophagoides pteronyssinus) and the purified allergen, leading to the 
inhibition of IgE allergen specific, suggesting a role in modulating allergen sensitisation 
and allergic reactions (Wang et al., 1996). SP-D has also been reported to bind to 
Aspergillus fumigatus, an allergy inducer in humans, enhancing agglutination and binding 
of the microbe to alveolar macrophages and neutrophils, with increased killing of 
Aspergillus fumigatus by phagocytosis and oxidative burst (Madan et al., 1997).  
Upon recognition of allergens and other pathogens, SP-D has the ability to activate 
or inhibit the adaptive immune system. SP-D has been reported to interact with dendritic 
cells and T-lymphocytes, by presenting E. coli to the adaptive immune cells, leading to the 
increased association of dendritic cells around sites of presentation (Brinker et al., 2001). 
SP-D has also been reported to inhibit the proliferation of T-lymphocytes, IL-2 and 
histamine release, with the aim of protecting the lung against collateral immune-mediated 
damage (Borron et al., 1998; Wang et al., 1998). 
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1.4.1.5.9 Necrotic/Apoptotic Cells  
SP-D has been shown to be important in clearing apoptotic cells, with SP-D (-/-) 
mice reported to contain more apoptotic and necrotic cells, with the alveolar macrophages 
reported to contain accumulated and degraded DNA on the surface. Using labelling 
experiments, the authors reported that SP-D bound to normal alveolar macrophages, but 
showed preferential interaction with phagocytes that contained degraded DNA (Palaniyar 
et al., 2003).  
1.4.1.5.10 SP-D and the immune system 
SP-D has been shown to interact with various immune system cells, such as 
macrophages and neutrophils, by means of membrane bound receptors (Miyamura et al., 
1994; Harshorn et al., 1998) and with soluble receptors such as gp-340. Glycoprotein 
340 (gp-340) was the first reported receptor for SP-D and was identified in BALF 
(Bronchoalveolar lavage fluid) of patients with PAP (Holmskov et al., 1997). Gp-340 is a 
soluble opsonin with the ability to stimulate alveolar macrophages (Tino & Wright, 1999). 
Cluster of differentiation 14 (CD-14) is an innate immune protein that can exist in 
membrane bound form (mCD-14) on monocytes, macrophages and neutrophils and as a 
soluble form (sCD-14) released/exocytosed by these cells (Wall et al., 2009). CD-14 has 
the ability to directly bind to smooth and rough LPS. SP-D has been reported to bind to 
CD-14 in a calcium dependent manner, with EDTA (calcium chelating) and mannose 
inhibiting the binding to CD-14. SP-D has been reported to be able to reduce the binding 
of CD-14 to smooth and rough LPS, suggesting the ability to alter the interactions of CD-
14 and LPS (Sano et al., 2000). The ability of SP-D to impact on CD-14 was shown in 
transgenic mice studies, where SP-D (-/-) knockout mice resulted in reduced CD-14 
presentation on alveolar macrophages, causing a reduced uptake of LPS and decreased 
production of TNF- α after LPS stimulation (Senft et al., 2005).  
SP-D has been reported to interact with calreticulin and CD-91 through the 
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collagen region. This interaction generated a pro-inflammatory signalling pathway and 
clearance of PAMPs by phagocytosis (Gardai et al., 2003). When not bound to a PAMP 
or DAMP, SP-D is reported to bind to Signal regulatory protein α SIRPα through the CRD 
region, initiating anti-inflammatory cytokine production (Gardai et al., 2003). 
Leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1), an inhibitory 
immune Ig-superfamily receptor, has been shown to bind to SP-D through the collagen 
region. The binding resulted in inhibition of reactive oxygen species production through 
LAIR-1, by inhibiting the FcαR-induced oxidative burst (Nordkamp et al., 2014).  
SP-D has been reported to bind to the immunoreceptor OSCAR. OSCAR has 
been reported to be present on monocytes, macrophages, neutrophils and dendritic cells 
and has the ability to enhance the pro-inflammatory response in monocytes and promote 
activation of inflammatory cell signalling proteins such as TNF-α. OSCAR was reported to 
bind to SP-D through the long collagen region attached to the CRD, with no binding seen 
when using a shorter recombinant fragment of human SP-D (Barrow et al., 2015).  
The ability of SP-D in enhancing pro or anti-inflammatory signals has been 
suggested to be dependent on the presence or absence of pathogens and the interaction 
with specific receptors. This suggestion seems to be supported by growing evidence in 
the literature; dodecamers of CRDs occur as the structural component of SP-D in the 
normal non-inflammatory lung, ensuring a reduced inflammatory signalling as access to 
the collagen regions is more restricted for pro-inflammatory molecules such as calreticulin, 
CD91 and OSCAR, and where the CRD is available to interact with SIRPα (anti-
inflammatory). When SP-D recognises PAMPs, DAMPs or CD14, the multimers have 
been suggested to dissociate into trimers, with NO suggested as the dissociating factor, 
leading to S-glycosylation of the N-terminal, enhancing the macrophages chemotaxis and 
leaving the collagen region to interact with pro-inflammatory molecules. Once the infection 
has been destroyed, LAIR-1 is suggested to reduce the NO burst, avoiding secondary 
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damage and uncontrolled inflammation (Guo et al., 2008; Leith-Larsen et al., 1999; 
Atochina-Vasserman, 2011). 
1.4.1.5.11 SP-D - Transgenic Studies and Pathogenesis 
Lung collectins have the ability to recognise a variety of pathogens and self-cells 
by binding to various motifs, leading to agglutination/aggregation, opsonisation, 
phagocytosis and the regulated release of inflammatory mediators. Knockout SP-D gene 
studies or transgenic studies of SP-D (-/-) mice have allowed for the understanding of the 
physiological role of SP-D in the normal lung and the impact of reduced SP-D levels in 
disease states. The loss of SP-D in mice has resulted in increased inflammatory response 
and impaired clearance of bacteria, virus, fungal pathogens and apoptotic cell clearance, 
suggesting a crucial role of SP-D in the maintenance of a healthy lung.   
Various studies into the role of SP-D in surfactant homeostasis have been 
performed, where SP-D (-/-) mice demonstrated abnormal type II cells, with increased 
pool sizes of alveolar macrophages and tissue phosphatidylcholine (PC), in comparison to 
the controls. The SP-D (-/-) mouse studies also reported increased numbers of large 
foamy alveolar macrophages, enlarged alveoli, abnormal morphology increased levels of 
surfactant lipids, and decreased tubular myelin, SP-A mRNA and SP-A (Korfhagen et al., 
1998; Botas et al.,1998). The levels of SP-D in the host have been suggested to be the 
crucial element, with a study reporting that mutant mice containing a heterozygous SP-D 
gene, with concentrations of 50% of normal wild-type, reported no signs of phenotype 
abnormality (Botas et al., 1998). The above studies suggest that SP-D is important in 
surfactant homeostasis, impacting on the respiratory process and surface tension 
reduction, if the levels of SP-D are greatly reduced. 
Transgenic studies of SP-D (-/-) have also been important in showcasing the 
important role that SP-D holds in pulmonary health, its contribution towards the normal 
physiology and in the clearance of microbes. SP-D (-/-) mice have been suggested to 
Chapter 1 Collectins 
39 | P a g e  
 
have impaired clearance of microbes and necrotic own cells. SP-D (-/-) mice infected with 
group B Streptococcus and H. influenzae through intratracheal instillation, showed 
increased levels of oxidant production (NO and hydrogen peroxide), pulmonary 
inflammation and reduced uptake of both organisms by alveolar macrophages. There was 
however no difference in the killing of both organisms. The authors suggested that the 
lack of SP-D could impact on the opsonisation and phagocytosis ability towards the 
microorganisms; however, the increased oxidant production contributed towards the killing 
of both organisms (LeVine et al., 2000). SP-D (-/-) mice infected with two strains of IAV, 
showed reduced clearance of one of the strains, while towards the second strain there 
was no difference from the controls. The infection of both strains of IAV in SP-D (-/-) mice, 
showed similar reactions in the mice, with an increased production of pro-inflammatory 
cytokines reported (LeVine et al., 2001). SP-D (-/-) mice have also been shown to have 
reduced clearance of cells with degraded DNA. In the SP-D (-/-) mice the alveolar 
macrophages showed accumulated DNA, suggesting that SP-D has a role in the 
clearance of apoptotic and necrotic own cells (Palaniyar et al., 2003). One interesting 
study using overexpressed SP-D (+/+) mice, reported increased clearance of E. coli K-12 
bacteria (Wu et al., 2003), suggesting that overexpressed SP-D could be beneficial in the 
clearance of microbes.   
As mentioned above, SP-D (-/-) mice have been reported to acquire chronic 
inflammation, emphysema (due to activated macrophages), fibrosis and increased 
oxidative response. SP-D (-/-) mice have been reported to show signs of Pulmonary 
Alveolar Proteinosis (PAP) at three weeks old, with the advancing of the age of the mice 
further progressing the disease state. PAP is a rare lung disease that leads to the 
accumulation of surfactants and larger and foamy alveolar macrophages within the alveoli, 
causing distal air space dilation that interferes with gas exchange (Wert et al., 2000).   
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1.4.1.5.12 Disease - Cause or Consequence of SP-D levels? 
SP-D levels have been investigated in a variety of lung diseases. These studies 
report variations in the level of SP-D, with all clinical conditions studied showing reduced 
levels of SP-D, with the suggestion that SP-D level variation is either the cause or 
consequence of specific clinical conditions. The reduction of SP-D levels to above 50%, is 
suggested to lead to lung morphology changes, with the reduction of the levels to below 
50% potentially halting pulmonary abnormalities (Wert et al., 2000). Reduced levels of 
SP-D have been reported in cystic fibrosis (CF), Chronic Obstructive Pulmonary Disease 
(COPD), smokers, Idiopathic pulmonary Fibrosis (IDF), Interstitial Pneumonia Associated 
with collagen vascular disease (IPCD), PAP and RSV virus infected patients BALF 
(Postle et al., 1999; Honda et al., 1996; Nishikiori et al., 2014; Kerr & Paton et al., 
1999). It remains to be investigated if the reduced levels of SP-D are either a cause or a 
consequence of the diverse pathologies.  
 Collectin structure and sequence  
The basic structural unit for all collectins is the trimer (Fig. 1.5), with most 
collectins sharing similar structural features, including a cysteine rich N-terminus, which 
allows for higher order multimers, by means of the formation of disulphide bonds; a 
collagen rich region domain of varying length and important in interacting with other 
immune receptors; an α-helical neck region, crucial in the trimerisation and orientation of 
the CRDs; and finally the CRD involved in the Ca2+ dependent binding to PAMPs and 
DAMPs. Some collectins have the ability to multimerise into larger structures, composed 
of various trimers attached together. Although collectins share similar structural features, 
differences in tissue expression, the number of cysteines in the N-terminal region, the 
length of the collagen region, the ability to multimerise and the preference of the CRD for 
specific glycoconjungates have been reported (Hartshorn et al., 2002). 
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1.4.2.1 Collectin trimerisation and multimerisation 
Collectins differ in the ability to multimerise, with impact on the binding affinities 
and recognition preferences for specific glycoconjugates. As a monomer, collectins have a 
low affinity for the carbohydrate targets, with the trimerisation into a basic trimer, with 
multiple recognition sites, yielding a stronger binding avidity to target molecules. Higher 
order multimers have been reported to have a higher affinity than lower multimers 
(Holmskov et al., 2003).  The collectins ability to multimerise has been reported to vary 
and this is displayed in Fig. 1.6.   
- SP-D has been reported to produce most often tetrameric cruciform-like structures 
(Fig. 1.6B) (Shrive et al., 2003) where 4 trimers come together, with further 
oligomerization, possible where 8 cruciform like structures combine, yielding over 96 
individual CRDs (12 CRDs x 8 cruciform like structures), denominated “fuzzy balls”. 
Trimers have also been reported (Fig. 1.6D) (Kishore et al., 2006; Crouch, 2000).  
- SP-A has been shown to form a hexamer of trimers, in which 6 trimers associate 
together to yield a molecule resembling a bouquet of flowers (Fig. 1.6C) (Head et al., 
2003; Kishore et al., 2006; Shrive et al., 2003). 
- MBP is reported to be very similar to SP-A, producing a hexamer of trimers, 
resembling a bouquet of flowers (Sheriff et al., 1994; Weis et al., 1991). 
- CL-43, CL-K1 and CL-L1 have been reported to produce only trimers (Fig. 1.6A). CL-
K1 has been reported to produce higher order oligomers in complex formation with 
other plasma protein such as MASP-1/3. (Holmskov et al., 1993; Hansen et al., 
2010; Ohtani et al., 1999; Axelgaard et al., 2013). 
Fig. 1.5 - A schematic representation of the 
collectins structural unit, the trimer. Each trimer 
is composed of three polypeptide monomers 
grouped together (trimerised). Adapted from 
Kishore et al., 2006.   
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- CL-46 and Conglutinin have been reported to share similar structure to SP-D, by 
forming tetramers of four trimers (Hansen et al., 2002; Hansen et al., 2002a). 
- CL-P1 produces membrane bound trimers (Ohtani et al., 2001; Ohtani et al., 2012). 
1.4.2.2 Sequence and structure 
The number of residues in each of the structural regions of selected collectins is 
shown in Table 1.5 and a sequence analysis of selected collectins is given in Fig 1.7. All 
sequences used in the production of the sequence analysis were sourced from the 
National Centre of Biotechnology Information (NCBI - http://www.ncbi.nlm.nih.gov/) with 
the following collectins from Homo sapiens, Rattus norvegicus and Bos taurus included: 
hSP-D (AAB59450.1), rSP-D (AAH70507.1) , bSP-D (CAD69922.1), hSP-A1 
(NP_001158119.1), hSP-A2 (AAI57891.1), bSP-A (AAI23547.1), rSP-A (2202163A), 
rMBP-A (NP_036731.2), rMBP-C (NP_073195.2), bConglutinin (NP_783630.2), hMBP 
(CAA34079.1), bCL-46 (NP_001001856.1), bCL-43 (AAI16148.), hCL-K1 (BAF43301.1), 
hCL-L1(NP_006429.2) and hCL-P1 (BAB72147.1). 
 
1 Trimer 
= 3CRDs 
SP-D, CL-46 
and Conglutinin 
SP-A and MBP 
CL-43, CL-K1 
and CL-L1 A B 
C 
D 
Fig. 1.6 A- The CL-43, CL-K1 and CL-L1 secreted collectins, with no higher 
multimers reported. CL-P1 is also a trimer, however it is membrane bound. B- CL-46, 
Conglutinin and SP-D produce a cruciform like structure, composed of a tetramer of 
trimers. C- SP-A and MBP, resembling a bouquet of flowers, similar to C1q. D- “fuzzy 
balls” produced by 8 SP-D cruciform like structures coming together. A, B, C images 
adapted from Kishore et al., 2006. D image taken from Crouch et al., 2000.  
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Collectin Number of 
Cysteines 
in N-
terminal 
region 
Number of 
Triplets in the 
collagen 
region 
Number of 
residues in the 
Neck region 
Length of 
CRD 
(number of 
residues) 
Literature reported in: 
Human SP-D 
 
2 59 Gly-X-Y 33 119 Hakansson & Reid, 2000 
Zhang et al., 2001 
Hansen & Holmskov, 2002a 
Weis & Drickamer, 1994 
Shrive et al., 2003 
Kishore et al., 2006 
Allen et al., 2001 
Human SP-A1 
and SP-A2 
1-2 23 Gly-X-Y 34 123 Elhalwagi et al., 1997 
Hakansson & Reid, 2000 
Uemura et al., 2006 
Kishore et al., 2006 
Human MBP 3 19 Gly-X-Y 34 113 Hakansson & Reid, 2000 
Sheriff et al., 1994 
Rat MBP-A 3 17 Gly-X-Y 34 114 Wallis & Drickamer, 1999 
Hakansson & Reid, 2000 
Weis & Drickamer, 1994 
Ng et al., 1996 
Rat MBP-C 2 19 Gly-X-Y 36 114 Van de wetering et al., 2004 
Ng et al., 1996 
Ng et al., 1998 
Hakansson & Reid, 2000 
Human CL-K1 
or COLEC 11 
1 24 Gly-X-Y 29 or 34 
(exact number 
unknown) 
122 Ohtani et al., 2012 
Keshi et al., 2006 
Selman & Hansen, 2012 
Human CL-L1 
or COLEC 10 
1 24 Gly-X-Y 37 122 Ohtani et al., 1999 
Hakansson & Reid, 2000 
Axelgaard et al., 2013 
Selman & Hansen, 2012 
Human CL-P1 2 49 Gly-X-Y 17 153 Ohtani et al., 2001 
Bovine CL-46 2 57 Gly-X-Y 28 127 Holmskov et al., 1995 
Hansen & Holmskov, 2002a 
Dec & Wernicki, 2006 
Lim & Holmskov, 1996 
Bovine CL-43 2 38 Gly-X-Y 31 128 Holmskov et al., 1995 
Hakansson & Reid, 2000 
Hansen & Holmskov, 2002a 
Dec & Wernicki, 2006 
Hansen et al., 2003 
Bovine 
Conglutinin 
2 57 Gly-X-Y 28 127 Sliwa-Dominak et al., 2010 
Hakansson & Reid, 2000 
Hansen & Holmskov, 2002a 
Dec & Wernicki, 2006 
Lim & Holmskov, 1996 
Table. 1.5 The data presented above is the culmination of all the current knowledge 
reported in literature, in regards to the composition of the N-terminal, Collagen Region, 
Neck Region and CRD for each of the collectin monomers reported.  
 
A total of 18 conserved residues have been previously reported to exist in the 
CRDs of 22 different extracellular collectins (hSP-D numbering); Lys243 (K), Cys261, 331, 
345 and 353 (C), Pro271 and 322 (P), Asn 277, 316 and 341 (N), Tyr314 (Y), Trp317 and 
340 (W), Glu321 and 329 (E), Gly338 (G), Asp342 (D) and Phe355 (F) (Hansen et al., 
2002; Drickamer,1993). A sequence alignment produced for the purpose of this thesis 
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used 15 (out of the 16 - 1 membrane bound collectin) extracellular secreted collectins 
displaying 19 conserved residues (Fig. 1.7). This differs from the reported 18 conserved 
residues, perhaps due to sequence updates or the discovery of new collectins (Hansen et 
al., 2002; Drickamer, 1993). The results presented here differ from the reported 
sequence analysis, in part due to the authors use of the Human SP-A last three residues 
as CDF, while in the above sequence, the final three residues for either SP-A1 or SP-A2 
are CEF, which is highly conserved in all the extracellular secreted collectins investigated. 
The extra conserved residue reported here is Glu354 (E).  
The only extracellular secreted collectin that does not have the 19 conserved 
residues is CL-K1, which shows variation and only 18 conserved residues, with a 
substitution of Tyr314 (Y) to Phe314 (F) occurring. This substitution does not seem to 
affect its structural features, as Phe contains an ortho hydrogen and Tyr a hydroxyl group 
on the aromatic ring. hCL-P1, the only non-extracellular secreted collectin investigated, 
contains 14 out of the 19 conserved residues; this could be a consequence of CL-P1 
being a membrane bound collectin (type II transmembrane) (Ohtani et al., 2001). 
Collectins can be divided into classical collectins and novel collectins. Novel 
collectins which include hCL-K1, hCL-L1 and hCL-P1 have been reported to have evolved 
separately from the classical collectins, with a weak lectin activity reported, in comparison 
with the classical collectins (Keshi et al., 2006; Ohtani et al., 2012). Classical collectins, 
due to similar evolutionary selection, contain residues that are conserved solely in the 
classical collectins; Gly241, Phe245 Arg272, Glu276, Ala279, Phe304 and Gly309. 
Phe304 is part of the hydrophobic cluster important in holding the CRD region between 
β4, β5, β6 (Fig.1.5) (Hakansson & Reid, 2000).  In humans, two SP-A isoforms have 
been reported, SP-A1 and SP-A2, consisting of up to 10 amino acid differences in both 
sequences, two in the signal sequence, six in the collagen region and two in the neck and 
CRD region (Garcia-Verdugo et al., 2002). 
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hSP-D  181 PGLKGDKGIP GDKGAKGESG LPDVASLRQQ V-EALQGQVQH LQAAFSQYK-K VELFPNGQSV 240 
rSP-D  182 PGLKGDRGAP GDRGIKGESG LPDSAALRQQ M-EALNGKLQR LEAAFSRYK-K AALFPDGQSV 241 
bSP-D  175 PGLKGDRGTP GERGAKGESG LAEVNALRQR V-GILEGQLQR LQNAFSQYK-K AMLFPNGRSV 234 
hSP-A1  54 –GLPGAPGIP GECGEKGEPG ERGPPGLPAH LDEELQATLHD FRHQILQTRGA LSLQGSIMTV 114 
hSP-A2  54 –GLPGAPGVP GERGEKGEAG ERGPPGLPAH LDEELQATLHD FRHQILQTRGA LSLQGSIMTV 114 
bSP-A   59 PGL------P GERGEKGEPG ERGPPGFPAY LDEELQGTLHE IRHQVLQSQGV LRLQGSVLAV 114 
rSP-A   56 PGAPGA---P GERGDKGEPG ERGLPGFPAY LDEELQTELYE IKHQILQTMGV LSLQGSMLSV 114 
rMBP-A  54 -------GAP GSQGPKGQKG DRGDSRAIEV KLANMEAEINT LKSKLELTN-K LHAFSMGKKS 107 
rMBP-C  66 ------KGAT GPKGDRGESV EFDTTNIDLE IA-ALRSELRA M--------RK WVLLSMSENV 112 
hMBP    74 ------KGDP G-KSPDGDSS L--AASERK- ----------A LQTEMARIK-K WLTFSLGKQV 114 
bCL-46 175 PGLKGDRGDP GERGAKGESG LADVNALKQR VTI-LEGQLQR LQNAFSRYK-K AVLFPDGQAV 234 
bCL-43 124 PGLKGDRGDP GEKGARGETS VLEVDTLRQR MRN-LEGEVQR LQNIVTQYR-K AVLFPDGQAV 183 
bCongl 175 PGLKGDRGDP GETGAKGESG LAEVNALKQR VTI-LDGHLRR FQNAFSQYK-K AVLFPDGQAV 234 
hCL-K1  60 –GRHGKIGPI GSKGEKGDSG 78-98-LRKA IGEMDN-QVSQ LTSELKFIK—N A--VAGVRET 129 
hCL-L1  80 -------GIP GEKGKAGT-- VCDCGRYRKF VGQ-LDISIAR LKTSMKFVK-N --VIAGIRET 128 
hCL-P1     ---------- ---------- ---------- ----------- ----------- ---------- 
 
hSP-D  241 GEKIFKTAGF VKPFTEAQLL CTQAGGQLAS PRSAAENAAL Q-QLVVAKNEA AFLSMTDSKT 300 
rSP-D  242 GDKIFRAANS EEPFEDAKEM CRQAGGQLAS PRFATENAAV Q-QLVTAHSKA AFLSMTDVGT 301 
bSP-D  235 GEKIFKTVGS EKTFQDAQQI CTQAGGQLPS PRSGAENEAL T-QLATAQNKA AFLSMSDTRK 294 
hSP-A1 115 GEKVFSSNGQ SITFDAIQEA CARAGGRIAV PRNPEENEAI A-SFVKKYNTY AYVGLTEGPS 174 
hSP-A2 115 GEKVFSSNGQ SITFDAIQEA CARAGGRIAV PRNPEENEAI A-SFVKKYNTY AYVGLTEGPS 174 
bSP-A  115 GEKVFSTNGQ SVNFDAIKEL CARVGGHIAA PRSPEENEAI V-SIVKKYNTY AYLGLVEGPT 174 
rSP-A  115 GDKVFSTNGQ SVNFDTIKEM CTRAGGNIAV PRTPEENEAI A-SIAKKYNNY VYLGMIEDQT 174 
rMBP-A 108 GKKFFVTNHE RMPFSKVKAL CSELRGTVAI PRNAEENKAI Q-E--VAKT-S AFLGITDEVT 164 
rMBP-C 113 GKKYFMSSVR RMPLNRAKAL CSELQGTVAT PRNAEENRAI Q-N--VAK-DV AFLGITDQRT 169 
hMBP   115 GNKFFLTNGE IMTFEKVKAL CVKFQASVAT PRNAAENGAI Q-NLI---KEE AFLGITDEKT 171 
bCL-46 235 GKKIFKTAGA VKSYSDAQQL CREAKGQLAS PRSAAENEAV A-QLVRAKNND AFLSMNDIST 294 
bCL-43 184 GEKIFKTAGA VKSYSDAEQL CREAKGQLAS PRSSAENEAV T-QLVRAKNKH AYLSMNDISK 243 
bCongl 235 GEKIFKTAGA VKSYSDAEQL CREAKGQLAS PRSSAENEAV T-QMVRAQEKN AYLSMNDIST 294 
hCL-K1 130 ESKIYLLVKE EKRYADAQLS CQGRGGTLSM PKDEAANGLM AAYLAQAGLAR VFIGINDLEK 190 
hCL-L1 129 EEKFYYIVQE EKNYRESLTH CRIRGGMLAM PKDEAANTLI ADYVAKSGFFR VFIGVNDLER 189 
hCL-P1 608 ---------- ---FEDAKLF CEDKSSHLVF INTREEQQWI KKQMVGR--ES HWIGLTDSER 653 
 
hSP-D  301 EGKFTYPTGE SL-VYSN-WAP-G EPNDDGGS----ED CVEIFTNGKW NDRACGEKRL VVCEF 355 
rSP-D  302 EGKFTYPTGE AL-VYSN-WAP-G EPNNNGGA----EN CVEIFTNGQW NDKACGEQRL VICEF 356 
bSP-D  295 EGTFIYPTGE PL-VYSN-WAP-Q EPNNDGGS----EN CVEIFPNGKW NDKVCGEQRL VICEF 349 
hSP-A1 175 PGDFRYSDGT PV-NYTN-WYR-G EPAGR-GK----EQ CVEMYTDGQW NDRNCLYSRL TICEF 228 
hSP-A2 175 PGDFRYSDGT PV-NYTN-WYR-G EPAGR-GK----EQ CVEMYTDGQW NDRNCLYSRL TICEF 228 
bSP-A  175 AGDFYYLDGA PV-NYTN-WYP-G EPRGR-GK----EK CVEIYTDGQW NDKNCLQYRL AICEF 228 
rSP-A  175 PGDFHYLDGA SV-NYTN-WYP-G EPRGQ-GK----EK CVEMYTDGTW NDRGCLQYRL AVCEF 228 
rMBP-A 165 EGQFMYVTGG RL-TYSN-WKK-D EPNDHGSG----ED CVTIVDNGLW NDISCQASHT AVCEF 219 
rMBP-C 170 ENVFEDLTGN RV-RYTN-WNE-G EPNNVGSG----EN CVVLLTNGKW NDVPCSDSFL VVCEF 224 
hMBP   172 EGQFVDLTGN RL-TYTN-WNE-G EPNNAGSD----ED CVLLLKNGQW NDVPCSTSHL AVCEF 226 
bCL-46 295 EGKFTYPTGE SL-VYSN-WAS-G EPNNNNAGQP--EN CVQIYREGKW NDVPCSEPLL VICEF 351 
bCL-43 244 EGKFTYPTGG SL-DYSN-WAP-G EPNNRAKDEGP-EN CLEIYSDGNW NDIECREERL VICEF 301 
bCongl 295 EGRFTYPTGE IL-VYSN-WAD-G EPNNSDEGQP--EN CVEIFPDGKW NDVPCSKQLL VICEF 351 
hCL-K1 191 EGAFVYSDHS PMRTF-NKWRS-G EPNNAYDE----ED CVEMVASGGW NDVACHTTMY FMCEF 246 
hCL-L1 190 EGQYMFTDNT PLQNYSN-WNE-G EPSDPYGH----ED CVEMLSSGRW NDTECHLTMY FVCEF 245 
hCL-P1 654 ENEWKWLDGT SPD-YKN-WKA-G QPDNWGHGHGPGED CAGLIYAGQW NDFQCEDVNN FICE- 711 
Fig. 1.7 - Sequence comparison of 16 collectins, 15 extracellular soluble and 1 membrane 
bound (hCL-P1). The sequences were sourced from National Centre of Biotechnology 
Information (NCBI - http://www.ncbi.nlm.nih.gov/) and the sequence analysis was 
performed using blast (NCBI - http://blast.ncbi.nlm.nih.gov/Blast.cgi). Each collectin was 
analysed against other collectins, with 14 out of the 15 extracellular soluble collectins 
containing 19 conserved residues (highlighted in blue), with hCL-K1 containing 18 
conserved residues. The amino acids important in coordinating the Ca1 are shown in 
bold. Highlighted in yellow are conserved amino acids present in the classical collectins. 
CRD Neck Collagen region 
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1.4.2.3 N-terminal region  
The N-terminal region of collectins shows little homology within the collectin family. 
Although there is limited similarity, the conservation of cysteine residues in all collectins 
seems to be a structural feature, with different numbers of cysteines present in each 
collectin N-terminal. Collectins typically contain an N-terminal region of 7-28 residues in 
length and containing 1-3 cysteine residues, see Table 1.5 (Velduizen et al., 2011; 
Crouch et al., 1994; Gupta & Surolia, 2007). Of the 9 collectins reported to date, 8 
contain a typical N-terminus of variable length, with the exception of Human CL-P1, which 
is a type II membrane protein containing an atypical N-terminus. CL-P1 includes an N-
terminal cytoplasmic region (37 residues long), followed by a transmembrane domain (21 
residues long) (Yoshida et al., 2003). 
The number of cysteines present in the N-terminal has been suggested in the 
literature to be important in the ability of collectins to form higher order multimers. One of 
the studies showed that mutations in one of the two cysteine residues within the N-
terminus in hSP-D, to a serine, failed to produce tetramers of trimers (natural assembly of 
SP-D), with only trimers reported. This study also reported that the mutation of cysteine to 
serine caused a phenotype similar to the one reported in SP-D gene knockout mice (SP-D 
(-/-), where emphysema and foamy macrophages developed in models of SP-D (-/-) mice, 
highlighting the importance of the multimerisation of SP-D in lung homeostasis (Zhang et 
al., 2001).   
Two cysteines have been suggested as necessary for the multimerisation of the 
trimers into higher order multimers. This suggestion is supported by the fact that CL-K1 
and CL-L1 contain only one cysteine residue in the N-terminal and seem to occur solely 
as a trimer, with no higher multimers reported to date (Ohtani et al., 1999; Axelgaard et 
al., 2013; Henriksen et al., 2013; Hansen et al., 2010). This does not seem to apply to all 
collectins; CL-43 is secreted as a trimer, despite containing two cysteine residues located 
in the N-terminus in similar positions to those in SP-D, known to produce higher order 
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multimers. The difference between SP-D and CL-43 lies in the collagen region, with CL-43 
containing a smaller collagen region than SP-D, which could impair additional interaction 
between trimers and inhibit the formation of higher order multimers. An example of how 
the collagen region can impact on the ability to produce high order multimers can be seen 
in human SP-A. SP-A exists as two isoforms, SP-A1 and SP-A2, with SP-A1 containing 
an additional cysteine at position 85, allowing for intermolecular disulphide bond formation 
and the creation of larger multimers than SP-A2 (Wang et al., 2007). Therefore, both the 
N-terminal and collagen regions appear to play crucial roles in allowing high order 
multimers to be formed. 
1.4.2.4 Collagen Region 
Collagenous regions are widely distributed in the animal kingdom, with current 
structural information on collagen regions derived from fibre diffraction studies and X-ray 
crystallographic studies (Beck & Brodsky, 1998; Gingras et al., 2011). Collagen 
structures can be recognised by the repetitive triplet of Gly-Xaa-Yaa sequences, where 
Xaa and Yaa can be any amino acid, but frequently include proline (Kishore et al., 2006; 
Haagsman et al., 2008). Collagen is formed by three left-handed helices which form a 
right handed collagen triple helix, which in the collectins is connected to the neck of three 
right handed helices which form a left handed coiled coil (Shrive et al., 2003). The 
collagen triple helix is held by interchain hydrogen bonds, between the amine groups of 
Glycine and carboxylic groups of the X amino acid. The three chains composing the 
collagen region are highly exposed to solvent, making the triple-helical collagen region a 
prime target for interacting with other molecules and for self-association (Kramer et al., 
1999). 
The length of the collagen region varies across the nine reported collectins (see 
Table 1.5), with hSP-D containing the largest collagen domain reported at 177 residues 
long, while the shortest collagen chain reported is 53 residues long in rMBP-A.  
Interruptions in the Gly-X-Y repeat pattern have been reported within the collagen domain 
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of SP-A and MBP, introducing a kink or region of flexibility in the SP-A and MBP trimeric 
stems, which then angle away from the central core, producing the bouquet-like structure, 
similar to C1q (Wallis & Drickamer, 1999; Voss et al., 1988).  
The biological importance of the kink seen in SP-A and MBP remains unknown, 
however mutational studies where two SP-A proteins were constructed without the 
interruption of the Gly-X-Y sequence, showed that the kink seen in SP-A and MBP is 
critical in the formation of the bouquet-like structure. The two SP-A proteins constructed 
were composed of the straight shaped collagenous domains under microscopic 
observation, with no resemblance to the usual bouquet like structure (Uemura et al., 
2006). 
The collagen region holds various biological functionalities, including the ability to 
produce higher order multimers and the ability to interact with immune receptors, yielding 
a pro or anti-inflammatory response. In MBP, the collagen region has been reported to be 
important in the binding of MBP-associated serine proteases (MASPs) and activation of 
the lectin pathway of complement (Thiel et al., 1997; Matsushita et al., 1995). SP-D has 
been reported to interact with various soluble receptors through the collagen region and 
this is discussed in more detail in 1.4.1.5.10. 
1.4.2.5 α-helical neck region 
The α-helical neck region is present in all collectins, consisting of short stretch 17-
37 residues long (see Table 1.5). The neck region has been proposed to be the main site 
where the trimerisation in collectins occurs, leading to the formation of a triple-helical 
parallel-coiled coil, which acts as a linker between the collagen region and the CRD of all 
three monomers (Shrive et al., 2003; Kovacs et al., 2002; Hoppe et al., 1994). 
The crucial role played by the α-helical neck region in the trimerisation of the three 
separate monomers into a trimer has been widely investigated in the literature. A study 
using NMR spectra reported that a fragment of human SP-D, containing 64 residues 
Chapter 1 Collectins 
49 | P a g e  
 
(seven Gly–X-Y repeats of the collagen (7x3=21) + 1 amino acid, the α-helical neck 
domain of 35 amino acids and 7 residues of the CRD), was used in collagenase digestion, 
removing all collagen triplets. The resulting fragment was able to undergo trimerisation, 
suggesting that trimerisation is independent of the collagen region and complete CRD 
(Hoppe et al., 1994). In contrast, studies into rat MBP-A neck + fragment of CRD was 
reported to be unable to form trimers, with the complete CRD region necessary for a 
stable trimer to be formed. Isolation of the CRD (without the neck region) has been 
reported to only produce dimers, with no trimers reported (Weis & Drickamer, 1994). It is 
interesting to note the differences seen in both studies, where the human SP-D isolated 
neck region can form stable trimers, while for rat MBP-A to form stable trimers, the 
complete CRD and neck region is necessary (Hoppe et al., 1994; Weis & Drickamer, 
1994).   
The reasons for these differences in terms of trimerisation properties has been 
suggested to occur due to differences in the length of the complete heptad repeat pattern 
present in the α-helical neck region of each collectin. Heptad repeats are blocks of seven 
residues, termed abcdefg, where a and d are often hydrophobic (non-polar) amino acids 
(often Leu or Ile), that can act as a linker to other protein domains (Thormahlen et al., 
1998). Human SP-D contains four complete heptad repeats (Zhang et al., 2001a; Hoppe 
et al., 1994), while rat MBP-A contains three complete heptads (Weis & Drickamer, 
1994; Kovacs et al., 2002). In SP-D and MBP, the heptad repeat pattern is composed of 
hydrophobic amino acids at a and d, which help to stabilise the neck domain; however, 
the fact that SP-D contains a fourth heptad repeat, means there are additional 
hydrophobic residues in the neck region that interact with the CRD. In SP-D, valine is 
present at position 204, 211 and 218, with Leucine present at position 207, 214 and 221, 
Phenylalanine at position 225 and Tyrosine at position 228, providing the α-helical turns 
prior to the helix termination (Fig. 1.5 and Fig. 1.7) (Zhang et al., 2001a; Kovacs et al., 
2002; Weis & Drickamer, 1994). The α-helical neck region therefore acts as a trimerising 
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linker holding the three CRDs in place, by means of strong hydrophobic forces. In human 
SP-D, the last residue of the neck region is a cis Proline at position 235, which causes a 
change to the fold from a α-helix to a β-strand (Shrive et al., 2003).  
1.4.2.6 Carbohydrate Recognition Domain (CRD) 
All collectins reported to date share a highly conserved carbohydrate recognition 
domain (CRD) and secondary structure homology (Cummings & McEver, 1999). The 
CRDs range between 113-153 residues long (Table 1.5 and Fig. 1.7), with noticeable 
similarities in the conserved binding pocket motifs. The CRD domain is the site where the 
collectins bind to non-self glycoconjugates on the surface of microorganisms in a calcium 
dependent manner, leading to neutralization, aggregation and opsonisation by 
macrophages, in combination with different collectin receptors (Hansen et al., 2002; 
LeVine et al., 2000; Palaniyar et al., 2003; Hartshorn et al., 1997). 
The trimerisation of the neck and CRDs is important in determining the relative 
orientation of the CRDs, thus impacting on antigen/ligand binding and recognition for all 
the collectin CRDs (Kovacs et al., 2002). The structural organisation of some CRDs has 
been reported to vary in different species and two examples of this are; the rat SP-A CRD 
domain produces a “T-shaped” structure, while MBP and SP-D produce a “Y-shaped” 
structure, with larger interdomain angles between the neck and the CRD (Head et al., 
2003). In addition, different species contain different spatial orientation in the CRDs.  The 
rat MBP CRDs are separated by 45 Å from each other, while in human MBP the 
separation is 53 Å (Sheriff et al., 1994; Weis & Drickamer, 1994). Sheriff and colleagues 
postulated that, similar to antibodies, the difference in spatial orientation of the CRDs 
across different species of collectins, could be the cause of differences in binding affinity 
for different antigenic regions (Sheriff et al., 1994). The ranking of collectins binding 
affinities are discussed in 1.4.5.  
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The CRD contains a long loop region (LLR) (Fig. 1.5) of structural and biological 
significance, as it is involved in the Ca2+ dependent carbohydrate binding reported in all 
collectins to date (Veldhuizen et al., 2011). In the LLR region three calcium ions have 
been reported; Ca1, Ca2 and Ca3. Calcium has the ability to make 6, 7 or 8 coordination 
bonds to moieties with partial or complete negative charge (see Fig. 1.8) (Katz et al., 
1996). 
 
In the collectin protein family, 8 coordination interactions have been reported; six 
highly conserved coordination bonds to the binding site residues and two coordination 
bonds with either two water molecules in the ligand-free structure or two hydroxyl groups 
of bound ligand (Shrive et al., 2003; Shrive et al., 2009; Hakansson et al., 1999; Wang 
et al., 2008; Clark et al., 2016). The Ca2+ is important in the recognition of 
glycoconjungates present in PAMPs and DAMPs and was initially denominated in the 
literature as Ca2 or Ca2+ binding site 1. In order to avoid confusion, throughout this thesis 
Ca2+ binding site 1 will be denominated Ca1 (Haagsman et al., 1990; Veldhuizen et al., 
2011). 
Ca1 is directly involved in the binding of carbohydrates and is responsible for the 
Asn341 
Glu321 
Asn323 
Glu329 
Asp342 
H2O 
Ca1 
Coordination bonds 
Fig. 1.8 An illustration of the coordination bonds of Ca1 with 5 coordinating residues 
of the rfhSP-D, including Glu321 (E), Asn323 (N), Glu329 (E,) Asn341(N) and 
Asp342 (2x) (D) and 2 coordination bonds made with 2 water molecules in the 
ligand-free structure or with 2 hydroxyls in the ligand-bound structure. The 
coordination bonds are displayed in pink dashed lines. Figure produced using 
PYMOL.  
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Ca2+ binding dependence seen in collectins. In the binding pocket, Ca1 is coordinated by 
five conserved residues present in the binding pocket of the CRDs of the collectins, and 
using hSP-D numbering these are; Glu321 (E), Asn 323 (N), Glu329 (E), Asn341 (N) and 
Asp342 (D) which makes two interactions with Ca1 (Fig. 1.8) (Shrive et al., 2003; Shrive 
et al., 2009). This produces a highly conserved motif, the EPN/E/WND motif, conserved in 
other collectins and species, such as rSP-D, bSP-D, rMBP-A, rMBP-C, hMBP, bCL-43, 
bCL-46, bConglutinin, hCL-K1, see also 1.4.5.2. 
Three other Ca2+ ions have been reported in the collectins (Ca2, Ca3 and Ca4) 
(Shrive et al., 2003; Sheriff et al., 1994; Weis et al., 1992). Ca1, Ca2 and Ca3 (see Fig. 
1.5) have been suggested to be important in the stability of the CRD. A study by 
Haagsman et al., 1990, using a collagenase-resistant fragment of SP-A, reported a link 
between resistance to proteolysis by both trypsin and chymotrypsin and Ca2+ 
concentrations, with a higher concentration of calcium ions producing a higher percentage 
of SP-A that remained undigested (Haagsman et al., 1990). A second study also 
highlighted the importance of the role of calcium ions in the CRD, where it was reported 
that the removal of Ca2+ affected the core structure of the CRD, with dramatic 
conformational changes in the loops. The absence of Ca2, which mediates the interaction 
between L1 and L4, produced a rigid body movement of L1 and some changes in L4. Ca1 
interacts with residues present in L3 and L4, with the Pro235 residue at the junction of the 
L3 and L4 loops in a cis conformation, locking L3 and L4 into a conformation that 
surrounds Ca1. The removal of Ca1 in MBP leads to the Pro235 residue adopting both the 
cis and trans conformations, with no preference reported, impacting on the structure of L3 
and L4. The trans conformation induces an extension of the loop away from the core of 
the protein, culminating in loss of carbohydrate binding affinity and increased sensitivity to 
proteolysis (Ng et al., 1998). 
Ca4 has been reported to be present in the structural studies of a recombinant 
fragment of human SP-D, where it was observed to occur at the bottom of the funnel 
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formed by the branching of the neck into the three CRDs, with the suggested role of 
perhaps acting as a secondary binding site for extended natural ligands. Ca4 is not 
present in all the structural studies reported, with the number of Ca2+ bound to each CRD 
under physiological conditions unclear at present. Three Ca2+ (Ca1, Ca2 and Ca3) are 
commonly found in X-ray crystal structures, with Ca4 suggested to be present when the 
concentration of Ca2+, in the crystallisation and cryo-protection stages, is 2 mM or above 
(Shrive et al., 2003). 
 Distinction between Self and Non-self 
Collectins have the ability to distinguish between self-cells and non-self-cells. Even 
though collectins have been reported to possess a broad selectivity for various sugars 
(Table 1.6), the presentation of the sugars in microbes and the geometrical arrangement 
of the CRDs have been suggested as the two mechanisms by which the discrimination 
between host cells glycoconjugates and the PAMPs and DAMPs occurs (Weis et al., 
1998). Collectin CRDs selectively bind to carbohydrates such as glucose, mannose, 
heptose and fucose, prevalent on glycolipids and glycoproteins decorating the surface of 
microbes, but not to sialic acid and other common carbohydrates commonly present as 
terminal sugars in host cell surface molecules. Self-cells normally carry widely spaced 
glycoconjungates, to which the CRDs of collectins cannot bind efficiently. The distance 
between each individual CRDs makes self-cells poor ligands for collectins, as these 
distances are often too far apart, making it impossible for more than one CRD within the 
trimer to interact with the self-cells. On the other hand, microbes often present narrowly 
spaced glycoconjungates on their surfaces, ideally positioned for the binding of multiple 
CRDs in the trimer (McCormack & Whitsett, 2002; Weis & Drickamer, 1994).   
 Glycosylation of collectins  
The glycosylation of collectins has been suggested to be an important post-
translational modification, impacting on signalling potential. Glycosylation is a chemical 
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process whereby carbohydrates are attached to proteins, as a consequence of co-
translational and post-translational modifications. Glycosylation can occur by means of 
different attachment mechanisms; N-linked glycans are attached to the nitrogen atom on 
Asn side chains, O-linked glycans are attached to the oxygen of the hydroxyl groups in 
Ser, Thr and Tyr; S-linked glycans are attached to the Sulphur groups of Met and Cys. 
The CRD of rSP-A (rat) and pSP-D (porcine) have been reported to be N-glycosylated 
(Head et al., 2003; van Eijk et al., 2002). CL-46 has been suggested to contain N-
glycosylation in the collagen region, similar to Human SP-D (Hansen et al., 2002; Leith-
Larsen et al., 1999). Human SP-D has been reported to be glycosylated in the collagen 
region and the N-terminal with the collagen region reported to contain both O- and N- 
linked carbohydrates (Leith-Larsen et al., 1999). The N-terminal of hSP-D has also been 
reported, both in in vivo and in vitro, to be S-glycosylated by pulmonary nitric oxide (NO), 
leading to the disruption of the multimer. The NO modifies the cysteine residues in the N-
terminal leading to dissociation into trimers, whereby the N-terminal-NO tail binds to 
calreticulin/CD91 initiating a pro-inflammatory response (Guo et al., 2008; Atochina-
Vasserman, 2011).  
 Sequence, structure and function  
1.4.5.1 Collectin binding affinities  
Collectins possess a broad range of monosaccharide specificity and affinity, with 
structural variations impacting on the ability of each collectin to specifically recognise and 
interact with different glycoconjugates, the ranking of binding affinities for each of the 
collectins are given in Table 1.6. 
The binding affinity of the diverse collectins varies, with the different residues 
present in and around the binding pockets contributing to specificity and affinity towards 
specific carbohydrates, with single and double mutational studies supporting this view. 
Classical collectins have a higher affinity for GlcNAc, ManNAc and Mannose, with the 
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novel collectins showing a higher affinity for L-fucose, GalNac and Mannose. The binding 
affinities of novel collectins have been demonstrated to be reduced in comparison with the 
classical collectins (Hakansson & Reid; 2000; Keshi et al., 2006). 
Carbohydrate binding by SP-D seems to preferentially recognise the α-anomeric 
configuration of carbohydrates that consist of a six-membered ring (five carbons and one 
oxygen) of either glucose or mannose type. The binding specificities and affinities of SP-D 
towards a variety of carbohydrates has been investigated by using ligand binding assays 
and binding competition assays of maltosyl-BSA, mannose and LPS (Table 1.6). SP-D 
Collectin Class Ranking of relative binding 
affinities 
Binding affinity 
established by: 
Literature reported 
in: 
MBP Classical Mannose > GlcNAc > L-
Fucose > ManNAc > Glucose 
ELBA Haurum et al., 1993 
 
SP-A Classical ManNAc >>> L-Fucose, 
Maltose > Glucose > Mannose 
SP-A2 higher affinity than 
SP-A1 for: Mannose, L-
Fucose, GlcNAc and GalNAc 
ELBA. 
Carbohydrate 
binding assay. 
Haurum et al., 1993 
Hansen et al., 2002 
Oberley & Sneyder, 
2003 
Conglutinin Classical GlcNAc >>> Mannose, ManN, 
L-Fucose > Glucose > 
ManNAc, GlcN, Maltose 
ELBA Haurum et al., 1993 
Hansen et al., 2002 
 
CL-46 Classical GlcNAc >>> ManNAc, 
Mannose > αMe-Man > 
Maltose and GlcN 
Competition 
assay GlcNAc-
BSA 
Hansen et al., 2002 
CL-43 Classical Mannose >>> ManNAc > L-
Fucose> GlcNAc > Glucose 
and Maltose >>> Galactose 
>Lactose >>GalNAC 
ELBA Holmskov et al., 
1993 
Hartshorn et al., 
2002 
Hansen et al., 2002 
SP-D Classical L-D-heptose> Maltose and 
Posphatidylinositol (PI) > 
Glucose > ManNac, ManN 
and GluN> D-Fucose and 
GalN > Mannose and D,D-
Heptose >>>Galactose, L-
Fucose and Lactose > GluNAc 
>GalNAc 
Competion 
assay maltosyl-
BSA, mannose 
and LPS. ELISA  
Persson et al., 1990 
Ogasawara et al., 
1992 
 Lim et al., 1994; 
Haczku et al., 2008 
Wang et al., 2008 
Hansen et al., 2002 
CL-K1 Novel L-Fucose > weakly to 
mannose 
Sugar-blot 
method and 
western blot. 
Keshi et al., 2006 
CL-P1 Novel GalNAc > L,D-Fucose and 
Galactose >>> Glucose > 
GlcNAc and Mannose 
Competion 
assay GalNac, 
fucose, 
galactose and 
mannose. 
Yoshida et al., 2003 
CL-L1 Novel Mannose, L-Fucose >> 
ManNAc >>> Glucose and 
GlcNAc 
Sugar-blot 
method and 
western blot. 
Axelgaard et al., 
2013 
Ohtani et al., 1999 
Table 1.6 The ranking of binding affinities for both the classical and novel collectins, >, >> and 
>>> more than 10, 50 and 100% respectively, higher binding than previous saccharide. ELBA - 
Enzyme-linked lectin binding assay, BSA – Bovine serum albumin. 
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shows preferential binding affinity for L-D-heptose> Maltose and Phosphatidylinositol (PI) 
> Glucose > ManNac, ManN and GluN> D-Fucose and GalN > Mannose and D,D-
Heptose >>> Galactose, L-Fucose and Lactose > GlcNAc > GalNAc (Persson et al., 
1990; Ogasawara et al., 1992; Lim et al., 1994; Haczku et al., 2008; Wang et al., 2008). 
1.4.5.2 Ligand binding pocket  
Collectins contain a fairly conserved calcium and ligand binding pocket motif. The 
amino acids important in coordinating the Ca1 are shown in Fig 1.9 with some of these 
residues, in addition to Ca1, also involved in ligand binding. 
The CRD of the collectins contains some structural conservation, with the 
variations reported leading to minimal structural diversity in the binding pocket of the CRD 
region. Even though the variations are often single site substitutions, these can impact on 
the specificity and affinity for different carbohydrates. The impact of these variations, in 
combination with variations in the residues flanking the binding pocket (positions hSP-D 
hSP-D                 320           330       340       350 
                       |             |         |         | 
hSP-D  311 SL-VYSN-WAP-GEPNDDGGS----EDCVEIFTNGKWNDRACGEKRLVVCEF 355 
rSP-D  312 AL-VYSN-WAP-GEPNNNGGA----ENCVEIFTNGQWNDKACGEQRLVICEF 356 
bSP-D  305 PL-VYSN-WAP-QEPNNDGGS----ENCVEIFPNGKWNDKVCGEQRLVICEF 349 
hSP-A1 185 PV-NYTN-WYR-GEPAGR-GK----EQCVEMYTDGQWNDRNCLYSRLTICEF 228 
hSP-A2 185 PV-NYTN-WYR-GEPAGR-GK----EQCVEMYTDGQWNDRNCLYSRLTICEF 228 
bSP-A  185 PV-NYTN-WYP-GEPRGR-GK----EKCVEIYTDGQWNDKNCLQYRLAICEF 228 
rSP-A  185 SV-NYTN-WYP-GEPRGQ-GK----EKCVEMYTDGTWNDRGCLQYRLAVCEF 228 
rMBP-A 175 RL-TYSN-WKK-DEPNDHGSG----EDCVTIVDNGLWNDISCQASHTAVCEF 219 
rMBP-C 180 RV-RYTN-WNE-GEPNNVGSG----ENCVVLLTNGKWNDVPCSDSFLVVCEF 224 
hMBP   182 RL-TYTN-WNE-GEPNNAGSD----EDCVLLLKNGQWNDVPCSTSHLAVCEF 226 
bCL-46 305 SL-VYSN-WAS-GEPNNNNAGQP--ENCVQIYREGKWNDVPCSEPLLVICEF 351 
bCL-43 254 SL-DYSN-WAP-GEPNNRAKDEGP-ENCLEIYSDGNWNDIECREERLVICEF 301 
bCongl 305 IL-VYSN-WAD-GEPNNSDEGQP--ENCVEIFPDGKWNDVPCSKQLLVICEF 351 
hCL-K1 201 PMRTF-NKWRS-GEPNNAYDE----EDCVEMVASGGWNDVACHTTMYFMCEF 246 
hCL-L1 200 PLQNYSN-WNE-GEPSDPYGH----EDCVEMLSSGRWNDTECHLTMYFVCEF 245 
hCL-P1 664 SPD-YKN-WKA-GQPDNWGHGHGPGEDCAGLIYAGQWNDFQCEDVNNFICE- 711 
Fig. 1.9 C-terminal sequences of selected collectins. Residues in the binding pocket 
which also coordinate to Ca1 are in bold and underlined. In light blue, the conserved 
residues of the various collectins analysed is shown. hSP-D, rSP-A, rMBP-A, rMBP-C 
and hMBP represent the only collectins whose structure has been solved.   
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325 and 343) is the main reason why some collectins exhibit a higher affinity for specific 
carbohydrates present on the variety of pathogens.  
Each collectin possesses a broad monosaccharide specificity and in general terms 
collectins can be divided into mannose/glucose type or galactose type (see also 1.3). Two 
motifs have been reported; the EPN/E/WND motif in hSP-D, rSP-D, bSP-D, rMBP-A, 
rMBP-C, hMBP, bCL-43, bCL-46, bConglutinin and hCL-K1 has been shown to have a 
high specificity for mannose, glucose (mannose is a C-2 epimer of glucose) and heptose 
(Zelensky & Gready, 2005; Shrive et al., 2003; Shrive et al., 2009; Wang et al., 2009; 
Clark et al., 2016). In other collectins variation occurs in the EPN tri-residue, especially in 
the Asn (N) residue. hSP-A1 and hSP-A2 contains EPA, bSP-A and rSP-A contains EPR 
and hCL-L1 contains EPS. Understanding the EPX/E/WND motif and its variations is 
crucial in understanding differences in binding affinities. hCL-P1, the only membrane 
bound collectin reported, possesses a QPD/E/WND motif (Table 1.6 and Fig. 1.9). 
SP-A in Humans, rats and bovine show some variation in the EPN tri-residue, 
where the third residue of the motif is substituted by an arginine (EPR) for rat and bovine 
SP-A and an alanine (EPA) for human SP-A (both A1 and A2). The change from EPN to 
either EPR or EPA does not seem to affect the binding affinity for mannose/glucose type 
carbohydrates (Haurum et al., 1993). Single mutational studies have shown that EPN, 
EPR and EPA have similar carbohydrate binding properties; rSP-A Arg (R) was 
substituted by Asn (N) and Ala (A) with no changes in the activity of rSP-A carbohydrate 
binding, type II cell binding, inhibition of surfactant secretion, lipid binding, lipid 
aggregation and lipid uptake by type II cells (Pattanajitvilai et al., 1998). This suggests 
that Asn (N) is not completely essential for the carbohydrate binding specificity towards 
mannose/glucose type carbohydrates, with Ala (A) and Arg (R) efficiently mimicking 
binding properties towards mannose/glucose carbohydrates. 
Human CL-L1 has also been shown to contain a variation in the EPN motif, with 
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the third residue changed from an Asn (N) to a Ser (S), producing an EPS motif. Contrary 
to SP-A (EPA and EPR motifs), this modification has been reported to allow hCL-L1 to 
recognise both mannose/glucose and galactose type sugars. hCL-L1 has been described 
as a “hybrid” collectin, placed between the normal mannose/glucose specific collectins 
and the collectins specific to galactose (Ohtani et al., 1999). It is interesting to note that 
this substitution of Asn (N) to a Ser (S) has also been reported in chicken SP-A 
(Hogenkamp et al., 2006). 
Human CL-P1 is the only collectin reported to date to have high specificity for 
galactose type carbohydrates. This has been suggested to be due to the QPD/E/WND      
(Fig. 1.9) motif and this has been shown in mutational studies, where a mutant of MBP 
containing QPD instead of the typical EPN, exhibited binding specificity changes, with a 
higher affinity towards galactose than mannose type carbohydrates (Drickamer, 1992). 
 Structural studies  
Structural studies of rat MBP, human MBP and rat SP-A have been carried out in 
addition to the large number of structural studies of hSP-D which are detailed elsewhere 
in this thesis. MBP was the first collectin to have its structure solved, with the rat MBP-A 
structure solved using MAD phasing (Weis et al., 1991); and a year later the first structure 
of rat MBP-A CRD complexed with ligand, oligomannose asparaginyl-oligosaccharide 
(Man6GlcNAc2Asn), was reported (Weis et al., 1992). The trimeric human MBP structure 
was reported in 1994 by Sheriff and colleagues, with MBP reported to organise itself into a 
hexamer of trimers (bouquet of flowers) (Sheriff et al., 1994). rSP-A has been 
investigated structurally in two different studies (Head et al., 2003; Shang et al., 2011), 
both in the ligand-free state and in ligand binding studies, see Table 1.7 for key structural 
studies reported to date for rMBP-A, rMBP-C, hMBP and rSP-A and the key findings 
reported. 
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Collectin Ligand-free or 
Ligand-bound  
Key findings and extra information. Literature 
reported in: 
rMBP-A Ligand-free The first reported structural study of collectins. 
Ligand-free dimeric fragment of rMBP-A used.  
Weis et al., 
1991 
Ligand-bound 
oligomannose 
asparaginyl-
oligosaccharide 
(Man6GlcNAc2Asn) 
The first reported ligand binding structural study of 
collectins. Ligand-free dimeric fragment of rMBP-A 
used.  rMBP-A recognises the ligand through the 
CRD and by binding to the equatorial hydroxyls of 
mannose O3’ and O4’.  
Weis et al., 
1992 
Ligand-free Ligand-free trimeric fragment of rMBP-A containing 
the neck-CRD displayed the same structure as the 
dimeric rMBP-A. 
Weis & 
Drickamer, 
1994 
Ligand-bound 
galactose and 
GalNAc 
Trimeric fragment of rMBP-A containing neck-CRD 
used. rMBP-A CRD bound to galactose and 
GalNAc through the O3’ and O4’ equatorial 
hydroxyls. 
Kolatkar & 
Weis, 1996 
Ligands-bound - 
α1-2, α1-3 and 
α1-6 di-mannose.  
Trimeric fragment of rMBP-A containing neck-CRD 
used. rMBP-A CRD bound to the various di-
mannose through the O3’ and O4’ equatorial 
hydroxyls. The orientation of the α1-6 di-mannose 
was reported to differ from the orientation of the α1-
2 and α1-3 di-mannoses, by binding in an 
orientation rotated 180° in regards to the CRD (O3’ 
and O4’ interchanged by 180°). 
Ng et al., 
2002 
rMBP-C  Ligand-bound – 
mannose, fucose 
and GalNAc 
Ligand-free dimeric fragment of rMBP-C used. 
rMBP-C CRD bound to the various ligands through 
the O3’ and O4’ equatorial hydroxyls. The binding 
mechanism of rMBP-C CRD towards mannose, 
fucose and GalNAc differed from the binding 
mechanism of rMPB-A CRD, with the hydroxyls 
rotated by 180° in regards to the CRD (O3’ and O4’ 
interchanged by 180°).  
Ng et al., 
1996 
hMBP Ligand-free  Trimeric fragment of hMBP containing neck-CRD 
used and displayed a similar structure to the 
trimeric fragment of rMBP-A 
Sheriff et al., 
1994 
rSP-A Ligand-free  Trimeric fragment of rSP-A containing neck-CRD 
used. The trimeric fragment of rSP-A was reported 
to be similar to the CRD fold reported for SP-D and 
MBP, with the only difference of the trimeric 
fragment of rSP-A containing a nearly perpendicular 
neck-CRD orientation, with lower interdomain 
angles.  
Head et al., 
2003 
Ligand-bound – 
mannose, α-
methylmannose 
and glycerol  
Trimeric fragment of rSP-A containing neck-CRD 
used. rSP-A CRD bound to mannose and α-
methylmannose through the O3’ and O4’ equatorial 
hydroxyls. Cryo-protectant glycerol molecule was 
also shown to bind at Ca1.  
Shang et al., 
2011.  
Table 1.7 Key structural studies reported to date for rMBP-A, rMBP-C, hMBP and rSP-A and the 
key findings reported for each study. Individual PDB entries given for each study. GalNAc; N-
acetylglucosamine.  
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1.5 Structural studies of Surfactant Protein D (SP-D) 
 Recombinant fragment of human SP-D (rfhSP-D)   
The work presented in this thesis is focused on the structural studies of a 
recombinant trimeric fragment of hSP-D complexed with lipopolysaccharides of gram-
negative bacteria. The trimeric recombinant fragment rfhSP-D has been expressed in E. 
coli and is composed of a short collagen domain, the α-helical coiled-coil neck region 
(residues 203-235) and three CRDs (residues 236-355). rfhSP-D constitutes only a small 
fragment (≈60kDa) of the entire natural tetrameric SP-D, but appears to exhibit similar 
therapeutic and biological activity both in vitro and in vivo as the full hSP-D (Shrive et al., 
2009).  
rfhSP-D in vitro was reported to have the ability to distinguish between human 
eosinophils from healthy donors and allergic patients, leading to increased apoptosis, 
oxidative burst and CD69 expression in allergic eosinophils. An increase of apoptosis of 
allergic eosinophils, without affecting normal eosinophils, was reported, suggesting an SP-
D mediated resolution of allergic-induced eosinophils inflammation (Mahajan et al., 2008). 
Various in vivo studies have investigated the potential of rfhSP-D as a therapeutic agent. 
rfhSP-D has been reported to reduce serum IgE and peripheral blood eosinophilia 
following a challenge by D. pteronyssinus allergen (Strong et al., 2003; Singh et al., 
2003). rfhSP-D was also shown to bind to the RSV virus, inhibiting RSV entry into 
epithelial cells and replication (Hickling et al., 1999). The challenge of Asperigillus 
fumigatus in mice led to an increase of IgE and IgG antibodies, peripheral and pulmonary 
eosinophilia, central bronchiectasis and expectoration in affected hosts, with mice dying 
after 7 days. The intranasal administration of rfhSP-D following the challenge resulted in 
an 80% survival rate, with similar results to AmB, an antifungal drug nephrotoxic (Madan 
et al., 2001). rfhSP-D has also been reported to have prevented endotoxin shock in new-
born lambs challenged with E. coli LPS (Ikegami, 2006). 
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The in vivo and in vitro studies, combined with structural studies, offer evidence for 
the potential of rfhSP-D as a therapy for various lung conditions. Structural studies have 
the advantage of providing information at the molecular level of the recognition and 
binding mechanisms of SP-D and rfhSP-D towards a variety of ligands. A variety of 
structural studies using rfhSP-D have been reported, with simple mono/di/tri saccharides 
as the ligands of choice, as these are characteristic components of SP-Ds’ natural 
ligands. Further structural studies of rfhSP-D with natural ligands (LPS) could provide 
additional knowledge into the recognition of larger and naturally occurring ligands, while 
providing further evidence of the medical potential of rfhSP-D.  
 All the structural studies of rfhSP-D (see Fig 1.10 for the representation of rfhSP-
D) in combination with a variety of mono/di/tri saccharides have enhanced the knowledge 
of the molecular mechanisms of pathogen recognition and binding. Residues which 
coordinate to Ca1 and ligand in known SP-D structures are included in Fig 1.9.  
A B 
Fig. 1.10 – The three-dimensional structure of ligand-free rfhSP-D.  A- a front-view of 
the rfhSP-D trimer with the three subunits forming the trimer, highlighted with different 
colours, with the Ca1, Ca2 and Ca3 shown for each subunit and with the Ca4 sitting in 
the neck-CRD interface. B- A top view of the rfhSP-D trimer with the three subunits 
forming the trimer highlighted with different colours, with the Ca1, Ca2 and Ca3 shown 
for each subunit, and with the Ca4 sitting in the neck-CRD interface. Image generated 
using PYMOL from PDB: 1PW9. 
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The work presented in this thesis is aimed at elucidating the binding mechanisms 
of longer natural ligands such as LPS, to characterise bacterial recognition and binding by 
rfhSP-D following on from previous work performed in our research group. As more 
structural data becomes available, showcasing the characterisation of the binding of 
longer ligands by rfhSP-D, the more evidence is presented for the medical potential of 
rfhSP-D, which may one day be exploited for the benefit of human health  
 Structural Studies of rfhSP-D  
1.5.2.1 Timeline  
Year -  
PDB 
Accession 
Findings and references 
1999 - 
1B08 
1st High resolution X-ray Crystallographic structural study of ligand-free rfhSP-D - 
Hakansson et al., 1999 
2003 - 
1PW9  
1PWB 
2nd structural study of ligand-free rfhSP-D with additional interactions reported. 1st 
reported rfhSP-D ligand-bound structural work with maltose. Binding occurs through 
equatorial hydroxyls O3' and O4' - Shrive et al., 2003   
2006 - 
2GGU 
2GGX 
rfhSP-D ligand-bound structural work with Maltotriose and P-Nitrophenyl Maltoside. 
Suggestion of an extension of ligand binding site to Phe335 - Crouch et al., 2006  
2007 - 
2OS9 
2ORK 
2ORJ 
rfhSP-D ligand-bound structural work with Myoinositol, Inositol-1-phosphate and N-
acetylmannosamine. Mutant rfhSP-D Arg343Lys yielded stronger binding for PI, a 
major surfactant lipid - Crouch et al., 2007    
2008 - 
2RIA 
2RIB 
2RIC 
rfhSP-D ligand-bound structural work with a variety of L-glycero-D-manno-heptoses, 
highly conserved in LPS. New binding mechanism reported, O6' and O7' hydroxyls 
groups - Wang et al., 2008   
2009 - 
3IKR 
3IKQ 
3IKP 
3IKN 
rfhSP-D ligand-bound structural work with mannobiose α1,4 and α1,2; Inositol 
Phosphate and Galactose. - Shrive et al., 2009   
2009 - 
3G83 
3G81 
3G84 
2009- rfhSP-D ligand-bound structural work with mannobiose α1,2 and α- Methyl 
mannoside. Mutant rfhSP-D Arg343Val increased affinity for Mannobiose - Crouch 
et al., 2009  
2013 - 
4M18 
 
rfhSP-D double mutant Asp325Ala and Arg343Val - 1st rfhSP-D (mutant) structural 
study inhibiting viral glycoprotein target - Goh et al., 2013  
2016 - 
4E52 
1st rfhSP-D ligand bound structural work with natural ligand, Haemophilus influenzae 
Eagan 4A PS, through L-glycero-D-manno-heptose, preferential binding over 
available glucose - Clark et al., 2016  
Table 1.8 A timeline of the all the rfhSP-D structural studies using X-ray diffraction and 
deposited in the protein data bank. The different structural studies are organised by date 
of report with key information for each structure given. PDB accession codes are given 
for each structural study published.  
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1.5.2.2 The ligand-free structure of rfhSP-D 
The ligand-free structure of rfhSP-D (Fig 1.11) has been investigated in two 
separate X-ray crystallographic studies. The overall structure of rfhSP-D reveals a trimeric 
assembly with three terminal CRD domains (236-355), spatially separated and linked to a 
α-helical coiled-coil neck region (203-235), where the transition of neck-CRD domain is 
made by the cis Pro235 (Hakansson et al.,1999; Shrive et al., 2003).  Three calcium 
ions (Ca1, Ca2 and Ca3) were first reported (Hakansson et al., 1999), with an additional 
calcium ion (Ca4) located at the trimeric axis of the neck-CRD interface and reported later 
(Shrive et al., 2003). Ca1 is the main site of ligand interaction and is coordinated by five 
fairly conserved residues. These coordinations are the result of six interactions between 
the Ca1 and the side chains of Glu321 (OE1), Asn323 (OD1), Glu329 (OE1), Asn341 
(OD1), Asp342 (OD1) and the main chain carbonyl (O) of Asp342 (using SP-D 
numbering). The protein-Ca1 interaction makes up six of the total of eight interactions of 
Ca1. The final two interactions are completed by two water molecules in the ligand-free 
structure of rfhSP-D (Fig. 1.11B) (Hakansson et al.,1999; Shrive et al., 2003). 
Ca2 is coordinated by the acidic side-chains of Asp297 (OD1), Glu301 (OE1), 
Asp324 (OD1) and Asp330 (OD1), and by a water molecule and the main chain carbonyl 
(O) of Glu329. Ca3 is coordinated by three acidic side chains Glu301 (OE1), Asp330 
(OD1 and OD2) and four water molecules (Fig. 1.11C). Ca2 has been suggested to be 
important in the stability of the CRD domain, as it stabilises the L4 through the interactions 
with the carbonyl (O) of Glu329, reducing any potential flexibility of the side chain and 
maintaining contact with Ca1 (Shrive et al., 2003). Ca2 and Ca3 are located near each 
other and share a coordinating residue, Glu301. Ca3 has been suggested to play a role in 
surface receptor interactions. Docking studies of SP-D suggested that flanking saccharide 
residues in trisaccharides form additional hydrogen bonds with residues outside the CRD 
binding pocket, contributing to the overall binding energy (Allen et al., 2001).  At present 
the full functions of Ca2 and Ca3 remain unknown, however it is interesting to note that 
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the proximity of Ca2 and Ca3 to the binding site Ca1 may allow for secondary ligand-
receptor interactions. Ca4 was reported to be located at the top of the funnel at the 
intersection of the three monomers and is coordinated by three Glu232 and three water 
molecules. The presence of the Ca4 seems to be dependent on the Ca2+ concentration 
present during the crystallisation stages (Shrive et al., 2003).  
1.5.2.3 Ca4 and the asymmetric Tyr228 
In the first reported structural study of rfhSP-D no Ca4 was reported. In this initial 
structure Tyr228 chain C was shown to be asymmetric. Tyr228 is part of the neck region, 
which is made up of eight helical turns before it is terminated by the helix breaker Pro235. 
The neck (coiled-coil) contains some buried residues; Val204, Leu207, Val211, Leu214, 
Val218, Leu221, Tyr228 and Glu232, all hydrophobic except for the Glu232. Glu232 and 
Lys246 (CRD) form long salt bridges in all subunits A (3.5Å), B (3.7Å) and C (2.8Å) 
offering the only intramolecular contact between neck (coiled coil) and CRD (Hakansson 
et al., 1999). 
When the Ca4 is not present in the neck-CRD interface (Fig 1.11D), this causes 
Glu232 in chain B to assume a new conformation by moving towards the centre of the 
funnel and the vicinity of Tyr228 in chain C. Tyr228 in chain C in turn moves deeper into 
the neck, leading to the formation of hydrogen bonds between both residues. Tyr228 
chain C is buried in the coiled-coil neck, while in chains A and B the Tyr is exposed and 
able to hydrogen bond with water molecules. The conformation of Glu232 in chain B in the 
absence of Ca4 differs from the orientation of Glu232 in chains A and C, as these remain 
in place and interact with Lys246 in chains A and C respectively. Lys246 in chain B 
maintains a similar orientation to Lys246 in chains A and C, although it no longer interacts 
with Glu232 in chain B.  
When Ca4 is present at the neck-CRD interface (Fig 1.11C), all three Glu232 
(subunit A, B, C) are in a similar conformation and all interact with Lys246 (subunit A, B, 
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C, respectively) and Ca4, with no interactions with the asymmetric Tyr228 in chain C. The 
conformation of Glu232-Lys246 in the presence of Ca4 is considerably more symmetric in 
comparison to the Ca4 depleted structure (Shrive et al., 2003). Therefore, two alternative 
conformations for Glu232 in chain B are possible and this can be seen in the structures 
represented in Fig 1.11C with Ca4 present and Fig 1.11D without Ca4 present. This 
conformational change does not seem to perturb the geometry of the neck-CRD interface 
(Hakansson et al., 1999; Shrive et al., 2003). 
The central pore where Ca4 sits has been suggested to be a secondary site for the 
binding of long extended natural ligands, such as lipopolysaccharides and phospholipids. 
A study using a rat SP-D neck-region homotrimer (no CRD, just neck coiled-coil) reported 
strong binding towards PI and DPPC (surfactant lipids), with similar binding affinities as 
hSP-D. The authors suggested that the SP-D neck homotrimer (no CRD) hydrophobic 
residues, which are normally buried within the SP-D neck/CRD interface region, but are 
exposed in the SP-D neck homotrimer (no CRD) have the ability to readily bind to 
surfactant lipids. Clearly the exposed neck of the SP-D neck homotrimer (no CRD) region 
does not exist in the biological molecule and therefore no firm conclusions can be drawn 
regarding the importance of these residues in binding surfactant lipids (Kishore et al., 
1996; Shrive et al., 2003).  
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Fig 1.11 A- Ligand-free structure of rfhSP-D shown from the top with Ca1, Ca2, Ca3, 
Ca4 and the binding pocket shown. B- close-up of the binding pocket showing the 
organisation of the five key residues Glu321, Asn323, Glu329, Asn341 and Asp342, 
showing the six coordination bonds between Ca1 (orange circle) and the protein 
binding pocket residues. In the ligand-free state the rfhSP-D Ca1 last two coordination 
bonds are completed by two water molecules (blue spheres). C- Close-up Ca2 and 
Ca3 and coordinating residues and water (H2O) molecules. D- Close-up of Ca4 at the 
neck-CRD interface. Ca4 (orange circle) is coordinated by three symmetrical Glu232 
and three water molecules (not present in the image). The orange box shows the 
orientation of the Glu232 in subunit B (in blue).  E- a representation of the loss of 
coordination between Ca4 (not present) and Glu232 in subunit B (in blue). This causes 
the Glu232 in subunit B to move deeper into the neck, forming a hydrogen bond with 
the asymmetric Tyr228 in subunit C. Images A, B and C were generated by PYMOL 
using PDB: 1PW9, while image D was generated using PYMOL using PDB: 1PWB.  
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1.5.2.4 Ligand-bound rfhSP-D structures 
The various ligand binding studies reported to date have demonstrated the variety 
of structural and functional differences in how rfhSP-D recognises the different ligands 
studied. Short mono-, di- and trisaccharide residues representative of longer natural 
ligands were used to highlight differences in specific ligand interactions and how key 
residues in the CRD domain contribute to the ability to recognise the variety of ligands.  
rfhSP-D has been reported to bind a variety of ligands including maltose (Glc-
α1,4-Glc), maltotriose (Glc-α1,4-Glc-α1,4-Glc), P-nitrophenyl-α-D-maltoside, N-acetyl-
mannosamine, mannobiose α1,2 and α1,4, α-Methyl-mannobiose, galactose, inositol 
phosphate (IP), L-glycero-D-manno-heptose, di-L-glycero-D-manno-heptose (α1,3), D-
glycero-D-manno-heptose and to Haemophilus influenzae Eagan 4A PS (through the 
highly conserved L-glycero-D-manno-heptose), see Table 1.9 for a direct comparison of 
how (which hydroxyls) rfhSP-D has been reported to bind to the various ligands. 
The first ligand-bound rfhSP-D structure used maltose (α1-4 glycosidic bond 
between Glc1-Glc2) with the maltose bound structure suggesting minimal conformational 
change upon binding, with the CRD site ready for the ligand binding. Ca1, Ca2 and Ca3 
were reported to be present in all three subunits of the homotrimer. The residues 
coordinating the Ca1 are Glu321 (OE1), Asn323 (OD1), Glu329 (OE1), Asn341 (OD1), 
Asp342 (OD1) and the main chain carbonyl (O) of Asp342, forming six coordination bonds 
with Ca1. The final coordination was achieved through the hydroxyl groups (OH), 
positioned equatorially on carbon 3 (O3’) and carbon 4 (O4’) of the terminal sugar (glc1), 
replacing the two water molecules reported in the ligand-free rfhSP-D structure (Fig. 
1.12A). Four residues that are important in coordinating Ca1 were also shown to be 
important in coordinating the glc1 of the disaccharide; the O3’ hydroxyl interacts with 
Glu321 OE2 and with ND2 of Asn323, while the O4’ hydroxyl interacts with OE2 of Glu329 
and with ND2 of Asn341 (Shrive et al., 2003).  
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Ligand and PDB 
accession code.  
Binding mechanism of rfhSP-D to reported ligands 
(which hydroxyls does rfhSP-D Ca1 bind to) 
Displayed 
in figure: 
Literature 
reported in:  
- Maltose (Glc1-
α1,4-Glc2) 
- 1PWB 
Binding- Ca1 binds to O3’ and O4’ equatorial 
hydroxyls of Glc1 + the O3’ interacts with Glu321 
OE2 and Asn323 ND2 and the O4’ interacts with 
Glu321 OE2 and Asn341 ND2.  
1.12A Shrive et 
al., 2003 
- Maltotriose (Glc-
α1,4-Glc-α1,4-Glc 
= Glc1-Glc2-Glc3) 
- 2GGU 
Binding- Ca1 binds to O3’ and O4’ equatorial 
hydroxyls of Glc1 + additional interactions similar to 
maltose (in terms of O3’ and O4’ and Ca1 
coordinating residues). Glc3 and Phe335 stacked 
together and suggested to provide additional 
stability.  
1.12B Crouch et 
al., 2006 
- P-nitrophenyl-α-
D-maltoside 
- 2GGX 
Binding- Ca1 binds to O3’ and O4’ equatorial 
hydroxyls of Glc1 + additional interactions similar to 
maltose. 
Similar to 
1.12A 
Crouch et 
al., 2006 
- N-acetyl-
mannosamine 
- 2ORJ 
Binding- Ca1 binds to O3’ and O4’ equatorial 
hydroxyls of ManNAc + additional interactions 
similar to maltose. 
Similar to 
1.12C 
Crouch et 
al., 2007 
Mannobiose α1,2 
(Man1-Man2) 
- 3G83 
- 3IKQ 
Binding- Ca1 binds to O3’and O4’ equatorial 
hydroxyls of Man1 + additional interactions similar 
to maltose 
1.12C Shrive et 
al., 2009; 
Crouch et 
al., 2009 
- Mannobiose  
α1,4 (Man1-Man2) 
- 3IKR 
Binding- O3’and O4’ equatorial hydroxyls of Man1 
+ additional interactions similar to maltose. Chain A 
and chain C orientation of the O3’ and O4’ hydroxyls 
of man1 interchanged by 180°. Chain B displays 
both orientations.  
1.12D Shrive et 
al., 2009 
- α-Methyl-
mannobiose 
- 3G81 
Binding- O3’ and O4’ equatorial hydroxyls of 
mannose. + additional interactions similar to 
maltose. 
Similar to 
1.12C 
Crouch et 
al., 2009 
- Galactose 
- 3IKN 
Binding- Ca1 binds to O1’ and O2’ hydroxyls of 
galactose + the O2’ interacts with Glu321 OE2 and 
Asn323 ND2 and the O1’ interacts with Glu321 OE2 
and Asn341 ND2. 
1.12E Shrive et 
al., 2009 
- Inositol 
Phosphate  (I-1-P) 
- 3IKP 
Binding- Ca1 binds to O4’ and O5’ hydroxyls of IP 1.12F Shrive et 
al., 2009 
- L-glycero-D-
manno-heptose 
- 2RIB 
Binding- Ca1 binds to O6’ and O7’ hydroxyls of the 
glycero group. 
Similar to 
1.12G but 
only with 
one Hep.  
Wang et al., 
2008 
- di-L-glycero-D-
manno-heptose 
(Hep1-α1,3-Hep2) 
- 2RIC 
Binding- Ca1 binds to O6’ and O7’ hydroxyls of the 
glycero group of HepI.  
1.12G Wang et al., 
2008 
- D-glycero-D-
manno-heptose 
- 2RIA 
Binding- Ca1 binds to O3’ and O4’ hydroxyls of the 
glycero group of HepI. 
1.12H Wang et al., 
2008 
- Haemophilus 
influenzae Eagan 
4A PS (L-glycero-
D-manno-heptose) 
- 4E52 
Binding- Ca1 binds to O6’ and O7’ hydroxyls of the 
glycero group of Hep, even though a Glc is available 
to bind through O3’ and O4’.   
1.12I Clark et al., 
2016 
Table 1.9 A direct comparison of the reported ligand binding structural studies of rfhSP-D 
displaying the differences in how (which hydroxyls) does rfhSP-D Ca1 achieve the final 
coordination. In bold on the left hand-side the PDB accession code for each of the displayed 
structures is given. 
 
Chapter 1 Structural studies of Surfactant Protein D (SP-D) 
69 | P a g e  
 
Other ligands tested have also been shown to be recognised by rfhSP-D through 
the O3’ and O4’ equatorial hydroxyls; maltotriose (α1-4 Glc1-Glc2-Glc3) (Fig. 1.12B) 
(Crouch et al., 2006), P-nitrophenyl-α-D-maltoside (Crouch et al., 2006), N-acetyl 
mannosamine (Crouch et al., 2007), mannobiose α1-2 (α1-2 Man1-Man2) (Fig. 1.12C) 
(Shrive et al., 2009; Crouch et al., 2009), mannobiose α1-4 (α1-4 Man1-Man2) (Fig. 
1.12D) (Shrive et al., 2009) and α-Methyl-mannobiose (Crouch et al., 2009).  
In the maltotriose structural study a secondary interaction was suggested, whereby 
the aromatic ring of Phe335 can act as an extended carbohydrate binding site, by 
stabilising the binding of CRDs near surfaces through stacking with carbohydrate rings or 
hydrophobic moieties in the same molecules (Fig. 1.12B). The authors reported that the 
maltotriose had stronger binding than maltose, with the suggested reason for the greater 
stability being the stacking of Phe335 and glc3 of the maltotriose. This secondary 
interaction appears to stabilise the ligand in such way, that all three chains were occupied 
by maltotriose and all showed evidence of orientation for all Glc1-Glc2-Glc3 (Crouch et 
al., 2006). 
Mannobioses α1-2 and α1-4 (Man1-Man2) were also used for ligand binding 
structural studies in complex with rfhSP-D. Mannobiose α1-2 is a highly typical repeating 
unit of mannan, normally displayed in N-linked glycans in viral targets (Tate et al., 2014), 
while mannobiose α1-4 offered the opportunity to compare how mannobiose and maltose 
binding compares, as both are α1-4 linked. Both ligands bound to Ca1 in a similar fashion 
to maltose, through the hydroxyls O3’ and O4’ of the terminal sugar (man1), with no 
reported interactions involving the non-terminal sugar (man2) (Fig. 1.12C for mannobiose 
α1-2) (Shrive et al., 2009; Crouch et al., 2009). In the mannobiose α1-4 structural study 
two different orientations of the ligand binding were observed. Chain A displayed a similar 
orientation to mannobiose α1-2 and maltose however, chain C shows a different 
orientation with the terminal man1 rotated by 180° (Fig. 1.12D), interchanging the 
residues with which the hydroxyls interact; O4’ interacts with Glu321 OE2 and Asn323 
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ND2, and O3’ with Glu329 OE2 and Asn341 ND2; in chain B there is evidence for both 
orientations of the man1 (Shrive et al., 2009).  
Different recognition mechanisms (how rfhSP-D Ca1 binds the carbohydrates 
hydroxyls) have been reported for other ligands tested, including galactose, inositol 
phosphate (I-1-P) and heptose derivatives that differ from those reported for maltose, 
maltotriose and mannobiose. Galactose has been reported to be recognised through a 
novel orientation with the O1’ and O2’ hydroxyls (Fig. 1.12E) of the ring structure binding 
to Ca1. O1’ was by coordinated by Glu329 OE2 and Asn341 ND2, while O2’ was 
coordinated by Glu321 OE2 and Asn323 ND2. SP-D has been reported to exhibit low 
affinity for Galactose which may reflect the novel binding orientation seen in the rfhSP-D 
galactose complex (Shrive et al., 2009). Inositol phosphate (I-1-P), an integral part of 
phosphatidylinositol (PI) surfactant lipid has been shown to be recognised by rfhSP-D Ca1 
through the hydroxyls groups O4’ and O5’ (Fig. 1.12F), with the phosphate group 
extending away from the binding pocket (Crouch et al., 2007; Shrive et al., 2009).  
Ligand binding structural studies into the heptose derivatives are of significant 
biological importance. Heptoses are main constituents of LPS core regions, especially L-
glycero-D-manno-heptose. Structural studies of rfhSP-D with a variety of heptoses have 
been performed, including 2-deoxy-L-glycero-D-manno-heptose, Allyl 7-O-carbamoyl-L-
glycero-D-manno-heptopyranoside, L-glycero-D-manno heptopyranosyl-(1-3)-L-glycero-D-
manno-heptopyranose, L-glycero-D-manno-heptose, D-glycero-D-manno-heptose (Wang 
et al., 2008) and Haemophilus influenzae Eagan 4A PS (Clark et al., 2016).  
L-glycero-D-manno-heptose bound to rfhSP-D Ca1 via the hydroxyls O6’ and O7’, 
with the hydroxyl groups assuming a similar conformation to the equatorial hydroxyl 
groups O3’ and O4’ in the maltose structure. This novel orientation had been previously 
unreported and is unique, as all reported structures show preference for equatorial 
hydroxyl groups. The authors decided to also investigate a di-heptose α1-3, as this is 
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representative of Hep1 and Hep2 in inner core LPS. The binding was similar to the 
heptose, with HepI binding to Ca1 and no further interactions with Hep2 (Fig. 1.12G) 
(Wang et al., 2008). D-glycero-D-manno-heptose was shown to bind through the O3’ and 
O4’ equatorial hydroxyls (Fig. 1.12H), similar to the maltose structure and suggesting that 
the L-glycero isomer is crucial in achieving the O6’ and O7’ Ca1 coordination (Wang et 
al., 2008).  
The structural study of rfhSP-D and Haemophilus influenzae Eagan 4A PS at 
Keele represents the first natural ligand reported. Structural studies performed previously 
had used mono, di, and tri-saccharides. The PS of Haemophilus influenzae Eagan 4A 
resembles the natural native state of LPS, with the only difference being the lack of Lipid 
A (delipidated) and a rearrangement of the Kdo group as a result of the delipidation (Clark 
et al., 2016).  
The rfhSP-D in complex with PS from H. influenzae Eagan 4A showed the binding 
to L-glycero-D-manno-heptose, in a similar fashion to that previously reported for mono 
and di- L-glycero-D- manno- heptose, (Fig. 1.12I) (Wang et al., 2008). There was no 
density for the β1-4 linked Glucose attached to the HepI, while HepI-α1-5Kdo showed a 
clear definition. The electron density for the Kdo suggests a closed 5-membered ring 
rather than the expected pyranose ring. This supports the findings that mild acid 
hydrolysis of O4-substituted Kdo causes a conformational change in the KDO. It is 
interesting to note that rfhSP-D bound to HepI and not the terminal Glc available in the 4A 
LPS (Fig. 1.12I), suggesting a novel interaction preference, where the proximal inner core 
region (HepI) is preferred over the distal core terminal sugar (Glc) (Clark et al., 2016). 
This however does not reflect on the ability of rfhSP-D to recognise distal core terminal 
sugars, especially when the inner core is shielded or unavailable. 
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Fig 1.12 Ligand-bound rfhSP-D structures of various ligands tested and reported in the literature 
(of special interest). All the figures illustrated display similar positioning of the key residues 
(Arg343 positioned on the right-hand side for direct comparison) and with the same residues 
illustrated in all the figures; Ca1 coordinating residues - Glu321, Asn323, Glu329, Asn341 and 
Asp342, with the flanking residues Asp325 and Arg343 also displayed. Fig. 1.13B contains an 
extra residue - Phe335. All rfhSP-D are displayed as sticks with green (carbon), red (oxygen) and 
blue (nitrogen) colours; Ca1 is displayed as a small blue sphere; ligands are displayed as sticks 
with light blue (carbon) and red (oxygen) colours; the coordination of Ca1 by the rfhSP-D residues 
and ligand is displayed as dashed lines (magenta). A- Maltose structure (Glc1-α1,4-Glc2) with 
Glc1 bound by the O3’ and O4’ equatorial hydroxyls to Ca1 (chain A) (PDB: 1PWB). B- 
Maltotriose structure (Glc-α1,4-Glc-α1,4-Glc = Glc1-Glc2-Glc3) with Glc1 bound by the O3’ and 
O4’ equatorial hydroxyls to Ca1 (chain C) (PDB: 2GGU). C- Mannobiose α1,2 (Man1-Man2) with 
Man1 bound by the O3’ and O4’ equatorial hydroxyls to Ca1 (chain A) (PDB: 3IKQ). D- 
Mannobiose structure α1,4 (Man1-Man2) with Man1 bound by the O3’ and O4’ equatorial 
hydroxyls to Ca1 but with the hydroxyls interchanged by 180° (chain C) in comparison to 
mannobiose α1,2 (PDB: 3IKR). E- Galactose structure, with galactose binding through the O1’ 
and O2’ equatorial hydroxyls to Ca1 (chain A) (PDB: 3IKN). F- Inositol phosphate structure, with 
the inositol binding through the O4’ and O5’ hydroxyls (PDB: 3IKP). G-  di-L-glycero-D-manno-
heptose (Hep-α1,3-Hep = Hep1-Hep2) structure, with Hep1 bound by the O6’ and O7’ hydroxyls 
to Ca1(chain C) (PDB: 2RIC). H- D-glycero-D-manno-heptose, with the D,D-heptose binding 
through the O3’ and O4’ equatorial hydroxyls (chain C) (PDB: 2RIA). I- Haemophilus influenzae 
Eagan 4A PS binds through the O6’ and O7’ hydroxyls of the L-glycero-D-manno-heptose (chain 
C), even though a glucose is available to bind through the O3’ and O4’ equatorial hydroxyls, 
suggesting preference of binding for L-D-Hep (PDB: 4E52). Figures generated using PYMOL. 
Ca
1 
Arg343 
Glu32
9 
Asp325 
Asp342 
Asn341 
Glu321 
H 
Asn323 
L-D-Hep1 
L-D-Hep2
D-D-Hep 
5 membered KDO 
L-D-Hep1 
Chapter 1 Structural studies of Surfactant Protein D (SP-D) 
74 | P a g e  
 
Additional interactions between rfhSP-D and bound carbohydrates in excess of the 
Ca1 coordinating residues (Glu321, Asn323, Glu329 and Asn341) have also been 
reported. Arg343 and Asp325 have been reported to flank the binding site, providing 
additional interactions with the ligand. In the maltose structure (Shrive et al., 2003) 
Arg343 NH1 interacts with glc2 O6’ and with Man1 O6’ of the mannobiose α1-2 structure 
(Shrive et al., 2009; Crouch et al., 2009); in the mannobiose α1-4 structure chain C the 
rotation of the terminal Man1 by 180° (interchanging the hydroxyls interacting with Ca1) 
causes the C6’ previously located near Arg343 to move to the opposite side of the binding 
site, allowing interactions between Arg343 and O2’ and Asp325 OD2 with the O1’ of the 
man1, the latter a previously unreported interaction (Shrive et al., 2009); the O5’ and O6’ 
of the galactose structure interact with Arg343 NH1 and NH2 respectively (Shrive et al., 
2009); additional interactions between Hep1 O2’ and Asp325 were also reported, 
suggesting that the flanking residues are important in the recognition of heptose (Crouch 
et al., 2006; Wang et al., 2008; Shrive et al., 2003 and 2009). 
 rfhSP-D mutants and the importance of residues 343 and 325 
The role of the flanking residues in providing secondary binding potential has led 
some researchers into exploring the impact that individual amino acids flanking the 
binding site can have in the recognition of different ligands. These studies have used 
rfhSP-D mutated by single or double site mutation of site 343 and/or 325 (flanking 
residues). These sites have been suggested as being important in discriminating 
glycoconjungates, with the ability to impact on binding affinities. 
Single mutant Arg343Val binding properties were investigated in complex with 
mannobiose α1-2, α1-3 and α1-6 linked and branched tri-mannose cores (Crouch et al., 
2009). The idea for this mutation arose from the greater ability of a fusion protein 
containing the SP-D neck and the conglutinin CRD (SP-D/Congneck+CRD) to aggregate, 
inhibit, and enhance phagocytosis and the oxidative response towards influenza A virus 
(IAV), than rfhSP-D. Conglutinin possess a Val at position 343 (hSP-D numbering), while 
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in hSP-D an Arg is present (Hartshorn et al., 2000). The authors decided to investigate 
the impact that Val343 could have on the binding affinity of SP-D towards IAV and created 
the Arg343Val rfhSP-D mutant. The Arg343Val rfhSP-D structural study showed similar 
binding to that reported for mannobiose α1-2 through the O3’ and O4’ hydroxyls, but to 
the man2, instead of the reported man1 in the mannobiose α1-2 rfhSP-D. Further 
interactions included hydrogen bonding between O2’ and O6’ and Arg349 and Glu347 
respectively. The study also reported that the mutation Arg343Val resulted in a 2-fold 
increase in affinity towards mannobiose α1-2 in comparison to rfhSP-D (Crouch et al., 
2009). The mutant Arg343Val has also been reported in a computational modelling study 
to be important in binding to N-acetyl-glucosamine and glucose, with increased binding to 
both carbohydrates when compared to ligand-free SP-D (Allen et al., 2004).  
Single mutant rfhSP-D Arg343Lys was produced in order to investigate the impact 
that a single mutation of Arg to Lys at position 343 could have on a variety of 
carbohydrate, PI and LPS binding affinities. The mutant Arg343Lys showed increased 
binding to PI, maltose, glucose and rough LPS (E. coli J-5 Rc LPS), in comparison with 
rfhSP-D. It is interesting to note that the Arg343Val mutation showed little impact on the 
binding to PI and rough LPS (Wang et al., 2008; Crouch et al., 2007).  
Following on from previous work where mutant rfhSP-D (Crouch et al., 2009; 
Crouch et al., 2007; Allen et al., 2004; Wang et al., 2008) containing a single site 
substitution impacted on binding affinities for different ligands, Goh et al., 2013 
investigated a double site substitution of rfhSP-D, where Asp325 was mutated to Ala325, 
while Arg343 was mutated to Val343. This new double mutant was investigated in 
combination with the N-linked glycan of hemagglutinin (HA), present in the envelope of 
IAV (Goh et al., 2013). In this structural study the double mutant rfhSP-D was shown to 
inhibit IAV in contrast to rfhSP-D which was shown to be ineffective against IAV. The 
double mutant of rfhSP-D showed similar results to the full length ligand-free SP-D. The 
double mutant was also shown to be more stable than the rfhSP-D, with stronger binding 
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reported, as additional hydrogen bonds and hydrophobic interactions with the HA Man-
α1,2Man-α1,2Man were seen. This study provided the first structural study of an innate 
host defence lectin inhibiting a viral glycoprotein target (Goh et al., 2013).  
In summary, as the evidence presented above suggests, the amino acids flanking 
the binding pocket at site 325 and 343 can alter the binding affinity for a variety of 
carbohydrates, making it crucial in the recognition of a variety of PAMPs presented on 
pathogens.  It is interesting to note the potential of using fusion proteins by associating 
specific structural domains with specific functional properties of different collectins, with 
the aim of enhancing antimicrobial activities towards specific pathogens.  
1.6 Conclusion 
The human lung is exposed to continuous physical and environmental challenges, 
whereby the clearance of pathogenic and commensal bacterium needs to occur by means 
of an adequate immune response, by minimising inflammation and maintaining normal 
lung homeostasis. Collectins have the ability to impact on lung homeostasis and act as 
PRRs, by recognising carbohydrates patterns on the surface of microbes, allergens and 
necrotic/apoptotic own cells (PAMPs and DAMPs). Collectins share conserved residues in 
the CRD and a binding pocket that enables pattern recognition of carbohydrates, in a 
calcium dependent manner, with variations in the sequence of the collectins impacting on 
the binding affinities for different carbohydrates.  
SP-D is the collectin of interest in the experimental work presented here and has 
been investigated in various studies for its ability in recognising bacteria, viruses, 
parasites, fungus and allergens and for its enhancement of an immune response by 
means of agglutination, opsonisation, phagocytosis or direct microbial activity. SP-D has 
also been investigated due to its dual role in pro and anti-inflammatory responses, 
dependent on the specific interactions with immune system receptors, in the presence or 
absence of PAMPs or DAMPs.  
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Various pathologies have been reported to show abnormal levels of SP-D, 
suggesting that SP-D levels could be a cause or consequence of disease state. rfhSP-D, 
a short recombinant fragment of SP-D has been demonstrated to hold similar biological 
activity as full length SP-D, suggesting that rfhSP-D could be used as a therapy to reduce 
lung inflammation or for the treatment of bacterial/viral infections. Various structural 
studies have been reported using rfhSP-D in combination with mono/di/tri-saccharide 
glycoconjugates normally present as PAMPS on the surface of the various pathogens. 
These have enhanced the knowledge of the recognition of PAMPS by SP-D, however 
these have been limited to small glycoconjungates.  
LPS is a major component of the outer membrane of gram-negative bacteria that 
can participate in host-bacterium interactions such as adhesion, colonisation, virulence 
and symbiosis, enhancing the survival of the bacterium. LPS can also elicit strong immune 
responses, with the ability to cause septic shock if untreated. The manner in which SP-D 
interacts with bacterial LPS varies, in part due to the high heterogeneity of the LPS, with 
smooth (O-antigen) and rough (lacking O-antigen) normally presented together in the 
bacterial OM, but also due to the ability of bacteria to vary the components of the LPS, 
enhancing its survival and masking important core carbohydrate ligands targeted by SP-
D.  
Various studies have investigated the ability of specific hSP-D residues, in 
particular Arg343 and Asp325 which flank the ligand binding pocket, to impact on the 
recognition and binding affinities of SP-D towards various carbohydrates, suggesting that 
mutations in specific residues could result in a higher affinity for specific carbohydrates, 
and in turn for specific pathogens. Fusion protein studies have also investigated the 
binding properties of SP-D neck and conglutinin CRD, resulting in increased clearance of 
IAV. It is interesting to note that a naturally formed heteromeric complex of two separate 
collectins has recently been reported (Henriksen et al., 2013), suggesting that the 
combination of separate collectins with different binding affinities seems to occur in 
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nature. Evidence for the therapeutic potential of rfhSP-D is increasing, with the work 
performed in this thesis focused on adding a further mini-chapter of information. 
The studies presented here follow the work of Professor Trevor Greenhough and 
Dr. Annette Shrive, and fellow and past members of our research group including, Ian 
Burns, Carrie Smallcombe, Amy Shaw and Jamie Littlejohn.  
rfhSP-D has been previously investigated in combination with a variety of simple 
carbohydrate ligands, resulting in vast knowledge of how SP-D interacts with a variety of 
ligands. The use of natural ligands represents the next step in the elucidation of how SP-D 
interacts with a variety of the pathogens. The structure of rfhSP-D bound to H. influenzae 
Eagan 4A LPS has previously been investigated in our research group (Clark et al., 
2016).  
In the work presented here, rfhSP-D has been investigated in complex with both 
intact and delipidated LPS from H. influenzae Eagan CA7 rough and S. enterica (serotype 
minnesota) R5 and R7 rough mutants. Other LPS were also investigated; E. coli J-5 rough 
LPS ligand was data collected to a low resolution, providing little evidence to suggest 
correct ligand orientation; S. enterica minnesota R4 rough mutant LPS and H. influenzae 
Wild-type Eagan LPS produced no crystal growth and therefore these will not be 
discussed in this thesis, and instead the experimental findings reported will concentrate on 
the H. influenzae Eagan CA7 PS and S. enterica minnesota R5 PS and R7 LPS. 
The aims of this work were to investigate further the binding mechanisms of rfhSP-
D with LPS and natural ligands by means of X-ray diffraction, using co-crystallisation as 
the main tool of crystal formation, with the aim of increased understanding of the 
interactions between SP-D and LPS by determination of the detailed binding modes and 
interactions between hSP-D and bacterial LPS. As more structural data becomes 
available, showcasing the characterisation of the binding of longer ligands by rfhSP-D, the 
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more evidence is presented for the medical potential of rfhSP-D, which may one day be 
exploited for the benefit of human health. 
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Chapter 2 - Experimental Techniques 
An introduction to the experimental techniques used in the experimental work in 
this thesis is given below, highlighting the expression and purification of rfhSP-D, the 
preparation of LPS and PS and the methods of crystal formation, data collection, data 
analysis and structure solution. 
2.1 Crystals 
A crystal is a solid containing an internal structure, where the atoms are arranged 
in a lattice constructed of identical unit cells. Distortions caused by lattice imperfection 
usually adversely affect how well the crystals diffract (X-ray scattering). Therefore, it is 
important to achieve a near perfect crystal, where virtually identical unit cells offer well-
defined, long-range, three-dimensional molecular order.   
 Unit Cell 
The unit cell is the smallest repeating structure (group of atoms) which has the 
overall symmetry of a crystal, and from which the entire lattice can be built by repetition in 
three dimensions (3D). By representing each unit cell by points, a crystalline lattice can be 
created, where each point in the lattice is in the same environment as every other point. 
Unit cells are described by three crystallographic distance axes a, b and c and three inter-
axial angles α, β and γ and are defined by space lattices (3D), which serve to display the 
symmetry of the lattice in a convenient manner (Fig. 2.1).  
α 
γ 
β 
c 
b 
a 
Fig. 2.1 A representation of a typical unit 
cell. Three crystallographic distances are 
expressed by a, b and c, with the three 
inter-axial angles α, β and γ. Together the 
unit cell parameters and angles can be 
used to define the unit cell in a space 
lattice.  
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The planes of atoms within the unit cell can be thought as sources of diffraction 
and can be assigned a set of three numbers called lattice indices or Miller indices hkl 
which are based on the intercepts of the planes with the unit cell axes. For example, a 
plane that passes through a=a, b=b, c=c is hkl 1,1,1, while a plane which is parallel to the 
ac face of the unit cell which intercepts b at b/2 is hkl 0,2,0. Within the crystal there are 
many planes, each part of a family of parallel planes with each plane separated from the 
adjacent member of the family by a distance dhkl determined by hkl and the unit cell size. 
 Crystal Symmetry and Bravais Lattices 
The molecules in the crystal can be related by different symmetry operations. A 
symmetry operation can be defined as a set of operations on an object that makes the 
resulting object indistinguishable from the original except in terms of rotation, translation 
and reflection. Different types of symmetry are possible, including rotation (with or without 
translation), reflection and inversion.  Reflection and inversion can only occur in crystals 
where the molecules can exist in both chiral forms of L and R. In biological 
macromolecules such as proteins, the amino acids are always L-handed, limiting the 
symmetry operations to rotation and translation only.  
The repeated unit cell gives rise to a 3D periodic lattice in one of 14 possible 
arrangements termed Bravais Lattices. These falls into 7 crystal systems depending on 
the symmetry and relative dimensions of the unit cell (Table. 2.1). 
Crystal System Lattice Type a,b,c and α, β γ 
restrictions 
Triclinic P - 
Monoclinic P, C α and  γ = 90˚  
Orthorhombic P, C, I, F α, β, γ = 90 ˚ 
Tetragonal P, I α, β, γ = 90 ˚ a=b 
Cubic P, F, I α, β γ = 90 ˚; a=b=c 
Trigonal (Rhombohedral) R α, β γ < 120 ˚; a=b=c  
Hexagonal P γ =120 ˚ α and β = 90 ˚; 
a=c 
Table 2.1 The 14 Bravais lattices (crystal system + lattice type) including a, b, c and 
α, β γ restrictions for each crystal system and lattice type. P indicates Primitive while 
C, I and F are unit cells that contain additional lattice points at the centre of one face 
(C), all faces (F) and at the centre of the unit cell (I). R indicates rhombohedral. 
Chapter 2 Crystals 
82 | P a g e  
 
 X-rays 
X-rays were initially discovered in 1895 by Wilhelm Conrad Rontgen and are a 
form of electromagnetic radiation with wavelengths of around 0.01-10 nm (0.1-100 Å). X-
rays have the ability to penetrate matter and produce relatively strong scattering. In 1912 
in Germany Max von Laue discovered that crystals could be used as a diffraction grating 
for X-rays. Max Von Laue, Paul Knipping and Walter Friedrich directed a beam of X-rays 
through a copper sulfate crystal and recorded the diffraction on a photographic plate. The 
photographic plate showed a large number of well-defined spots arranged in a pattern of 
intersecting circles, around the spot produced by the central beam. Confirmation of this 
discovery came from England by William Henry Bragg and William Lawrence Bragg, 
confirming the findings of Max von Laue and colleagues. In 1913 the Braggs proposed an 
equation (known as Braggs law) which connected the observed scattering with reflections 
from evenly spaced planes within the crystal. Max von Laue received the Nobel Prize for 
his discovery of the diffraction of X-rays by crystals in 1914 and in 1915 the Braggs 
received the Nobel Prize for their services in the analysis of crystal structures by means of 
X-rays (Eckert, 2012). 
The wavelength of the X-rays spectrum makes them ideal to measure the inter-
atomic bond length, such as C-C bonds with 1.5 Å bond lengths. X-rays interact with the 
electrons surrounding the atoms in the crystals, making them oscillate and causing the X-
rays to diffract. X-ray diffraction is the product of electromagnetic elastic scattering without 
a change of wavelength and energy, meaning that the outgoing X-rays have the same 
energy (and wavelength) as the incoming X-rays, with the only difference being the 
direction of propagation of the electromagnetic wave. 
 Diffraction by Crystals  
Diffraction from crystals creates X-ray “reflections” from the planes of the crystal 
and uses the concept that X-rays are scattered from the electrons surrounding the atoms 
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in the crystal in an ordered fashion. Individual molecules scatter X-rays weakly, making 
them hard to be detected, while the crystals can act as amplifiers of diffraction due to their 
repeated unit cells (ordered molecules), where each molecule can diffract in similar 
manner to each other, augmenting the diffraction of X-rays. The amplification of the 
intensities is proportional to the number of unit cells present in the crystal.  
The reflections produced from sets of planes in the crystals can be described by 
using Bragg’s Law. Bragg’s Law shows that a set of parallel planes with index hkl and 
interplanar spacing dhkl produces a diffracted beam when X-rays of wavelength λ, impact 
upon the planes at an angle θ and are reflected at the same angle if 2d sin(θ) =nλ.  This 
means that the rays reflected from successive planes in a family of parallel planes emerge 
from the crystal in phase, interfering constructively to produce a strong diffracted beam. 
For other angles where Bragg’s Law is not satisfied the waves emerging from successive 
planes are out phase (they have not travelled distances which differ by a whole number 
(n) of wavelengths λ), so they interfere destructively and no “reflected” beam emerges at 
that angle. A representation of Braggs’s law is given in Fig. 2.2. Large angles of reflection 
θ correspond to small interplanar distances d with the largest angle observable on the 
diffraction pattern corresponding to the minimum d that can be resolved. This is called the 
resolution limit of the crystal and is related to the level of structural detail which can be 
determined from the crystal.  
Fig. 2.2 A representation of Bragg’s law. Reflected beams are reflected at the same angle 
θ as the incident beam, from the lattice planes of a crystal, if the condition 2d sin(θ) = nλ is 
achieved, leading to the successive lattice planes in a crystal producing an in phase 
reflected beam. 
1 
2 
3’ 3 
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 Data Collections and diffraction images  
Data collection for the purpose of structural determination is the consequence of 
two separate processes, the production of high quality crystals suitable for study, and the 
optimisation of different factors at the X-ray beamline, with the aim of providing detailed 
structural information about the protein being investigated. Data collection consists of 
collecting a complete set of reflection intensities (Ihkl) with the highest resolution possible 
(Fig. 2.3). 
Data collection starts when the crystal is mounted on the goniometer and rotated 
by small angle (0.1-2°), often referred to as φ (phi), with respect to the incoming X-ray 
beam, with the total angular range varying between 90-180°, depending on the unit cell 
symmetry of the crystal (Xuong et al., 1968; Leslie, 2006). The scattered diffraction is 
collected by the detector, with the aim of collecting accurate measurements of Ihkl and 
standard uncertainties (σI) for all hkl. The detector must have a large active area and 
good spatial resolving power to be able to measure a large number of closely spaced 
diffraction spots. The crystal to detector distance can be varied so that the diffraction 
pattern fills the active area of the detector. The crystal in the goniometer uses a cryo-
N i t r o g e n C r y o 
s t r e a m 
D i f f r a c t e d X - r a y s , 
R e f l e c t i o n s 
B e a m s t o p 
D e t e c t o r 
X - r a y s 
M o u n t e d c r y s t a l 
N y l o n l o o p 
M o t h e r l i q u o r 
φ 	  a n g u l a r r o t a t i o n 
Fig. 2.3 Typical data collection set up performed at the Diamond Light Source (DLS). The 
crystal is mounted into a goniometer which is rotated by φ ° in relation to the incoming X-
rays. The diffracted reflections from the crystal are collected on a detector. The flash 
frozen crystal is kept at cryogenic temperatures by a stream of nitrogen gas. 
(frozen)	
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stream, which blows a stream of cooled nitrogen gas over the frozen crystal to maintain its 
temperature. 
The detector could be a charge-coupled device (CCD), which provides a rapid 
readout time and converts the incident photons into electrical charge, forming a 2-D array, 
with the charge proportional to the intensity of the incident light (Smyth & Martin, 2000); 
or the new generation of X-ray pixel detectors such as PILATUS 6M (specifically 
dedicated for protein crystallography) a single-photon counting digital detector (Taguchi 
et al., 2008).  Each reflection can be used to obtain the direction in which that particular 
beam was diffracted by the crystal, with the computer constructing the diffraction pattern 
(diffraction images) using the intensity and direction for each individual diffracted beam 
that produces a reflection on the detector. Diffraction images (Fig. 2.4) consist of images 
covered in spots (Bragg reflections), with the low resolution spots at the center normally 
having stronger intensities than those towards the edge of the detector which contain the 
high resolution information. At the center of the image a blank area is present, where a 
beam-stop is used, normally made of lead or tungsten, which prevents the beam of 
undiffracted X-rays burning a hole in the detector, see Fig. 2.4 for the representation of an 
X-diffraction image. Each and every spot on the diffracted images contains structural 
information about each and every atom in the crystal – where it is and how many 
electrons there are contributing to each diffraction maximum.  
Diffraction by crystals can be affected by crystal lattice imperfections (mosaicity), 
resulting in poor spot shape (overlapping and smearing of spots) and limited resolution. 
Protein crystals suffer from a mosaic spread, as there is a variety of flexible residues held 
together by weak forces. Zero mosaicity, where the unit cells are perfectly aligned would 
create reflections of high intensity, not measurable, suggesting that some mosaicity is 
essential. In the real world, the crystal is composed of blocks of unit cells slightly 
misaligned (crystal packing defects). Crystals with high mosaicity usually diffract to low 
resolution (Evans et al., 2011; Leslie, 2006). A variety of variables can impact on the 
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Fig. 2.4 A typical image of an X-ray diffraction snap of a protein crystal on a CCD 
detector. At the center of the image the beam-stop is visible, with the Bragg reflections 
(the spots) surrounding the center of the beam. The spots in the center of the image 
are of higher intensity, while the spots towards the edge represent higher resolution.  
This image was taken on 30/1/15 at DLS beamline I04-1 from the rfhSP-D crystal RS46 
B61. Maximal resolution is 2.6 Å.  
crystal order such as the molecular weight of the protein, solvent content, unit-cell volume, 
sample-mounting method and sample cooling method. 
2.2 Fourier transform and Structure Factors 
A Fourier transform (direct) is the lens simulating operation that a computer 
performs, where the Fourier transform of the structure is the amplitudes and phases. As a 
result, the reverse is also true, the reverse Fourier transform of the amplitudes and 
phases of the diffracted waves gives rise to the generation of the electron density map, 
providing the link between the diffracted spots that reach the detector and the location and 
nature of the diffracting atom/electron in the crystal. The direct and reverse Fourier 
transforms allows for the conversion between a Fourier sum description of the reflections 
to a Fourier sum of the electron density map (ie structure) and vice-versa. 
The reflections that are detected/collected during data collection contain 
information (in the amplitude and phase) about each and every atom in the crystal (where 
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it is, i.e. the structure) and these can be described by a Structure Factor (Fhkl) equation 
containing one term for each atom in the unit cell. The electron density in turn can be 
described by a Fourier sum in which each term is a Structure Factor. 
Extrapolating the information that reaches the detector (diffraction pattern), into the 
position of atoms/electrons (electron density) in the crystal by means of reserve Fourier 
transform, requires that the angle of diffraction, the amplitude of the diffracted waves and 
the phases are known. The angle of diffraction is calculated from the detector; the 
amplitude of the waves is directly related to the intensities (amplitude of Fhkl is proportional 
to the square root of the reflection intensity Ihkl) and is expressed in terms of the structure 
factor amplitude |Fhkl|, describing a specific reflection in the diffraction pattern.  The other 
part of the structure factor for each hkl, the phase, will have to be estimated and 
calculated at a later stage, as this cannot be measured from the diffraction pattern. 
2.3 Data processing and Model building 
Data processing of the rfhSP-D data sets was performed by using the 
Collaborative Computational Project number 4 (CCP4) integrated suite of programs that 
allows the determination of macromolecular structures from X-ray crystallographic data.  
Various programs of the CCP4 integrated suite were used during the data processing 
including iMOSFLM, AIMLESS, TRUNCATE, UNIQUIFY, RE-INDEX (at times), 
REFMAC5 and COOT (Winn et al., 2010; Emsley & Cowtan, 2004). 
 Data Integration 
The data collection stage provides the information required to calculate the 
reflection intensities Ihkl and standard uncertainties (σI) for all hkl, the integration of the 
different images containing reflections specific to different angles is achieved through 
three different stages. Stage 1 - the indexing of the diffraction spots determines the unit 
cell parameters, using two separate diffraction images normally 90˚ apart in φ. Stage 2- 
the refinement of the initial unit cell parameters and the estimate of the crystal mosaicity. 
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Stage 3- prediction of the positions of the Bragg reflections on all the diffractions images 
followed by integration of all the images, generating Ihkl and standard uncertainties (σI) for 
all hkl.  
The three stages are completed using the iMOSFLM and AIMLESS computer 
programs within the CCP4 suite. During the indexing stage, two diffraction images 90° 
apart in φ are used in aiding iMOSFLM to generate a variety of possible unit cells and 
parameters with different penalty points, with the unit cell and space group of the lowest 
penalty normally preferred, unless the space group has been previously determined. The 
penalty is based on how well spot positions predicted from the unit cell and crystal 
orientation match those observed on the images. The chosen space group and 
parameters are then superimposed to fit the observed diffraction spots, miller indices hkl 
are assigned and the spot intensities are then measured. The merging of the intensities 
based on symmetry and direct equivalents (multiple measurements) is done by the 
AIMLESS program (Evans & Murshudov, 2013; Leslie, 2006). At this point we have all 
the Intensities Ihkl and standard uncertainties (σI) for all hkl. 
 TRUNCATE, UNIQUIFY and RE-INDEX 
The program TRUNCATE generates the structure factor amplitudes from the 
reflection intensity Ihkl. TRUNCATE is also important in assessing any twinning in the 
crystals tested, by performing twinning tests. Twinning is the result of two separate 
crystals, growing in the same crystal lattice, leading to the asymmetric units being added 
to the growing crystal that do not follow a symmetry operation of the true crystal space 
group. 
The CCP4 UNIQUIFY program allows the generation of a unique list of reflections 
for a given unit cell with a given symmetry and has the ability to set Free-R- flag for each 
reflection and give indications on the completeness of the data set. The RE-INDEX 
program allows the reindexing of hkl, symmetry and space group. 
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 Phase determination – Molecular replacement  
X-rays are electromagnetic waves containing an amplitude and phase. The final 
component missing in the production of the electron density map is the phase 
determination. When collecting the diffraction of the scattering X-rays we count the 
photons (amplitude), without any information of the phases being recorded. The 
determination of the phase is therefore crucial, and can be achieved by indirect methods 
or by using phases calculated initially from similar solved structures.  The phase of each 
diffracted ray can be calculated using methods such as molecular replacement, 
isomorphous replacement and anomalous scattering either by using multiple or single 
(MAD and SAD) wavelength (Taylor, 2010). The experimental work performed in this 
thesis was based on the structural studies of natural ligands in complex with rfhSP-D. The 
phases were determined by using ligand-free models of rfhSP-D previously reported 
(Shrive et al., 2003) and by means of molecular replacement, as the rfhSP-D structures 
are all isomorphous. 
 Electron density maps 
The main objective in X-ray crystallography is to reveal the distribution of electrons 
within the asymmetric unit such that the features of the molecule in question are revealed.  
The electron density map is a three-dimensional map of the crystal structure, determined 
from the scattering of X-rays from the electron clouds of atoms in the crystal lattice. This 
describes the contents of the unit cell averaged over the whole crystal and not the single 
unit cell. This is important especially when we consider crystal disorder and how it impacts 
on the data resolution.  
The Fourier (electron density) maps produced by means of molecular replacement 
(for phase determination) can be divided into two types of map both of which use the best 
estimate of the phases available at the time. Direct maps are calculated from measured 
amplitudes Fobs, usually (and throughout this work) combined with calculated structure 
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factor amplitudes Fcalc, initially using phases derived from molecular replacement. 
Difference maps use the difference between Fobs and Fcalc which reveals errors in the 
structure. The difference map uses Fobs - Fcalc (+ phases) and has the ability to show 
positive density in the map where more electrons are present than have been modelled, 
i.e. suggesting an additional molecule or ligand present, and negative density suggesting 
that the model should have fewer electrons, i.e. specific atoms in the model are placed in 
the wrong site (Wlodawer et al., 2008; Terwilliger et al., 2007). The Direct maps used 
here were 2Fobs - Fcalc (+ phases) which combines the Fobs map with a difference map, 
thus showing both the structure and errors in the structure, see Fig. 2.5.  
Where	H2O	
would	be	-	not	
modelled	in	
Fig. 2.5 Electron density map of the rfhSP-D ligand-free binding pocket. Two maps are 
visible in the image. The direct map (2Fobs-Fcalc) in blue and visualised at 1σ 
surrounds the amino acids and is produced from measured amplitudes Fobs and 
estimated phases derived from molecular replacement. The (Fobs – Fcalc) difference 
map can be seen in the image by the green and red contours visualised at 3σ. The 
green contour suggests that more electrons are present in the data than in the model, in 
this case two water molecules (not modelled) would sit as indicated. The red contour 
suggests that the model, should have less electrons, such as an amino acid or amino 
group is positioned in the wrong site in the map. This map was produced by using the 
crystal RS46 B63 at 2.02 Å, collected on the 16/1/15 on in DLS beamline I04-1. 
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The contour of the electron density map produced can be varied, but often the 
direct map is normally visualised at 1σ (1 standard deviation), while the difference map is 
normally visualised at 3σ (3 standard deviations), where σ represents the rmsd of all map 
points from the average value; see Fig. 2.5 for the representation of a typical electron 
density map, showing the direct and difference maps. The level of contour is an important 
feature in the electron density maps and it is important not to use lower contour levels as 
these might be misleading and emphasise noise and not real features of the protein 
(Wlodawer et al., 2008; Terwilliger et al., 2007).  
 REFMAC5 
REFMAC5 is a macromolecular refinement program. REFMAC5 allows models to 
be refined by means of rigid body refinement, where a similar known model structure is 
used together with the measured structure factors Fobs. It also provides full 
crystallographic refinement of the solved structure against the experimental data. The rigid 
body refinement rotates and translates the known model structure to match the diffraction 
data, and acts as a starting point in the building and refinement of the unknown structure. 
The molecular replacement target is essentially to find the best fit of the experimental data 
to a known model in terms of the match between structure factors calculated from the 
positioned known model and those measured from the diffraction images.  In this 
experimental work the rfhSP-D data sets were fitted against the known rfhSP-D model, 
the best fit then being used to calculate an initial electron density map.  
The use of rigid body refinement as the first stage of data refinement is normal 
practice in our research group, as most often we investigate ligand bound structures, 
where limited conformational changes occur between different ligands and rfhSP-D.  The 
second stage of refinement compares the now solved structure with the experimental 
data, allowing all structural parameters to be varied in a restrained way so as to maintain 
good geometry throughout the structure. 
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 Structure refinement and model building 
As mentioned above, the work presented in this thesis was based on the X-ray 
diffraction of crystals containing rfhSP-D in complex with natural ligands from gram-
negative bacteria, where the main focus was the interaction between the rfhSP-D binding 
pocket and the different carbohydrates present on natural ligands. The aim of experiments 
using X-ray crystallography is the production of a model of interest, in this case rfhSP-D 
interacting with natural ligands, which, when Fourier transformed, explains the diffraction 
data as accurately as possible. For this we use refinement (REFMAC5) and model 
building programs (COOT). The refinement allows for the optimisation of the different 
parameters in the model, by refining atomic coordinates and atomic displacements (B 
factors), while the model building program gives the ability to incorporate bound ligands 
(LPS and PS) and metal sites (Ca2+) and to make corrections to the maps arising from the 
refinements. Refinement and model building are used together to add parts of the model 
and to incorporate structural changes that often the refinement program cannot compute. 
COOT was used as the preferred program of choice in the model building and ligand 
building steps (Winn et al., 2010; Emsley & Cowtan, 2004). All the ligands used were 
similar to those in previous reported structures, as lipopolysaccharides share conserved 
residues. One important aspect when solving the structure and building the ligand into the 
final model is over-fitting of the ligand into the model. All the data presented in this thesis 
is of low resolution (>3Å) and this causes two problems; the risk of over-fitting and the 
ambiguity of the carbohydrate preference by rfhSP-D. This will be further developed in the 
results chapters (3 and 4), highlighting proposed reasons as to why the specific crystals 
did not diffract further. 
 Crystallographic parameters and indicators of data quality 
It is important to understand how different parameters are representative of data 
quality in X-ray crystallography. Different parameters can be used to assess the quality of 
the diffraction data and the quality of model (how it was fitted into electron density. 
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Important parameters include resolution, data completeness, I/σ (signal to noise ratio), 
multiplicity, R-factors, B-factors, rms deviations (rmsd) of bonds length and angles, and 
the Ramachandran plot. 
2.3.7.1 Data collection parameters and indicators of data quality 
Resolution is measured in Angstroms (1 Å = 10-10m) and is the first indicator of 
data quality, defined as the minimum spacing (d) of the crystal lattice planes that can 
provide measurable diffraction spots by X-rays. In simple terms, resolution is the level of 
detail that can be visualised in the electron density maps. The structural detail or 
resolution of the map can be divided into Low (>3 Å), Medium (3.0 - 2.0 Å), High (2.-0 - 
1.2 Å) and Atomic (1.2 - 0.8 Å), where the smallest d spacing is representative of a higher 
resolution. In ligand bound structures normally a resolution of 2.5 Å or better is required 
(Evans et al., 2011) to identify the binding molecule and remove any ambiguity. Data 
completeness is the measure of how complete the data is, in terms of Ihkl for all unique hkl 
within the resolution range, or in simpler terms it is the number of X-ray diffraction 
reflections measured in the data set compared to how many there are. Completeness 
should be as close to 100% as possible, with an acceptable I/σ. I/σ is a value 
representative of different variables impacting both the data collection (spatial distortion, 
radiation damage and detector imperfections, with a higher value being preferred as this 
represents a higher threshold of measured signal over the averaged noise) and the 
merged data itself in terms of the number and spread of the different measurements of a 
reflection contributing to the calculated mean for that reflection. One important aspect in 
improving I/σ is the use of small φ (angle of rotation) angles, as this improves the I/σ for 
weaker reflections (Leslie, 2006; Evans et al., 2011). Multiplicity is calculated as the 
number of measured reflections divided by the number of unique reflections 
(measured/unique), with the symmetry in the crystal resulting in the presence of 
equivalent reflections in the diffraction data (high symmetry crystal yields a high 
multiplicity). High multiplicity is often the result of multiple measurements of the same 
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reflection, improving the accuracy of the measured intensities. Residual merge (Rmerge) 
and residual symmetry (Rsymm) are also used as data quality indicators, with the Rmerge 
being the measure of the agreement among the multiple measurements of the same 
reflection and Rsymm being the measure of agreement between all symmetry related 
reflections in a data set. 
2.3.7.2 Indicators of model quality 
Model quality indicators include crystallographic R-factors, consistency with 
expected geometrical parameters, atomic temperature factors and the Ramachandran 
plot. The standard crystallographic R-factor or Rwork is a measure of agreement between 
the crystallographic model and the experimental X-ray diffraction data in terms of the 
observed structure factor amplitudes and the calculated structure factor amplitudes, Fobs 
and Fcalc respectively, with a low R-factor suggesting a better agreement between data 
and model. The free R-factor Rfree is similar to the R-factor but it shows the agreement 
between a subset of reflections not included in refinement.  Rfree is thus a better indicator 
of model quality than Rwork, as it provides a less-biased measure of the refinement 
process. The temperature factors B for each atom is a measure of how much an atom 
vibrates/oscillates around its position in a specific model. Unusually large B-factors 
suggest that an atom may be misplaced or perhaps not detectable in the data. Rmsd is a 
measure of how the final crystallographic models matches expected bond lengths and 
bond angles, with rmsd values lower than 0.02 Å for bonds lengths and lower than 4 
degrees for bond angles expected in a high quality crystallographic model. The 
Ramachandran plot is based on the main chain conformational angles in the model, 
highlighting regions or individual amino acids that differ in terms of expected conformation. 
 Fast data processing (fast_dp) 
When collecting data at the DLS, where a data set (set of diffraction images, 
where φ is varied) is collected, immediately following data collection the fast_dp, a small 
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python program that uses XDS (integration software using three-dimensional profile fitting) 
(Mueller et al., 2012), CCP4 and CCBX (computational crystallography toolbox), is used 
to deliver data processing results quickly, by integrating the diffraction images (measuring 
intensities) and indexing the diffraction spots (assigning unit cell and hkl according to the 
position on the detector). Fast_dp is often used to offer an indication of data quality, 
without the need to index all images in-house. If the data looks promising, the indexing 
and integration of the diffraction images and spots is then carried out more carefully and 
robustly in-house. 
2.4 rfhSP-D protein preparation 
 rfhSP-D protein 
The molecular weight of the rfhSP-D used in this experimental work was 
calculated using ProtParam sequence analysis tool from the ExPASY proteomics server 
(http://www.expasy.org ), where the molecular weight of the rfhSP-D trimer was calculated 
to be 56448 Da, while a single monomer was calculated to be 18816 Da. 
2.4.1.1 Protein preparation – Expression  
The expression of rfhSP-D used in the experimental work was performed by 
collaborators; Howard W. Clark, Rose-Marie Mackay, Jens Madsen at the University of 
Southampton, Department of Child Health, Division of Clinical and Experimental Sciences, 
Faculty of Science, Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton 
General Hospital, Southampton, United Kingdom, according to the method reported in 
Singh et al., 2003. The expression of rfhSP-D was performed in Escherichia coli, yielding 
a rfhSP-D that consisted of a short segment of eight N-terminal Gly-X-Y triplets with 
substitution of Ser for Pro in position 2 (residue 180), followed by an α-helical coiled-coil 
neck region (203-235) and the globular CRD region (203-355) (Singh et al., 2003). 
 
Chapter 2 rfhSP-D protein preparation 
96 | P a g e  
 
2.4.1.2 Protein preparation – Purification 
The protein used for crystallisation should be of high purity, in order to ensure the 
formation of homogenous crystals. If purification of the protein is not performed correctly, 
a heterogeneous solution may either prevent crystal growth or may produce crystals 
which are not homogeneous in terms of their molecular content (McPherson & Gavira, 
2014).  
In this experimental work two different rfhSP-D expressed batches were used, 
denominated in our research group as Prep-2 and Batch 6 (both rfhSP-D trimers). The 
initial steps of purification were performed by the collaborators reported in 2.4.1.1, where 
Prep-2 was affinity purified and size exclusion chromatography treated in TBS and 5 mM 
EDTA and Batch 6 was affinity purified only. Upon receiving the different batches of the 
rfhSP-D from the collaborators, additional steps were taken to ensure that the rfhSP-D 
solution was suitable for protein crystallography, including buffer exchange and 
concentrating the protein to suitable concentration. 
2.4.1.2.1 Dialysis 
Dialysis was performed as the method of choice to buffer exchange the rfhSP-D 
solutions into 50 mM Tris base, 150 mM NaCl, 10 mM CaCl2 pH 7.4, a favourable solution 
where rfhSP-D is normally stored (termed protein buffer hereafter). The dialysis technique 
used Visking dialysis tubing, which allows the diffusion of small molecules through the 
porous tubing, but not larger molecules such as proteins. Prior to using the Visking 
dialysis tubing, these were cleaned of any heavy metals. An appropriate length of tubing 
was placed in 500 ml beaker containing 1 mM EDTA and 2% (≈ 0.24 M) sodium 
bicarbonate solution and heated to ≈ 80° C for 30 minutes on a hotplate with stirring. After 
80 minutes the Visking tubing was removed and rinsed thoroughly inside and out with 
deionised water. The protein was loaded into the Visking tubing and placed into a beaker 
of protein buffer containing 100x the sample volume inside the Visking tubing. The buffer 
was replaced after 12 hours and the dialysis was run for 24 hours at 4° C. 
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2.4.1.2.2 Protein Concentration 
The protein concentrations of the different batches of rfhSP-D were established by 
using the Nano Drop 1000 Spectrophotometer (Thermo Scientific) that allows for the 
measurements of the absorbance at 280 nm and calculation of concentration using the 
ExPASy extinction coefficient for rfhSP-D (P35247). The spectrophotometer method is 
based on the ability of aromatic rings of amino acid residues such as Tyr, Phe and Trp in 
proteins to absorb UV-light at 280 nm. The UV-light absorbance at 280 nm can be used to 
calculate the aromatic amino acid content and total concentration in solution, with the Trp 
residue being responsible for most of the absorbance of UV-light at 280 nm. Once the 
extinction coefficient has been established for a specific protein with a known amino acid 
sequence, the protein concentration in solution can be calculated from its absorbance. 
Protein concentration is an important variable in achieving crystallisation which is 
dependent on the supersaturation of the protein in solution, i.e. the protein concentration 
is higher than its solubility (Vekilov, 2010).  
2.5 Protein Crystallisation  
The first publication reporting the crystallisation of proteins occurred in 1840 by 
Hunefeld (Ferry, 1923). Flat plate-like crystals (haemoglobin crystals) appeared when the 
blood of an earthworm was pressed between two slides of glass and allowed to dry. 
These observations by Hunefeld suggested for the first time that proteins could be 
obtained by slow evaporation or slow dehydration. During the 19th century protein 
crystallisation was developed as a purification tool and was used as validation of chemical 
purity. Since then, there have been many advances in the knowledge of how 
crystallisation occurs. Protein crystallography is used as a technique to obtain single 
crystals of pure protein for X-ray Crystallography. The first characterised protein using X-
ray crystallography was myoglobin in 1958 (Kendrew et al., 1958).   
The crystallisation of specific proteins usually proceeds by , mixing with precipitant 
buffers in an aqueous environment. Protein solubility properties are governed by their 
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three-dimensional folded structures, with the hydrophobic regions tucked inside the 
protein and hydrophilic regions on the surface. Protein crystals can grow in a drop of 
aqueous mother liquid containing a variety of reagents which promote self-assembly of 
the irregularly shaped proteins into an ordered and regular crystal lattice structure. The 
self-assembly into an ordered state is defined by weak non-covalent intermolecular 
interactions. Due to the irregular shape of the protein molecules (Weichenberger et al., 
2015), during the self-assembling of protein molecules into a crystal, approximately 30 – 
80% of the crystal volume is occupied by solvent content from the precipitant buffers 
(Matthews, 1968; Matthews, 1976). Protein solubility is dependent on ionic strength, pH, 
temperature and the presence of precipitants such as organic solvents, polymorphs and 
salts (Vekilov, 2010; McPherson & Gavira, 2014).  
Protein crystals are limited in size, very soft, crush easily, disintegrate if 
dehydrated, exhibit weak optical properties and diffract X-rays relatively poorly. They are 
also temperature sensitive and are susceptible to radiation damage. The extent of the 
diffraction pattern from a crystal, and hence the level of detailed information it contains 
about the structure, is directly correlated with its degree of internal order. 
 Nucleation and Growth – Crystal formation 
Protein crystal formation can be divided into two separate steps; nucleation and 
growth, with both steps dependent on the supersaturation (protein in solution is 
supersaturated) of the mother liquor. Nucleation represents the first stage, where the 
molecules shift from a disordered state to an ordered one and where crystal nuclei are 
formed, forming a site upon which other molecules are deposited as the crystal grows. 
The nucleation rate is dependent on the ability to overcome an energy barrier, with low 
supersaturation suggesting a slower nucleation rate, while a high supersaturation 
produces a higher nucleation rate (Vekilov & Vorontsova, 2014; Asherie, 2004). The 
growth stage of the crystals represents the second step and is dependent on the crystal 
nuclei formation. The growth stage can occur by different mechanisms of incorporation of 
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the new molecules, such as transport of atoms through solution, attachment of atoms to 
the surface, movement of atoms on the surface and the attachment of atoms to edges and 
kinks (Malkin et al., 1995; McPherson et al., 2000). Upon the formation of stable nuclei 
in solution, the crystal will continue to grow until the system reaches equilibrium. As long 
as non-equilibrium forces and supersaturation are present in solution, this will drive the 
crystal growth forward.  
Proteins will remain in solution until a critical concentration (supersaturation) is 
reached. This critical concentration normally termed the supersaturated state is crucial in 
the crystallisation of proteins. Achieving this state can be explained by a transition of four 
phases (Fig. 2.6), with phase one in the aqueous state and stages two, three and four in 
the solid phase.  
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Fig. 2.6 The phase diagram for the crystallisation of macromolecules, displaying the 
transition of the different regions. In the stable region, the molecules have high 
solubility; in the metastable region the nucleic develop into crystals; in the labile region 
both nucleation and growth occurs; the final state is precipitation, which is unfavorable 
for crystallisation. Image adapted from McPherson & Gavira, 2014. 
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 The first phase represents a stable region, where the molecules have high 
solubility. The second phase, denominated metastable, is where the nuclei develop into 
crystals. The third phase is known as the labile or supersaturated stage, where both 
nucleation and growth can occur. The final stage is precipitation, which is unfavourable for 
crystal formation with precipitates forming faster than the crystals (Asherie, 2004). 
Supersaturation of proteins can be achieved by the modification of an under-saturated 
solution, where the solubility of the protein is reduced and the attraction between protein 
molecules in solution is increased. Properties such as pH, salt concentration, buffer 
concentrations, adding bridging ions and adding ions can be varied with the aim of 
decreasing protein solubility. Vapour diffusion is a common technique used in achieving 
supersaturation. 
 Crystallisation by Vapour Diffusion  
Vapour diffusion is a method used in crystallography to produce protein crystals, 
where variables can be controlled to allow the molecules to change between the aqueous 
phase and the solid phase, yielding protein crystals. This method has been employed in 
the production of all rfhSP-D protein crystals used in the experimental work described 
here. Vapour diffusion relies on the lowered concentration of a solution in the mother 
liquor (protein + buffer), in comparison to higher concentration in the reservoir (buffer). By 
osmosis, water molecules will move from the mother liquor, which contains a lower 
solution concentration, to the reservoir which has a higher solution concentration, 
“dehydrating” the mother liquor, and raising the concentration of the buffer precipitants 
and the protein concentration. As water molecules move to the reservoir, protein 
molecules come closer together in the protein solution reaching a supersaturated state 
and allowing for nucleation and growth to occur (Fig. 2.7). 
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2.5.2.1 The Sitting-drop Vapour Diffusion Method 
The protein crystals used in the structural studies reported here were grown using 
the sitting drop vapour diffusion method (Fig. 2.7). This method consists of using 24 well 
Linbro plates, where the precipitant buffers are added to the reservoir, with volumes 
equaling 0.5-1 ml. The precipitant buffers used were a combination of a variety of different 
components, prior filtered using a SatoriusMinisarts+ cellulose membrane of 0.2 µm. A 
micro-bridge (Molecular Dimensions) containing a hollow groove is placed within the cell. 
To the micro-bridge a protein solution aliquot of 1 µl was added with a protein 
concentration of 7.5-8 mg/ml. From the reservoir one aliquot of 1 µl was added to the 
protein aliquot producing a 2 µl drop containing 1:1 of protein solution and precipitant 
buffer. The precipitant buffers used were either structure screens (commercial industrial 
screens) or were prepared in house. The wells were then sealed with high vacuum grease 
seal (Dow Corning, USA) and glass cover slips (Menzel-Glaser, Braunschweig, Germany, 
22 mm), ensuring that the wells were airtight and preventing evaporation loss from the 
well. The trays were left to equilibrate at ambient temperature in the cupboards in the 
laboratory and were observed using a Leica microscope occasionally, noting changes in 
the solution. 
2.5.2.2 Structure/industrial Screens 
Structure/industrial screens are based on indications and leads from previously 
reported buffer precipitants successfully used in protein crystal growth for X-diffraction. 
These provide hundreds of different mixtures of precipitant buffer with different salts, 
buffers, precipitant and pHs in an aqueous solution, ready to be used in the initial trials of 
protein crystallisation. Structure screens are ideal for the identification of suitable 
conditions that allow specific protein crystal growth. In the case of the experimental work 
reported in this thesis, for the co-crystallisation of rfhSP-D with a variety of ligands, the 
suitable conditions had to be identified and the structure screens provided an initial 
evaluation of potential precipitant buffers. The structure screens used in this experimental 
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work were purchased from Molecular Dimensions Ltd, Structure Screen 1 – SS1 (MD1-
01-CF) and Structure screen 2 –SS2 (MD1-02), offering 100 different crystallization 
conditions. 
2.5.2.3 Co-crystallisation vs ligand-soaked crystals  
The production of rfhSP-D protein crystals performed in this work differed from 
previously reported methods. In previous work, rfhSP-D protein crystals were initially 
produced in various precipitant buffers, with the ligands of interest soaked in to the 
Fig. 2.7 A representation of the sitting-drop vapour diffusion method. A- A picture of the 
24 well Linbro plate is given. The orange square surrounds one of the wells. B- One of 
the 24 wells. C- Representation of successful crystal growth, where crystals are formed 
in solution. 
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crystals at later stages during the cryo-protection stage (Wang et al., 2008; Shrive et al., 
2003; Shrive et al., 2009), while in the work presented here a new method attempted to 
co-crystallise (in the same solution) rfhSP-D in combination with different LPSs. In our 
research group crystallisation of rfhSP-D ligand-free protein crystals have been a routine 
practise, where a variety of different molecular weights of polyethylene glycol (Peg) 2000 
(2K), 4000 (4K), 6000 (6K), 8000 (8K) and 10000 (10K) and 0.1 M Tris at different pHs 
ranging between 6 and 8.5, were successful in producing high quality ligand-free rfhSP-D 
crystals 
In the work reported here, an attempt to co-crystallise rfhSP-D in combination with 
various ligands has been investigated. The co-crystallisation method uses the sitting-drop 
vapour diffusion method, where the final drop in the microbridge contains a 1:1 ratio of 
buffer precipitant and rfhSP-D in combination with specific ligands in solution. This means 
that the nucleation of ligand-bound rfhSP-D molecules will occur surrounded by molecules 
of the ligand, potentially impacting on the intermolecular contacts and crystal formation. 
When using the soaking method, if we imagine a ligand-free crystal of rfhSP-D already 
formed, if we soak ligands that we know can bind to rfhSP-D, this ligand can diffuse 
through pores in the crystal and hopefully bind to rfhSP-D molecules. Once the ligand is 
inside the crystal it is constrained to the already formed crystal contacts between the 
various rfhSP-D molecules. The already formed crystal contacts could impact on the 
binding of the ligand by rfhSP-D molecules, particularly in the case of longer ligands. The 
co-crystallisation method could allow for longer ligands to be used, as the crystal contacts 
are formed with the ligand already bound. 
 Crystal Preparation and Data Collection 
All data collection was performed at the Diamond Light Source, Harwell Science 
and Innovation Campus, Fermi Ave, Didcot OX11 0QX on the Macromolecular 
Crystallography beamlines. Different data collections were carried out on specific crystals 
Chapter 2 Protein Crystallisation 
104 | P a g e  
 
of interest, which were treated with cryo-protectant and flash-frozen before diffraction took 
place.  
2.5.3.1 Cryo-protection, Flash Freezing and Radiation Damage  
Cryo-protection and flash freezing are two steps employed in the preparation of 
the crystals for X-ray diffraction and transportation. Both of these steps can greatly reduce 
radiation damage and reduce the formation of ice crystals, simplifying the handling of the 
crystals and improving diffraction resolution. 
2.5.3.1.1 Cryo-protection 
The cryo-protection method employed in this experimental work was based on two 
separate strategies of cryo-protection, strategy 1 and strategy 2. Cryo-protection is the 
first step in preparing the crystals for X-ray diffraction. Crystals of interest and suitable for 
X-ray diffraction were cryo-protected using Glycerol, Polyethylene glycol (Peg 400) and 2-
methyl-2,4-pentanediol (MPD) all hydrophilic cryo-protectants.  
Specific cryo-protection details for specific crystals will be given in chapters 3 and 
4, but in a general manner, strategy 1 was based on sequential additions to the mother 
liquor of increasing concentrations of the cryo-protectant in a buffer corresponding to the 
mother liquor and any ligand to be soaked in to the crystal. The cryo-protectant was 
added at increasing concentrations of 5, 10, 15 and 20%. 2 µl of each concentration (20% 
twice) was added with 2 minutes’ intervals between. The final volume of cryo-protectant 
added equalled 10µl, which was then exchanged, where 10µl of the mother liquor is 
removed and replaced with the same volume of the highest concentration (10 µl of 20%). 
For specific rfhSP-D crystals the gram negative bacterial lipopolysaccharide (LPS) and 
polysaccharide (PS) were added in combination with the cryo-protectants. Strategy 2 was 
based on the addition of 0.5 µl (twice) of 50% cryo-protectant. This strategy was initially 
used due to limited availability of specific ligands as it reduces the volume necessary to 
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achieve cryo-protection. Both strategies will be discussed in more details in the respective 
chapters. 
2.5.3.1.2 Flash freezing  
Cryo-protection allows for the flash freezing of crystals without major impacts on 
the crystal lattice, freezing the crystal in an amorphous vitreous state. Protein crystals in 
the mother liquor contain and are surrounded by water molecules. When flash freezing the 
crystals, if no cryo-protectant is used, ice crystals are formed disrupting the crystal lattice, 
as water expands when it freezes impacting on the X-ray diffraction and data quality. The 
crystals of interest were mounted using a free-standing method for mounting crystals, 
where the crystal is held by surface tension in a nylon loop in a pin, containing the 
crystallisation precipitants and hydrophilic cryo-protectants (Teng, 1990), and submerged 
in liquid nitrogen (100K) for a rapid freezing mechanism. Flash freezing has the ability to 
greatly reduce the impact of X-ray radiation upon the crystal lattice, by absorbing up to 
70x more radiation than a crystal tested at room temperature, before significant 
degradation in the crystal order occurs (Nave & Garman, 2005).   
2.5.3.1.3 Radiation damage  
Radiation damage is the consequence of X-ray radiation on the ordered lattice of 
the crystal, whereby the biological molecules absorb the X-ray radiation. The impact of X-
rays on the crystals can cause heating, breakage of disulphide bonds and production of 
free radicals, which can cascade through the crystal causing damage (Garman, 2010). 
Before the introduction of cryo-protection and flash freezing, biological crystals 
were exposed to x-rays at room temperature. The high radiation dose in the crystals 
meant that multiple crystals needed to be exposed in order to collect sufficient data.  The 
introduction of cryo-protection and flash freezing in 1990 reduced the need for multiple 
crystals to be exposed and simplified the transportation requirements. The cryogenic 
temperatures used slow the radical species produced, allowing time for the data to be 
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collected, before radiation can induce disorder in the crystal lattice (Garman, 2010). 
Another direct benefit is that only one crystal often needs to be used to collect an entire 
dataset. 
In summary, the use of cryo-protectants and flash freezing has contributed to 
improving the data quality and reducing radiation damage, however some considerations 
must be employed when using both methods. Cryo-protectant must be optimised as it has 
the potential to impact on and damage crystal formation and in the worst case scenario to 
dissolve the crystals; flash-freezing has been reported to have the potential to cause 
crystal contraction, causing significant change in the molecular packing and perturbation 
in the crystal lattice (Juers & Matthews, 2001).    
2.6 Lipopolysaccharides (LPS) 
Various bacterial Lipopolysaccharides (LPS) were investigated as natural ligands 
for ligand bound structural studies with rfhSP-D: Escherichia coli J-5 LPS (Sigma-Aldrich-
L5014), Salmonella enterica (serotype minnesota) R5 (Enzo Lifesciences- ALX-581-017-
L002) and R7 (Enzo Lifesciences ALX-581-018-L002) and Haemophilus influenzae Eagan 
CA7 LPS was provided by collaborators; Mary E. Deadman and Derek W. Hood at 
Mammalian Genetics Unit, MRC Harwell, Harwell Science & Innovation Campus, 
Oxfordshire, United Kingdom.  
 LPS in Crystallography 
In crystallography the evaporation method (for crystal production) requires a liquid 
phase, composed of protein solution, buffer precipitant and water. The liquid phase 
creates a problem when dealing with LPS as its amphipathic nature makes it relatively 
insoluble in solution. As described in 1.2, the LPS is composed of a hydrophobic lipid A 
linked to a hydrophilic core and O-antigen (when present). The glycosidic bond linking the 
lipid A and the rest of the LPS is labile. The method used in this thesis for the delipidation 
of the LPS into PS was mild acid hydrolysis. 
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 Hydrolysis of LPS 
The LPS were hydrolysed and the Lipid A was removed, leaving the PS of interest.  
The chemical hydrolysis was performed for the Escherichia coli J-5 LPS, Salmonella 
minnesota R5 LPS and Haemophilus influenzae Eagan CA7 LPS. The hydrolysis method 
is a chemical reaction that occurs by the action of a mild acid. The hydrolysis of LPS 
breaks the glycosidic bond holding the lipid A and the remaining of the polysaccharide 
together, yielding water molecules and two separate fractions that can be separated by 
centrifugal action (Morrison & Leive, 1975). The hydrolysis method was carried out 
various times for the different LPS, with ≈ 80% hydrolysis yield (expected weight PS/ 
measured weight PS x100) typically achieved. 
2.6.2.1 Hydrolysis Method 
Preparation of the PS from LPS is achieved by the hydrolysis method reported in 
Masoud et al., 1994 and Masoud et al., 1997, where the method of using 2% aqueous 
acetic acid and refluxing it at 100° C for 2.5 hours is performed. The LPS is a very light 
and fluffy white powder and care was taken when weighting 10-25 mg. The weighed LPS 
was then added into a 25 ml round bottom flask, containing a magnetic stirrer. To this 5 ml 
of 2% acetic acid was added and gently stirred using a magnetic stirrer device.  The round 
bottom flask was then attached to the reflux condenser and placed in a sand bath at 100° 
C; a thermometer was used to regularly check the temperature. The hydrolysis timing 
started when the temperature of the sand bath reached 100° C and was left for 2.5 hours.  
After that time the heating was turned off and the round bottom flask was raised out of the 
sand bath and allowed to cool. Once the round bottom flask had cooled sufficiently, the 
water reflux condenser was switched off. The contents of the round flask were then 
transferred into a 15 ml plastic centrifuge tube and left to cool further in the fridge for 30-
60 minutes at 4° C. The centrifuge tubes were then placed in a centrifuge (HERMLEZ400) 
and centrifuged at the top speed of 2424 g for 30 minutes at 4° C.  The top supernatant 
was carefully removed using an automatic pipette and transferred into another storage 
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tube, without disturbing the pellet. The pellet was then re-dissolved and re-suspended in 1 
ml of deionised water and further centrifuged a further two times as mentioned above. 
Upon the completion of the second and third spin, 1 ml of each supernatant was removed 
from the centrifuge tubes and added to the storage tube containing the PS. The storage 
tube containing the PS was placed in a savant speed vacuum and lyophilised into a dry 
powder to be weighted out. 
2.6.2.2 Acetic Mild Acid Hydrolysis - Impact on LPS structure 
The use of mild acid hydrolysis has been suggested to cause a structural and 
chemical rearrangement of the normal 3-Deoxy-α -D-manno-oct-2-ulosonic acid (Kdo), 
especially in LPS species with a single Kdo, such as H. influenzae, with no reported 
information regarding LPS with two or more Kdos, such as is the case for E .coli and S. 
minnesota. Hydrolysis causes the normal 6-membered Kdo ring to rearrange into a 5-
membered ring anhydro Kdo. This novel 5-membered anhydro Kdo has been visualised in 
X-ray diffraction data (Clark et al., 2016) where the best electron density model fit for the 
Kdo was a 5 membered cyclic 4,7 anhydro Kdo derivative. Mild acid hydrolysis impacts on 
the phosphate groups present on the heptoses and Kdo group of the inner core of the 
LPS (Danan et al., 1982; Auzanneau et al., 1991), with a β-elimination of the phosphate 
group attached to the Kdo at position 4, leading to the pyranose ring opening and 
subsequent 4,7 ring closure (Masoud et al., 1997; Clark et al., 2016). The position 4 of 
the Kdo in E. coli and S. minnesota LPS is normally linked to the KDO-II. The ability of 
acetic acid mild hydrolysis to impact on the structure of LPS during the delipidation stage 
does create some uncertainty in terms of the physiological validity of the rfhSP-D 
interactions with the LPS. At present, only a few methods have been reported, such as 
sonication and hydrogen fluoride, to solubilise LPS without using hydrolysis. Due to the 
necessity of solubilising LPS in order to visualise the natural interactions between rfhSP-D 
and LPS, some time was spent investigating and testing potential methods to solubilise 
the full LPS. 
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 Triton X-100 and Absolute Ethanol 
Triton X-100 (Sigma-Aldrich) is a non-ionic detergent composed of an aromatic 
hydrocarbon (hydrophobic group) and polyethylene oxide chain (hydrophilic group) with a 
reported non-denaturant nature (le Marie et al., 2000), important when co-crystallising the 
LPS with rfhSP-D. Absolute ethanol is also an amphipathic molecule consisting of an ethyl 
group linked to a hydroxyl group. Ethanol has been reported to have aided in the 
solubilisation of smooth LPS (Sharma et al., 2013). The potential of both amphipathic 
molecules was investigated in three separate experiments. 
2.6.3.1 The solubilisation mechanism in polar solutions – like dissolves 
like 
The introduction of a non-polar group into a solution containing water molecules 
disrupts the hydrogen bonding network of the H2O molecules and increases the entropy 
(ordered systems have low entropy) in solution (Ahmed et al., 2016; Privalov & Gill, 
1989), resulting in the aggregation of non-polar solutes and limited solubilisation potential. 
At low concentrations, LPS could in theory be solubilised in solution, forcing the water 
molecules into creating a “cage” or hydration shell surrounding the hydrophobic lipid A. 
Fatty acids, which are normally poorly hydrated are limited to a low concentration that can 
be incorporated in solution. The concentration of hydrophobic solutes and the number of 
hydration shells and water molecules available for hydration have also been reported to 
be inversely correlated (Di Tommaso et al., 2014; Hsieh & Wu, 1996; Raschke & Levitt, 
2005; Xu & Dill, 2005; Schmid, 2001). 
The low concentration of LPS that can be incorporated into solutions is the main 
reason why the hydrolysis of the LPS is performed, in order to increase the concentration 
of the soluble PS in solution. The concentration of ligand in solution often needs to be in 
excess of the concentration of the protein in order to achieve significant binding. 
Increasing the concentration of the LPS without using hydrolysis leads to the precipitation 
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Hydrophilic Hydrophobic 
Fig. 2.8 A representation of the Triton X-100 molecule. The picture on the left shows a 
2-D representation of the molecule and the image was produced using CHEMDRAW. 
The picture on right the shows a 3-D representation of Triton X-100 and the image was 
produced using CHEMBIO3D ULTRA. The hydrophilic polyethylene oxide chain can be 
repeated 9-10 times, while the hydrophobic component is made up of the aromatic 
hydrocarbon group.  
and non-solubilisation of the LPS, with eye visible “chunks” of LPS in suspension, 
irrelevant for the actual concentration in solution, as its solubility or hydration shell limit 
has been exceeded.  The idea was to use both amphipathic molecules to increase the 
solubility (and concentration) of LPS in solution with rfhSP-D, in the hope that a protein 
co-crystal would form with the LPS bound to the rfhSP-D CRD.   
2.6.3.2 Triton X-100 
Triton X-100 is a non-ionic surfactant/detergent consisting of a hydrophilic 
polyethylene oxide chain (repeated 9-10 times) and a hydrophobic aromatic hydrocarbon 
group.  Triton X-100 surfactant is a non-denaturant, with no reported impact on protein 
structure (Fig. 2.8) (le Marie et al., 2000). Triton X-100 is widely used in the solubilisation 
of lipid bilayers and in the isolation of integral membrane proteins (le Marie et al., 2000).  
An important feature when using surfactant Triton X-100 is to understand its critical 
micellar concentration (CMC).  
A micelle is an aggregate of surfactant molecules dispersed a polar liquid. The 
micelle forms colloidal-sized clusters in solutions, where the hydrophilic component is in 
contact with the polar solvent, while the hydrophobic group is sequestrated in the centre of 
the micelle. Each surfactant exhibits a specific CMC below which the surfactants are 
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Fig. 2.9 A representation of the surfactant Triton X-100 in a polar solution. Below the 
CMC the surfactants will be found in solution as monomers. When the concentration of 
surfactant is above the CMC specific to the surfactant, the monomers in solution will 
come together forming a micelle.  Image produced using Lichtenberg et al., 2013 as a 
source.  
present in solution as monomers and individual chains; if the concentration of surfactants 
in solution is greater than the CMC, they come together forming a micelle (Fig. 2.9). The 
formation of micelles is dependent on the specific surfactant used, as these vary in 
hydrocarbon molecules chemistry and length, with different packing effects and hydration 
shells, producing varying CMCs (Heerklotz et al., 1997; Lichtenberg et al., 2013). The 
CMC for triton X-100 has been reported to be ≈ 0.25 mM (le Marie et al., 2000). 
 
 
 
 
 
2.6.3.3 Absolute Ethanol 
Absolute ethanol is a pure form of ethanol, containing less than 1% of H2O 
molecules and is composed of an ethyl group linked to a hydroxyl group (Fig. 2.10). 
Ethanol ranks high in the polarity index (a measure of how it interacts with various polar 
solvents) (Torres et al., 2011) with the ability to impact on the solubility of lipids in the cell 
membrane (Sun & Sun, 1985) and in increasing dispersion properties of lipid molecules 
of poorly water soluble drugs (Sek et al., 2006), making it a good candidate for the LPS 
solubilisation trials.  
Ethanol has been reported to have a detrimental effect on protein structures, by 
denaturing the protein and altering hydrophobic interactions. Ethanol’s denaturing 
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Hydrophilic Hydrophobic 
Fig. 2.10 A representation of an ethanol molecule. The picture on the left shows a 2-D 
representation of the molecule produced using CHEMDRAW. The picture on the right 
shows a 3-D representation of Triton X-100 and the image was produced using 
CHEMBIO3D ULTRA.   
properties have been investigated in hen egg white lysozyme, where up to 63% ethanol 
(v/v) did not induce conformational changes in the protein structure, with lysozyme protein 
molecules reported to have increased repulsive electrostatic forces. Above 63% of ethanol 
(v/v) concentration led to conformational changes in lysozyme, including the 
transformation from an α-helix-rich structure to a β-sheet rich structure, or rod-like 
structures with a high content of α-helices (Tanaka et al., 2001; Pace et al., 2004). The 
above suggests that the concentration of ethanol used will have to be rather low so not to 
impact on the structural organisation of rfhSP-D.  
 
2.6.3.4 Triton X-100 and absolute ethanol in combination with LPS  
Triton X-100 and absolute ethanol have been investigated and reported in the 
literature to interact with LPS.  Triton X-100 has been reported to have the ability to 
associate into micelles containing Triton X-100 and LPS molecules (Weiser et al., 1967). 
Triton X-100 has also been shown to have the ability to impact on the ratio of micelles to 
monomers of LPS, with a high concentration of detergent used yielding more monomers 
than micelles, disrupting the LPS micelle structure (Jang et al., 2009). This disruption of 
the LPS micelles, when Triton X-100 is used above the CMC, occurs by means of non-
polar interactions between the alkyl chains of LPS and Triton X-100 (Li et al., 2004). 
Ethanol has been reported to have been used in crystallisation attempts of peptidoglycan 
recognition protein in combination with LPS. In the reported crystallisation the crystals of 
peptidoglycan protein were soaked for over 48 hours in a solution containing 30% 
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precipitant buffer and 30% ethanol, into which the LPS was dissolved at approximately 
20mg/ml (Sharma et al., 2013). 
2.6.3.5 Impact of Triton X-100 and Ethanol on LPS solubility 
The determination of the success of solubilising LPS in Triton-X-100 and/or 
absolute ethanol was assessed by three key conditions: (1) did a specific concentration of 
triton X-100 and/or a % (v/v) of absolute ethanol improve the solubility of the full LPS, 
evaluated by means of direct observations using light microscopy? (2) where the first 
condition was met, did the specific concentration of triton X-100 and/or % (v/v) of absolute 
ethanol in combination with specific LPS and rfhSP-D yield protein crystals? (3) where the 
first and second conditions were met; was there any bound ligand present and what was 
the preference of crystal packing (space group)?  The introduction of LPS rich in fatty 
acids (4-6 hydrocarbon chains composed of 12-14 carbon atoms each) (Kabanov & 
Prokhorenko, 2011) into a polar solution creates a hydrophobic effect. LPS can be 
presented in a membrane bound form or as free LPS, where the free LPS often contains a 
low CMC, dependent on the length of LPS (smooth vs rough) (Parikh & Chorover, 2007).  
In these experiments free LPS was used. The introduction of free LPS into a polar 
solution will create a hydrophobic effect (Fig 2.11), where the hydrophilic component (core 
and O-antigen if present) will be able to hydrogen bond with water molecules, while the 
hydrophobic lipid A will have limited hydration by water molecules. At a high concentration 
(above CMC) the LPS will assemble into micelles, where the lipid A is internalised and 
excluded from the polar solvent (Parikh & Chorover, 2007). When considering the LPS it 
is important to highlight that the Lipid A is highly conserved, with its chemical structure 
commonly composed of two phosphorylated glucosamine units typically acylated with four 
to six fatty acids (Wang et al., 2015; Frecer et al., 2000). The remainder of the LPS, 
which normally includes Kdo, heptose, glucose and galactose, is hydroxyl rich and able to 
form hydrogen bonds with polar solutions and so able to solubilise in solution (Parikh & 
Chorover, 2007). Smooth LPS, containing the hydrophilic O-antigen, has a higher 
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A B 
No hydrogen bonding between non-
polar hydrocarbons and polar water 
molecules 
First hydration shell. 
Second hydration 
shell. 
 Hydration shells. 
Fig 2.11 A- Image adapted from Que et al., 2000. This is a representation of the 
hydration of lipid A by water molecules. Blue stars represent water molecules solvating 
the hydrophobic fatty acids and interacting with other water molecules without any 
hydrogen bonding occurring between water molecules and the hydrocarbons. Orange 
stars represent water molecules which interact with other water molecules and are 
placed to hydrogen bond with the hydrophilic components of the Lipid A. Inside the 
small orange boxes are the components of the lipid A able to form hydrogen bonds with 
the water. B- Hydration shells surround the LPS hydrocarbon without any interaction 
between the two. The first hydration shell water molecules are ordered by the second 
shell, which in turn are ordered by the third shell and so on. The number of hydration 
shells is dependent on the number of hydrophobic solutes in solution and the number 
of water molecules available. Image produced using CHEMBIO3D ULTRA. 
hydrophilic to hydrophobic ratio, higher CMC and higher solubility compared to rough LPS 
which lacks the O-antigen (Park et al., 2009; Kabanov & Prokhorenko, 2011). 
 
The introduction of LPS into a polar solution is limited to a small hydration potential 
and a small concentration of LPS (Fig 2.11). The lipid A exhibits little hydrogen bonding 
potential, with the glucosamine units reported to consist of 27 hydrogen bond acceptor 
atoms, including 8 of which are also hydrogen donors, with on average approximately 18 
hydrogen bonds being made with the water molecules. Over 50% of all the hydrogen 
bonds occur by means of the phosphate groups in the di-glucosamine, while the 6 
carbonyl groups provide approximately 16%. The di-glucosamine hydroxyl groups offer 
limited hydrogen bond potential (Murzyn & Pasenkiewicz-Gierula, 2015), see Fig 2.11. 
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The LPS core region and O-antigen (if present) offer a much higher hydrogen 
bonding potential. The phosphate groups have been reported to produce a pattern of 
negative molecular electrostatic potential, allowing engagement in electrostatic 
interactions or hydrogen bonding with polar solvents or cations (Frecer et al., 2000a). The 
hydration of the LPS in a polar solvent will be dependent on its concentration, with a 
limited number of LPS molecules that can be accommodated in the “cages” surrounded 
by hydration shells of water molecules. These LPS molecules will be organised through 
repulsion of the polar water molecules (first hydration shell) by the lipid A fatty acids and 
by means of van der Waals interactions between them (Chandler, 2005).  In the first 
hydration shell water molecules will reorganise themselves and optimise hydrogen 
bonding with neighbouring water molecules, with no interaction between hydrophobic 
solutes and the first hydration shell water molecules (Fig 2.11B) (Chaplin, 2007; Ahmed 
et al., 2016; Tomlinson-Phillips et al., 2011).  
The solubility of hydrophobic solutes such as LPS is influenced by the nature and 
extent of how they group together, especially for a high concentration of LPS where all the 
molecules are trying to be accommodated in “cages” surrounded by a fixed and limited 
number of polar molecules. This is expected to create a negative order (high entropy) and 
favour precipitation/insolubility of the LPS. However, the grouping of the hydrophobic 
solutes together increases the solvation of the hydrophobic solutes thus decreasing the 
entropy and increasing the solubility. The coming together of hydrophobic residues 
increases the order in the system, suggesting that the solute-water interactions do not 
contribute to the solubility potential, but instead the solute-solute interactions are the main 
reason for the limitation in aqueous solubility of hydrophobic solutes in a polar solution 
(Privalov & Gill, 1989; Zhang & Gobas, 1995; Ruelle et al., 1994). 
The introduction of the Triton X-100 and/or absolute ethanol in combination with 
the LPS into an aqueous solution will initially contribute to the disruption of the hydrogen 
bonding of ordered molecules as both molecules have a hydrophobic component. This 
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Hydrophobic Hydrophilic 
Forced together (hydrophobic forces) 
HB 
HB 
Fig 2.12 Not to scale. A representation of the proposed mechanism on how Triton X-
100 and absolute ethanol can aid in the solubility of LPS in polar solutions. In Fig 
2.10B there was no hydrogen bonding between the hydrocarbons and the water 
molecules. By being forced together, the hydrophobic fatty acids and the hydrophobic 
components of both molecules could allow the hydrophilic components of Triton X-100 
and absolute ethanol to hydrogen bond with water molecules, increasing the order in 
solution and the LPS solubility. Image produced using CHEMBIO3D ULTRA.  
forces the hydrophobic regions of both lipid A and Triton X-100 and/or absolute ethanol to 
group together, minimising the surface area in contact with the polar solvent. The 
hydrophilic components of Triton X-100 and absolute ethanol form the maximum possible 
number of hydrogen bonds with water molecules in the first hydration shell, (Lazaridis & 
Paulaitis, 1992; Skvarla, 2001), see Fig 2.12.  The concentrations of Triton X-100 and 
ethanol should not exceed their reported CMC. At the CMC, the number of monomers 
available to interact with the lipid A is maximised.   
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Chapter 3 - Ligand binding structural studies of co-crystallised 
rfhSP-D and H. influenzae Eagan CA7 PS 
3.1 Introduction  
The crystallographic studies performed in this chapter were aimed at producing co-
crystallised protein crystals of a recombinant fragment of human SP-D (rfhSP-D) in 
complex with Haemophilus influenza Eagan CA7 polysaccharide (delipidated - minus lipid 
A) to investigate the recognition mechanism and structural interactions between protein 
and ligand. A similar and shorter LPS than CA7 LPS has been previously investigated in 
our research group, H. influenzae Eagan 4A PS (delipidated), containing Kdo-HepI-GlcI 
and it was demonstrated that the preferential binding occurs through the HepI (Clark et 
al., 2016). The binding of the HepI was similar to previous reported binding of heptose 
sugars (Wang et al., 2008), where the rfhSP-D recognised the Eagan 4A LPS through the 
O6’ and O7’ hydroxyls groups of HepI. Binding affinity studies using rfhSP-D with Eagan 
4A (1 Hep), CA7 (2 Heps) and Wild-Type (3 Heps) H. influenzae LPS, have demonstrated 
that the binding affinity of rfhSP-D is higher for the Eagan 4A (established by sugar 
competition assays with the results calculated through ELISA analysis), with the increase 
of branching and heptoses in CA7 and wild-type yielding reduced binding affinity in 
comparison with the Eagan 4A (Clark et al., 2016). Strains containing more heptoses 
induced stronger inflammatory responses in mice models, suggesting that H. influenzae 
has developed the ability to shield the core from immune surveillance and that the binding 
and recognition of core saccharides by SP-D seems more favourable when compared to 
the non-core saccharides. The study of rfhSP-D with CA7 LPS offered the opportunity to 
investigate the preference of rfhSP-D binding for terminal outer core saccharides (Glc) or 
the non-terminal inner core saccharides (HepI and HepII) and the opportunity to 
characterise the binding and orientation of the ligand. Both terminal and non-terminal 
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oligosaccharides have been suggested as the primary site of binding and recognition of 
LPS by SP-D.   
 H. influenzae Eagan wild-type type b LPS 
H. influenzae Eagan type b is a typeable strain with the ability to cause various 
different disease (King, 2012), especially in infants between 6-12 months of age, with 
80% of all H. influenzae induced disease occurring in the first five years of life 
(Hambleton & Davies, 1975). The LPS of H. influenzae has been shown to be able to 
cause symptoms without the presence of the whole organism, suggesting that the LPS 
holds the toxicity in H. influenzae (Syrogiannopoulos et al., 1988). The LPS from H. 
influenzae Eagan has been suggested to have the ability to mimic human glycolipids and 
the ability to reversible switch its terminal epitopes (phase variation) in the oligosaccharide 
portion (Li et al., 2001). The mimicking of the hosts epitope Galα1-4Gal disaccharide by 
means of presentation in the LPS allows H. influenzae bacteria to become resistant to 
killing, masking it from the immune system (Weiser et al., 1998). Phase variation allows 
for the position of the carbohydrates to be varied, including the pattern of non-
carbohydrate components such as phosphate substituents, O-acetyl groups and ester 
linked glycine moieties (Schweda et al., 2007). The phase variation is proposed to be an 
evolutionary mechanism that allows for the survival of the bacteria by means of rapid 
adaptation to the changing microenvironments in the host (Hood et al., 1999).  Phase 
variation occurs by the loss or gain of one or more of the four base repeats during DNA 
replication by means of slipped-strand misparing, producing frame shifts and resulting in 
high frequency phase variation of the oligosaccharide core (Fox et al., 2005; Hood et al., 
1996). This high frequency phase variation is the main reason why the H. influenzae LPS 
biosynthesis is considered diverse. This results in the carbohydrate structure and non-
carbohydrate substituents varying and affecting the recognition of the LPS structures by 
the host immune system, with a positive effect on the biological properties of the organism 
(Raetz & Whitfield, 2002). The capsule of typeable H. influenzae surrounds the OM of 
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the bacteria and in H. influenzae Eagan type b it is composed of five-carbon sugars 
(ribitol). Capsular expression is limited to one capsular serotype per clone of H. 
influenzae, with no signs of antigenic variation; only the quantity or thickness of the 
capsule seems to vary between individual bacteria (Crisel et al., 1975; Corn et al., 1993).  
The H. influenzae Eagan Wild-Type LPS structure was first reported in 1997 to be 
composed of a lipid A glycosidically linked to a single Kdo, which in turn is linked to HepI 
(Fig. 3.1). The inner core structure contains a trisaccharide heptose with each heptose 
substituted by a hexose residue. Kdo, HepII and HepIII were shown to be phosphorylated 
by either phosphoethanolamine (PEA) or by a phosphate group (P). The Kdo can have a 
PEA or P group in position 4, giving rise to two subpopulations. H. influenzae antigenic 
diversity is seen in the various epitopes reported for HepII, with Hex4 (Glc-Glc), Hex5 
(Gal-Glc-Glc) and Hex6 (Gal-Gal-Glc-Glc) all reported to be present. The Hex 6 terminal 
structure is Gal-Gal similar to Pk blood group antigen (Massoud et al., 1997). 
 
 
 
 H. influenzae Eagan 4A and CA7 mutant LPS 
H. influenzae Eagan 4A PS has been used in structural studies in combination with 
rfhSP-D (PDB: accession code 4E52). The Eagan 4A PS used in the structural studies 
contained a trisaccharide of Kdo-HepI-Glc, where the Kdo structure suffered 
Kdo I Hep I Glc I 
PPEA 
Lipid A 
Hep II PEA Glc II Glc III 
Hep III 
Gal II Gal III 
Gal I P 
	
 
 
 
 
 
 
 
a1,5 b1,4 
4 
a2,6 
a1,3 
6 
4 b1,2 
 
b1,4 b1,4 a1,4 a1,3 
a1,2 
Hex6 Hex5 Hex4 
Fig. 3.1 H. influenzae Eagan Wild-Type LPS. In this LPS 3 hexoses are possible as 
extensions from the HepII. In dotted lines (orange) the CA7 LPS is shown. Glc - 
Glucose; Hep - L-D-Heptose, Kdo - 3-deoxy-D-manno-octulosonic acid; Gal - 
Galactose; P - Phosphate; PEA - Phosphoethanolamine. Image adapted from 
Masoud et al., 1997. 
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conformational changes upon the delipidation of Lipid A and loss of the P or PEA group in 
position 4, see 2.6.2.2 for more information. Mutant CA7 PS was used in the co-
crystallisation attempts in combination with rfhSP-D. The CA7 mutant LPS used in this 
experimental work in comparison with the Eagan 4A LPS contains an extra Hep (HepII) 
phosphorylated by a PEA, with no hexose extensions off HepII (Fig. 3.2). CA7 Eagan LPS 
is produced by a orfH deletion, impacting on the addition of Glc to HepII (Fig. 3.2) (Hood 
et al., 1996a).      
3.2 Results 
The aim of the experiments reported in this chapter was to co-crystallise rfhSP-D 
and CA7 PS bound together in order to investigate by means of X-ray diffraction the 
binding interactions between CA7 PS and rfhSP-D in detail. All the crystallisation 
experiments detailed in this chapter were carried out at Huxley Building, Keele University, 
Staffordshire. All data collection took place at Diamond Light Source (DLS), Diamond 
House, Harwell Science and Innovation Campus, Fermi Ave, Didcot, Oxfordshire. Protein, 
LPS and buffer constituents.  
 Protein, LPS and buffer constituents 
rfhSP-D supply, purification and preparation were performed as previously 
described in 2.4.1. The rfhSP-D batch used in combinations with CA7 PS was prep-2 and  
the structure/industrial screens were from Molecular Dimensions. 
Fig. 3.2 The Eagan 4A LPS containing a trisaccharide Glc-Hep-Kdo linked to the Lipid 
A and with Kdo phosphorylated by either Phosphate and/or Phosphoethanolamine. 
The LPS from Eagan CA7 containing an extra phosphorylated HepII in comparison to 
the 4A LPS is displayed. Glc - Glucose; Hep - L-D-Heptose, Kdo - 3-deoxy-D-manno-
octulosonic acid; P - Phosphate; PEA - Phosphoethanolamine. 
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 Hydrolysis of CA7 LPS 
The hydrolysis of Eagan CA7 LPS was performed according to the method 
previously described in 2.6.2 and was performed by Ian Burns in our research group. The 
supplied Eagan CA7 LPS molecular weight was calculated by the addition of individual 
glycoconjungates and lipid A, yielding a molecular weight of approximately 2856 Da, with 
Lipid A (1800 Da) accounting for 63% of the Mw (Que et al., 2000). 10 mg of CA7 LPS 
were hydrolysed and yielded 8 mg of PS. This value may be an overestimation with the 
potential for some of the Lipid A to be present in solution with the PS. The 8 mg were 
dissolved in 100 µl of deionised water and produced a concentration of 40 mM for storage 
and to be used in the co-crystallisation attempts with rfhSP-D. 
 Co-crystallisation of rfhSP-D and CA7 PS  
The co-crystallisation of rfhSP-D in combination with CA7 PS was performed 
according to the methods described in 2.5. The final crystallisation drop was composed of 
a 1:1 ratio of specific precipitant buffers and rfhSP-D at 7.5 mg/ml (0.42 mM), CA7 PS at 
10 mM and Ca2+ concentration at 5 mM in the drop.   Structure screens 1 and 2 (SS1 and 
SS2) were initially used to establish growth conditions. If positive results were achieved 
(crystal growth), follow ups were carried out where the initial conditions were varied 
slightly in order to improve crystal morphology and in order to identify the best precipitant 
conditions. Follow ups consisted of the refinement of the initial conditions in the SS1 and 
SS2, in order to find the optimum environment to produce suitable high resolution crystals 
for X-ray diffraction. A total of 2 µl was placed in the micro-bridge, with the CA7 PS in 
excess of the number of rfhSP-D monomer binding sites by 23.8 x (molar excess), with 
the aim of ensuring that the ligand bound to rfhSP-D with high occupancy.   
3.2.3.1 Initial structure screens 
Five 24-well Linbro plates were initially set down on 17/12/2013 containing SS1 
and SS2 with the following tray codes, RS20, RS21, RS22, RS23 and RS24, and 
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containing the 100 structure screen buffer precipitants and rfhSP-D at 7.5 mg/ml in 
combination with CA7 PS at 10 mM (23.8x ligand molecular excess to rfhSP-D monomer). 
Positive crystal growth was achieved for structure screen 1 condition 5 (tray RS20, well 
A5), structure screen 1 condition 28 (tray RS21, well A4), structure screen 1 condition 40 
(tray RS21, well C4), structure screen 1 condition 44 (tray RS21, well D2) as shown in 
Table 3.1. SS1 conditions 5, 28 and 44 gave the most promising looking crystals. 
Condition 5 produced crystals resembling thin squares, condition 28 and 44 produced 
crystals with variety of shapes, including rectangles and small squares. 
3.2.3.1.1 SS1 condition 5: RS20 A5 
SS1 condition 5 produced various crystals suitable for X-ray diffraction and 3 
crystals were collected and frozen for testing at Diamond Light Source. This condition 
produced mostly multiple layered squares and some singles ones shown in Fig. 3.3  
 
 
Well ID Comments and conditions 
RS20 
A5 
This well was set down on 17/12/2013. The condition used in this well comes 
from SS1 condition 5. This well contained 0.1 M Na acetate pH 4.6 and 2.0 M 
Ammonium Sulphate. 
RS21 
A4 
This well was set down on 17/12/2013. The condition used in this well comes 
from SS1 condition 28. This well contained 0.1 Na Hepes pH 7.5 and 0.8 M 
NaH2PO4/ H2KO4P 
RS21 
D2 
This well was set down on 17/12/2013. The condition used in this well comes 
from SS1 condition 44. This well contained only 2.0 M Ammonium sulphate. 
RS21 
C4 
This well was set down on 17/12/2013. The condition used in this well comes 
from SS1 condition 40. This well contained 0.2 M Ammonium Phosphate 
Monobasic, 0.1 M Tris pH 8.5 and 50% MPD.  
Table 3.1 The initial SS1 co-crystallisation trial wells that showed positive crystal growth 
 
Fig 3.3 The typical morphology 
produced in the RS20 A5 well is 
displayed, with various crystals 
produced resembling thin and often 
multiple square plates.  
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3.2.3.1.2 SS1 condition 28: RS21 A4 
 SS1 condition 28 produced multiple crystals with a total of 8 crystals cryo-
protected and stored in liquid nitrogen to be tested at the DLS. Squares and triangles 
were the typical morphology seen and shown in Fig. 3.4. RS21 A4 crystals took over 8 
months to grow and when the crystals were seen, limited quantities of CA7 PS were 
available and so this condition was not followed up any further. 
3.2.3.1.3 SS1 condition 44: RS21 D2 
Similar to the RS21 C4 well, RS21 D2 initially produced promising results with 
nucleation and crystal growth observed and a follow up was produced, RS34 (discussed 
below). The initial nucleation and crystal growth was somehow halted, with no further 
crystal growth or new nucleation occurring as time passed. This was rather surprising, 
especially considering that the follow up RS34 yielded various crystals in a short period of 
time.  
3.2.3.1.4 SS1 condition 40: RS21 C4 
RS21 C4 well (and follow up RS33) wells initially produced promising results 
where nucleation and crystal growth was observed. However, as time passed it became 
evident that no further nucleation and growth was occurring, with only a few small 
Fig. 3.4 The typical morphology of the crystals grown in the RS21 A4 well is shown. 
This well was particular successful in growing crystals. Even though many crystals 
grew over time, the majority of crystals diffracted to a very low resolution.  
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nucleated crystals produced and not suitable for X-ray diffraction. Both trays were 
regularly examined for over three years, with no further crystal growth observed.  
3.2.3.2 Follow up screens 
Positive crystals growth in SS1 and SS2 conditions were followed up in order to 
find the optimum environment to produce suitable high resolution crystals for X-ray 
diffraction. The concentration of rfhSP-D and CA7 PS remained the same in the drop as in 
the SS1 and SS2 co-crystallisation attempts, producing a 23.8 x ligand molecular excess 
to rfhSP-D monomer. Three out of the four positive hits from the initial structure screens 
were followed up as shown in Table 3.2, where each precipitant buffer was varied slightly 
in order to optimise the crystal growth.  
 
The final positive indication from the structure screen, RS21 A4, resulted in 
positive crystal growth, but unfortunately it took over 8 months for the crystals to develop 
and at that time limited quantities of CA7 LPS were available and so it was decided not to 
follow up the condition. In total 11 24-well Linbro plates were produced and ≈ 150 
precipitant buffers and/or variations investigated. 
SS tray ID and well Follow up tray Initial conditions and variations 
RS20 A5 (SS1 5) RS32 This well was set down on 14/02/14. SS1 
condition 5 contained 0.1M Na acetate pH 4.6 
and 2.0M Ammonium Sulphate. In the follow up a 
3 by 3 (9 wells) were produced, where the pH of 
the Na acetate and concentration of Ammonium 
Sulphate were varied, pH 4.3, 4.6 and 4.9; and 
1.8M, 2.0M and 2.2M respectively.  
RS21 C4 (SS1 40) RS33 This well was set down on 14/02/2014. SS1 C.40 
contained K/Na tartrate 0.4M. In the follow up 3 
wells were produced with varying concentrations 
of K/Na tartrate, 0.35M, 0.4M and 0.45M.  
RS21 D2 (SS1 44) RS34 This well was set down on 13/3/2014. SS1 C.44 
contained 2.0M Ammonium Sulphate. The follow 
up 3 wells were produced with varying 
concentrations of Ammonium Sulphate, 1.8M, 
2.0M and 2.2M. On the 19/3/14 another 2 wells 
were made at 2.0M ammonium sulphate (B2 and 
C2).  
Table 3.2 The three follow up trays produced from the initial positive hits in SS1. 
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3.2.3.2.1 Follow up to SS1 RS20 A5: RS32 
RS32 was produced as a follow up from RS20 A5. In this tray a 3 by 3 screen was 
produced, shown in Table 3.3. This follow up proved to be very successful as all 9 wells 
produced protein crystals. The crystals produced were often multiple or layered, with a 
few single crystals. In total over 30 crystals were collected from the different wells and 
exposed at DLS. The typical morphology of the crystals resembled thin squares plates, 
with triangles and irregular shaped crystals also seen; see Fig. 3.5 for the typical 
morphology of crystals produced. All the crystals exposed from this tray were shown to be 
protein. RS32 A1 well (in combination with RS34 B2 – see below) produced some of the 
crystals with the best diffraction and resolution achieved. 
 
3.2.3.2.2 Follow up to SS1 RS21 D2: RS34 
RS34 tray was produced as a follow up from RS21 D2 well. In this tray 3 wells 
were initially set down, with two other wells added at a later date, see Table 3.4. Similar to 
 1 2 3 
 
A 
 
 
0.1M Sodium Acetate pH 4.3 
Ammonium Sulphate 1.8M 
0.1M Sodium Acetate pH 4.6 
Ammonium Sulphate 1.8M 
0.1M Sodium Acetate pH 4.9 
Ammonium Sulphate 1.8M 
 
B 
 
 
0.1M Sodium Acetate pH 4.3 
Ammonium Sulphate 2.0M 
0.1M Sodium Acetate pH 4.6 
Ammonium Sulphate 2.0M 
0.1M Sodium Acetate pH 4.9 
Ammonium Sulphate 2.0M 
 
C 
 
 
0.1M Sodium Acetate pH 4.3 
Ammonium Sulphate 2.2M 
0.1M Sodium Acetate pH 4.6 
Ammonium Sulphate 2.2M 
0.1M Sodium Acetate pH 4.9 
Ammonium Sulphate 2.2M 
Table 3.3 Tray RS32, the follow up to RS20 A5 (SS1 5). All wells produced protein crystals 
with RS32 A1 well produced some of the best diffraction (+ and resolution) of crystals - 
shaded in grey. 
A B 
Fig. 3.5 The typical morphology of the crystals produced in RS32 wells. Crystals 
were most often multiple with an undefined morphology. The brown precipitate in the 
solution is the CA7 PS. A RS32 well A3. B RS32 well B2. 
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Fig. 3.6 The typical morphology of the crystals produced in RS34 wells. Crystals 
were most often multiple with an undefined morphology. The brown precipitate in the 
solution is the CA7 PS in solution. A- RS34 well A2. B- RS34 well B2. 
B A 
the RS32 wells, RS34 wells were also very successful in producing many protein crystals, 
with all five wells producing various crystals. The crystals were shown to be most often 
multiple or layered, with only a few single crystals adequate for X-ray diffraction. The 
typical morphology of the crystals produced was also similar to that seen for the RS32 A1 
well, with mainly squares and triangles produced, see Fig. 3.6. A total of 12 crystals were 
collected and tested at DLS. RS34 B2 well (in combination with RS32 A1) also produced  
some of best resoltution achieved.  
3.2.3.2.3 Follow up to SS RS21 C4: RS33 
No suitable crystals were observed in either RS21 C4 or the follow up tray RS33, 
and these will not be discussed further.  
3.2.3.3 Cryo-protection of rfhSP-D and CA7 PS crystals 
3.2.3.3.1 Cryo-protection strategies 
Cryo-protection of crystals of interest was performed according to the method 
described in 2.5.4.1.1, where both strategy 1 and strategy 2 were employed. Over 50 co-
 1 2 3 
A Ammonium Sulphate 1.8M Ammonium Sulphate 2.0M Ammonium Sulphate 2.2M 
B  Ammonium Sulphate 2.0M  
C  Ammonium Sulphate 2.0M  
Table 3.4 Tray RS34, the follow up to RS21 D2 (SS1 44). All wells produced protein 
crystals. B2 and C1 were set down at a later stage 
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crystals of rfhSP-D and CA7 PS were cryo-protected and flash-frozen with X-ray data 
being collected in each case. 2-methyl-2,4-pentanediol (MPD) was chosen as sole cryo-
protectant to be used, as previous trials in our research group demonstrated that MPD is 
normally a good cryo-protectant for rfhSP-D crystals. Strategy 1 was initially used where 
increasing concentrations of MPD were added in 2 µl volume aliquots at 2 minute intervals 
to the micro-bridge. In this strategy each of the four different concentrations of MPD (5, 
10, 15 and 20%) contained 10 mM of CA7 PS in a solution which matched the particular 
well conditions. This strategy produced a final concentration of MPD of ≈ 20%, CA7 PS ≈ 
10 mM and Ca2+ ≈ 1.2 mM in the micro-bridge and this was used in the cryo-protection of 
crystals from RS20 A5 and from follow up RS32 C2. The cryo-protected crystals were 
subsequently looped out of the drop and stored in liquid nitrogen.  
Strategy 2 was employed in order to ration the limited quantity of CA7 PS while 
maintaining the CA7 PS present in micro-bridge at a reasonable concentration. Strategy 2 
was based on the addition of 0.5 µl (twice) of 50% MPD, with 2-minute interval between 
additions, with no CA7 PS in the cryo solutions. Strategy 2 produced a final concentration 
of MPD of ≈ 16.6%, CA7 PS ≈ 7 mM and Ca2+ ≈ 3.33 mM in the micro-bridge. Strategy 2 
was used in the cryo-protection of crystals from RS32 and RS34 follow ups. The cryo-
protected crystals were subsequently looped and stored in liquid nitrogen.   
3.2.3.3.2 RS20 A5 (SS1 - C5): Cryo-protection information 
The cryo-protection used for the SS1 condition 5 crystals (RS20 A5) was based on 
the strategy 1, where CA7 PS was soaked in together with the different concentrations of 
MPD (see Table 3.5). The cryo-protection was successful in cryo-protecting the crystals 
and no ice rings were detected during data collection. 
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3.2.3.3.3 RS32 (follow up to RS20 A5, SS1 - C5): Cryo-protection information 
In the RS32 tray both strategies for cryo-protection were applied. Strategy 1 
containing the PS CA7 as a soak Strategy 1 containing the PS CA7 as a soak (10mM) 
was initially used for the RS32 C2 well. Due to the limited stock of CA7 PS, strategy 2 was 
then chosen as a preferential choice for the remaining wells - RS32 A1,2,3; B1,2,3 and C1 
and 3. Cryo-protection by using both strategy 1 and 2 was rather successful, with most 
crystals tested showing no signs of ice rings. Only the crystals from the RS32 A1 well 
showed signs of some ice rings, suggesting poor cryo-protection. Due to the high number 
of crystals tested it is unfeasible to detail every single cryo-protection here; instead the 
information regarding the important well RS32 A1 will be given below. RS32 A1 well is of 
significant interest, as this produced a crystal RS32 A12 (crystal 2) used in the structure 
solution and molecular building of the CA7 PS into rfhSP-D model. 
The RS32 A1 well was cryo-protected with the MPD strategy 2. During the cryo-
protection the crystal seemed rather happy with the two additions of 50% MPD. However, 
in the diffracted data ice rings were visible, suggesting poor cryo-protection of the crystals 
in this well. The RS32 A12 crystal used in the structure solution at later stages also 
showed ice rings in the diffracted data. The method used to cryo-protect the RS32 A1 well 
is shown in Table 3.6. In strategy 2 no CA7 PS ligand was present in the solution.  
Well Conditions MPD % Volume (µl) Time in solution 
(minutes) 
Comments 
0.1 M Na 
Acetate pH 
4.6, 2.0M 
ammonium 
sulphate and 
CA7 PS at 
10mM. 
5 +2 2 The first cryo-
protection using 
a co-crystal of 
both rfhSP-D 
and PS CA7. 
10 +2 2 
15 +2 2 
20 +2 2 
20 +2 2 
20 -10 (solution 
reservoir) + 10 
of 20% MPD – 
Exchanged 
7 
Table 3.5. The cryo-protection performed in the RS20 A5 well. Strategy 1 was used as 
the cryo-protection method and included R5 PS at 10mM in each of the solutions of the 
5, 10, 15 and 20% MPD 
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Well Conditions 
+ 
MPD % Volume (µl) Time in solution 
(minutes) 
Comments 
0.1M Na 
acetate pH 4.3 
and 1.8M 
Ammonium 
Sulphate   
50 +0.5 ≈2 RS32 A12 
crystal seemed 
to sustain the 
additions of 
50% MPD  
50 +0.5 ≈2 
Table 3.6 The cryo-protection performed in the RS32 A1 well. Strategy 2 was used 
as the cryo-protection method with no ligand present in the 50% MPD cryo solution.  
3.2.3.3.4 RS34 (follow up to RS21 D2, SS1 - C44) – Cryo-protection 
information 
In RS34 tray only strategy 2 was used, where no CA7 PS was added during the 
cryo-protection stages. The crystals from this well were able to sustain the additions of 
50% (twice) MPD, with no signs of crystals degradation. The X-ray diffracted data also 
showed that the crystals were cryo-protected efficiently with no signs of ice in the 
diffraction images. Similar to the RS32 well, the high number of crystals cryo-protected 
and tested makes it unfeasible to detail every single cryo-protection. Instead, the cryo-
protection of the RS34 B2 well will be detailed below. This well produced a crystal, RS32 
B21 (crystal 1) used in structure solution and molecular building of the CA7 PS and the 
rfhSP-D model.  
The RS34 B2 well was cryo-protected with the MPD strategy 2. The crystals 
collected maintained their morphology during the cryo-protection stages, with the 
diffraction data suggesting successful cryo-protection. The method used for the cryo-
protection of RS34 B2 is shown in Table 3.7. The RS34 B21 crystal was present in the 
cryo for 6 minutes.  
Well 
Conditions 
+ 
MPD % Volume (µl) Time in solution 
(minutes) 
Comments 
2.0M 
Ammonium 
sulphate 
 
50 +0.5 ≈2 The RS34 B21 crystal 
seemed to sustain the 
additions of 50% MPD 50 +0.5 ≈2 
Table 3.7 The cryo-protection performed in the RS34 B2 well. Strategy 2 was used 
as the cryo-protection method, with no ligand present in the 50% MPD cryo solution. 
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 X-ray diffraction and Data collection 
Due to the high number of co-crystals tested only the crystals that yielded 
significant results will be discussed in detail. Successful data collection from crystals with 
resolution up to 3.5Å or above were further investigated by means of data analysis using 
the CCP4 software (see 2.5.5), with the aim of investigating the presence of CA7 in the 
co-crystallised rfhSP-D crystals. From the structure screen SS1, 11 crystals were 
collected and exposed at Diamond Light Source. RS20 A5 and RS21 A4 produced 
various proteins crystals. From the follow ups, an impressive 42 crystals were prepared 
and exposed at Diamond where most of the crystals tested were shown to be protein. Five 
crystals produced the best resolution; RS34 A22 (Tray RS34, Well A2, Crystal 2), RS32 
A12, RS32 A31, RS34 B21 and RS32 B27 (Table 3.8) and these were data analysed 
further in order to determine the quality of the electron density maps. 
A total of 53 crystals were tested at DLS, with 90% of the crystals being protein 
crystals and approximately 10% small molecule (salts). Additional details of the data 
collection for the two crystals (RS32 A12 and RS34 B21) used in the production of the 
electron density maps of rfhSP-D complexed with Eagan Ca7 PS are given below. 
 
Crystal 
Code 
Date 
exposed 
 Data Collection 
resolution 
Data 
Analysis 
Beamline Structure 
Solution 
Notes 
RS34 
A22 
27/4/14 DC ≈3.73 Å Yes I03 No The best 
resolution 
achieved 
for the 
co-
crystals 
CA7 PS 
RS32 
A12 
5/7/14 DC ≈3.05 Å Yes I04-1 Yes 
RS32 
A31 
5/7/14 DC≈ 3.37 Å Yes I04-1 No 
RS34 
B21 
5/7/14 DC ≈3.24 Å Yes I04-1 Yes 
RS32 
B27 
25/9/15 DC≈4.18 Å Yes I04-1 No 
Table 3.8 Summary of data collection for the crystals with the best resolution (fast_dp), 
RS32 A12 and RS34 B21 data sets offered the best resolution data (shaded in grey).   
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A 
B 
Fig. 3.7 Images collected at DLS for the RS32 A12 crystal. A The crystal before a 
SNAP was taken to evaluate the quality of the crystal. B the diffraction pattern 
produced by one of the SNAPS. Some ice rings can be seen in the image. 
3.2.4.1 RS32 A12 Crystal – Data collection 
 This co-crystal was exposed on 5/7/14 on the I04-1 beamline. The parameters 
used in the snap and data collection are shown in Table 3.9. The final concentration of 
CA7 PS was ≈ 7 mM (16.67 x molecular excess of ligand to rfhSP-D monomer) following 
cryo-protection. The morphology of the crystal resembled a small and fairly thin and very 
pretty square plate, shown in Fig. 3.7A. The initial exposures of this crystal (snap) showed 
some signs of ice rings, see Fig. 3.7B. Following the snap of the crystal, EDNA, the 
diffraction characterisation and data collection strategy software at DLS, suggested a 
maximum resolution of 3.5 Å.  
SNAP  
or DC 
Start 
Angle (˚) 
φ  (˚) Total φ 
(˚) 
Number 
of  
Images 
Exposure 
per Image 
(s) 
Total 
Exposure 
(s) 
Maximum 
Resolution 
(Å) 
Detector 
Distance 
(mm) 
Transmission 
(%) 
SNAP 0 0 90 3 0.5 1.5 1.8 292 47 
 
DC 115 0.2 134 670 0.034 22.78 3 393.1 47 
Table 3.9 The parameters used for the initial SNAP and for the data collection of the 
RS32 A12 crystal. SNAP- first diffraction; DC- data collection; φ (phi) – rotation angle. 
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3.2.4.2 RS34 B21 Crystal - Data collection 
This co-crystal was also exposed on 5/7/14 on the I04-1 beamline. The final 
concentration of CA7 PS was ≈ 7 mM (16.67 x molecular excess of ligand to rfhSP-D 
monomer) following cryo-protection. This crystal was initially snapped, with no signs of ice 
rings. EDNA suggested a maximum resolution of 3.55 Å and data was collected using the 
parameters shown in Table 3.10. This particular crystal was a nice square plate (Fig. 
3.8A), with the one of the corners of the crystal broken.  
 Data Processing 
3.2.5.1  fast_dp data processing 
The RS34 A22, RS32 A12, RS32 A31, RS34 B21 and RS32 B27 data were initially 
analysed at Diamond via fast_dp (see Table 3.8), with RS34 A22 diffracting to 3.73 Å, 
SNAP  
or DC 
Start 
Angle 
(˚) 
φ  (˚) Total 
(˚) 
Number 
of  
Images 
Exposure 
per Image 
(s) 
Total 
Exposure 
(s) 
Maximum 
Resolution 
(Å) 
Detector 
Distance 
(mm) 
Transmission 
(%) 
SNAP 0 0 90 3 0.5 1.5 3.5 463 75 
 
DC 45 0.2
5 
124 496 0.034 16.864 3 393.1 100 
Table 3.10 The parameters used for the initial SNAP and for the data collection of the 
RS34 B21 crystal. SNAP- first diffraction; DC- data collection; φ (phi) – rotation angle.  
A B 
Fig. 3.8 Images collected at DLS for the RS34 B21 crystal A- On the left, the picture of 
the crystal before a snap was taken to evaluate the quality of the crystal. The loop was 
rather dirty making it hard to visualise the crystal. B- On the right, the diffraction pattern 
produced following one of the snaps. 
Chapter 3  Results 
133 | P a g e  
 
RS32 A12 to 3.24 Å, RS32 A31 to 3.37 Å, RS34 B21 to 3.05 Å and RS32 B27 to 4.18 Å.  
All the five data sets analysed indicated a novel space group, the tetragonal P4 2 2, 
previously unreported for rfhSP-D. The novel space group encouraged the possibility that 
CA7 PS was bound to the rfhSP-D protein, impacting on the crystal contacts and yielding 
a new molecular arrangement in the crystal (space group). The decision was made to 
investigate the data sets that looked more promising, by indexing and integrating the 
spots and images in house, RS32 A12 and RS34 B21 were decided as the best out the 
five. The remaining three data sets, contained one or more poor statistical parameters, 
making them less useful in the structure solution and molecular building of rfhSP-D and 
CA7 PS. The poor statistical parameters were: the RS34 A22 - data set had a low 
completeness (data not shown); the RS32 A31 - data set gave a higher Rmerge, (data not 
shown) and the RS32 B27 - data set had the lowest resolution out of the five data sets 
and so it was not investigated further. RS32 A12 and RS32 B21 offered better statistical 
parameters and were chosen as the best data sets to be used in data solution. 
3.2.5.2  iMOSFLM / CCP4 data processing 
Following on from the data analysis using the fast_dp of RS32 A12 and RS34 B21 
data sets, the images and spots were integrated and indexed in house using iMOSFLM. 
During this process the space group was confirmed as P4212. Using AIMLESS, various 
different runs were investigated, where batches of images containing a high Rmerge were 
unselected and the resolution of the data limited (decreased). After various runs of 
AIMLESS, the data resolution was limited to 3.10 Å for RS32 A12 and RS34 B21 to 2.98 
Å, with a great improvement in the Rmerge. TRUNCATE was used to investigate the 
twinning of the both data sets, with no twinning reported. UNIQUEIFY was used to add the 
free R-flag, while the RE-INDEX program was used to re-index the space group into 
P4212. See Table 3.11 for the data processing crystallographic parameters following in 
house indexing.  
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Data 
collection 
Parameters  
RS32 A12 RS34 B21 
Overall, 
InnerShell and 
OuterShell 
Overall InnerShell OuterShell Overall InnerShell OuterShell 
Wavelength 
(Å) 0.92000 0.92000 
Low 
Resolution 
limit (Å) 
77.01 77.01 3.31 77.06 77.06 3.16 
High 
Resolution 
limit (Å) 
3.10 8.77 3.10 2.98 8.94 2.98 
Space Group P4 21 2 P4 21 2 
Unit Cell 
lengths (Å) a=112.45, b=112.45, c=105.67 a=112.52, b=112.52, c=105.75 
α, β, γ (°) 90, 90, 90 90, 90, 90 
N. of 
reflections 59195 2679 10517 79268 3004 13072 
N. of Unique 
reflections 12450 603 2233 12781 510 2058 
Average I/σ 8.7 23.6 2.7 9.5 22.3 3.4 
CC (1/2) 0.993 0.999 0.715 0.994 0.996 0.843 
Completeness 
% 97.9 94.2 98.5 90.2 86.6 91.1 
Rmerge % 13.0 3.4 52.2 13.3 5.2 50.1 
Multiplicity 4.8 4.4 4.7 6.2 5.9 6.4 
Fast_dp (DLS) 
or processed 
in house 
Processed in house Processed in house 
Table 3.11 Data processing parameters, following the in house indexing and 
integration of images and spots for the RS32 A12 and RS34 B21 data sets. 
 
 Rigid Body Refinement  
The molecular replacement was performed by Dr. Annette Shrive using the ligand-
free rfhSP-D structure (PDB: accession code 1PW9) and using AMoRe program (CCP4). 
The molecular model produced was denominated rig_rs34.  The R-factors for the 
REFMAC5 rigid body refinement for the RS32 A12 data were 36.91% for the Rfree and 
36.14% for the R-factor; for RS34 B21 38.33% for Rfree and 36.72% for the R-factor. This 
model contained the coordinates for the three chains of rfhSP-D minus the calcium and 
waters. The rigid body refined model allowed for the inspection of the binding site in terms 
of the presence of the Ca2+ and the investigation of the overall structural organisation of 
key residues in each of three subunits. 
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  Initial Electron Density maps  
The direct electron density map (2Fobs - Fcalc) and the difference map (Fobs - 
Fcalc) were initially created by using the rigid body refined ligand-free rig_rs34 model for 
the phases. The electron density maps for both RS32 A12 and RS34 B21 produced 
following rigid body refinement showed the usual overall structure of rfhSP-D, previously 
reported in the literature (Shrive et al., 2003; Shrive et al., 2009; Wang et al., 2008). The 
electron density maps and the superimposed model rig_rs34 corresponded well. The 
electron density maps showed the three chains A, B and C and the overall structure seen 
in the trimeric aggregate with the three C-terminal globular domains (236-355) and the 
three chains linked through the α-helical coiled-coil neck region (203-235). Both the RS34 
B21 and RS32 A12 electron density maps showed suitable density for ligand modelling 
(Fig. 3.9 A and Fig 3.9 B respectively) and the findings of both maps will be detailed 
together in the subsequent pages. 
A B 
Glu321 
Asn341 
Asn323 
Glu329 
Asp342 
Asn341 
Glu321 
Asn323 
Glu329 
Asp342 
Where Ca1 is positioned. 
Not modelled  
Fig. 3.9 RS34 B21 and RS32 A12 electron density maps for the binding pocket in chain 
B produced following the rigid body. In both images, the direct map (2Fobs-Fcalc) is in 
blue and contoured at 1σ and the difference map (Fobs-Fcalc) positive density is in 
orange and contoured at 2σ.  The electron density displays a similar shape, suggesting 
that the same ligand (Hep or Glc) had bound in both separate crystals. In both images, 
important Ca1 coordinating residues are displayed, including Glu321, Asn323, Glu329, 
Asn341 and Asp342; no Ca1 was modelled at this stage. A. RS34 B21 electron density 
map. B. RS32 A12 electron density map. Figures A and B generated using PYMOL. 
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It is important to mention that these two maps showed remarkable similarities, with 
both electron density maps producing similar density (in terms of shape), suggesting a 
similar ligand orientation and overall similar structural organisation of rfhSP-D. Fig 3.9 A 
displays the RS34 B21 map, while Fig. 3.9 B displays the RS32 A12 map of chain B.  
Even though the electron density maps produced following the rigid body 
refinement for RS32 A12 and RS34 B21 showed the overall structure of rfhSP-D 
previously reported in literature for the P21 space group (Shrive et al., 2003; Shrive et 
al., 2009; Wang et al., 2008), significant differences were noted in all three chains, 
particularly in terms of Ca1, Ca2 and Ca3 occupancy.  
3.2.7.1 Chain A 
In both data sets, chain A showed no density for Ca1, Ca2 and Ca3, with the 
binding pocket located in the vicinity of a symmetry related molecule. Chain A showed an 
unusual binding pocket with no suggestion of Ca1 and with some shifts seen for the Ca1 
coordinating residues (Glu321, Asn323, Glu329, Asn341 and Asp342). The density 
surrounding the pocket in chain A was very weak, but an attempt was made to 
characterise the shifts seen in some residues upon the loss of the Ca1. The loss of Ca1 in 
the binding pocket resulted in an increased electronegativity in the pocket with Asn341 
and Glu321 suggested to rotate away from their normal position (Fig. 3.10 A). The 
symmetry related molecule chain A sits right above the binding pocket of chain A, leaving 
no space for ligand. Fig. 3.10 B shows the binding pocket of chain A and the nearby 
symmetry related molecule. 
3.2.7.2 Chain B  
In both data sets chain B showed density for ligand and positive density for the 
Ca1, however no density for Ca2 and Ca3 could be visualised. The density surrounding 
the binding pocket was poorly defined in terms of the orientation of the ligand, creating 
some problems and ambiguity when characterising the right ligand and its orientation. A 
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symmetry related rfhSP-D molecule is again located in the vicinity of the binding pocket 
potentially impacting on the orientation of the bound ligand. Chain B will be discussed in 
more detail below, as it was the only chain of rfhSP-D with electron density which 
suggested bound ligand.  
3.2.7.3 Chain C 
In both data sets chain C resembled the typical unliganded rfhSP-D binding 
pocket, with density for Ca1 and coordinating waters. Similar to chain A and B, no density 
A B 
Glu321 
Glu321 
Asn323 
Asn323 
Glu329 
Glu329 
Asp342 
Asp342 Asn341 
Asn341 
-ve density 
+ve density 
No density for Ca1 
Symmetry related molecule 
located in the vicinity of chain A 
binding pocket.  
Fig. 3.10 Electron density map of RS34 B21 data set showing chain A binding pocket, 
the lack of Ca1 and the nearby symmetry related molecule. In both images Glu321, 
Asn323, Glu329, Asn341 and Asp342 are labelled; the direct map (2Fobs-Fcalc) is 
displayed in blue and contoured at 1σ. A- in addition to the direct map the difference 
map (Fobs-Fcalc) is also displayed in orange for positive density and red for negative 
density; contoured at 2σ. Positive (+ve) density surrounding Glu321 suggests that the 
residue is rotated away from the binding pocket as no Ca1 is present for coordination. 
The head of Asn341 is surrounded by negative (-ve) density, suggesting that this 
particular residue also suffers a rotation away from the normal position when Ca1 is not 
present. B- the location of the symmetry related molecule suggests that even if Ca1 
was present no ligand could fit in the tight space between the chain A binding pocket 
and symmetry related molecule. In this image the density has been expanded (radius 
of contour) to display the symmetry related molecule. Figures A and B generated using 
PYMOL.  
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for Ca2 and Ca3 could be visualised. Similar to chain A, a symmetry related molecule sits 
very near the chain C binding pocket, potentially impacting on the binding of the ligand. 
3.2.7.4 Ca4 
No density could be visualised for the presence of Ca4 in either data set. Ca4 has 
been suggested to be linked to the levels of calcium during the cryo-protection stage, with 
a concentration of Ca2+ of 2 mM or above needed for binding in the neck funnel (Shrive et 
al., 2003).   For both RS32 A12 and RS34 B21 crystals, strategy 2 was used as the cryo-
protection of choice. When using cryo-protection strategy 2, the final concentration of Ca2+ 
achieved (3.33 mM) should have been enough for the Ca4 to be present, suggesting that 
the presence/absence of Ca4 is not exclusively dependent on the final concentration Ca2+. 
3.2.7.5 BLEND software – Merging RS32 A12 and RS34 B21 into one data 
set  
BLEND software is part of the suite of programs present in the CCP4 suite, 
allowing for the management and merging of multiple data sets into a single merged data 
set. BLEND software is used following the integration and indexing of the spots and 
images by iMOSFLM. In this case RS32 A12 and RS34 B12 were integrated and indexed 
as reported in 3.2.5.2. BLEND software can be used to offset challenging problems when 
merging various data sets into a single one, with the BLEND software facilitating the task 
of building a complete data set from partial or separate data from multiple crystals, by 
merging these together. BLEND works by optimally assisting in the selection of optimal 
groups of data sets from multiple crystals prior to scaling, by using cluster analysis. 
Cluster analysis is a technique often used in statistical data analysis, whereby groups, or 
in this case data sets, are grouped together in a cluster according to how similar they are 
with respect to other data sets in other clusters. Both the data sets RS32 A12 and RS34 
B21 were very similar with the same molecular arrangement, making the process of 
grouping these together very easy (Foadi et al., 2013).  
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BLEND software works in two separate stages. The first stage is the analysis 
mode where both data sets are analysed individually and tested for overall radiation 
damage. At the first stage the user can choose the space group and in this case P4212 
space group number 90 was chosen. The analysis mode produces a variety of output files 
including Blend_Summary.txt, containing tabulated information for all datasets being 
processed with each data set given a serial number, and a Clusters.txt file containing 
information about the Linear Cell Variation (LCV). The LCV is an important analysis of the 
merged data and a good indication of isomorphism (similarity of crystalline form between 
two separate data sets) with a value below 1% indicating a good degree of isomorphism. 
The analysis mode of the BLEND software for both RS32 A12 and RS34 B21 produced a 
LCV of 0.07% showing a high degree of isomorphism ("CCP4 Program Suite: BLEND"). 
The second stage is the combination mode where the information from the stage 
analysis mode is used and the data is clustered together. This produces a variety of 
Output files including Merging_Statistics.info, Unscaled_001.mtz, Scaled_001.mtz and an 
Aimless_001.log. The combination mode offers the possibility of running AIMLESS in 
combination with the BLEND program producing a scaled mtz, or the possibility of using 
the unscaled mtz and manually running it through AIMLESS. In this experimental work the 
unscaled mtz was used in various runs of AIMLESS with the data limited to 3.10 Å. 
TRUNCATE and UNIQUEIFY programs were used in order to prepare the merged data to 
be used in REFMAC5 and for the production of the electron density map, see Table 3.12 
for the data analysis crystallographic parameters of the BLEND merged data. 
3.2.7.5.1 Electron density map of BLEND merged data (RS32 A12 + RS34 
B21) 
The electron density map for the BLEND merged data was produced as previously 
reported in 3.2.7 where the direct (2Fobs - Fcal) and the difference map (Fobs - Fcal) were 
initially created by using the rigid body refined ligand-free rig_rs34 model for the phases. 
The R-factors for the rigid body movement for the BLEND merged data were 36.37% for 
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the Rfree and 38.46% for the R-factor (for the two individual data sets:  RS32 A12 Rfree – 
36.91% R-factor – 36.14%; RS34 B21 Rfree – 38.33% R-factor – 36.72%).  
The electron density of the BLEND merged data failed to show any new density 
not present in the electron density maps of the individual data sets, RS32 A12 and RS34 
B21. The problem in this case when merging both data sets together is that the RS34 B21 
electron density map (in terms of ligand occupancy) is a significantly better data set than 
RS32 A12. When merging both data sets some of the limitations seen in the RS32 A12 
data set will be merged with the RS34 B21 better data, yielding in this case a higher Rmerge 
for the merged data at 3.1Å. As BLEND merged data failed to provide extra new density 
and actually produced a less informative map than RS34 B21 in terms of bound ligand, no 
further work was performed using the BLEND merged data, and instead the RS34 B21 
was chosen as the only data set to be used to display the experimental findings and for 
model building.   
Data collection 
Parameters  
Merged data - Blend  
Overall, 
InnerShell and 
OuterShell 
Overall InnerShell OuterShell 
Wavelength (Å) 0.92000 
Low Resolution 
limit (Å) 77.03 77.03 3.31 
High Resolution 
limit (Å) 3.10 8.77 3.10 
Space Group P4 21 2 
Unit Cell lengths 
(Å) a=112.48, b=112.48, c=105.70 
α, β, γ (°) 90, 90, 90 
Number of 
reflections 219585 9896 39120 
Unique reflections 12853 657 2287 
Average I/σ 15.3 32.8 6.0 
CC (1/2) 0.994 0.993 0.945 
Completeness % 99.9 99.3 100 
Rmerge % 17.5 6.5 56.6 
Multiplicity 17.1 15.1 17.1 
Fast_dp (DLS) or 
processed in 
house 
Processed in house 
Table 3.12 Data analysis parameters, following in-house merging 
of the RS32 A12 and RS34 B21 data sets through the BLEND 
and AIMLESS software. 
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 Restrained refinement  
Restrained refinement was carried out for RS32 A12 and RS34 B21. RS34 B21 
offered the best electron density map, resolution and data to illustrate the best estimate of 
the rfhSP-D bound to H. influenzae CA7 PS, in terms of ligand orientation and protein 
structural organisation. It is important to mention that all the findings reported below for 
the RS34 B21 electron density map were checked against the RS32 A12 data, with the 
two data sets showing similar electron density shape, suggesting similar ligand 
orientation, preference and protein structural organisation. As both maps share common 
features only the RS34 B21 data set will be discussed below. 
The restrained refinement is the second stage of refinement, where rigid body 
refined models are refined, while maintaining good geometry. The RS34 B21 best model 
was completed using REFMAC5 and COOT. R-factors improved slightly from the initial 
rigid body refinement for the final model of RS34 B21 and were 20.69% for the R-factor 
(or Rwork) and 25.21% for the Rfree. The Ramachandran analysis showed that 95.96% 
(MOLPROBITY) of the residues modelled were in the preferred regions. No waters were 
modelled as this resolution makes it very difficult to determine the waters location. Some 
positive density in the map was not modelled, such as for weakly defined solvent 
molecules. 
 Molecular Model Building - RS34 B21  
The initial rigid body density surrounding the binding pocket provided little 
evidence for the correct orientation of the ligand. In this case for CA7 PS, only three ligand 
carbohydrates are available to bind to CA1 and protein in the chain B binding pocket; 
HepI, HepII and Glc, represented in Fig. 3.2. Kdo has been reported to be a low affinity 
ligand for rfhSP-D (Wang et al., 2008).  
Initially, both heptose and glucose carbohydrates were positioned according to 
previous reported binding orientations and hydroxyl locations in relation to Ca1, where the 
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heptose bound to rfhSP-D Ca1 via the hydroxyls O6’ and O7’ (Wang et al., 2008; Clark et 
al., 2016), while glucose bound by the equatorial hydroxyls O3’ and O4’ (Shrive et al., 
2003).  
Positioning both possible ligand carbohydrates in similar positions to those 
previously reported in the literature was carried out to ensure that the coordinating 
hydroxyls were located in the correct place with respect to Ca1. To date all the ligand 
bound rfhSP-D structures show fairly similar hydroxyl positions and distances between the 
Ca1 and the hydroxyls of the coordinating ligand. Fig. 3.11 displays both heptose and 
glucose orientations as reported in the literature and how they fit into the density of RS34 
B21, before any refinement attempt was performed.  
Heptose 
Glucose 
Fig. 3.11 The fitting of both a L-D-heptose and glucose as reported in literature (Clark 
et al., 2016; Shrive et al., 2003), PDB: 4E52 and 1PWB respectively and before 
refinement. In both figures Ca1 is displayed as a yellow sphere, with the Ca1 
coordinating residues also displayed (Glu321, Asn323, Glu329, Asn341, Asp342); 
glucose is displayed with the carbons in blue and with the oxygens in red; L-D-heptose 
is displayed with the carbons in yellow and the oxygens in red. The ligands in Figure A 
and B are rotated by 180° to each other. The direct map (2Fobs-Fcalc) is displayed in 
blue and contoured at 1σ. Figures A and B generated using PYMOL . 
180° rotation 
Glu329 
Glu329 
Glu321 
Asn341 
Asn341 
Asp342 
Asp342 
Asn323 
Ca1 
Ca1 
L-D-heptose Glucose Glucose 
A B 
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When considering which carbohydrate ring was coordinated to Ca1, glucose in the 
same orientation as that reported in the literature (Shrive et al., 2003; Crouch et al. , 
2006) was used to attempt to explain the density surrounding the binding pocket (Fig. 
3.11). The equatorial O4’ hydroxyl group was placed in a similar location to that in 
literature and interacting with OE2 of Glu329 and ND2 of Asn341; the O3’ hydroxyl group 
was placed near OE2 of Glu321 and ND2 of Asn323. The refinement of the glucose 
model against the electron density yielded a Rfree of 25.26% (Fig. 3.12 A). A second ligand 
model was also tested whereby the glucose was rotated by 180° such that the positions of 
the hydroxyls O3’ and O4’ were interchanged, yielding a significantly worse map (data not 
shown). 
Fig. 3.12 The fitting of heptose or glucose in Chain B as reported in (Clark et al., 2016; 
Shrive et al., 2003), PDB: 4E52 and 1PWB respectively and subsequent refinement 
results. In both figures Ca1 is displayed as a yellow sphere, with the Ca1 coordinating 
residues also displayed (Glu321, Asn323, Glu329, Asn341, Asp342); glucose is 
displayed with the carbons in blue and the oxygens in red; heptose is displayed with 
the carbons in yellow and the oxygens in red. The direct map (2Fobs-Fcalc) is 
displayed in blue and contoured at 1σ. The difference map (Fobs-Fcalc) is displayed in 
orange for positive (+ve) density and red for negative (-ve) density and contoured at 
2σ. A- The glucose model produced an Rfree of 25.26% with the suggestion that the 
glucose did not fit the well, with negative density features seen near C1’ and O1’. B- 
The heptose model produced an Rfree of 25.50%, with positive density suggesting that 
the O6’ and O7’ hydroxyls could be interchanged by rotation of the ligand in relation to 
the reported orientation. Figures A and B generated using PYMOL. 
Glu321 Glu321 Asn323 
Asn32
3 
Asp342 Asp342 
Glu329 
Glu329 
Asn341 Asn341 
Ca1 
-ve density 
+ve density 
Glucose Heptose 
A B 
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The heptose model was also positioned according to the orientation reported in the 
literature (Clark et al., 2016; Wang et al., 2008), with the O6’ and O7’ hydroxyls 
coordinating to Ca1 (Fig. 3.11). The refinement of the heptose model yielded a significant 
higher Rfree than the glucose model, of 25.50%. The refined map of the heptose model 
displayed contrasts of positive density on the opposite side where the pyranose ring 
structure was present and negative density where the heptose (as reported) was placed, 
suggesting that the ligand could be rotated to interchange the O6’ and O7’ hydroxyls, 
changing the manner in which the ring is positioned (Fig. 3.12 B).   
The refinement of glucose (Fig. 3.12 A) and heptose (Fig. 3.12 B) initially placed 
as reported in the literature does not seem to offer a good density fit between model and 
data. The heptose refinement displayed positive density opposite to where the pyranose 
ring was located, suggesting an interchange of the hydroxyls coordinating Ca1. A variety 
of models (20+) where the hydroxyls were interchanged and the sugar rotated by 180° in 
relation to the reported heptose orientation were placed in the density seen following rigid 
body refinement (Fig. 3.13), in order to investigate the possibility that the heptose 
hydroxyls were interchanged and this was refined against the data (Fig. 3.14). Of the 
various models attempted only two models are displayed in Fig. 3.13, model 1 and model 
2 with the only difference between the two models being a 180° rotation about the C5-C6 
bond.  
The refinement of the heptose models (model 1 and model 2) as shown in Fig. 
3.13 produced improvements in the Rfree with model 1 producing an Rfree of 25.21% and 
model 2 25.22%. The density surrounding the hydroxyls and the adjacent C5 was good, 
however, the density surrounding the remainder of the ring was rather poor, making it very 
difficult to define a correct orientation for the ring and to discriminate between model 1 and 
model 2. The model 1 refined structure is displayed in Fig.3.14. The orientation of the O6’ 
and O7’ hydroxyls and the residues which they interact with are similar to both structures 
reported in the literature (Wang et al., 2008; Clark et al., 2016), suggesting that this 
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structure could offer evidence of a novel mode of orientation and binding for the heptose 
sugar. The minimal difference in Rfree between model 1 and model 2 suggests that more 
than one orientation of the heptose ring could have bound to the rfhSP-D, causing the 
averaged density to produce a weaker density surrounding the pocket and creating 
problems when defining the right orientation.  
 
Of all the models tested and refined and using the knowledge of the Rfree and 
direct visualisation of the electron density maps for discrimination between models, the 
best model suggests that a heptose and not a glucose is bound to the rfhSP-D chain B 
binding pocket. The fact that the glucose did not fit the density as well as the heptose and 
gave a higher Rfree is not surprising as recent work by Clark and co-workers showed that 
Fig. 3.13 The fitting of both models of the heptose where the hydroxyls are 
interchanged and the sugar rotated 180° in relation to the orientation reported in the 
literature in the rigid body refinement density (Clark et al., 2016; Wang et al., 2008), 
before any refinement was performed. In the figure Ca1 is displayed as a yellow 
sphere, with the Ca1 coordinating residues also displayed (Glu321, Asn323, Glu329, 
Asn341, Asp342); heptose model 1 is displayed with the carbons in blue and the 
oxygens in red; heptose model 2 is displayed with the carbons in white and the 
oxygens in red, showing ≈ 180° ring rotation with respect to the C5-C6 bond. The direct 
map (2Fobs-Fcalc) is displayed in blue and contoured at 1σ. Figure generated using 
PYMOL. 
 
Glu321 
Asn323 
Asp342 
Glu329 
Asn341 
 Heptose - model 1 (blue) 
Ca1 
 Heptose - model 2 (white) 
 C5-C6 bond about 
which bond rotation 
between both models 
took place 
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the H. influenzae Eagan 4A mutant LPS binding to rfhSP-D occurred through the non-
terminal heptose, even with a terminal glucose available for binding (Clark et al., 2016). A 
second point to consider and reported in 1.4.5.1 is that SP-D and rfhSP-D have been 
shown to have a higher affinity for heptose (L-D-Hep) than glucose, so it is not surprising 
to see the heptose bound instead of the glucose, when both sugars are available. 
  
 Final Model 
The electron density map of the ligand binding site in chain B (Fig. 3.14 and Fig. 
3.15)  suggests that the orientation and binding of heptose occurs by rotating the sugar by 
180°about C5-C6 so that the positions of the hydroxyl groups O6’ and O7’ are 
interchanged in comparison to reported structures (Wang et al., 2008; Clark et al., 2016) 
as shown in Fig. 3.14 and Fig. 3.15. The hydroxyl O6’ in the novel orientation is 
interacting with Glu329 OE1 (2.78 Å) and Asn341 OD1 (2.93 Å) which are also 
Glu329 
Asp342 Asn341 
Glu321 
Asn323 
Ca1 
Heptose model 1, 
i.e the best model 
after refinement 
Fig. 3.14 The final model (model 1) displayed following refinement, with the heptose 
sitting 180° rotated in relation to previously reported structures (Clark et al., 2016; 
Wang et al., 2016), with the positions of the coordinating hydroxyls then interchanged. 
In the figure Ca1 is displayed as a yellow sphere, with the Ca1 coordinating residues 
also displayed (Glu321, Asn323, Glu329, Asn341, Asp342). The heptose model is 
displayed with the carbons in blue and the oxygens in red. The direct map (2Fobs-
Fcalc) is displayed in blue and contoured at 1σ. Figure generated using PYMOL.  
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coordinating Ca1. The hydroxyl O7’ in the novel orientation is interacting with Glu321 OE2 
(2.30 Å). Further interactions seen include the heptose ring O5’ coordinating with Asn341 
ND2 (2.82 Å) and the O4’ linkage which connects to the Glc possibly interacting with 
Asp325 (2.67 Å). The strong electron density surrounding C5 clearly suggests that the 
heptose is indeed rotated, with C5 coming off at a different angle from the reported 
structures.  The reasons why the Eagan CA7 heptose shows a different orientation from 
previous heptose structures will be discussed in more detail in 3.3.6. The refinement 
statistics for the best model are given in Table. 3.13. 
Refinement statistics 
Data Range (Å) 77.01 - 3.10 
No. of protein atoms 3457 
No. of residues chain A and B 205-355 
No. of residues chain C 206-355 
No. of water molecules N/A 
No. of calcium ions 2 
No. of ligand atoms 14 
Rwork (%) 20.69 
Rfree (%) 25.21 
RMSD bond length (Å) 0.015 
RSMD bond angle (°) 1.9 
Average B-values (Å2)a 
Protein main chain 56.6 
Water N/A 
Ligand 58.466 
Ramachandran plot values (%) 
Favoured 95.96 
Outliers 0.45 
Table 3.13 The refinement statistics of the best model. a defined according to Baverage defined 
according to MOLPROBITY. 
 
The best model suggests that the heptose C4 is directed towards the flanking 
residue Asp325 within hydrogen bonding distance and that heptose C2 is inclined towards 
the Arg343 flanking residue placing the C2-OH within hydrogen bonding distance of 
Arg343 NE, NH1 or NH2. The Arg343 orientation in the density suggest a novel 
orientation, where the Arg343 moves away from the C2 of the heptose in order to 
accommodate the sugar in its novel orientation, leading to the head of Arg343 directed 
towards the nearby Glu347. Glu347 in turn moves towards the Arg343 head group such 
that both residues are within distance to form a salt bridge between the Glu347 OE1/OE2 
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and Arg343 NH2. The novel orientations for both Arg343 and Glu347 provide additional 
strong evidence that the final model is correct.  
Arg343 and Asp325 have been suggested in the literature to be important in 
discriminating glycoconjugates and to have the ability to impact on binding affinities. 
Arg343 presented in this model assumes a novel conformation previously unreported for 
the unliganded and liganded structures of rfhSP-D. In the reported structures Arg343 
flanks the binding site with only slight differences in conformation reported, but always 
with the head group of Arg343 facing up, flanking the binding pocket (Shrive et al., 2003; 
Crouch et al., 2006; Wang et al., 2008; Clark et al., 2016). In the model presented here 
the density for the Arg343 shows density to suggest a novel conformation of Arg343, 
where the head group of Arg343 tilts away from its normal orientation, in order to 
accommodate the novel orientation of the HepI (Fig. 3.16 and 3.17). This leaves the C2 
hydroxyl of Hep within hydrogen bonding distance of Arg343 NH2, NH1 and NE. When 
the Arg343 head group tilts away from the C2-OH of the Hep, it comes in close contact 
with Glu347, causing the Glu347 OE1 and OE2 to assume a preferred orientation in order 
to hydrogen bond with Arg343 NH2, OE1-NH2 and OE2-NH2 distances are 2.49 Å and 
2.94 Å respectively and this is displayed in Fig. 3 17. The interaction reported between 
Arg343 and Glu347 is a novel interaction, with no previous structural work displaying such  
an interaction.   
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Fig. 3.15 The novel orientation of HepI with the Hep rotated by 180° resulting in the positions of the O6’ and O7’ hydroxyls being 
interchanged. The Arg343 head group moves away from C2-OH in order to accommodate the novel orientation of HepI. The positions 
where HepI would link to Kdo, Glc and HepII are shown. In the figure Ca1 is displayed as a grey sphere, with the Ca1 coordinating 
residues also displayed (Glu321, Asn323, Glu329, Asn341, Asp342) and Arg343; heptose model is displayed with the carbons in blue and 
with the oxygens in red; H. influenzae 4A structure (PDB: 4E52) is displayed for direct comparison with the carbons in brown and the 
oxygens in red. Stereo image of the best model, 4A structure and direct map (2Fobs-Fccalc) in blue surrounding the HepI and contoured 
at 1σ, figure generated using Molecular Graphics CCP4 (CCP4mg). 
Glu321 Glu321 
Asn323 
Asn323 
Asn341 Asn341 
Asp342 Asp342 
Glu329 
Glu329 
Arg343 Arg34
3 
Where Kdo linkage is 
Where HepII linkage is 
Ca1 Ca1 
Best model CA7 Eagan4A published structure 
Where Glc linkage is 
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HepI C2-OH 
Fig. 3.16 An illustration of the shifts seen in Arg343 and Glu347, in order to accommodate the novel orientation of the Hep. In the figure 
Ca1 is displayed as a yellow sphere, with the Ca1 coordinating residues also displayed (Glu321, Asn323, Glu329, Asn341, Asp342); 
heptose model is displayed with the carbons in blue and with the oxygens in red. The direct map (2Fobs-Fcalc) is displayed in blue and 
contoured at 1σ, while the difference map (Fobs-Fcalc) positive (+ve) density is displayed in orange and contoured at 2.5σ. The Arg343 
and Glu347 residues are located near positive density suggesting a different conformation for both residues. Stereo image generated 
using PYMOL. 
Glu329 
Asp342 
Asn341 
Glu347 
Arg343 
Glu321 
Asn323 
Ca1 
+ve density 
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Arg343 and Glu347 as 
reported in 4A structure 
(PDB: 4E52) in pink/purple  
Novel Orientation 
for Arg343 
Novel Orientation 
for Glu347 
Fig. 3.17 An illustration of Arg343 and Glu347 after refinement, with both residues in the novel orientation. NH2 of Arg343 is within 
distance to hydrogen bond to Glu347 OE1 (2.49 Å) and OE2 (2.94 Å); a salt bridge between Arg343 and Glu347 is suggested. In 
pink/purple Arg343 and Glu347 are displayed as reported in the 4A H. influenzae structure (PDB: 4E52) (Clark et al., 2016) with residues 
in pink (carbon), blue (nitrogen), red (oxygen) showing the Arg343 and Glu347 in the reported structure. In the figure Ca1 is displayed as 
a yellow sphere, with the Ca1 coordinating residues also displayed (Glu321, Asn323, Glu329, Asn341, Asp342) with the carbons (green), 
oxygen (red) and nitrogen (blue); heptose (Hep1) model is displayed with the carbons in blue and with the oxygens in red. The direct map 
(2Fobs-Fcalc) is displayed in blue and contoured at 1σ. The interaction suggested between Arg343 and Glu347 represents a previously 
unseen and unreported interaction, a consequence of a novel orientation of binding by HepI. Stereo image generated using PYMOL. 
HepI 
Glu329 Asp342 
Asn341 
Glu321 
Asn323 
Ca1 
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The best model and density suggests that HepI and not HepII is bound, with 
density coming off the C3 of the best model and where HepII would be, with the electron 
density map showing space for the Kdo at position 1 and Glc at position 4, but with no 
density seen for either sugar suggesting conformational freedom about the glycosidic 
linkage. As illustrated in Fig. 3.2 HepI is linked to Kdo at position 1, HepII at position 3 and 
Glc at position 4, while HepII is linked to HepI at position 1 and a PEA group at position 6. 
The best model and density suggest that HepI is binding with some density coming off C3, 
suggesting that only HepI could bind this way. The rotation of the ring of the Hep in order 
to check if HepII was binding and subsequent best fit into the density around C1 failed to 
produce adequate density for the ring. A second point to consider is that HepII contains a 
PEA group at position C6, which to the best of our knowledge could be present or absent, 
as the full impact of hydrolysis on the phosphate derivatives remains incomplete. If the 
PEA was present, HepII could not bind through the O6’ and O7’ hydroxyls. It is important 
to mention that even though the best model suggests an orientation of binding, this does 
not exclude that other orientations of the main ring heptose could have bound, but with 
the density shown it was impossible to provide evidence for other orientations of the main 
ring heptose.  
A novel orientation of heptose (HepI) binding to the rfhSP-D is therefore proposed 
and the model illustrated in Fig. 3.18 and Table 3.14 and summarised as follows; the 
electron density suggests that a heptose sugar rotated by 180° with respect to the 
examples in the literature, with the positions of hydroxyls O6’ and O7’ interchanged  offers 
the best fit; the electron density present at the C3 linkage suggests that only HepI could sit 
in this density, as HepII contains no C3 linkage; rotating the HepII ring in order to fit C1 of 
HepII near C3 of HepI failed to produce adequate density, suggesting that HepI and not 
HepII is bound; finally the changes seen in the Arg343 and Glu347 residues, where 
Arg343 moves away from C2 of the heptose, coming into proximity of Glu347 which in 
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turn moves towards Arg343, leaving both residues within adequate distance for a salt 
bridge, gives strong evidence to support the model presented here. 
 
 
 
 
 
 
 
 
 
 
 
Atom 1 Ca1 coordinating 
residues/ligand 
Chain B (Å)- 
Best model 
Chain C (Å)- 
Best model 
4A Chain B 
(Å) 
4A Chain C 
(Å) 
Ca1 Glu321 OE1 2.34 2.71 2.57 2.55 
Ca1 Asn323 OD1 2.33 2.38 2.42 2.37 
Ca1 Glu329 OE1 2.84 2.43 2.44 2.31 
Ca1 Asn341 OD1 2.58 2.33 2.40 2.42 
Ca1 Asp342 OD1 2.35 2.35 2.27 2.25 
Ca1 Asp342 O 2.94 2.64 2.56 2.59 
Ca1 Hep Hydroxyl - O6’ 2.35 N/A 2.42 2.44 
Ca1 Hep Hydroxyl - O7’ 2.37 N/A 2.58 2.53 
Table. 3.14 Ca1 and coordinating residues interatomic distances for RS34 B21 
Chain B and C. For RS34 B21 chain B the distances to the Hep hydroxyls O6’ and 
O7’ are the distances calculated for the best model and shown in Fig. 3.14 and Fig. 
3.15. For comparison, the H. influenzae Eagan 4A bound structure (PDB: 4E52) 
chains B and C are shown (Clark et al., 2016). No Ca1 was visualised for Chain A in 
the RS34 B21 data and so no interatomic distances could be calculated. Chain C 
contained Ca1 but no ligand bound with the N/A implying no ligand presence. 
 
 
Glu347 
Arg343 
Asp325 Ca1 
C2-OH HepI 
Fig. 3.18 The proposed novel orientation of HepI bound in the rfhSP-D binding pocket 
chain B. In the model the C2 of the HepI occupies the position where normally Arg343 
would be located, causing the Arg343 to move away into proximity of Glu347. Glu347 
in turn moves towards Arg343 and is within hydrogen bonding distance. C2-OH of the 
HepI is within hydrogen bonding distance of NE, NH1 or NH2 of Arg343, with Glu347 
OE1 and OE2 within distance for a salt bridge with Arg343 and displayed with red 
dashed lines. In the model Ca1 is seen in yellow sphere with the coordinating residues 
(Glu321, Asn323, Glu329, Asn341 and Asp342) and Asp325 also shown. Pink dashed 
lines demonstrate the interaction of Ca1 and coordinating residues. Image generated 
using PYMOL.   
Asn323 
Glu321 
Asp342 
Asn341 
Glu329 
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3.3 Discussion 
 Co-crystallisation of rfhSP-D in combination with CA7 PS  
The co-crystallisation of rfhSP-D in combination with CA7 PS produced many 
crystals in the structure screens SS1 and SS2, with RS20 A5 (SS1 C.5), RS21 A4 (SS1 
C.28), RS21 C4 (SS1 C.40) and RS21 D2 (SS1 C.44) showing positive crystal growth. 
These conditions produced a variety of morphologies including thin squares, triangles and 
non-square plates. The squares produced in SS1 and SS2 resembled the ligand-free 
rfhSP-D crystals normally produced in our research group, with the only difference being 
that these were rather thin, problematic when using X-ray radiation.  
 Follow up crystals 
Three follow ups were produced from SS1 and SS2 conditions; RS20 A5 – RS32, 
RS21 C4– RS33 and RS21 D2 – RS34, where the initial conditions were varied slightly, in 
order to optimise the crystal growth. From the three follow ups produced, only RS32 and 
RS34 tray produced positive protein crystals. Both of these conditions were fairly similar, 
with both conditions containing ammonium sulphate, suggesting that a high concentration 
of ammonium sulphate >1.8 M, favours the formation of rfhSP-D co-crystals bound to CA7 
PS. RS32 and RS34 trays produced similar morphologies to the initial SS1 conditions, 
where most of the crystals formed resembled thin squares however, most often layered. 
Single squares were often the crystal morphology of choice looped for X-ray diffraction. 
Both trays were successful in growing a myriad of crystals, with easily over 200 crystals 
produced in both wells. Unfortunately, these were often multiple (twinned) and odd-
shaped, with limited number of single crystals formed.  
All 42 crystals tested from the follow ups were shown to be protein, offering 
several proteins co-crystals to be used in X-ray diffraction in the hope of achieving a high 
resolution (< 2 Å) and accurately characterise the binding of CA7 PS to rfhSP-D. 
Unfortunately, the resolution seen led to some ambiguity in the characterisation of rfhSP-
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D and CA7 PS. The resolution of 80% of the crystals tested was very low >6 Å, with the 
resolution of the remaining 20% of the crystals tested and data collected, often around the 
3.05 - 4.00 Å, which is considered rather low in accurately characterising ligand binding 
studies (Evans et al., 2011).  
 Data Analysis of promising crystals  
Out of the 53 crystals of rfhSP-D co-crystallised in complex with H. influenzae PS 
CA7 and tested at DLS, only 2 crystals achieved an acceptable resolution to be used in 
the characterisation of structural ligand studies. Of the 53 crystals tested 90% were 
protein, even though these were often poor diffracting crystals, suggesting that conditions 
used during crystallisation favoured crystal growth. However, there is evidence to suggest 
a high internal disorder upon formation of the crystals, especially when we consider that 
ligand-free rfhSP-D crystals have been grown in our research group and diffracted to 
1.4Å. 
 Data processing and analysis 
RS32 A12 and RS34 B21 electron density maps were both used for model 
building, as these offered the best overall resolution limited to 3.10 Å and 2.98 Å 
respectively. Both crystals were indexed and integrated in house using iMOSFLM. 
AIMLESS was used to scale and merge the multiple observations of reflections together 
into an average intensity. The use of the AIMLESS software was particularly important in 
modifying the statistical parameters, as it allows batches of images to be selected on the 
basis of acceptable statistical parameters and Rmerge for integration in iMOSFLM  
Initially for both RS32 A12 and RS34 B21 the resolution used was 3.3Å and 3.1Å 
respectively. Batch selection was carried out to achieve a Rmerge overall ≈ 12% and outer 
shell of ≤40% for both data sets (data not displayed) and a final resolution of 3.3 Å and 
3.10Å respectively. There are conflicting views in the literature on role of Rmerge as the 
criterion for choosing the cut-off resolution (Evans, 2011a; Wlodawer et al., 2008). The 
Chapter 3  Discussion 
156 | P a g e  
 
Rmerge has the disadvantage that it increases with the data multiplicity, although the more 
observations that are averaged the better the merged data (Evans, 2011a). In the highest 
resolution shell the target Rmerge has been reported as 30-40% for low symmetry crystals 
and up to 60% for high-symmetry crystals (Wlodawer et al., 2008). This was the main 
idea when aiming for a Rmerge ≤40% in the outer shell, however the P4212 tetragonal 
space group is a high symmetry space group with eight symmetry operations possible and 
yielding high multiplicity, suggesting that the Rmerge could be allowed to reach 60% in the 
outer shell. Not over-limiting the data resolution allowed a higher resolution model with a 
lower Rfree and Rfree-Rwork gap, all important when defining the ligand and its correct 
orientation. 
 Electron Density Maps  
The RS32 A12 and RS34 B12 electron density maps were used in model building 
in the binding pocket of chain B. Both electron density maps were created using a rfhSP-D 
model identical to that in the unliganded P21 space group (Shrive et al., 2003). The 
electron density maps shown in Fig. 3.9, were very similar at 1σ and both datasets were 
merged in to one to produce an electron density map of the merged data. BLEND was 
used to merge RS34 B21 and RS32 A12 after iMOSFLM, into one merged dataset. The 
electron density map of the merged data was unfortunately very poor and did not add any 
novel information not seen in the RS32 A12 and RS34 B21 individual electron density 
maps. Of the two, the RS34 B21 map appeared somewhat better than the RS32 A12 map 
and the RS34 B21 electron density map was used to model the CA7 PS bound to rfhSP-
D. The best model was also checked against the RS32 A12 data, with similar findings to 
those reported for RS34 B21 data.   
 The final model 
Chain A, B and C showed the overall structure of rfhSP-D similar to that reported 
in literature for the P21 space group (Shrive et al., 2003; Shrive et al., 2009; Wang et al., 
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2008), with the trimeric aggregate with the three C-terminal globular domains (236-355) 
and the three chains linked through the α-helical coiled-coil neck region (203-235).  The 
chain A and C binding pockets are located in the vicinity of a symmetry related molecule 
with little or no space to accommodate the long ligands tested, which explains why no 
binding was seen. Chain A is particularly tight with the symmetry related molecule facing 
the binding pocket in chain A. For the chain C binding pocket there is more room than in 
chain A, however it seems to hinder carbohydrates larger than monosaccharides, with 
only space to accommodate one carbohydrate. Ligand binding was only seen in chain B, 
but again the symmetry related molecule is present in vicinity of the binding pocket, 
potentially impacting on the orientation of longer bound ligands. 
The lack of Ca1, Ca2 and Ca3 in chain A, Ca2 and Ca3 in chain B and Ca2 and 
Ca3 in chain C and no Ca4, is somewhat surprising (note that this is also seen for the 
ligands reported in chapter 4 for the P4 21 2 co-crystallised rfhSP-D). At first sight it seems 
probable that the loss or absence of these calcium ions was in part due to a low 
concentration of Ca2+ during the cryo-protection stages. However, the finding that P21 
crystals (reported in chapter 4), produced using the exact same method of co-
crystallisation showed Ca1, Ca2 and Ca3 present in all chains suggests that other 
variables are also important.  As the loss of Ca1, Ca2, Ca3 and Ca4 is also reported in 
chapter 4, an overall discussion and hypothesis for the reason why we saw the absence 
of the Ca2+ will be given in chapter 5.   
Modelling the most likely ligand and the correct orientation that had bound, into the 
binding pocket density in chain B, required the investigation of many different possibilities. 
H. influenzae CA7 PS provides four possible epitopes for recognition by rfhSP-D: 1-  
through the Kdo linked to the lipid A by C7-OH (O7’) and C8-OH (O8’); 2- through the 
inner core HepI by C6-OH (O6’) and C7-OH (O7’); 3- through the terminal Glc by C3-OH 
(O3’) and C4-OH (O4’); 4- through the HepII bound to HepI by means of C3-OH (O3’) and 
C4-OH (O4’). If the PEA group was lost during the hydrolysis process HepII O6’ and O7’ 
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would be available to bind rfhSP-D however, at present it remains unknown if following 
hydrolysis the PEA group would be present or absent. Kdo has been reported to be a very 
low affinity ligand for rfhSP-D and so it was discarded as the potential sugar bound to Ca1 
in rfhSP-D chain B, leaving HepI, HepII and Glc as potential ligands (Wang et al., 2008) 
Fig. 3.19 displays the possible binding sites of the H. influenzae CA7 PS, excluding the 
Kdo. High resolution structural studies of rfhSP-D complexed with glucose (Shrive et al., 
2003; Crouch et al., 2006) and heptose (Wang et al., 2008; Clark et al., 2016) have 
been reported in literature, allowing for a direct comparison between the possible ligand 
bound models and those reported in the literature.  
 
Fig. 3.19 An illustration of the H. influenzae CA7 PS molecule and possible sites of 
binding to rfhSP-D using current knowledge and reported data. rfhSP-D has been 
reported in the literature to bind glucose (Glc) through the equatorial C3-OH (O3’) and 
C4-OH (O4’) hydroxyls (Shrive et al., 2003); rfhSP-D has been reported to bind to 
heptose through the C6-OH (O6’) and C7-OH (O7’) in the L-D-heptose, while the D-D-
heptose isomer has been shown to not bind through the O6’ and O7’ hydroxyls, but 
instead through the equatorial O3’ and O4’ hydroxyls, in similar manner to glucose 
(Clark et al., 2016; Wang et al., 2008). Both L-D and D-D heptoses contain a 
mannose ring structure, near identical to glucose (only C2-OH different - C2 epimers). 
The Kdo has been reported to be a very low affinity ligand and so it was discarded as a 
potential ligand. Figure generated using PYMOL.   
HepI 
HepII 
Glc 
KDO 
C4-OH 
C3-OH C4-OH 
C6-OH C7-OH 
PEA 
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Previous structural work and binding affinity studies have shown that SP-D and 
rfhSP-D binding to LPS is Ca2+ dependent, with the recognition dependent on the binding 
of terminal residues (such as glucose) or inner core residues (such as heptose). Kuan and 
co-workers reported that SP-D displayed poor binding of longer Ra mutants and smooth 
LPS strains, with the suggestion that long LPS can “mask” the binding sites associated 
with preferred inner core binding. The shorter LPS mutants Rc and Rd of S. enterica 
minnesota demonstrated a higher binding by SP-D than the Ra mutant rough LPS, 
suggesting that inner core residues such as heptose and terminal core glucose are the 
preferred binding epitopes (Kuan et al., 1992).  
SP-D and rfhSP-D binding affinities have been investigated using different mutants 
of purified H. influenzae Eagan LPS and whole bacteria, H. influenzae Eagan 4A LPS (1 
heptose), H. influenzae Eagan CA7 LPS (2 heptoses) and H. influenzae Eagan Wild-type 
LPS (3 heptoses). Both SP-D and rfhSP-D showed a high binding affinity for 4A LPS and 
whole bacteria, with subsequent increase in the number of heptoses and branching 
yielding poorer binding, 4A> CA7> Wild-type. (Clark et al., 2016).   
Crystallographic studies using delipidated H. influenzae Eagan 4A LPS soaked 
into rfhSP-D ligand-free crystals, reported that the PS bound to the rfhSP-D via the 
heptose and through the hydroxyls O6’ and O7’, even though terminal glucose was also 
available for binding (Clark et al., 2016). The binding of the heptose in the H. influenzae 
4A PS was reported to be similar to the heptose previously reported by Wang and co-
workers, with the only difference being that H. influenzae Eagan 4A PS HepI showed a 
ring rotation away from flanking Asp325 (Wang et a., 2008; Clark et al., 2016). The 
rfhSP-D bound to H. influenzae 4A study offers a direct comparison to the experimental 
work reported here, extending the knowledge of how different mutant H. influenzae LPS 
binds to rfhSP-D, with the only difference being that the H. influenzae CA7 LPS mutant 
contains an extra heptose (HepII) phosphorylated at position 6. 
Chapter 3  Discussion 
160 | P a g e  
 
In order to correctly characterise the ligand binding in pocket chain B a variety of 
models with different ligands of Hep or Glc were used, with different orientations 
(hydroxyls rotated) tested. The glucose model as reported in the literature (Shrive et al., 
2003) yielded a Rfree of 25.26%; the heptose model as reported in the literature (Clark et 
al., 2016; Wang et al., 2008) yielded a Rfree of 25.50%. The novel orientation of heptose, 
where the O6’ and O7’ hydroxyls were interchanged and rotated by 180° yielded 25.21% 
in model 1 and 25.22% in model 2. The difference between model 1 and model 2 lies on 
rotation of the C5-C6 bond, with the minimal difference seen in the Rfree suggesting more 
than one possible orientation of the ring rotation could have bound.  Therefore, taking into 
consideration the Rfree and direct visualisation of the difference map, the best model tested 
suggested that the H. influenzae CA7 PS bound to the rfhSP-D through a heptose by the 
O6’ and O7’ hydroxyls. Surprisingly the heptose bound to Ca1 assumes a different 
conformation to that in the Eagan 4A PS, with the heptose rotated such that the positions 
of the O6’ and O7’ hydroxyls are interchanged. Discriminating between model 1 and 
model 2, see Fig 3.13 for reference, as the best model solely using the Rfree is not 
possible, however supporting model 1 (i.e the best model) are two novel orientations of 
two residues; the Arg343 flanking residue and the nearby Glu347. Both residues assume 
a novel orientation and conformation in order to accommodate the novel orientation of 
heptose. 
The Glu347-Arg343 interaction is clearly defined by strong density (Fig. 3.16 and 
Fig. 3.17) suggesting that in order to accommodate the novel orientation of heptose, the 
flanking Arg343 residue needs to move away from heptose C2-OH. If Arg343 did not 
assume this novel orientation the heptose could not bind using the orientation reported. 
Asp325, the other flanking residue, is directed towards heptose C4-OH, again within 
distance for hydrogen bond potential.  
Considering that the H. influenzae Eagan CA7 PS contains two heptoses, HepI 
and HepII (if the PEA group of HepII was lost during hydrolysis) that could bind through 
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the O6’ and O7’ hydroxyls, it was important to determine the most likely heptose binding. 
According to the electron density map and best model, the heptose with the C2-OH facing 
the Arg343 group fits well with the electron density seen around heptose C3-OH. The C3-
OH position can be explained only for HepI binding to Ca1. The HepII-HepI linkage is α1-
3, indicating that the electron density seen around C3-OH represents the linkage between 
HepI-HepII with HepI bound to rfhSP-D. Rotating the main ring structure in order to fit C1-
OH into the density, where C3-OH was previous located, failed to provide a good fit, again 
indicating HepI rather than HepII binding.  A second point to note when considering if 
HepII is bound is the presence of the PEA group at position O6’ of the HepII. The 
hydrolysis procedure has been reported to impact on the presence of phosphate groups 
and derivatives attached to the Kdo however, it remains unclear if it could also affect 
phosphate groups attached to the inner core heptoses (Danan et al., 1982; Auzanneau 
et al., 1991; Masoud et al., 1997). Therefore, at present, the full impact of mild acid 
hydrolysis on the PEA group present on HepII remains unknown, suggesting that the PEA 
may or may not be present. HepI is the same heptose reported for the shorter H. 
influenzae Eagan 4A PS mutant (Clark et al., 2016), which raises the questions why has 
HepI assumed this novel orientation, rotated by 180°, and how does this correlate with the 
higher binding affinity for Eagan 4A LPS (1 heptose) as compared to Eagan CA7 LPS (2 
heptoses) (Clark et al., 2016). 
In order to attempt to answer both questions, four ligand models were constructed; 
Model A- H. influenzae Eagan 4A PS model  containing the Kdo-HepI-Glc with HepI 
bound as reported in literature (Clark et al., 2016); Models B and C- H. influenzae Eagan 
CA7 PS also containing the Kdo-HepI-Glc, but with an extra HepII bound to HepI by an 
α1-3 linkage and phosphorylated at position 6 by a PEA (Model B- HepI O6’ and O7’ 
hydroxyls positioned similarly to those reported for 4A PS; Model C- the HepI rotated by 
180° with respect to Ca1, i.e the best model for CA7 PS); Model D- H. influenzae Wild-
type Eagan PS (incomplete) containing the CA7 core plus a phosphorylated HepIII at 
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position 4 bound to HepII by α1-2 and a GlcI bound to HepII by α1-3 (HepI O6’ and O7’ 
bound and in similar orientation to model C for CA7 PS). Models A, B and C were used in 
attempting to answer questions 1, while models A, B and D were used in attempting to 
answer question 2.  
3.3.6.1 Question 1 – why is the Eagan CA7 HepI rotated by 180° compared 
to the Eagan 4A HepI? 
 
Question 1 explains why the novel orientation of HepI Eagan CA7 PS has 
occurred, with HepI rotated by 180° in comparison to the reported H. influenzae Eagan 4A 
PS HepI. It is important to understand that the rfhSP-D and CA7 complex was formed by 
co-crystallisation which implies no crystal packing constraints with the CA7 ligand free to 
assume its preferred and most stable orientation, with subsequent co-crystallisation. The 
fact that the CA7 is only found in the B subunit, and that when bound it does not mimic the 
high affinity binding shown by the Eagan 4A mutant (Clark et al., 2016) either here or 
presumably in solution, suggests that this is not quite so straightforward as it first appears.  
Three models were used in the attempt to answer the above question – model A – 
containing the 4A PS as reported in literature (Clark et al., 2016); model B – containing 
the CA7 PS HepI in similar orientation seen in 4A and model C- containing the CA7 PS 
HepI rotated by 180° so that the positions of hydroxyls O6’ and O7’ are interchanged with 
respect to Ca1.  
Model A and model B were constructed according to the position of the anhydro 
Kdo and HepI reported in the literature for the Eagan 4A (Clark et al., 2016). In this 
orientation it was possible to rotate the Glc and HepII (for CA7, Model B) to positions 
where they did not clash internally or with protein. Model C containing the rotated H. 
influenzae Eagan CA7 PS was placed in a similar orientation to HepI as shown in Fig. 
3.15, while ensuring that all the sugars of model C were within acceptable distances from 
each other and from the protein. While rotating the sugars of model C into acceptable 
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distances, a patch of density was observed located in the vicinity of Arg349, near where 
the PEA group off HepII would be located. Model C was fitted in similar orientation to that 
reported in this chapter for HepI, with the PEA in the density and refined, see Fig. 3.20A 
for the PEA fitting in the initial density and Fig. 3.20B for the density seen after 
refinement.  
 
 
 The density seen around the putative PEA bound to HepII following refinement 
suggested a possible orientation of how HepII and PEA could be oriented in model C, with 
the PEA group within hydrogen bonding distance of Arg349. Fig. 3.21 shows an 
illustration of the Eagan CA7 PS model C orientation in comparison with the Eagan 4A PS 
orientation reported in the literature (Clark et al., 2016). 
 When superimposing model A, B and C together (Fig. 3.22), no evident reason 
can be seen as to why the Eagan CA7 PS HepI model B did not bind as reported for the 
PEA 
HepII 
+ve density 
Arg343 
Arg349 
Arg349 
B A 
Fig. 3. 20 An illustration of the position of the density seen (orange box) when building 
model C containing the CA7 PS with the novel orientation of HepI; the PEA group 
seems to be located near Arg349. For both figures the direct map (2Fobs-Fcalc) is in 
blue and contoured 1σ.  A- The density seen located in the vicinity of the PEA group 
before refinement, with the difference map (Fobs-Fcalc) positive density in orange and 
contoured at 2.5σ. B- The density seen after refinement, suggesting that the PEA could 
be present in this orientation. Figures A and B generated using PYMOL.  
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Eagan 4A PS model A. In Model A (4A) and model B (CA7) the HepI orientation is 
pointing outwards, towards the long loop region (LLR) loop 3 (L3) and L4, with the model 
C (CA7-rotated) facing inwards and above chain B. Therefore, bearing in mind that model 
C arises from this structural study while Model B represents a manual placement to avoid 
clashes, in terms of spatial organisation both model B and C could have enough space 
with no clashes and no steric restrictions. 
 
 
 
 
 
 
 
 
 
 
It is thus clear that the adoption of the novel conformation, which it seems 
reasonable to assume reflects the low affinity binding mode in solution, is due to additional 
constraints on the CA7 internal conformation, the overall interaction of CA7 with rfhSP-D 
in the region of the binding pocket, or both, preventing the adoption of the high affinity 4A 
Model C (blue) Model A (yellow) 
Arg349 
Glu347 
Arg343 
Asp325 Ca1 
Fig. 3.21 An illustration of how model C (CA7 PS) would be orientated using the novel 
orientation of HepI rotated by 180° in comparison to Eagan PS model A (PDB: 4E52). 
Model C is displayed in blue (carbons), red (oxygens), orange (nitrogen) and dark blue 
(phosphate) with corresponding model residues Arg349, Glu347 and flanking residues 
Arg343 and Asp325 displayed in green (carbons), red (oxygens) and blue (nitrogen). 
Model A is displayed in yellow (carbons) and red (oxygens) with the corresponding 
model residues Asp325, Arg343, Glu347 and Arg349 displayed as reported in the 4A 
PS structure (Clark et al., 2016) in brown (carbons), red (oxygens) and blue 
(nitrogens). The position of Asp325, Arg343, Glu347 and Arg349 in the 4A structure 
(model A) differ significantly from the position of Asp325, Arg343, Glu347 and Arg349 
seen for the CA7 best model (model C). No Ca1 coordinating residues displayed. 
Figure generated using PYMOL. 
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binding mode. This is consistent with binding of the CA7 by rfhSP-D both before and after 
the formation of the crystal lattice.  
When fitting model C, the PEA group attached to the HepII sits in the vicinity of the 
residue Arg349 offering the potential of extra protein-ligand interactions, not possible in 
model B where the PEA would face outwards towards the middle of L3 and L4. However, 
in order for HepI to assume this novel orientation reported here, and for the PEA group of 
HepII to be in vicinity of Arg349, Arg343 and Glu347 need to assume the novel and 
previously unreported orientation by forming a salt bridge. The positive indication of the 
presence of PEA attached to HepII suggests that the hydrolysis procedure has no effect 
on this particular phosphate substitution. 
Model A 
L3 
L4 
Model C 
Model B 
Fig. 3.22 An illustration of the superposition of models A, B and C. Model A shows the 
reported Eagan 4A PS (PDB: 4E52) displayed in magenta (Clark et al., 2016). Model B 
shows the Eagan CA7 PS with HepI in similar orientation to the HepI in 4A PS and with 
the PEA group above L3 and L4, displayed in dark blue. Model C shows the novel 
orientation reported here for the HepI with the PEA group attached to HepII in the 
vicinity of Arg349.  Chain B is displayed using ribbons and in red. Image generated 
using MOLECULAR GRAPHICS.  
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Therefore, when answering the question as to why the novel orientation of HepI is 
adopted, on the basis that binding occurs before crystal lattice formation by those subunits 
with H. influenzae Eagan CA7 bound in chain B, it is proposed to be the consequence of 
an inability to adopt the high affinity 4A mode of binding accompanied by the loss of the 
preferred ligand to binding pocket fit, and the associated interactions with the binding site 
flanking residues, compensated for in part by extra protein-ligand interactions additional to 
those possible in the standard HepI orientation.  
As the Eagan CA7 is seen only in subunit B, it is not clear whether this binding 
occurs before or after formation of the crystal lattice. The alternative to binding before 
crystal lattice formation is that the protein forms a lattice from ligand-free rfhSP-D 
molecules with subsequent binding of the Eagan CA7. When superimposing model A and 
model B and using the crystal constraints and symmetry related molecules, it is clear that 
the Eagan CA7 PS in the same orientation as the Eagan 4A (model B) could not fit in the 
space between the chain B binding pocket and symmetry related rfhSP-D molecules. The 
CA7 PS entering the binding site of ligand-free P4212 crystals could not assume the 
model B (similar to 4A) orientation due to the HepII-PEA of the CA7 PS clashing with 
Ala278-288Asn in chain A of a symmetry related rfhSP-D molecule (Fig 3.23A), while 
PEA is located near to Thr255-257 of chain B of a symmetry related rfhSP-D molecule 
(Fig. 3.23B).  Therefore, it appears that the Eagan CA7 PS HepI could not be introduced 
into this crystal form (P4212) with the same orientation as the Eagan 4A PS. Rotating the 
HepII in order to not clash with symmetry related molecules, causes the HepII to clash 
with the Kdo in one direction and with HepI O2’ when rotated towards the other side. 
The weight of the evidence suggests that H. influenzae Eagan CA7 PS is unable 
to adopt the standard high affinity preferred binding orientation shown by Eagan 4A, with 
crystals forming from rfhSP-D -CA7 complexes with a single subunit occupied by CA7 in 
the novel orientation. These discussions are revisited in Chapter 5 where the results of 
this study are considered alongside those for the S. enterica minnesota LPS/PS in 
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Chapter 4 as well as the previous work on Eagan 4A (Clark et al., 2016) and heptose 
itself (Wang et al., 2008). 
4A LPS (magenta) 
and Ca7 LPS (dark 
blue) 
Symmetry related 
molecule chain B 
Chain B 
Symmetry related  
molecule chain A 
A 
PEA 
4A LPS (magenta) 
and Ca7 LPS  
(dark blue) 
Thr255-257Ala – chain B 
Ala278-288Asn – chain A 
Chain 
B 
B 
Fig. 3. 23 Superimposed H. influenzae Eagan 4A PS model A (PDB: 4E52) (Clark et al., 
2016) structure as reported in the literature and represented in magenta, with the H. 
influenzae Eagan CA7 PS model B using a similar orientation to the 4A LPS and represented 
in dark blue. In light blue chain B is shown containing the Ca1 coordinating residues and the 
flanking residues Arg343 and Asp325. Ca1 is modelled in red. In green, chain A of a 
symmetry related molecule and in gold chain B of a symmetry related molecule. A.  using 
ribbons, the display of how the CA7 PS (dark blue) could not bind in the same orientation as 
the 4A PS (magenta) due to clashes with the symmetry related molecule chain A (green). B.  
using cylinders and similar display to A, HepII-PEA (dark blue) of the CA7 PS could not bind 
through the same orientation as 4A LPS, as it clashes with the symmetry related molecule of 
chain A sequence Ala278-288Asn, with the PEA group in proximity to the symmetry related 
molecule chain B Thr255-Ala257. A and B displayed using MOLECULAR GRAPHICS. 
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3.3.6.2 Question 2 – How does the novel orientation of HepI shown for 
Eagan CA7 PS relate to the decreasing affinity of SP-D and rfhSP-D 
for Eagan wild type, (3 Heps), CA7 (2 Heps) and 4A (1 Hep)? 
 The current knowledge of the bound orientation seen for the HepI of Eagan 4A PS 
(Clark et al., 2016) and the novel orientation and interactions reported here for HepI of 
the Eagan CA7 PS suggests an explanation of the reduction in binding reported in the 
literature as the number of heptoses increases in the Eagan mutants; 4A, CA7 and Wild-
Type. 
The novel orientation reported in this chapter for CA7 (model C) HepI includes 
additional interactions between the HepII-PEA group and the Arg349 residue. Wild-type 
Eagan PS contains the conserved CA7 PS structure, offering the possibility for the HepII-
PEA to be located in a similar place to that for CA7. This suggests that the wild-type could 
also assume the novel orientation of HepI shown by the Ca7 PS.  
Using HepI as the binding preference for all mutants and superimposing the Eagan 
4A PS as reported (model A), and the Eagan CA7 (model C) and wild-type PS (model D) 
rotated with respect to the 4A PS, the wild-type Eagan can be modelled without any 
clashes between carbohydrate and protein and with favourable steric interactions (Fig. 
3.24). It is important to mention that CA7 and wild-type models can only occur if Arg343 
and Glu347 assume the novel orientations as reported here for the CA7 structure. For 
practical reasons the complete wild-type PS could not be modelled, especially the 
extensions coming off the Glc bound to HepII; see Fig. 3.1 for a representation of the wild-
type Eagan LPS structure. 
HepI was considered to be the preferred binding site where rfhSP-D could 
recognise H. influenzae PS mutants, in part due to the 4A PS (Clark et al., 2016) CA7 PS 
(reported here) complexes however, other recognition sites are possible; 4A PS offers two 
recognition sites for SP-D, Glc (O3’ and O4’) and HepI (O6’ and O7’); CA7 PS offers three 
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recognition sites for SP-D, Glc (O3’ and O4’), HepI (O6’ and O7’) and HepII (O3’ and O4’); 
Wild-type PS offers four recognition sites for SP-D, Glc (O3’ and O4’), HepI (O6’ and O7’), 
HepII (O3’ and O4’) and HepIII (O6’ and O7’) (Shrive et al., 2003; Wang et al., 2008; 
Clark et al., 2016). 
 The length of the LPS structures has been shown to be inversely correlated with 
binding affinities, meaning that longer LPS ligands bind more weakly than shorter LPS 
ligands to SP-D and rfhSP-D. Eagan 4A PS (1 Hep) has been shown to bind much more 
strongly than CA7 PS (2 Heps), which in turn shows a stronger binding than Wild-type (3 
Heps) (Clark et al., 2016). Wild-type Eagan LPS contains a larger chain, 3 Heps and four 
available recognition sites, but actually shows weaker binding than CA7 and 4A, 
suggesting that chain branching can hinder recognition by SP-D.  
A 
L4 
C 
D 
Fig. 3.24 Superposition of the reported Eagan 4A PS (PDB: 4E52, A and displayed in 
magenta), the Eagan CA7 PS (C and displayed in light blue) reported here and the 
wild-type Eagan (D and displayed in yellow) positioned in a similar manner to the CA7 
PS. Chain B of rfhSP-D, including L4, is displayed in red using ribbons.  Image 
produced using MOLECULAR GRAPHICS (Clark et al., 2016). 
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The three-dimensional structure and conformations of oligosaccharides such as H. 
influenzae 4A, CA7 and Wild-type Eagan LPS are dependent on the orientation of the 
glycosidic torsion angles and steric interactions with water or solvent molecules and 
protein, especially in aperiodic chains such as LPS (Kirschner & Woods, 2001). H. 
influenzae Eagan 4A HepI contains only two linkages to other sugars; HepI-Kdo α 1,4 and 
Glc-HepI β 1,4. The CA7 and Wild-type HepI contain three linkages; HepI-Kdo α 1,5, Glc-
HepI a β 1,4 and HepII-HepI α 1,3. The extra linkage seen in the CA7 and Wild-type has 
been suggested to introduce steric constraints which might affect the binding by hSP-D to 
HepI (Clark et al., 2016). 
Fig. 3.24 reveals a particular and interesting feature. The LLR region, specifically 
L4 of the LLR (see Fig 1.4 A) seems to sit very close to the Wild-type PS (model C) Glc 
bound to the HepII and where Hex3, Hex4 and Hex5 are present, suggesting a possible 
space restriction for the wild-type Eagan (Fig. 3.25 C). When taking a closer look into the 
organisation of the LLR L4, it seems to sit very close to the binding pocket, suggesting 
that it could play a role in the binding affinity of longer ligands. Superimposing the present 
CA7 model and the model reported for the 4A PS (Clark et al., 2016) a nice fit between 
the models can be seen. However, when examining the L4 for both models, the L4 in the 
4A PS bound structure seems to be much closer to the Ca1 than that in the CA7 structure, 
suggesting that L4 could have some flexibility, see Fig. 3.25 A and B for an illustration. 
The position of the L4 in the CA7 structure suggests movement away from the binding 
pocket, perhaps to accommodate the longer CA7 PS ligand, which contains an extra 
HepII potentially phosphorylated at position 6 by PEA, in comparison to the 4A PS. This 
could also suggest that L4 could prevent longer ligands binding in the preferred 
orientation. L4, containing the Asn323-Glu329 residues, has been reported to show 
conformational changes upon the loss of Ca2 (Ng et al., 1998), as in the present CA7-
bound structure reported here. At present, it is not possible to determine if the extra 
flexibility seen is the consequence of the loss of Ca2 or the presence of the CA7 ligand. 
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Achieving the preferred binding mode via HepI, while assuming favourable steric 
interactions and carbohydrate-protein interactions would appear to be the main reason 
why a reduction in binding as branching increases is observed. The Eagan CA7 HepI LPS 
novel orientation seems to offer a higher binding potential than if the CA7 HepI was 
orientated in similar orientation the 4A. Wild-type HepI can assume a similar orientation to 
the CA7 HepI, however the Glc extension coming off HepII is in close proximity with L4 
suggesting limited space to accommodate subsequent hexose additions and leading to 
unfavourable steric interactions and poorer binding. The last consideration to make is that 
L4 REPORTED FOR 4A 
PS  
L4 IN THE CA7 PS  
Where Hex4 
would link 
L4 
Very 
Close 
Fig. 3. 25 An illustration of the position of L4 and 
the superposition of the 4A PS as reported (A and 
displayed in magenta), the CA7 PS (C and 
displayed in light blue) and the wild-type Eagan (D 
and displayed in yellow). For A and B- In brown 
and using ribbons the chain B of the 4A PS is 
displayed and in black the L4 (Ans323-329Glu) of 
the CA7 complexed model is also displayed. As 
shown in both A and B the L4 of the 4A PS model 
seems to be located closer to the Ca1 than the L4 
for the CA7 PS model, suggesting that L4 has 
some flexibility and could also act as a restriction 
for longer ligands. C- Model D containing the Glc 
and possible Hexose extension is shown to be very 
close to L4, potentially leading to unfavourable 
steric contacts.  
A B
 
C 
Chapter 3  Summary 
172 | P a g e  
 
as part of the novel orientation of the CA7 HepI PS, Arg343 and Glu347 need to also 
assume the novel orientation reported here, with all other structures reported displaying a 
different orientation for both Arg343 and Glu347. This suggests that although the novel 
orientation for Arg343 and Glu347 can occur, it may be a less favourable conformation. 
3.4 Summary 
The work performed in this chapter undertook the co-crystallisation of rfhSP-D in 
complex with H. influenzae CA7 PS and followed the work performed and reported for the 
shorter H. influenzae 4A PS (Clark et al., 2016). Co-crystallisation was achieved, as 
previous soaks of CA7 PS into ligand-free rfhSP-D crystals failed to reveal any binding. 
The co-crystallisation of rfhSP-D and CA7 PS was highly successful in producing a myriad 
of protein crystals, with two data sets collected that provided sufficient detail to be used in 
the model building and characterisation of the recognition and binding of Eagan CA7 PS 
by rfhSP-D. While the electron density maps for both data sets displayed somewhat 
ambiguous density, the identification of novel conformations for the flanking residue 
Arg343 and for Glu347, and the novel salt bridge interaction between the two residues, 
provides additional evidence for the orientation of HepI in the binding pocket of rfhSP-D 
chain B. HepI shows a completely novel mode of interaction, with HepI rotated by 180° 
about C5-C6 which switches the positions of the coordinating hydroxyls with respect to 
those in the Eagan 4A PS complex. Similar to the reported structure for the rfhSP-D – 
Eagan 4A PS complex (Clark et al., 2016), HepI seems to be the preferred binding 
determinant for rfhSP-D, even when Glc and HepII are available to bind via O3’ and O4’ 
equatorial groups (Shrive et al., 2003; Wang et al., 2008). When attempting to explain 
the reasons behind the novel orientation of HepI, a full model of the CA7 PS was built and 
positioned with favourable steric interactions and within acceptable distances to the rfhSP-
D chain B. The expected position of the PEA group attached to the HepII in the full model 
of the CA7 PS was putatively located in the electron density vicinity of Arg349, suggesting 
a possible interaction between PEA and Arg349. Finally, when superimposing all three H. 
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influenzae models and investigating the reasons why increased branching in H. influenzae 
mutants has been reported to lead to poor binding to rfhSP-D and SP-D, the position of 
hSP-D L4 was seen to be located in close proximity to Ca1 suggesting a potential role in 
binding longer ligands, but also as a possible constraint in terms of favourable spatial 
orientation for longer LPS ligands.   
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Chapter 4 - Structural study of co-crystallised rfhSP-D and S. 
enterica minnesota LPS and PS strains. 
4.1 Introduction  
  The use of LPS in structural studies with rfhSP-D creates a series of difficulties, 
including the insolubility of the intact LPS and the possibility of structural changes in the 
polysaccharide as a result of mild acid hydrolysis to remove the lipid A and hence 
increase solubility. The hydrolysis of LPS can be easily performed and is a fairly efficient 
method of removing the lipid A, yielding a purified PS component which can be dissolved 
in a solution containing the rfhSP-D. Even though the hydrolysis method can efficiently 
separate the lipid A from the PS, it can also impact on structural components of the PS, by 
causing conformational and structural changes to the Kdo (Danan et al., 1982; 
Auzanneau et al., 1991; Clark et al., 2016). Of particular importance is the β elimination 
of phosphate components when present on the Kdo resulting in significant rearrangement 
of the Kdo (Danan et al., 1982; Auzanneau et al., 1991; Clark et al., 2016). It could be 
argued that this structural change in the Kdo reduces the physiological validity of the 
binding interactions determined through structural studies, although the key interaction 
has been shown to be mediated through Hep rather than Kdo (Clark et al, 2016). 
Solubilising the intact LPS would allow further characterisation of how hSP-D interacts 
and recognises the various glycoconjugates present on the surface of pathogens but 
there are few reports in the literature of methods to achieve this.   
Therefore, the initial aim of the study of Salmonella enterica (serotype minnesota) 
LPS was to develop a suitable method of dissolving the full LPS for the R7 rough strain. 
These attempts yielded promising results, suggesting the potential to partially or fully 
solubilise full LPS to a concentration which can be used in crystallography.
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The initial experiments evaluated the potential of Triton X-100 and absolute 
ethanol in aiding in the partial or full solubilisation of full LPS, and the production of co-
crystals of rfhSP-D in complex with S. enterica minnesota LPS R7. E. coli O111:B4 LPS 
was initially used due to its abundant availability in our laboratory. The co-crystals 
produced were used to investigate the binding of rfhSP-D to solubilised S. enterica 
minnesota R7 LPS by means of X-ray diffraction. A third LPS (PS) ligand was also used, 
with S. enterica minnesota R5 PS (RcP-), a slightly longer strain than R7 LPS, being 
hydrolysed and used by soaking into the co-crystals of rfhSP-D and R7 LPS. All the 
crystallisation attempts occurred at Huxley Building, Keele University, Staffordshire. The 
data collection took place at Diamond Light Source (DLS), Diamond House, Harwell 
Science and Innovation Campus, Fermi Ave, Didcot, Oxfordshire. rfhSP-D supply, 
purification and preparation were performed as previously described (see Chapter 2). The 
rfhSP-D batch used in combinations with full LPS was Batch 6 and the structure/industrial 
screens were from Molecular Dimensions. 
 Lipopolysaccharide ligands 
The LPS used were Escherichia coli O111:B4 (Sigma-Aldrich – L4391), 
Salmonella enterica minnesota R5 (Enzo Lifesciences- ALX-581-017-L002) and R7 (Enzo 
Lifesciences ALX-581-018-L002). 
4.1.1.1 Escherichia coli O111:B4 smooth LPS 
The E. coli O111:B4 smooth LPS strain is an R3 core type (Fig. 4.1). This 
serotype can produce rough strain LPS, such as the E. coli J-5 (Rc) rough strain LPS. The 
O111:B4 LPS is composed of the lipid A linked to a core region rich in heptoses, 
glucoses, galactoses and the O-antigen, which is normally composed of GlcNac, GalNac 
and Gal (Stenutz et al., 2006). The O111:B4 LPS structural components were first 
proposed in 1975 to produce two different fractions, where LPS fraction 1 (12324.7 Da) 
contained 11 repeats of the O-antigen, while LPS fraction 2 (6022.3 Da) contained 3 
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repeats of the O-antigen (Morrison et al., 1975). HepI and HepII in the inner core can be 
phosphorylated leading to increased heterogeneity. The high heterogeneity seen in 
smooth LPS creates a problem when investigating specific strains (Freudenberg et al., 
2008).  At present the characterisation of the O111:B4 LPS and different fractions remains 
incomplete. 
 
 
4.1.1.2 Salmonella enterica minnesota R7 (Rd1P-) rough mutant LPS  
Salmonella enterica minnesota R7 full LPS was the rough strain chosen to be 
investigated in more detail. This particular LPS was of high interest, as the core includes a 
double Hep and a triple Kdo, adding to the knowledge base of hSP-D – LPS interactions 
in addition to the H. influenzae Eagan 4A (1 Hep, 1 Kdo) and Eagan Ca7 (2 hep, 1 Kdo) 
structures reported here and by Clark et al., (2016). The co-crystallisation of the full R7 
LPS with rfhSP-D was dependent on the novel solubility method reported here (and 
chapter 2). Structural studies of rfhSP-D bound to full LPS have never been reported in 
the literature, suggesting that if the co-crystallisation of rfhSP-D and R7 LPS was 
successful, it would offer the opportunity to investigate and characterise in detail the 
binding between rfhSP-D and full LPS for the first time.  
Salmonella R7 rough strain LPS was first reported in 1966 and occurs by means of 
mutations in the incorporation of the hexose GlcI to HepII, followed by a mutation in the 
phosphorylation of HepI and subsequent inactivation of phosphorylation of HepII. Both 
mutations produce a rough LPS containing the Lipid A, three KDOs and two Heps, where 
Fig. 4.1 The proposed structure of O111:B4 LPS, with the inner and outer core 
structures represented. At present due to the high heterogeneity seen in the LPS 
strains the full structure of the O111:B4 E. coli LPS remains unknown. Glc- Glucose; 
Hep- L-D-Heptose, KDO- 3-deoxy-D-manno-octulosonic acid; Gal- Galactose; GlcNAc 
- N-acetyl-glucosamine; P- Phosphate; PEA- Phosphate ethanolamine. Image adapted 
from Raetz & Whitfield, 2002 and Morrison et al., 1975 
Glc II Kdo I Hep I Hep II 
Kdo II 
α1,5 
α2,6 
Lipid A 
Glc III 
α1,3 
P 
Glc I Gal I 
GlcNAc I 
GlcNAc II 
4 
α1,3 
α 2,4 
α1,3 
Hep III 
α1,7 
α1,7 
α1,3 
α1,3 α1,3 
P 
4 
O-antigen 
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the Heps are phosphate free (Fig. 4.2) (Holst & Brade, 1991; Jousimies & Makela, 
1974; Schnaitman & Klena, 1993; Raetz & Whitfield, 2002; Luderitz et al., 1966). 
It is important to note that during the biosynthesis of the LPS, the order of gene 
activation and enzyme transfers have been suggested to follow sequentially. This 
suggests that mutations leading to the non-addition of GlcI and phosphate groups would 
impact on the addition of, for example, HepIII to HepII or GalI or GalII to GlcI, yielding an 
incomplete core region (Parker et al., 1992; Yethon et al., 1998). 
4.1.1.3 Salmonella enterica minnesota R5 (RcP-) rough mutant LPS 
R5 LPS exhibits a similar structure to R7 LPS (Fig. 4.2), containing just an extra 
glucose (GlcI) bound to HepII. This strain arises from a single mutation in the 
phosphorylation of HepI, inhibiting and impacting on the phosphorylation of HepII and the 
addition of GalI and GalII to the GlcI. If the phosphorylation of HepI and HepII occurs, this 
initiates the extension from GlcI where GalI and GalII are added, producing an Rb2 strain 
Muhlradt et al., 1967; Schnaitman & Klena, 1993; Jousimies & Makela, 1974; Raetz & 
Whitfield, 2002. 
Kdo I Hep I Hep II 
Kdo II 
α1,5 
α2,6 
Lipid A 
α2,4 
Kdo III 
α2,4 
α1,3 α1,3 Glc 
R5 
R7 
Fig. 4.2 The proposed structure of S. enterica (minnesota) R7 LPS containing a HepII-
HepI-KdoI-KdoII-KdoIII pentasaccharide bound to the Lipid A and the R5 LPS 
containing an extra Glc. Both LPSs contain the same KdoIII-KdoII-KdoI-HepI-HepII 
pentasaccharide (orange box). Hep- L-D-Heptose, Kdo- 3-deoxy-D-manno-octulosonic 
acid, Glc- glucose. Image produced by using information in Holst & Brade, 1991; 
Jousimies & Makela, 1974; Luderitz et al., 1966.  
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4.2 Ligand preparation  
 Solubility of E. coli O111:B4 LPS in Triton X-100 and Ethanol  
Triton X-100 and absolute ethanol were used in three separate experiments, in 
order to investigate their potential as solubilising agents of full LPS. The solubility of 
O111:B4 LPS in absolute ethanol and/or Triton X-100 was performed as previously 
described in chapter 2, where 24 well Linbro plates were used, except that no protein was 
added to the micro-bridge and instead the solution contained 1:1 rfhSP-D storage buffer 
(50 mM Tris base, 150 mM NaCl, 10 mM CaCl2 pH 7.4) and O111:B4 LPS at varying 
concentrations and in combination with various concentrations of Triton X-100 and/or, 
absolute ethanol.  An initial investigation was performed to evaluate the solubility limit of 
O111:B4 E. coli LPS in rfhSP-D storage buffer, with 6 mg/ml (0.65 mM) of O111:B4 LPS 
in rfhSP-D storage buffer representing the solubility limit. The impact of the varying 
concentrations of Triton X-100 and absolute ethanol on specific concentrations of 
O111:B4 were investigated by means of light microscopy visualisation and by comparison 
to solutions containing just O111:B4 LPS and rfhSP-D storage buffer. 
The molecular weight of O111:B4 E. coli LPS was calculated to be approximately 
9173.5 Da based on the two separate fractions previously reported to be present in the 
O111:B4 LPS. Since LPS is rather heterogeneous and no other information has been 
reported regarding the % of each fraction, it was assumed that both fractions existed in 
equal quantities (Morrison et al., 1975). 
4.2.1.1 E. coli O111:B4 LPS solubilised in Triton X-100 
Different concentrations of the E. coli O111:B4 LPS solution were prepared; 8 
mg/ml (0.87 mM), 10 mg/ml (1.09 mM), 12 mg/ml (1.31 mM), 14 mg/ml (1.53 mM) and 16 
mg/ml (1.74 mM). Six solutions of Triton X-100 were added to the LPS solutions (0.5 µl) 
producing a final concentration of 1 mM, 0.5 mM, 0.4 mM, 0.3 mM, 0.2 mM, and 0.1 mM 
of Triton X-100 + LPS (final volume 2 µl), with the aim of investigating the impact of Triton 
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X-100 above and below the CMC (Table 4.1). This produced 30 different mixtures (LPS + 
Triton X-100), which were compared against LPS solutions at 8 mg/ml, 10 mg/ml, 12 
mg/ml, 14 mg/ml and 16 mg/ml with no Triton X-100 present.   
The various different concentrations of Triton X-100 tested on specific O111:B4 
LPS concentrations demonstrated that a concentration of Triton X-100 at 0.2-0.3mM can 
improve the solubilisation of O111:B4 LPS in storage buffer at 16 mg/ml, (Fig. 4.3).  
 
LPS concentrations at 8 mg/ml, 10 mg/ml, 12 mg/ml and 14 mg/ml + Triton X-100 
at 0.2 mM or 0.3 mM also demonstrated similar results to the 16 mg/ml mixture. The 
addition of 0.2-0.3 mM Triton X-100 to the various solutions produced a clear and 
homogeneous solution. When the concentration of Triton X-100 used was above 0.3 mM, 
the solution seemed slightly cloudy and at 0.1 mM it appeared precipitated.  
 
4.2.1.2 O111:B4 LPS solubilised in absolute ethanol 
Different concentrations of the E. coli O111:B4 LPS solution were prepared; 15 
mg/ml (1.64 mM), 20 mg/ml (2.18 mM), 25 mg/ml (2.73 mM), 30 mg/ml (3.27 mM) and 35 
mg/ml (3.82 mM) in combination with 30% (v/v) absolute ethanol (Table 4.1) as reported 
in the literature (Sharma et al., 2013). 0.6 µl of ethanol was added to each of the different 
concentrations of LPS, producing five different mixtures (LPS + 30% (v/v) absolute 
A B C 
Fig. 4.3 A- 16 mg/ml O111:B4 LPS in rfhSP-D storage buffer, no detergent added. 
Typically, the LPS does not mix in solution, with eye visible “chunks” of LPS in 
suspension. B- 16 mg/ml O111:B4 LPS in rfhSP-D storage buffer + 0.3mM Triton X-
100. No LPS “chunks” were seen and the solution looked homogenous. C- 16 mg/ml in 
O111:B4 LPS rfhSP-D storage buffer + 0.2 mM Triton X-100. Similar to B, at 0.2 mM 
Triton X-100 seemed to solubilise the LPS producing a fairly homogeneous solution.  
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ethanol) with 2 µl final volume. This was compared against solutions of LPS at 15 mg/ml, 
20 mg/ml, 25 mg/ml, 30 mg/ml and 35 mg/ml with no ethanol added. 
E. coli 
LPS 
(mg/ml) 
Just Triton X-100 Just 
absolute 
ethanol 
 Triton X-100 and absolute ethanol in 
combination 
Triton X-100 (mM) Absolute 
ethanol 
(%) (v/v) 
Solution 
Number 
Absolute 
Ethanol 
(%) (v/v) 
Triton 
X-
100 
(mM) 
E.coli 
LPS 
(mg/ml) 
8 1 0.5 0.4 0.3 0.2 0.1 N/A 1 10 0.25 40 
10 1 0.5 0.4 0.3 0.2 0.1 N/A 2 10 0.25 35 
12 1 0.5 0.4 0.3 0.2 0.1 N/A 3 10 0.25 30 
14 1 0.5 0.4 0.3 0.2 0.1 N/A 4 20 0.25 40 
15 N/A N/A N/A N/A N/A N/A 30 5 20 0.25 35 
16 1 0.5 0.4 0.3 0.2 0.1 N/A 6 20 0.25 30 
20 N/A 30 7 30 0.25 40 
25 N/A 30 8 30 0.25 35 
30 N/A 30 9 30 0.25 30 
35 N/A 30     
Tablle 4.1 The illustration of the three experiments performed to investigate the solubility potential 
of E. coli O111:B4 LPS using Triton X-100 alone (shaded in yellow), absolute ethanol (v/v) (shaded 
in green) and using a combination of Triton X-100 and absolute ethanol together (shaded in blue). 
In the Triton X-100 experiment 30 different mixtures (LPS + Triton X-100) were investigated, with a 
concentration of Triton X-100 at 0.2-0.3mM (in red in the table) improving the solubility of the LPS 
at 8, 10, 12, 14 and 16mg/ml. The second experiment used only absolute ethanol 30% (v/v), with a 
concentration of LPS up to 20mg/ml (in red in the table) showing signs of improved solubility. At 
25, 30 and 35mg/ml absolute ethanol 30% (v/v) seemed inefficient in improving the solubility of the 
LPS with the three solutions looking saturated. The final experiment used a combination of Triton 
X-100 at 0.25mM (the CMC limit of Triton X-100) and absolute ethanol at 10, 20 and 30% (v/v). In 
this experiment solution 8 and 9 (LPS at 35mg/ml and 30mg/ml respectively) (displayed in red in 
the table) were both successful in partially or fully solubilising the E. coli LPS, suggesting that up to 
35mg/ml a combination of Triton X-100 and absolute ethanol (v/v) could aid in the solubilisation of 
the LPS.  
At 30% (v/v) absolute ethanol can aid in partially or fully solubilising O111:B4 LPS 
up to 20 mg/ml. Both15 mg/ml and 20 mg/ml of O111:B4 LPS produced a visibly clearer 
solution, but at 25 mg/ml or above the solutions seemed saturated with visible LPS 
“chunks” in suspension (Fig. 4.4). 
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A B C 
Fig. 4.4 A- 30% (v/v) absolute ethanol seemed to dissolved O111:B4 LPS up to 20 
mg/ml, with the solution looking homogenous B- At 25 mg/ml the solution started to 
look saturated with bits of LPS in suspension. C- At 30 mg/ml the solution looked 
saturated with many bits of LPSs in solution.  
 
4.2.1.3 O111:B4 LPS solubilised in triton X-100 and absolute ethanol 
Three ethanol concentrations (10%, 20% and 30% (v/v)) and three LPS 
concentrations were tested (30 mg/ml (3.27 mM), 35 mg/ml (3.82 mM) and 40 mg/ml (4.36 
mM). In the earlier 30% ethanol trials the LPS seemed saturated at 25 mg/ml, and the 
effect on this saturated solution of adding Triton X-100 was investigated. As Triton X-100 
alone at 0.2 mM and 0.3 mM concentrations showed a positive effect on the solubilisation 
of the LPS, a solution midway between, at ≈0.25 mM (the CMC limit for triton X-100) was 
used.  In total 9 mixtures were made up as shown in Table 4.1. 
Of all the mixtures tested, solutions 8 and 9 seem to hold the most potential for the 
partial or full solubilisation of the LPS (Fig. 4.5), displaying a homogenous solution with no 
signs of large LPS “chunks”. Solution 8 contained a higher concentration of LPS, in 
comparison to solution 9 and this was visible as it showed some precipitation. All the 
solutions containing 10 or 20% ethanol were less effective at solubilising the LPS. At 40 
mg/ml of LPS all the solutions seemed full of precipitation and debris.  
Solutions 8 and 9 both present themselves as suitable mixtures for the 
solubilisation of O111:B4 LPS, suggesting that up to 35 mg/ml of O111:B4 LPS can be 
solubilised by using a mixture of 0.25 mM triton X-100 and 30% ethanol. Solution numbers 
8 and 9 were performed a further three times to ensure the feasibility and reliability of the 
results and in all three attempts the same results were produced, a clear and 
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homogeneous solution with no big “chunks” of LPS in suspension. 
 Solubility limit of S. enterica minnesota R7 LPS in Ethanol and 
Triton X-100 
The conclusions from the O111:B4 LPS experiments were used to investigate the 
solubility of R7 S. enterica minnesota LPS in combination with both Triton X-100 and 
absolute ethanol. The molecular weight of R7 S. enterica minnesota LPS was calculated 
by addition of the individual weights of the glycoconjugates and lipid A, yielding a 
molecular weight of approximately 2880.36 Da, with the lipid A accounting for 62% of the 
total molecular weight of the LPS (Holst & Brade, 1991; Jousimies & Makela, 1974; 
Schnaitman & Klena, 1993; Raetz et al., 2002; Que et al., 2000).  
R7 S. enterica minnesota LPS solubility was investigated using the combination of 
0.25 mM Triton X-100 and 30% (v/v) absolute ethanol. The estimated maximum R7 S. 
enterica minnesota LPS concentration was defined by calculating the concentration (mM) 
corresponding to the maximum O111:B4 LPS solubility observed in 0.25 mM and 30% 
(v/v) absolute ethanol (35 mg/ml - 3.67 mM). This equates to 10.57 mg/ml = 3.67 mM for 
the R7 S. enterica minnesota LPS. 
Errors in this estimate are likely to arise when considering that O111:B4 E. coli 
LPS is smooth (longer), while R7 S. enterica minnesota LPS is a rough strain (shorter) 
A B 
Fig. 4.5 Using a combination of 0.25 mM Triton X-100 and 30% (v/v) absolute ethanol 
seemed to have dissolved the O111:B4 LPS up to 35 mg/ml, with both solutions 8 
(image B) and 9 (image A) being fairly homogenous. A- Solution 9 - 30% (v/v) absolute 
ethanol + 0.25 mM of Triton X-100 and 30 mg/ml LPS. B- Solution 8 - 30% (v/v) 
absolute ethanol + 0.25 mM of Triton X-100 and 35 mg/ml LPS. 
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with a different ratio of hydrophilic to hydrophobic components (Park et al., 2009; 
Kabanov & Prokhorenko, 2011). A solubility trial was performed using 0.25 mM Triton X-
100 and 30% absolute ethanol and four different concentrations of R7 S. enterica 
minnesota LPS around the estimated maximum achievable; 7.69 mg/ml (2.67 mM), 10.57 
mg/ml (3.67 mM), 13.48 mg/ml (4.67 mM) and 16.33 mg/ml (5.67 mM). At 7.69 mg/ml 
(2.67 mM), 10.57 mg/ml (3.67 mM) and 13.48 mg/ml (4.67 mM) the R7 S. enterica 
minnesota LPS produced a homogenous and clear solution, while at 16.33 mg/ml (5.67 
mM) the solution appeared saturated and with LPS in suspension. This experiment 
suggested that a maximum concentration of approximately 13.48 mg/ml (4.67 mM) of the 
R7 S. enterica minnesota LPS could be solubilised in rfhSP-D storage buffer, by using a 
mixture of 0.25 mM Triton X-100 and 30% (v/v) absolute ethanol. 
 Hydrolysis of S. enterica minnesota R5 
The hydrolysis of S. enterica minnesota R5 LPS was performed according to the 
method previously described in Chapter 2. The molecular weight of S. enterica minnesota 
R5 LPS was calculated as ≈ 3030.36 Da by the addition of all glycoconjunagtes and Lipid 
A. The lipid A portion accounted for ≈ 1800 Da (Que et al., 2000), making up 58.8% of the 
LPS. 2 mg of R5 LPS were initially hydrolysed, yielding ≈0.7 mg of PS representing 84% 
hydrolysis efficiency. The 0.7 mg of R5 PS were dissolved in ≈35 µl of deionised water, 
producing a concentration of ≈50 mM for storage and for use in crystal soaking. 
4.3 Co-crystallisation of rfhSP-D in combination with solubilised R7 
LPS  
The co-crystallisation of rfhSP-D in combination with R7 LPS was performed 
according to the methods described in Chapter 2. The final drop was composed of a 1:1 
ratio of specific precipitant buffers and the protein/LPS solution containing rfhSP-D at 7.5 
mg/ml (0.42 mM), R7 S. enterica minnesota LPS at 4.67 mM and 30% (v/v) absolute 
ethanol + 0.25 mM of Triton X-100. The Ca2+ concentration was ≈ 5 mM in the drop. 
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Structure screens were initially used to establish growth conditions.  A total of 2 µl was 
placed in each micro-bridge with R7 LPS at 11.1-fold excess over the rfhSP-D monomer 
binding site. Six 24-well Linbro plates containing the 100 structure screen buffer 
precipitants of SS1 and SS2 were set down on 6/10/2014, with the following tray codes; 
RS43, RS44, RS45, RS46, RS47 and RS48.  Positive crystal growth was seen in RS43 
C3 (SS1 C.15), RS44 A2 (SS1 C.20), RS44 B4 (SS1 C.28), RS45 A2 (SS1 C.38), RS46 
B6 (SS2 C.12) and RS47 A1 (SS2 C.19) (Table 4.2).    
 
Eight follow ups were produced in a similar manner to that previously described in 
Chapter 3 (Eagan CA7), but failed to produce any crystal growth. As a as result the eight 
follow ups will not be discussed further. In total 14 24-well Linbro plates were produced 
and over 130 precipitant buffers and/or variations were investigated. 
 RS44 A2 (SS1-20), RS45 A2 (SS1-38), RS46 B6 (SS2-12), RS47 A1 
(SS2-19) 
These wells produced a variety of morphologies (Fig. 4.6) with a total of 15 
crystals collected, cryo-protected and frozen for testing at Diamond Light Source. All four 
Tray + 
Well ID 
Comments and conditions 
RS43 
C3 
This well was set down on 6/10/2014. The condition used in this well comes from SS1 
condition 15. This well contained 0.2M Mg acetate, 0.1M MES pH 6.5 and 20% PEG 
8K.  
RS44 
A2 
This well was set down on 6/10/2014. The condition used in this well comes from SS1 
condition 20. This well contained 0.2M Calcium acetate, 0.1M MES pH 6.5 and 18% 
PEG 8K.  
RS44 
B4 
This well was set down on 6/10/2014. The condition used in this well comes from SS1 
condition 28. This well contained 0.1M Na Hepes pH 7.5, 0.8M Na/K dihydrogen 
Phosphate.  
RS45 
A2 
This well was set down on 6/10/2014. The condition used in this well comes from SS1 
condition 38. This well contained 0.1M Tris pH 8.5 and 8% PEG 8K.  
RS46 
B6 
This well was set down on 6/10/2014. The condition used in this well comes from SS2 
condition 12. This well contained 0.1M Na Hepes pH 7.5 and 10% PEG 6K and 5% 
MPD.  
RS47 
A1 
This well was set down on 6/10/2014. The condition used in this well comes from SS2 
condition 19. This well contained 0.1M Na Hepes pH 7.5 and 10% PEG 6K and 8% 
Ethylene Glycol. 
Table 4.2 The six wells that produced positive crystal growth from the SS1 and SS2 buffer 
precipitants.  
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A B C 
Fig. 4.6 Typical crystal morphologies. A- RS44 A2 well B- RS46 B6 well C- RS47 A1 
well.  
wells produced similar shaped crystals, with rectangular, cubic, thin square plates and 
other irregular shapes seen. 
 RS43 C3 (SS1- 15) 
The RS43 C3 well produced various crystals with varied morphologies, such as 
squares, rectangles and odd-shaped crystals (Fig. 4.7). 
 RS44 B4 (SS1- 28) 
The RS44 B4 well produced various crystals, mostly thin squares and rectangles, 
with a few multiple/layered crystals (Fig. 4.8).  
Fig. 4.7 The typical crystal 
morphology produced in the RS43 
C3 well. As can be seen in the image 
a variety of morphologies were seen, 
mostly irregular shaped crystals. The 
brown precipitation in the solution is 
the S. enterica minnesota R7 LPS in 
solution.  
Fig. 4.8 The typical morphology 
of crystals produced in the RS44 
B4 well is shown. Mostly thin 
squares were produced in this 
well.  
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4.4 RS44 A2 (SS1-20), RS45 A2 (SS1-38), RS46 B6 (SS2-12), RS47 
A1 (SS2-19) 
 Cryo-protection  
Cryo-protection was performed according to the method described in Chapter 2. A 
total of 33 co-crystals of rfhSP-D and R7 LPS were cryo-protected, flash-frozen and with 
X-ray data being collected in each case. Glycerol was chosen as the cryo-protectant of 
choice. Strategy 2 was initially used due to the experimental problems in mixing the R7 
LPS + 30% ethanol + 0.25 mM of Triton X-100 with Glycerol. Strategy 2 was based on the 
addition of 0.5µl (twice) of 50% glycerol, with a 2-minute interval between additions. 
Strategy 2 produced a final concentration of Glycerol ≈ 16.6%, R7 LPS ≈ 3.11 mM and 
Ca2+ ≈ 3.33 mM in the micro-bridge. While using strategy 2, no ligand was present in the 
cryo solution. This strategy was used in the cryo-protection of crystals from the RS44 A2, 
RS45 A2, RS46 B6 and RS47 A11 wells (Table 4.3). The cryo-protection was successful 
in cryo-protecting the crystals, as no ice rings were detected during data collection and the 
crystals were able to sustain the addition of 50% glycerol. 
 Data collection  
Due to the high number of co-crystals tested only the crystals that yielded 
significant results will be discussed in detail. Successful data collection from crystals with 
Well Solutions + Glycerol 
% 
Volume 
added (µl) 
Time in solution 
(minutes) 
Comments 
RS44 A2 - 0.2M Calcium acetate, 
0.1M MES pH 6.5 and 18% PEG 8K.  
RS45 A2 - 0.1M Tris pH 8.5 and 8% 
PEG 8K. 
RS46 B6 - 0.1M Na Hepes pH 7.5 
and 10% PEG 6K and 5% MPD. 
RS47 A1 - 0.1M Na Hepes pH 7.5 
and 10% PEG 6K and 8% Ethylene 
Glycol. 
  
50 +0.5 ≈2 No ligand 
present in 
all four cryo 
solutions.  50 +0.5 ≈2 
Table 4.3 The method of the cryo-protection performed for each of the RS44 A2, RS45 
A2, RS46 B6 and RS47 A1 wells. No ligand was soaked in together with the cryo.  
Chapter 4 RS43 C3 (SS1–C5) 
187 | P a g e  
 
a resolution up to 4.0Å or above were further investigated by means of data analysis using 
the CCP4 software (see 2.5.5), with the aim of investigating the presence of S. enterica 
minnesota R7 LPS in the co-crystallised rfhSP-D crystals. Four crystals showed a medium 
to low resolution and were used in data analysis; RS44 A22 (crystal 2 from RS44 A2), 
RS45 A21, RS46 B63 and RS47 A1, shown in Table 4.4.  
Table 4.4 The four crystals with best resolution are shown, including the date of testing, 
the resolution of the data collection and the DLS beamline where data was collected.  
The RS44 A22, RS45 A21, RS46 B63 and RS47 A11 data sets were analysed by 
using the fast_dp for the subsequent production of each electron density map using the 
CCP4 suite as described in chapter 2. The four crystals were all in the ligand-free P21 
space group, with similar unit cell dimensions as reported in the literature (Shrive et al., 
2003; Shrive et al., 2009). For each data set the respective electron density map was 
produced in order to evaluate ligand presence. The production of each map revealed that 
the R7 LPS co-crystals with the P21 space group were ligand-free, with no sign of ligand 
occupancy in any of the subunits. The electron density maps showed a typical unliganded 
rfhSP-D trimer structure, where Ca1, Ca2 and Ca3 were present for subunit A, B and C 
and with no density for Ca4 (Shrive et al., 2003; Shrive et al., 2009). The electron 
density maps of the four data sets are not displayed in this thesis. 
4.5 RS43 C3 (SS1–C5) 
The attempts to co-crystallise rfhSP-D in combination with R7 S. enterica 
minnesota LPS Triton X-100 and ethanol described above produced ligand-free P21 
crystals, where no binding between the rfhSP-D and R7 LPS occurred (Shrive et al., 
2003; Shrive et al., 2009). This offers the opportunity to use the remaining ligand-free 
crystals to soak in other ligands. Therefore, once it had been shown that all the R7 LPS 
co-crystals tested were in fact ligand-free, it was decided to use the remaining wells 
Crystal Code Date Tested Data Collection Beamline Notes 
RS45 A21 16/1/15 DC- 2.01 Å I04-1 These represented 
the best crystals in 
terms of resolution.  
RS44 A22 16/1/15 DC- 3.74 Å I04-1 
RS46 B63 30/1/15 DC- 2.02 Å I04-1 
RS47 A11 30/1/15 DC- 2.52 Å I04-1 
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(RS43 C3 and RS44 B4) to investigate the binding of the S. enterica minnesota R5 PS. S. 
enterica minnesota R5 PS is very similar to R7, containing just an extra glucose, making it 
an ideal candidate for ligand binding studies. 
The crystals in well RS43 C3 were cryo-protected using strategy 2, where 50% 
glycerol in combination with R5 PS at 10mM in the well precipitant buffer were added.   
The cryo-protection used for the RS43 C3 well is shown in Table 4.5. with a total of 5 
cryo-protected crystals collected and frozen for testing at Diamond Light Source on 
beamline I04-1 on 13/4/15. The cryo-protection was successful as no ice rings were 
detected during data collection and the crystals sustained the addition of 50% glycerol. 
The RS43 C35 data set (co-crystallised with solubilised R7 LPS, followed by 
addition of the R5 PS via cryo-protection) was analysed by using fast_dp. The crystal was, 
as had been observed for all previous co-crystals detailed above, in the typical ligand-free 
P21 space group, with similar unit cell dimensions as reported in the literature (Shrive et 
al., 2003; Shrive et al., 2009). The electron density map produced in order to evaluate 
ligand presence revealed no sign of ligand occupancy in any of the subunits. The electron 
density maps showed a typical unliganded rfhSP-D trimer structure, where Ca1, Ca2 and 
Ca3 were present for subunit A, B and C and with no density for Ca4 (Shrive et al., 2003; 
Shrive et al., 2009). The electron density map is not displayed in this thesis. 
Well Conditions + Glycerol % Volume 
added (µl) 
Time in solution 
(minutes) 
Comments 
 
0.2M Mg acetate, 
0.1M MES pH 6.5, 
20% PEG 8K and 
R5 PS at 10mM  
  
50 +0.5 ≈2 
The soaking of PS into an 
LPS co-crystallised rfhSP-
D crystals was due to 
previous crystallisation 
attempts showing that P21 
crystals were being 
produced, with no 
indication of LPS in the co-
crystals.   
50 +0.5 ≈2 
Table 4.5 The cryo-protection performed in the RS43 C3 well. Strategy 2 was used as the 
cryo-protection method and included R5 PS at 10mM.  
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4.6 RS44 B4 (SS1-C28) 
The RS44 B4 well represented one of the last wells with protein crystals produced 
by the unsuccessful attempts at co-crystallisation with the R7 LPS and Triton X-100 + 
absolute ethanol. As the previous attempt (RS43 C3) soaking the R5 PS at 10mM had 
been unsuccessful, a higher concentration of R5 PS (21mM) equating to ≈50x molecular 
excess of ligand to rfhSP-D monomer was used, with the aim of introducing the R5 PS in 
to the ligand binding site.  
 Cryo-protection 
The cryo-protection of this well used strategy 1, with R5 PS at ≈21 mM present in 
the glycerol cryo solution which was added at increasing glycerol concentration to the 
well, with a final exchange performed (Table 4.6). The final Ca2+ concentration was ≈ 1.2 
mM in the micro-bridge following exchange, with the R7 LPS from the original co-
crystallisation also present in solution. 
In total 13 cryo-protected crystals were collected and flash frozen for testing at 
Diamond Light Source. The cryo-protection was successful in cryo-protecting the crystals, 
as no ice ring were detected during data collection.  
Well Conditions + Glycerol % Volume added 
(µl) 
Time in solution 
(minutes) 
Comments 
0.1M Na Hepes 
pH 7.5, 0.8M Na/K 
dihydrogen 
Phosphate and R5 
PS at 21mM.  
5 +2 2 Similar to the RS43 C3 
well cryo-protection 
details. Previous 
crystals produced a 
P21 space group 
suggesting that no R7 
LPS was bound to the 
rfhSP-D and so R5 PS 
was added as a soak. 
10 +2 2 
15 +2 2 
20 +2 2 
20 +2 2 
20 
-10 (solution 
reservoir) + 10 
of 20% 
Glycerol– 
Exchanged 
6 
Table 4.6 The cryo-protection method performed on the RS44 B4 well. This well was 
cryo-protected using Glycerol 5, 10, 15 and 20% where the R5 PS was present in each 
cryo solution at ≈21 mM.  
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 Data collection 
Crystal number 12 from RS44 B4 (RS44 B412) was exposed on 9/7/15 on the I04-
1 beamline. This crystal had been co-crystallised with rfhSP-D with R7 S. enterica 
minnesota LPS at 4.67 mM + 30% (v/v) absolute ethanol + 0.25 mM of Triton X-100, and 
then R5 PS at ≈ 21 mM was soaked in during the cryo-protection stages. This suggests 
that this particular crystal could have interacted with two similar ligands. The crystal 
morphology resembled a tiny square (Fig. 4.9A), with one of corners cracked. The initial 
exposure of this crystal (SNAPS), showed positive protein diffraction spots with no sign of 
ice rings in the diffraction images.  Following the snap EDNA suggested a maximum 
resolution of 3.0 Å. The parameters used in the snap and data collection are shown in 
Table 4.7.  
 
SNAP 
or DC 
Start 
Angle 
(˚) 
φ  
(˚) 
Total   
φ  (˚) 
Number 
of  
Images 
Exposure 
per 
Image (s) 
Total 
Exposure 
(s) 
Maximum 
Resolution 
(Å) 
Detector 
Distance 
(mm) 
Transm
ission 
(%) 
SNAP 0 0 90 3 0.5 1.5 3.0 578.5 100 
 
DC 96 0.2 125 625 0.1 62.5 2.5 474 100 
Table 4.7 Parameters used for the initial SNAP and for the RS44 B412 data collection. 
SNAP- first diffraction; DC- data collection; φ (phi) – angle of diffraction. 
A B 
Fig 4.9 Images collected at DLS for the RS44 B412 crystal A- On the left, the picture 
of the crystal before a snap was taken to evaluate the quality of the crystal. B- On 
the right, the diffraction pattern produced following one of the snaps with the 
characteristics Braggs spots, proving that the crystal was protein.  
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 Data Processing  
The RS44 B412 diffraction spots and images were indexed and integrated in the 
P4212 space group using iMOSFLM, not the usual space seen for rfhSP-D crystals, 
perhaps influenced by the presence of the R7 ligand in the co-crystallisation. Using 
AIMLESS various different runs were investigated, where batches of images containing a 
high Rmerge were unselected and the resolution of the data limited (decreased). The data 
resolution was eventually limited to 3.3 Å, with a great improvement in the Rmerge. 
TRUNCATE was used to investigate the twinning of the data set, with no twinning 
reported.  UNIQUEIFY was used to add the free R-flag, while RE-INDEX was used to re-
index the space group into P4212. See Table 4.8 for the data processing parameters 
following in house processing.   
Data collection 
Parameters  RS44 B412 
Overall, 
InnerShell and 
OuterShell 
Overall InnerShell OuterShell 
Wavelength (Å) 0.92000 
Low Resolution 
limit (Å) 64.28 64.28 3.56 
High Resolution 
limit (Å) 3.3 8.73 3.3 
Space Group P4 21 2 
Unit Cell lengths 
(Å) a=113.70, b=113.70, c=107.00 
α, β, γ (°) 90, 90, 90 
Number of 
reflections 54188 2822 11577 
Unique 
reflections 10886 641 2227 
Average I/σ 8.7 14 4.8 
CC (1/2) 0.987 0.998 0.906 
Completeness 
% 98.9 96.8 99.5 
Rmerge % 12.9 3.9 30.8 
Multiplicity 5.0 4.4 5.2 
Fast_dp (DLS) 
or processed in 
house 
Processed in house 
Table 4.8 The data processing parameters for RS44 B412. This data 
set produced the P4212 tetragonal space group, also reported in 
chapter 3, suggesting that R7 LPS was perhaps influencing crystal 
contact formation.   
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 Rigid Body Refinement  
The molecular replacement was performed by Dr. Annette Shrive using the ligand-
free rfhSP-D structure (PDB: accession code 1PW9) and using AMoRe program (CCP4). 
The R-factors for the REFMAC5 rigid body refinement for the RS32 A12 data were 
38.27% for the Rfree and 39.74% for the R-factor. This model contained the coordinates for 
the three chains of rfhSP-D minus the calcium and waters. The rigid body refined model 
allowed a map to be calculated for the inspection of the binding site in terms of the 
presence of the ligand and Ca2+ and the investigation of the overall structural organisation 
of key residues in each of three subunits. 
 Initial Electron Density map 
The direct electron density map (2Fobs - Fcalc) and the difference map (Fobs - Fcalc) 
were initially created by using the rigid body refined ligand-free model for the phases. The 
electron density maps for RS44 B412 following rigid body refinement showed the usual 
overall structure of rfhSP-D, previously reported in the literature (Shrive et al., 2003; 
Shrive et al., 2009; Wang et al., 2008). The electron density map and the superimposed 
model corresponded well. The electron density maps showed the three chains A, B and C 
and the overall structure seen in the trimeric aggregate with the three C-terminal globular 
domains (236-355) and the three chains linked through the α-helical coiled-coil neck 
region (203-235). As for the Eagan CA7 PS bound structure reported in Chapter 3, 
significant differences were noted in all three chains, particularly in terms of the Ca2 and 
Ca3 occupancy (Shrive et al., 2003; Shrive et al., 2009; Wang et al., 2008). 
As for the rfhSP-D - Eagan CA7 PS structure, only chain B showed density around 
the binding pocket to suggest bound ligand. The RS44 B412 crystal was in contact with 
two separate S. enterica minnesota strains R7 LPS (initial co-crystallisation) and R5 PS 
(added during cryo-protection) (see Fig. 4.2).  
Chapter 4 RS44 B4 (SS1-C28) 
193 | P a g e  
 
Chain A showed density for Ca1, shown in Fig. 4.10, which represented the first 
co-crystal P4212 electron density map showing the presence of the Ca1, however no 
density for Ca2 and Ca3 was seen. As for the rfhSP-D - Eagan CA7 structure (Chapter 3) 
a symmetry related molecule sits above the Chain A binding pocket within distance for 
potential intermolecular contact. Chain B is the only subunit showing suitable density for 
ligand building (Fig. 4.11), with density seen for Ca1, but no density for Ca2 or Ca3. Chain 
C, as seen in all P4212 crystals, resembled the typical unliganded rfhSP-D binding pocket, 
with density for Ca1 and a symmetry related molecule in close proximity to the binding 
pocket, potentially impacting on the binding of the large ligands. Finally, no density for the 
presence of Ca4 could be seen, as reported for the Eagan CA7 complex in Chapter 3. 
Glu321 
Asn323 
Glu329 
Asn341 
Asp342 +ve density for Ca1 
Symmetry related molecule 
located in the vicinity of chain A 
binding pocket.  
Fig. 4.10 Electron density map of RS44 B412 showing the chain A binding pocket, with 
density for Ca1 and the nearby symmetry related molecule. The location of the 
symmetry related molecule suggests no ligand could fit in in the tight space between 
the chain A binding pocket and the symmetry related molecule. In the figure Glu321, 
Asn323, Glu329, Asn341 and Asp342 are labelled; the direct map (2Fobs-Fcalc) is 
displayed in blue and contoured at 1σ; the difference map (Fobs-Fcalc) is displayed in 
orange for positive (+ve) density and contoured at 2.5σ. In this image the density has 
been expanded (radius of contour) to display the symmetry related molecule. Figure 
generated using PYMOL. 
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 Restrained Refinement  
Restrained refinement was carried out for RS44 B412 as this offered the only co-
crystal with suggested ligand presence. The RS44 B21 best model was completed using 
REFMAC5 and COOT. R-factors improved from the initial rigid body refinement for the 
final model of RS44 B21 and were 25.01% for the R-factor (or Rwork) and 29.46% for the 
Rfree. The Ramachandran analysis showed that 95.29% (MOLPROBITY) of the residues 
modelled were in the preferred regions. No waters were modelled as this resolution 
makes it very difficult to determine the waters location. Some positive density in the map 
was not modelled, such as for weakly defined solvent molecules. 
Glu321 
Asn323 
Glu329 
Asn341 
Asp342 
+ve density for Ca1 
+ve density for ligand 
2Fobs-Fcalc density 
for ligand  
Fig. 4.11 RS44 B412 electron density map produced following the rigid body for the 
binding pocket in chain B. In the figure the direct map (2Fobs-Fcalc) in blue and 
countered at 1σ and the difference map (Fobs-Fcalc) positive (+ve) density in orange 
and countered at 2.5σ are both displayed. In the figure positive density can be seen for 
Ca1 (not modelled at this stage) and density for the ligand important Ca1 coordinating 
residues are displayed, including Glu321, Asn323, Glu329, Asn341 and Asp342 and 
these are labelled in the image. Figure generated using PYMOL. 
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The decision not to model some of the density seen between particular residues or 
sequences was made due to the low resolution of the data set and the high number of 
molecules that may be present in the crystal including; Na Hepes, Na/K dihydrogen 
Phosphate, Ethanol, Triton X-100, Glycerol, water, S. enterica minnesota R7 LPS and R5 
PS strains. This omission may contribute to relatively high values for Rwork and Rfree. 
 Molecular Model Building 
The electron density seen in binding pocket of chain B suggests a heptose, 
however, because this particular crystal was exposed to both S. enterica minnesota R7 
LPS and R5 PS, created some difficulties in the characterisation of the correct S. enterica 
minnesota fragments. A heptose carbohydrate was initially modelled into the electron 
density suggesting a good fit between model and density and evidence that heptose was 
bound to rfhSP-D. The electron density of the refined heptose model clearly suggested 
further density at the C1 and C3 linkages of the heptose (Fig. 4.12). 
Due to the fact that the RS44 B412 crystal had been exposed to two similar LPS of 
S. enterica minnesota it was necessary to further model the linkages in order to attempt a 
characterisation of the bound ligand, in this case S. enterica minnesota R7 LPS or R5 PS. 
S. enterica minnesota R7 LPS contains the LipidA-KdoIII-KdoII-KdoI-HepI-HepII structure, 
while S. enterica minnesota R5 PS contains the KdoIII-KdoII-KdoI-HepI-HepII-Glc 
structure, with both strains containing the same KdoIII-KdoII-KdoI-HepI-HepII core 
pentasaccharide (Fig. 4.2). In order to differentiate which ligand had bound to the rfhSP-D 
chain B, the electron density surrounding the binding pocket would have to suggest the 
presence of a Glc off HepII, meaning that R5 PS was bound, or the presence of the lipid 
A, suggesting that the R7 LPS was bound. During the extensive and long refinement 
process no convincing evidence could be found for the presence of Glc or lipid A. 
Therefore, no suggestion can be made about which ligand has bound.Due to the fact that 
the RS44 B412 crystal had been exposed to two similar mutants of S. minnesota it was 
necessary to further model the linkages in order to attempt a characterisation of the bound 
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ligand, in this case S. minnesota R7 LPS or R5 PS. S. minnesota R7 LPS contains the 
LipidA-KdoIII-KdoII-KdoI-HepI-HepII structure, while S. minnesota R5 PS contains the 
KdoIII-KdoII-KdoI-HepI-HepII-Glc structure, with both mutants containing the same KdoIII-
KdoII-KdoI-HepI-HepII core pentasaccharide. In order to differentiate which ligand had 
bound to the rfhSP-D chain B, the electron density surrounding the binding pocket would 
have to suggest the presence of a Glc off HepII, meaning that R5 PS was bound, or the 
presence of the lipid A, suggesting that the R7 LPS was bound. During the extensive and 
long refinement process no convincing evidence could be found for the presence of Glc or 
lipid A. Therefore, no suggestion can be made about which mutant has bound. 
Asp342 Asn341 
Asn323 
Glu321 
Ca1 
Hep 
C3-OH where HepII or Glc would be C1-OH where KdoI or HepI would be 
Glu329 
Fig. 4.12 The electron density for the RS44 B412 crystal with L-D-heptose orientated 
as reported in the literature (Clark et al., 2016) and after refinement PDB: 4E52. The 
density suggests linkages and likely orientations of other linked carbohydrates. In the 
figure Ca1 is displayed as a yellow sphere, with the Ca1 coordinating residues also 
displayed (Glu321, Asn323, Glu329, Asn341, Asp342); Heptose is displayed with the 
carbons in blue and with the oxygens in red. The direct map (2Fobs-Fcalc) is displayed 
in blue and contoured at 1σ. Figure generated using PYMOL.  
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The electron density (Fig 4.12) suggests that a heptose is bound at the Ca1 site 
and there are indications of linkages at Hep C1 and C3. Two possible ligand models could 
explain the density at the linkages of heptose C1 and C3; Model 1- KdoI-HepI-HepII (R7 
LPS or R5 PS), with HepI bound or Model 2- HepII-HepI-Glc (R5 PS), with HepII bound. 
Both models were tested and refined. For the trisaccharide Kdo-HepI-HepII, the atom 
types, topology and chemical parameters (bond lengths and angles) were produced using 
PRODRG, a CCP4 supported program and part of the CCP4 suite.  PRODRG produced 
an output pdb containing the ligand and a crystallographic information file (CIF) containing 
all the information specific to the trisaccharide. The CCP4 monomer library did not include 
description of Kdo-Hep linkages and chemical parameters (“CCP4 Program Suite: 
PRODRG”). Upon examination of the refined electron density maps, model 1- KdoI-HepI-
HepII, with HepI bound to rfhSP-D, is suggested as the best model to explain the electron 
density. In addition, Model 2 was discarded as a possible model for two separate reasons; 
Firstly, for Model 2 the HepII L-glycero group containing the O6’ and O7’ hydroxyls sit on 
the opposite site of the binding pocket to the density seen after refinements (Fig. 4.13A). 
Any attempts to place the L-glycero hydroxyls groups into the density seen were 
unsuccessful, as the HepII is bound by C3 to C1 of HepI with the L-glycero group located 
on the opposite site of the ring to where density was present. In order to place the L-
glycero hydroxyls in the observed density the HepI-HepII linkage would have to change 
from the typical α1-3 to a α 1-4, as illustrated in Fig. 4.13. Secondly, for Model 2 there is 
electron density present in the vicinity of O4’ of HepII (Fig. 4.13A) whereas there is no 
linkage off HepII at position 4 for S. enterica minnesota R7 LPS or R5 LPS (Fig. 4.2). 
Model 1 was refined to Rfree 29.46%, while Model 2 Rfree 29.54%.  Model 2 was rejected in 
favour of Model 1 by taking into consideration the Rfree, direct visualisation of the electron 
density maps and the potential linkage seen near where HepI (model 2) or KdoI (model 1) 
would be situated, with only model 1 KdoI explaining the potential linkage to KdoII. The 
above considerations suggest that model 1 offers a better fit than model 2 and so it is 
suggested as the most likely model, with HepI bound to rfhSP-D chain B binding pocket.  
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Fig. 4.13 The electron density seen for both Model 1 Kdo-HepI-HepII with HepI bound and 
Model 2 HepII-HepI-Glc with HepII bound to the rfhSP-D binding site. Model 1 displayed with 
carbons in yellow and oxygens in red (shown in images B and C) and model 2 displayed with 
carbons in light blue and oxygens in red. In images A and B 2Fobs-Fcalc map displayed and 
contoured 1σ, while image C contoured at 0.9σ, displayed in blue; Fobs-Fcalc contoured 3σ 
in all 3 images, with negative density displayed in red and positive density displayed in green 
A- Model 2 HepII cannot explain the density seen, with Model 1 offering a better fitting when 
the Kdo occupies the same place. B- Model 1 showing KdoI in place of HepII (image A). 
KdoI can explain the density seen on the right of HepII in image A, offering a better fitting 
than Model 2. C- Viewing the map at 0.9σ gives evidence to suggest another linkage, 
however HepI in image A cannot explain this density as there are no linkages coming off 
HepI in position 4; instead KdoI can explain this possible linkage as KdoI is linked to KdoII 
through position 4 of KdoI. Model 1 Rfree 29.46% and Model 2 Rfree 29.54%. Images 
generated using CCP4mg.  
Arg343 
Arg343 
Glu329 Glu329 
The HepI-HepII-Glc could not explain 
the density seen around HepI. Fitting 
the Kdo in place of HepI means that 
the C7 of Kdo occupies this density 
suggesting a better fit.  
This patch of density at 1rms 
does not give much 
information, however as this is 
reduced to 0.9 σ it clearly 
suggests a potential linkage. 
HepI cannot explain this 
linkage seen at C4-OH, while 
KdoI fits the density better as 
shown in images B and C. 
Asn323 
Glu321 
Arg343 
Ca1 
Asn341 Glu329 
At 0.9 σ there is evidence to suggest a 
linkage near the C4 of KdoI where KdoII 
would be. HepI cannot explain this density. 
Better fit using the KdoI in place of the 
HepI, suggesting that the KdoI-HepI-
HepII fitted the density better at 1rms. 
Glu321 
Asn323 
Glu321 Ca1 Asn341 Asn341 Ca1 
Asn323 
A 
B C 
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 Final model 
The electron density map of the binding pocket in chain B gives evidence to 
support Model 1 - KdoI-HepI-HepII, see Fig. 4.14, with HepI bound in the binding pocket 
through the O6’ and O7’ hydroxyl groups. The refinement statistics for the best model 
(model 1) are given in Table. 4.9. 
Refinement statistics 
Data Range (Å) 64.28 - 3.3 
No. of protein atoms 3457 
No. of residues chain A and B 205-355 
No. of residues chain C 206-355 
No. of water molecules N/A 
No. of calcium ions 3 
No. of ligand atoms 42 
Rwork (%) 25.01 
Rfree (%) 29.46 
RMSD bond length (Å) 0.013 
RSMD bond angle (°) 1.6 
Average B-values (Å2)a 
Protein main chain 44.6 
Water N/A 
Ligand 63.282 
Ramachandran plot values (%)b 
Favoured 95.29 
Outliers 0.22 
Table 4.9 The refinement statistics of the best model. a defined according to Baverage. 
b defined according to MOLPROBITY. 
 
The orientation of the HepI hydroxyls agrees with previous reported structural 
studies showing L-glycero-D-manno-heptose bound in the binding pocket (Wang et al., 
2008; Clark et al., 2016). This orientation is different from that reported here for H. 
influenzae CA7 PS (Chapter 3) where the hydroxyls sit interchanged through a 180° 
rotation of HepI (in relation to Ca1). The proposed binding of Hep1 follows the orientation 
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reported in the literature allowing for a direct comparison of the Ca1 coordination to both 
protein and ligand (HepI O6’ and O7’ hydroxyls) (Table. 4.10).  
The O6’ hydroxyl is interacting with Glu321 OE2 and Asn341 ND2 and the O7’ is 
interacting with Glu329 OE2 in similar manner to reported in literature (Wang et al., 2008; 
Clark et al., 2016) (Table 4.11). The refinement of HepI showed good density to allow 
modelling of glyosidic bond extensions at C1 and C3. Hep1 at C1 is bound to KDO by α1–
5, with HepII bound to HepI by α1–3. The model containing KdoI-HepI-HepII was further 
refined (Rfree  29.46%), with the resulting density giving evidence for a likely orientation 
and best fit of KdoI-HepI-HepII. The density surrounding the Kdo is weak, with only a part 
of the sugar ring fitting the density at 1σ but the density surrounding C7 of the Kdo, and 
density seen near O4’ where KdoII is expected to link, made it possible to suggest a likely 
orientation for KdoI. KdoI is modelled in the normal six membered ring structure, with no 
evidence to suggest structural change following hydrolysis (Clark et al., 2016). 
Following various runs of refinement there was clear density to suggest the best 
orientation of HepII. For the KdoI and HepII no other interactions with the protein were 
 Ca1 coordinating 
residues/ligand 
Chain A 
(Å) 
Chain B 
(Å) 
Chain C 
(Å) 
4A Chain B 
(Å) 
4A Chain C 
(Å) 
Ca1 Glu321 OE1 2.68 2.59 2.68 2.57 2.55 
Ca1 Asn323 OD1 2.42 2.51 2.24 2.42 2.37 
Ca1 Glu329 OE1 2.79 2.64 2.70 2.44 2.31 
Ca1 Asn341 OD1 2.79 2.55 2.18 2.40 2.42 
Ca1 Asp342 OD1 2.59 2.18 2.70 2.27 2.25 
Ca1 Asp342 O 2.69 2.51 2.49 2.56 2.59 
Ca1 Hep Hydroxyl - O6’ N/A 2.50 N/A 2.42 2.44 
Ca1 Hep Hydroxyl - O7’ N/A 2.67 N/A 2.58 2.53 
Table. 4.10 Ca1 coordination distances for RS44 B412 chains A, B and C. For chain B the 
distances between Ca1 and the Hep hydroxyls O6’ and O7’ are the distances calculated 
from the best model and shown in Fig. 4.15 and 4.16. The best model shows a similar 
Hep orientation to reported structures with the Hep hydroxyls O6’ and O7’ located in 
similar locations to those in the literature (Wang et al., 2008; Clark et al., 2016). Chain A 
and C showed no ligand occupancy. For comparison the H. influenzae Eagan 4A bound 
structure (PDB: 4E52) chain B and C is shown (Clark et al., 2016).  
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seen, however the density does suggest that both saccharides have little conformational 
freedom about the glycosidic linkage. This ordered orientation for both KdoI and HepII 
suggests that protein constraints or crystal contacts, through KdoIII-KdoII or the Glc if 
present, are holding both saccharides in place.  In terms of the flanking residues Arg343 
does not form any interactions with the KdoI-HepI-HepII. Asp325, located on the opposite 
site of the binding pocket, is within hydrogen bonding distance of O5’ of HepI (2.67 Å).  
 
 L-D-Heptose (Wang 
et al., 2008) 
4A L-D-Heptose 
(Clark et al., 2016) 
Final model, with 
HepI bound 
L-D-
Heptose 
Atom2 Chain 
A (Å) 
Chain 
B (Å) 
Chain 
C (Å) 
Chain 
A (Å) 
Chain 
B (Å) 
Chain 
C (Å) 
Chain 
A (Å) 
Chain 
B (Å) 
Chain 
C (Å) 
6-OH Glu321 
OE2 2.50 2.56 2.52 N/A 2.50 2.59 N/A 2.80 N/A 
Asn341 
ND2 3.19 3.00 3.22 N/A 2.92 3.06 N/A 2.88 N/A 
Asn341 
OD1 2.98 3.30 3.27 N/A 3.03 3.05 N/A 3.70 N/A 
7-OH Asn341 
ND2 3.16 3.02 3.02 N/A 2.85 2.84 N/A 3.37 N/A 
Glu329 
OE2 2.69 2.68 2.63 N/A 2.69 2.62 N/A 2.49 N/A 
Asp342 
O 3.68 3.32 3.10 N/A 3.00 2.94 N/A 3.13 N/A 
Table 4.11 Distances between the HepI hydroxyls O6’ and O7’ and the Ca1 
coordinating residues in the proposed Model 1 KdoI-HepI-HepII, with HepI bound in 
the binding pocket. The reported distances of the HepI of the H. influenzae Eagan 
4A PS bound structure and in the disaccharide Hep bound structure, PDB: 4E52 
and 2RIB respectively (Clark et al., 2016; Wang et al., 2008) are included for 
comparison. N/A implies no ligand presence or occupancy. 
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Fig. 4.14 The density in the electron density map from the RS44 B421 gives evidence to suggest that the KdoI-HepI-HepII (carbons 
in yellow) can be modeled, with HepI bound to the rfhSP-D. The HepI hydroxyls orientation is similar to reported in the literature 
(Clark et al., 2016; Wang et al., 2008) but different from that reported for the CA7 PS in chapter 3. Density for the main ring KdoI is 
relatively poor at 1σ, however at 0.9σ there is clear indications to suggest that the KdoI should be positioned in this orientation. 
Density for the HepII main ring is relatively strong, with the positions of the glycerol O6’ and O7’ a bit more ambiguous as these may 
have free rotation. Ca1 coordinating residues are displayed (Glu321, Asn323, Glu329, Asn341 and Asp342) displayed with the 
carbons in green. Model 1 is displayed with the carbons in yellow and oxygens in red. 2Fobs-Fcalc map contoured at 1σ and 
displayed in blue over model 1. Stereo Image generated using CCP4mg.  
KdoI HepI 
HepII 
Asn341 
Glu321 
Asp342 Glu329 
Asn341 
Ca1 
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4.7 Summary and Conclusions 
Triton X-100 and absolute ethanol have been used in combination with LPS 
(Weiser et al., 1968; Li et al., 2004; Jang et al., 2009; Sharma et al., 2013) to increase 
the solubility of LPS for use in structural studies. The initial experiments described here 
showed firstly that a 0.2-0.3 mM concentration of Triton X-100 can aid in the solubilisation 
of E. coli O111:B4 LPS up to 16 mg/ml, secondly that 30% (v/v) absolute ethanol can 
improve the solubility of O111:B4 LPS up to 20 mg/ml. By combining the two solvents, 
0.2-0.3 mM Triton X-100 in combination with 30% (v/v) absolute ethanol, the E. coli 
O111:B4 LPS solubility was further improved, up to 35 mg/ml.  
The co-crystallisation of rfhSP-D in combination with R7 LPS solubilised in 30% 
absolute ethanol (v/v) and 0.25mM Triton X-100 was initially carried out using the SS1 
and SS2 100 buffer precipitants, with RS43 C3 (SS1-15), RS44 A2 (SS1-20), RS44 B4 
(SS1-28), RS45 A2 (SS1-38), RS46 B6 (SS2-12) and RS47 A1 (SS2-19) wells producing 
positive crystal growth. The six conditions produced a variety of crystal morphologies 
including thin and thick square plates, triangles and some irregular shapes. Eight follow 
ups were produced from the initial SS1 and SS2 positive crystal growth conditions, but 
these did not produce any crystals.  
Out of the 33 crystals collected and tested at DLS the majority of the crystals were 
of protein which diffracted to medium to low resolution (>4.0Å). Initially four crystals were 
analysed further as these offered the best overall data; RS44 A22 - 3.74 Å, RS45 A21 – 
2.01 Å, RS46 B63 – 2.02 Å and RS47 A11 – 2.52 Å. The maps produced for the RS44 
A22, RS45 A21, RS46 B63 and RS47 A11 crystals, all of which were in the P21 space 
group, showed no signs of ligand occupancy, with a typical ligand-free rfhSP-D trimer as 
reported in the literature (Hakansson et al., 1999; Shrive et al., 2003). As all these co-
crystallised R7 LPS – rfhSP-D crystals did not contain bound ligand, a second ligand (S. 
enterica minnesota R5 PS) was soaked into the remaining two R7 LPS co-crystallisation 
wells RS44 B4 and RS43 C3. Crystal RS43 C35 diffracted to 3.00 Å in the space group 
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P21 but again the electron density map did not indicate bound ligand (R7 LPS or R5 PS). 
Crystal RS44 B412 diffracted to 3.30 Å and was indexed as space group P4212.  The 
soaked R5 PS was at a very high molecular excess,  ≈ 50 x PS to rfhSP-D chain. Whether 
the crystal had formed in P4212 due to the influence of the solubilised R7 LPS or for other 
reasons associated with the crystallisation conditions is not clear.  
Despite the limited resolution of the data, the electron density in the binding pocket 
of chain B gave a strong indication of ligand and its orientation; however, as two different 
S. enterica minnesota strains with a common trisaccharide core were in contact with the 
crystal, discriminating between the two did not prove possible and no evidence can be 
given here as to whether the bound ligand is R7 LPS or R5 PS as both have the same 
core pentasaccharide KdoIII-KdoII-KdoI-HepI-HepII with an additional terminal glucose off 
HepII in the R5 strain.  
Two models were initially built with Model 1 refined to Rfree 29.46%, while Model 2 
refined to Rfree 29.54%. The final model 1 containing the KdoI-HepI-HepII trisaccharide in 
chain B, with HepI bound to Ca1 is suggested as the best model. The final Rfree achieved 
is somewhat high, however considering that the data resolution was limited to 3.3Å and 
there was significant electron density which could not be modelled in, the final Rfree of 
29.46% does represent an acceptable and meaningful model. The additional electron 
density may be due to a variety of molecules or ions associated with the RSB44 B4 well 
including, Na Hepes, Na/K dihydrogen Phosphate, Ethanol, Triton X-100, Glycerol and 
Water (Read et al., 2011). 
The orientation of HepI was similar to that previously reported in literature for Hep 
bound in the rfhSP-D CRD binding site, with the O6’ hydroxyls positioned in the vicinity of 
Glu321 and Asn323 and O7’ in the vicinity of Glu329 and Asn341 (Wang et al., 2008; 
Clark et al., 2016). The HepI ring orientation is very similar to the ring orientation reported 
by Wang and co-workers (PDB: 2RIC), and by Shrive and co-workers (PDB: 4E52) with 
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KdoI sitting in similar position to the reported anhydro Kdo in Eagan 4A LPS (Wang et al., 
2008; Clark et al., 2016). Further interactions between protein and HepI include the 
Asp325 flanking residue, which is within distance to hydrogen bond with O5’ of HepI (2.67 
Å). 
The electron density seen for the glycosidic extensions of the bound HepI suggest 
a particular orientation of KdoI and HepII. The density surrounding the linkage and ring of 
HepII is fairly strong, while the density surrounding the KdoI is poorer. The density seen 
for KdoI is rather ambiguous, with some of the main ring not fitting the density at 1 rms, 
however density can be seen to explain the glycerol groups at C7-OH and C8-OH, which 
may be fixed by interaction with non-modelled water molecules, while the density in the 
vicinity of the C4-OH of KdoI could arise from the α2-4 linkage between KdoII and KdoI. 
The KdoI reported here best fits the electron density as a normal six membered ring and 
not the 5-membered anhydro Kdo reported for the hydrolysed Eagan 4A LPS (Clark et 
al., 2016). In terms of Ca2+ occupancy, and contrary to the Eagan CA7 study reported in 
Chapter 3, the Ca1 in chain A was present in the typical unliganded binding pocket 
(Shrive et al., 2003; Shrive et al., 2009), with no Ca2, Ca3 and Ca4 present. 
To date no structural studies of rfhSP-D in complex with S. enterica minnesota 
rough strains have been reported, the results presented here offering for the first time an 
insight into the recognition of S. enterica minnesota LPS by hSP-D. Ligand binding studies 
using S. enterica minnesota strains complexed with hSP-D and rfhSP-D have reported 
that S. enterica minnesota Re strains, containing just a Kdo disaccharide bound to the 
lipid A and lacking any heptose and glucose, did not bind to either SP-D or rfhSP-D 
(Wang et al., 2008). This suggests that the presence of inner core heptoses, or terminal 
glucoses, is a key factor in the recognition of S. enterica minnesota LPS by SP-D. The 
results presented here demonstrate that the preferred mode of binding is via the inner 
core heptose HepI. 
Chapter 5 Co-crystallisation and crystal form 
206 | P a g e  
 
Chapter 5 - General discussion, Conclusions and Future Work 
The work presented in this thesis aims to increase our knowledge of the 
recognition of gram-negative bacteria by surfactant protein D through structural studies of 
rfhSP-D complexed with H. influenzae Eagan CA7 PS and S. enterica minnesota R7 LPS 
and R5 PS. The co-crystals reported in this work were an essential advance as all 
previous attempts to soak Eagan CA7 PS in to ligand-free crystals had failed and this LPS 
represents an important step in the characterisation of hSP-D recognition of H. influenzae 
following on from the Eagan 4A structural study (Clark et al., 2016). Unfortunately, while 
ligand-free rfhSP-D crystals soaked with ligand generally diffract to high resolution (Shrive 
et al., 2003 and 2009; Clark et al., 2016), weak diffraction and low maximum resolution 
were a recurrent problem for many of the crystals of rfhSP-D grown in the presence of 
LPS ligands. 
5.1 Co-crystallisation and crystal form 
The idea of using the co-crystallisation approach was firstly in order to utilize 
longer ligands in combination with rfhSP-D, initially for the Eagan CA7 PS and S. enterica 
minnesota R7 LPS, which on all previous occasions had led either to crystals degrading 
and dissolving rapidly or there being no bound ligand seen in the structure (for those that 
didn’t dissolved). Secondly, this approach might be applicable  as a more general method 
for other ligands which could not be soaked in to the ligand-free crystals. If the right ligand 
is chosen (known to bind to SP-D) and the right conditions are in place (buffer precipitant 
and concentration of protein and ligand), co-crystallisation could produce a different 
crystal form for rfhSP-D with bound ligand in place. 
5.2 Calcium binding 
The absence of Ca2 and Ca3 in all the structures arising from the crystallisation 
conditions which produce the tetragonal crystal form (see Table 5.1) is somewhat 
puzzling. Ca2 and Ca3 have been suggested to be important in the stability of the CRD, 
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with the loss of Ca2 reported to lead to movement of loop L1 and changes in loop L4 (Ng 
et al., 1998). The potential impact of the loss of Ca2 and Ca3 leads to L4 being located 
further away from Ca1.  
At first sight it may be proposed that the loss of the Ca2 and Ca3 could be caused 
by insufficient Ca2+ during crystallisation and cryo-protection. However, the concentration 
of Ca2+ used during the crystallisations here is in line with previous work performed over 
many years in our research group, where no incomplete Ca2+ occupancy in any of the 
chains has been seen. In addition, the unliganded crystals of S. enterica minnesota R7 
LPS (P21) where co-crystallisation with rfhSP-D had been unsuccessful were produced 
using standard Ca2+ concentrations in the crystallisation and cryo-protection stages and 
all showed the presence of Ca2 and Ca3 for all the chains of rfhSP-D (Table 5.1). 
Incomplete Ca2 and Ca3 occupancy has been previously reported in the literature 
in the structural study of a trimeric recombinant fragment of rat SP-A, containing neck and 
CRD domains, demonstrating the presence of Ca1 but with Ca2 and Ca3 absent (Head et 
 Chain A 
CA7 PS Final 
Model  
B 
R7 LPS/R5 
Final Model  
C  
Other P4212 
Co-crystals  
D 
Other P21 
Co-crystals  
E 
4A PS 
Ca1 A X P X P P 
Ca2 A X X X P P 
Ca3 A X X X P P 
Ca1 B P P P P P 
Ca2 B X X X P P 
Ca3 B X X X P P 
Ca1 C P P P P P 
Ca2 C X X X P P 
Ca3 C X X X P P 
Ca4 Neck-CRD 
interface 
X X X X X 
Ligand A X X X X X 
 B P P V X P 
 C X X X X P 
Table. 5.1 Direct comparison of the different Ca2+ occupancy. A- The final model for the 
CA7 PS, where HepI is bound in the novel orientation (Chapter 3). B- The final model for 
the R7 LPS/R5 PS model containing the KdoI-HepI-HepII trisaccharide with HepI bound 
(Chapter 4). C- Includes RS34 A22, RS32 A31, RS32 A12 and RS32 B27 (Chapter 3) and 
P4212 crystals of rfhSP-D in complex with E. coli J-5 PS (data not shown). D- Includes 
RS43 C35, RS44 A22, RS45 A21, RS46 B63 and RS47 A11. E- for comparison the H. 
influenzae Eagan 4A bound structure (PDB: 4E52) is shown (Clark et al., 2016). P- 
present, X-  not present, V- variable. 
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al., 2003). Additional investigations performed by Head and co-workers, using Samarium 
ions during MAD phasing experiments, reported a metal ion binding site located in the 
vicinity of the Ca2 site in rfhSP-D (Shrive et al., 2003; Head et al., 2003). Head and co-
workers suggested that the Ca1 site is filled before the Ca2 in the recombinant fragment 
of rat SP-A and this may also be the case for rfhSP-D co-crystals, particularly where the 
crystallisation buffer and additives compete with rfhSP-D for calcium ions.  
A possible contributory reason for the loss of Ca2 and Ca3 in rfhSP-D molecules 
may be the effect of the PS and LPS on the Ca2+, as LPS is known to be highly reactive 
with aqueous metal cations such as calcium (Selvarengan et al., 2010). LPS-LPS 
interactions when membrane bound have been reported to be modulated by Na+, Ca2+ 
and Mg2+, with these cations playing key roles in the organisation of LPS, by providing 
bridging potential between negatively charged groups and reducing the strong negative 
electrostatic repulsion between LPS molecules (Kucerka et al., 2008).  Divalent cations 
such as Ca2+ can induce changes in terms of hydration, fluidity and aggregate structure of 
the LPS membranes (Nascimento et al., 2013), leading to Ca2+ compacting the LPS 
molecules and preventing water from penetrating the outer/inner core of the membrane 
bound LPS (Kucerta et al., 2008). Furthermore, LPS phosphate and carbonyl groups 
have been reported to bind to Ca2+ while remaining hydrated by H2O, achieving a double 
layer around the phosphorylated carbohydrates (Dias et al., 2014a). This suggests that 
the LPS and PS molecules used here can chelate Ca2+ present in the surrounding 
environment and that this may be a contributor to the loss of Ca2 and Ca3. The 
crystallisation method used for both Eagan CA7 and S. enterica minnesota R7 LPS 
introduces rfhSP-D molecules, the Ca2+ and the PS or LPS in solution together, with the 
rfhSP-D and PS or LPS in competition for the Ca2+. Therefore, the lack of Ca2 and Ca3 
can be suggested in part to be a consequence a direct competition for Ca2+ in solution by 
rfhSP-D molecules and PS or LPS molecules, with the PS or LPS clustering the Ca2+ and 
in effect impacting on the occupation of the Ca2 and Ca3 sites (Dias et al., 2014; Dias et 
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al., 2014a). This may also extend to an influence on the loss of Ca1 in some subunits 
where ligand is not seen to bind, for example Chain A in the final Eagan CA7 PS structure 
where spatial restraints appear to prevent ligand binding. 
Alongside the impact of the ligand, the crystallisation and cryo-protection 
conditions will certainly play a major role in determining the occupancy of all the calcium 
sites and it does appear that the conditions which drive the crystallisation in to the 
tetragonal space group are also associated with the loss of Ca2 and Ca3, and the loss of 
Ca1 in those chains where ligand cannot, or does not, bind. The exception to this appears 
to be the rfhSP-D crystal which was crystallised in the presence of S. enterica minnesota 
R7 LPS and subsequently soaked with R5 PS through the cryo-buffer. This reinforces the 
influence of not only the crystallisation conditions but also the cryo-protection buffers. 
5.3  Recognition and binding of LPS by rfhSP-D 
The structures reported here provide evidence to suggest a significant advance in 
our understanding of how the recognition and binding of bacterial LPS by collectins 
occurs. Previous work reported in the literature revealed not only the bound sugar 
interacting with Ca1 and binding site residues through a pair of hydroxyls positioned in a 
similar manner to the mannose equatorial pair O3’ and O4’, but also that the orientation of 
the bound sugar in the binding site, interactions of the linked sugars with the binding site 
flanking residues, and spatial and steric constraints also play major roles in determining 
binding affinity. Both H. influenzae Eagan CA7 PS (Chapter 3) and S. enterica minnesota 
R5/R7 (Chapter 4) display HepI bound to the Ca1, with secondary protein-ligand 
interactions also playing key roles in determining binding affinity.   
 Orientation of the bound Heptose 
The binding orientation of the bound Hep in the H. influenzae Eagan 4A PS 
structure (Clark et al., 2016) was reported to be similar to the Hep binding reported by 
Wang and co-workers (Wang et al., 2008), suggesting a preferred binding mode and 
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orientation of bound Hep. S. enterica minnesota R5/R7 HepI (Chapter 4) assumes the 
preferred binding mode with evidence from the model supporting the view that the 
alternative binding (180° rotation about C5-C6 which interchanges the hydroxyls which 
coordinate Ca1) was also possible, with no spatial or steric constraints. The H. influenzae 
Eagan CA7 structure reported here does however show the alternative orientation of the 
bound Hep, with a significant shift in terms of the angle of entry of the Hep ring with 
respect to the binding pocket. It is reasonable to assume that the different orientations 
make different overall interactions with the binding pocket as a whole, and that the affinity 
for the preferred orientation is greater than that for the alternative (the O6’ and O7’ 
heptose hydroxyl positions interchanged). 
The structural data presented here and in the literature (Clark et al., 2016) 
suggest a preferred mechanism of inner core heptose recognition via the O6’ and O7’ 
heptose hydroxyls, even though a terminal Glc may also be available to bind through the 
O3’ and O4’ equatorial hydroxyls. This HepI recognition and binding is supplemented by 
additional interactions between the remainder of the LPS inner core and protein, when 
possible. However, the novel orientation of HepI for the H. influenzae Eagan CA7 mutant 
demonstrates that SP-D can also interact with LPS ligands through different HepI 
orientations, giving rise to increased flexibility in the recognition and binding of target 
pathogens.   
5.4 Implications and Future Work  
The innate immune system provides an efficient and rapid immunological 
response to a variety of pathogens. In humans and in vertebrates, upon infection the 
innate immune system has the ability to activate the adaptive immune system, leading to 
an enhanced and specialised response to the infection causing organism. The ability of 
the innate immune system to provide an effective and potent defence against pathogens 
is dependent in part on the recognition of the variety of PAMPs on the surface of the 
different pathogens, and DAMPs following necrosis, which is achieved by innate immune 
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proteins such as PRRs. Collectins are secreted PRRs with the ability to recognise a 
variety of glycoconjugates on the surface of bacteria, viruses and fungi.  
rfhSP-D, a recombinant fragment of hSP-D, has been shown to be biologically and 
therapeutically active (Madan et al., 2001; Hickling et al., 1999; Strong et al., 2003; 
Singh et al., 2003; Ikegami, 2006); understanding the binding mechanisms of collectins 
to pathogens offers the potential to further develop chimeric or recombinant fragments 
that could one day be used in order to enhance the immune response towards particular 
pathogens. Gram negative bacterial LPS is a major inducer of sepsis, with increasing 
clinical complications in LPS induced infections. The problematic increase of antibiotic 
resistant bacteria is a growing public health threat, with current over use of antibiotics and 
the growing number of superbugs posing a significant health risk. Therefore, while it 
remains important to source and fund novel antibiotics, it is also important that the search 
continues for novel therapies that can be used in the recognition and clearance of 
bacteria.   
The recombinant fragment rfhSP-D offers the potential to be used as a novel 
therapy in the recognition and activation of immune system towards bacteria/viral 
clearance.  rfhSP-D has been widely investigated in vitro and in vivo with reported similar 
positive properties as the full length SP-D. However, before rfhSP-D can be considered as 
a therapeutic agent, it is important to understand how recognition occurs and what the 
roles of specific residues are in binding to pathogens. This is where structural studies 
come in, by elucidating at the atomic level the interactions between protein and the 
various pathogens and providing information on which residues are important. Knowledge 
of the residues that help achieve binding is key, as mutational studies have shown the 
impact of changing one or two amino acids in the binding pocket, leading to varied 
affinities towards different ligands.  
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The production of rfhSP-D with specific mutations to recognise specific pathogens, 
may then lead to a drug-free biological pathogen clearance specific treatment, currently 
with no known contraindications or side effects. Future structural studies will hopefully 
lead to a complete understanding of how best to modify and use rfhSP-D to target specific 
disease causing organisms, exploiting the untapped therapeutic potential of rfhSP-D 
(Clark et al., 2010).   
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